10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

For the quarterly period ended: September 30, 2018

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ________ to ________

Commission file number: 0-22945

HELIOS AND MATHESON ANALYTICS INC.

(Exact Name of Registrant as Specified in Its Charter)

Delaware	13-3169913
(State or Other Jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
Empire State Building, 350 Fifth Avenue, New York, New York 10118	(212) 979-8228
(Address of Principal Executive Offices)	(Registrant’s Telephone Number, Including Area Code)

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes☒ No☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes☒ No☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or, an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒	Smaller reporting company	☒
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes☐ No☒

As of November 9, 2018, there were 1,612,561,916 shares of common stock, with $.01 par value per share, outstanding.

HELIOS AND MATHESON ANALYTICS INC.

INDEX

PART I	FINANCIAL INFORMATION	1
ITEM 1.	Financial Statements	1
	Condensed Consolidated Balance Sheets as of September 30, 2018 (unaudited) and December 31, 2017	1
	Condensed Consolidated Statements of Operations and Comprehensive Loss for the Three and Nine Months Ended September 30, 2018 and 2017 (unaudited)	2
	Condensed Consolidated Statement of Change in Stockholders’ Deficit for the Nine Months Ended September 30, 2018 (unaudited)	3
	Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2018 and 2017 (unaudited)	4
	Notes to the Condensed Consolidated Financial Statements (unaudited)	5
ITEM 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	45
ITEM 3.	Quantitative and Qualitative Disclosures about Market Risk	52
ITEM 4.	Controls and Procedures	52
PART II	OTHER INFORMATION	53
ITEM 1.	Legal Proceedings	57
ITEM 1A.	Risk Factors	57
ITEM 2.	Unregistered Sales of Equity Securities and Use of Proceeds	57
ITEM 3.	Defaults upon Senior Securities	57
ITEM 4.	Mine Safety Disclosures	57
ITEM 5.	Other Information	57
ITEM 6.	Exhibits	58
SIGNATURES		60
EXHIBIT INDEX

i

Part I. Financial Information

Item I. Financial Statements

HELIOS AND MATHESON ANALYTICS INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

	September 30, 2018			December 31, 2017
	(Unaudited)
ASSETS
Current assets:
Cash and cash equivalents	$	4,850,972		$	24,949,393
Accounts receivable - less allowance for doubtful accounts of $61,614 and $72,335 at September 30, 2018 and December 31, 2017, respectively		30,722,585			27,470,219
Prepaid expenses and other current assets		3,469,645			3,557,811
Total current assets		39,043,202			55,977,423
Property and equipment, net of accumulated depreciation of $332,447 and $274,587 at September 30, 2018 and December 31, 2017, respectively		379,666			234,035
Intangible assets, net		30,097,399			28,536,782
Goodwill		49,148,120			79,137,177
Investment in films		13,403,433			-
Deposits and other assets		635,172			147,171
Total assets	$	132,706,992		$	164,032,588
LIABILITIES AND STOCKHOLDERS’ EQUITY/(DEFICIT)
Current liabilities:
Accounts payable and accrued expenses	$	17,691,260		$	13,144,003
Deferred revenue		27,035,060			54,425,630
Due to related parties		1,150,000			-
Liabilities to be settled in stock		5,988,363			21,320,705
Convertible notes payable, net of debt discount of $0 and $2,444,368 at September 30, 2018 and December 31, 2017, respectively		-			2,061,072
Warrant liability		60,809			67,288,800
Derivative liability		-			4,834,462
Notes payable		2,775,000			-
Total current liabilities		54,700,492			163,074,672
Convertible notes payable, net of current portion and debt discount of $0 and $1,392,514 at September 30, 2018 and December 31, 2017, respectively		-			1,550,555
Notes payable, net of current portion		5,923,250			-
Total liabilities		60,623,742			164,625,227
Commitments and Contingencies
Stockholders’ equity/(deficit):
Preferred stock, $0.01 par value; 2,000,000 shares authorized; 20,500 and 0 shares issued and outstanding as of September 30, 2018 and December 31, 2017, respectively		205			-
Common stock, $0.01 par value; 5,000,000,000 shares authorized; 1,357,590,536 issued and outstanding as of September 30, 2018; 100,000,000 shares authorized; 95,925 issued and outstanding as of December 31, 2017		13,575,906			959
Paid-in capital		461,370,934			150,595,611
Accumulated other comprehensive loss - foreign currency translation		(156,399	)		(103,980	)
Accumulated deficit		(377,266,866	)		(189,495,185	)
Total Helios and Matheson Analytics Inc. stockholders’ equity/(deficit)		97,523,780			(39,002,595	)
Noncontrolling interest		(25,440,530	)		38,409,956
Total stockholders’ equity/(deficit)		72,083,250			(592,639	)
Total liabilities and stockholders’ equity/(deficit)	$	132,706,992		$	164,032,588

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements

1

HELIOS AND MATHESON ANALYTICS INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(UNAUDITED)

	Three Months Ended September 30,						Nine Months Ended September 30,
	2018			2017			2018			2017
	(Unaudited)			(Unaudited)			(Unaudited)			(Unaudited)
Revenues:
Consulting	$	802,114		$	1,173,023		$	2,471,223		$	3,672,036
Subscription		78,921,951			-			198,488,038			-
Marketing, promotional services, and film revenue		1,615,177			-			3,991,575			-
Total revenues		81,339,242			1,173,023			204,950,836			3,672,036
Cost of revenue		109,635,383			946,308			424,371,078			2,969,357
Gross (loss)/profit		(28,296,141	)		226,715			(219,420,242	)		702,679
Operating expenses:
Selling, general & administrative		18,121,681			2,243,440			58,340,040			8,023,886
Research and development		85,943			621,754			465,407			1,555,095
Loss on impairment of goodwill		38,524,016			-			38,524,016			-
Depreciation & amortization		1,387,106			437,785			4,036,034			1,302,381
Total operating expenses		58,118,746			3,302,979			101,365,497			10,881,362
Loss from operations		(86,414,887	)		(3,076,264	)		(320,785,739	)		(10,178,683	)
Other income/(expense):
Change in fair market value – derivative liabilities		(4,933,938	)		(11,115,463	)		8,311,106			(10,434,611	)
Change in fair market value – warrant liabilities		4,217,981			(17,038,711	)		194,058,069			(17,038,711	)
Gain/(loss) on the extinguishment of debt		45,516,809			(683,885	)		60,524,508			(683,885	)
Gain on exchange of warrants		-			-			301,487			-
Interest expense		(95,575,954	)		(11,563,078	)		(189,305,904	)		(16,856,284	)
Interest income		4,474			14,436			26,101			51,695
Total other income/(expense)		(50,770,628	)		(40,386,701	)		73,915,367			(44,961,796	)
Loss before income taxes		(137,185,515	)		(43,462,965	)		(246,870,372	)		(55,140,479	)
Provision for income taxes		10,283			(2,747	)		46,953			39,110
Net loss		(137,195,798	)		(43,460,218	)		(246,917,325	)		(55,179,589	)
Net loss attributable to the noncontrolling interest		7,583,015			-			59,145,644			-
Net loss attributable to Helios and Matheson Analytics Inc.		(129,612,783	)		(43,460,218	)		(187,771,681	)		(55,179,589	)
Other comprehensive loss – foreign currency adjustment		(23,699	)		(7,355	)		(52,419	)		(6,066	)
Comprehensive loss	$	(129,636,482	)	$	(43,467,573	)	$	(187,824,100	)	$	(55,185,655	)
Basic and diluted loss per share:
Net loss per share attributable to common stockholders – basic and diluted	$	(0.20	)	$	(5.79	)	$	(0.87	)	$	(8.35	)
Weighted average shares – basic and diluted		642,704,390			7,500,558			216,795,141			6,607,149

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements

2

HELIOS AND MATHESON ANALYTICS INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY/(DEFICIT)

(UNAUDITED)

	Preferred Stock				Common Stock				Additional Paid-In			Accumulated other comprehensive			Accumulated			Noncontrolling			Total Shareholders’ Equity
	Shares		Amount		Shares		Amount		Capital			income			Deficit			Interest			(Deficit)
Balance at December 31, 2017		-	$	-		95,925	$	959		150,595,611		$	(103,980	)	$	(189,495,185	)	$	38,409,956		$	(592,639	)
Settlement of warrant liability for March warrant exchange		-		-		18,186		182		12,893,983												12,894,165
Settlement of warrant liability for June warrant exchange						90,472		905		5,201,195												5,202,100
Warrant liability which ceases to exist		-		-		-		-		53,998,650												53,998,650
Conversion of convertible notes and interest to shares of common stock		-		-		729,185,600		7,291,856		75,253,988												82,545,844
Shares issued for settlement of a liability		-		-		4,909		49		15,670,637												15,670,686
MoviePass shares issued in advance of services		-		-		-		-		324,369												324,369
Share based compensation		-		-		71,760		718		7,197,987												7,198,705
Derivative liability which ceases to exist		-		-		-		-		80,366,991												80,366,991
Equity raise, net of transaction fees		-		-		627,993,083		6,279,931		113,143,948												119,423,879
Shares issued for February public offering		-		-		76,400		764		96,911,616												96,912,380
Reclassification of February public offering to derivative liability		-		-		-		-		(158,944,798	)											(158,944,798	)
Shares issued for April public offering		-		-		44,000		440		27,677,118												27,677,558
Reclassification of April public offering to warrant liability		-		-		-		-		(33,997,600	)											(33,997,600	)
Preferred shares issued in conjunction with June notes		20,500		205		-		-		2,773,041												2,773,246
Shares issued in connection with Moviefone acquisition		-		-		10,201		102		7,599,356												7,599,458
Adjustment of noncontrolling interest in connection with the MoviePass Acquisition		-		-		-		-		4,704,842									(4,704,842	)		-
Net loss		-		-		-		-		-						(187,771,681	)		(59,145,644	)		(246,917,325	)
Foreign exchange translation		-		-		-		-		-			(52,419	)								(52,419	)
Balance at September 30, 2018		20,500	$	205		1,357,590,536	$	13,575,906	$	461,370,934		$	(156,399	)	$	(377,266,866	)	$	(25,440,530	)	$	72,083,250

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements

3

HELIOS AND MATHESON ANALYTICS INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

	For the Nine Months Ended September 30,
	2018 (Unaudited)			2017 (Unaudited)
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$	(246,917,325	)	$	(55,179,589	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization		4,036,034			1,302,381
Gain on exchange of warrants		(301,487	)		-
Change in fair market value - derivative liabilities		(8,311,106	)		10,434,611
Change in fair market value - warrant liabilities		(194,058,069	)		17,038,711
(Gain)/loss on extinguishment of debt		(60,524,508	)		683,885
Provision for doubtful accounts		(10,721	)		8,005
Non-cash interest expense		173,022,046			16,856,284
Impairment of Goodwill		38,524,016			-
Share based compensation in exchange for services		10,186,007			2,251,115
Amortization and impairment of film costs		3,809,548			-
Amortization of deferred revenue		(13,308,643	)
Shares issued in advance of services		324,369			-
Change in operating assets and liabilities:
Accounts receivable		(3,241,645	)		147,171
Prepaid expenses and other current assets		(2,871,148	)		(110,697	)
Unbilled receivables		-			(3,388	)
Deposits and other assets		(488,001	)		(79,823	)
Investment in films		(17,212,981	)		-
Accounts payable and accrued expenses		10,331,786			(992,962	)
Deferred revenue		(14,081,927	)		-
Net cash used in operating activities		(321,093,755	)		(7,644,296	)
CASH FLOWS FROM INVESTING ACTIVITIES:
Sale of property and equipment		-			1,929
Advanced from related parties		1,150,000			-
Purchases of equipment		(203,491	)		(109,785	)
Acquisition of intangible asset		-			(195,143	)
Payments for acquisition of business net of cash acquired		(1,000,000	)		(5,000,000	)
Net cash used in investing activities		(53,491	)		(5,302,999	)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from convertible notes payable		108,657,986			11,950,000
Redemption of convertible notes payable		(63,856,937	)		-
Payment of deferred financing fees		(2,170,328	)		-
Payment of Make-Whole Interest		(5,000,000	)		-
Payment for exchange warrants		(779,219	)
Proceeds from equity raises, net of transaction fees		244,013,817			-
Proceeds from issuance of June notes and preferred shares, net of transaction fees		20,235,925			-
Extinguishment of September Placement note		-			(80,000	)
Net cash provided by financing activities		301,101,244			11,870,000
Net change in cash		(20,046,002	)		(1,077,295	)
Effect of foreign currency exchange rate changes on cash and cash equivalents		(52,419	)		(6,066	)
Cash, beginning of period		24,949,393			2,747,240
Cash, end of period	$	4,850,972			1,663,879
Supplemental disclosure of cash and non-cash transactions:
Cash paid during the period for interest	$	16,283,858			253,407
Cash paid for income taxes	$	-			5,975
Non-cash investing and financing activities
Conversion of convertible notes and interest to shares of common stock	$	82,546,858			10,297,936
Exercise of investor warrants to shares of common stock	$	18,875,484			-
Warrant liability which ceases to exist	$	53,998,650			-
Change in carrying value of convertible common stock equity	$	-			152,763
Debt discount for derivative and warrant liability	$	(118,080,530	)		-
Derivative ceases to exist - reclassified to paid in capital	$	(80,366,991	)		4,674,682
Increase in debt for new original issue discount	$	27,606,850			7,827,984
Reclassification of warrant from public offering to derivative liability	$	(158,944,798	)		-
Reclassification of April public offering to warrant liability	$	(33,997,600	)
Non-cash fees relating to public offering	$	(19,100	)		-
Issuance of warrants in public offering	$	192,942,398
Interest capitalized as debt	$	3,345,670
Non-cash consideration for Moviefone acquisition		(13,074,959	)

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements 

4

HELIOS AND MATHESON ANALYTICS INC.

Notes to Condensed Consolidated Financial Statements

1. General

The accompanying unaudited condensed interim consolidated financial statements (“interim statements”) of Helios and Matheson Analytics Inc. (“Helios and Matheson”, “HMNY” or the “Company”) have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X of the Securities and Exchange Commission (the “SEC”). Accordingly, they do not include all the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments and disclosures necessary for a fair presentation of these interim statements have been included. The results reported in these interim statements are not necessarily indicative of the results that may be reported for the entire year. The consolidated balance sheet as of December 31, 2017 was derived from the audited consolidated financial statements as of and for the year ended December 31, 2017. These interim statements should be read in conjunction with the Company’s consolidated financial statements for the year ended December 31, 2017. 

2. Business and Basis of Presentation

Business

Since 1983, the Company has provided high quality information technology, or IT, services and solutions including a range of technology platforms focusing on big data, business intelligence, and consumer-centric technology. More recently, to provide greater value to stockholders, the Company has sought to expand its business primarily through acquisitions that leverage its capabilities and expertise.

On November 9, 2016, the Company acquired Zone Technologies, Inc., a Nevada corporation (“Zone”), a state-of-the-art mapping and spatial analysis company. On December 11, 2017, the Company acquired a majority interest in MoviePass Inc., a Delaware corporation (“MoviePass”), whose primary product offering is MoviePass™, the nation’s premier movie theater subscription service. MoviePass allows its subscribers to see up to three movies a month, from a schedule of select movies, in theaters nationwide, for a low fixed price and additional movies at a discounted price.

In January 2018, the Company formed the Company’s wholly-owned subsidiary, MoviePass Ventures LLC, a Delaware limited liability company (“MoviePass Ventures”), which aims to collaborate with film distributors to share in film revenues while using the data analytics that MoviePass offers for marketing and targeting services reaching MoviePass’ paying subscribers using the platform.

In April 2018, the Company acquired the Moviefone brand and related assets (“Moviefone”). Moviefone is an entertainment information and marketing service which provides its users with access to the entire entertainment ecosystem. Moviefone delivers movie show times and tickets, trailers, TV schedules, streaming information, cast and crew interviews, photo galleries and more. Moviefone’s editorial coverage includes up-to-date entertainment news, trailers and clips, red-carpet coverage and celebrity features.

On May 15, 2018, the Company formed MoviePass Films LLC, a Delaware limited liability company (“MoviePass Films”), to focus on studio-driven content and new film production for theatrical release and other distribution channels. On May 23, 2018, the Company executed a binding letter of intent (the “LOI”) with Emmett Furla Oasis Films LLC (“EFO”) pursuant to which EFO acquired a 49% membership interest in MoviePass Films.

On July 16, 2018, the Company formed 10 Minutes Gone, LLC, a Delaware limited liability company (“10 Minutes Gone”), for the purpose of engaging in the production and distribution of the film 10 Minutes Gone.

On July 16, 2018, 100% of the membership interests in Georgia Film Fund 79, LLC, a Delaware limited liability company (“GFF79”), formed on January 16, 2018 by EFO, for the purpose of engaging in motion picture production was transferred to 10 Minutes Gone.

Basis of Presentation

The Company’s condensed consolidated financial statements have been prepared in accordance with U.S. GAAP. The condensed consolidated financial statements include all accounts of the Company and its wholly owned and majority owned subsidiaries. The Company consolidates entities in which it owns more than 50% of the voting equity interests and controls operations. All intercompany transactions and balances among consolidated subsidiaries have been eliminated. The Company consolidated the operations of MoviePass as of December 11, 2017, Moviefone as of April 4, 2018, MoviePass Ventures as of January 2018 and MoviePass Films as of May 15, 2018.

5

HELIOS AND MATHESON ANALYTICS INC.

Notes to Condensed Consolidated Financial Statements

Reverse Stock-Split

On July 24, 2018, the Company effected a reverse stock-split of its issued and outstanding common stock at a ratio of one-for-250 (“Reverse Stock Split”). The Company filed a Certificate of Amendment to its Certificate of Incorporation with the Secretary of State of the State of Delaware effecting the Reverse Stock Split. The Reverse Stock Split did not affect the number of authorized shares of common stock, which, following the increase in authorized shares effected on July 23, 2018 discussed in Note 11, remains at 5,000,000,000 shares. A proportionate adjustment was made to (i) the per share exercise price and the number of shares issuable upon the exercise or conversion of the Company’s outstanding equity awards, options and warrants to purchase shares of common stock and outstanding convertible notes and (ii) the number of shares reserved for issuance pursuant to the Company’s 2014 Equity Incentive Plan. The accompanying condensed consolidated financial statements and notes give retroactive effect to the Reverse Stock Split for all periods presented.

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Significant estimates made by management include, but are not limited to, allowance for doubtful accounts, purchase accounting allocations, recoverability and useful lives of property, plant and equipment, identifiable intangibles and goodwill, warrant liabilities, derivative liabilities, the valuation allowance of deferred taxes, contingencies and equity compensation. Actual results could differ from those estimates.

Reclassification

Certain prior period amounts have been reclassified to conform to current period presentation.

3. Summary of Significant Accounting Policies

Revenue Recognition

ASC 606 Revenue from Contracts with Customers (“ASC 606”)

The Company adopted the new revenue standard, ASC 606, using the modified retrospective method with respect to all non-completed contracts as of January 1, 2018. This method required retrospective application of the new accounting standard to all unfulfilled contracts that were outstanding as of January 1, 2018. Revenues and contract assets and liabilities for contracts completed prior to January 1, 2018 are presented in accordance with ASC 605.

6

HELIOS AND MATHESON ANALYTICS INC.

Notes to Condensed Consolidated Financial Statements

The Company has determined that there were no adjustments required with respect to the adoption of ASC 606 with respect to any prior periods.

Disaggregation of Revenue

	Three Months Ended September 30,				Nine Months Ended September 30,
	2018		2017		2018		2017
	(Unaudited)		(Unaudited)		(Unaudited)		(Unaudited)
Revenues:
Consulting	$	802,114	$	1,173,023	$	2,471,223	$	3,672,036
Subscription		78,921,951		-		198,488,038		-
Marketing, promotional services, and films		1,615,177		-		3,991,575		-
Total revenues	$	81,339,242	$	1,173,023	$	204,950,836	$	3,672,036

The following is a description of the principal activities from which the Company generates revenue, including from consulting customers and subscribers.

Consulting Revenue

Consulting revenues are recognized as services are provided. The Company primarily provides consulting services under time and material contracts, whereby revenue is recognized as hours and costs are incurred. Clients for consulting revenues are billed on a weekly or monthly basis. Revenues from fixed fee contracts are recorded when work is performed on the basis of the proportionate performance method, which is based on costs incurred to date relative to total estimated costs. Any anticipated contract losses are estimated and accrued at the time they become known and estimable. Unbilled accounts receivables represent amounts recognized as revenue based on services performed in advance of customer billings. Revenue from sales of software licenses is recognized upon delivery of the software to a customer because future obligations associated with such revenue are insignificant.

Subscription Revenue

Subscription revenue consists primarily of subscription fees for monthly, quarterly, semi-annual or annual subscriptions. Revenue from subscriptions is recognized on a straight-line basis when the performance obligations to provide each service for the period are satisfied, which is over time as subscription services can be used by subscribers at any time. Consumers purchasing subscriptions generally pay on an annual or monthly basis, and any prepaid amounts for subscription services are recorded as deferred revenue and amortized to revenue evenly over the service period which begins once a subscriber has activated his or her subscription.

Marketing, Promotional Services, and Films

The Company also generates revenue from marketing services primarily related to major motion picture releases. Marketing revenue is generated through e-mail and digital advertising to the Company’s subscriber base and pursuant to a contract for such services with the movie distributor. Such agreements are short-term and are generally represented by a fully executed customer agreement. Revenue is recognized as performance obligations are satisfied which generally occurs within a month of the date the contract begins. Payment terms on marketing agreements vary and payment is generally due once the performance obligations have been satisfied. Revenue from our participation in the theatrical release of feature films is recognized as earned based on our share of the ultimate expected revenue.

Deferred Revenue

Subscription fees are generally paid in advance by credit card through merchant processors. Subscription fees received in advance of completion of the performance obligations are recorded as deferred revenue until such time the services are provided to the customer.

7

HELIOS AND MATHESON ANALYTICS INC.

Notes to Condensed Consolidated Financial Statements

Goodwill

The Company reviews goodwill for impairment, typically during the fourth quarter of each year, and periodically analyzes whether any indicators of impairment have occurred. The Company performs reviews of each of its reporting units that have goodwill balances. During the third quarter of 2018, due to a significant decline in its MoviePass subscribers resulting primarily from substantial changes made to our service offerings during the third quarter, the Company deemed it more appropriate to assess impairment of goodwill and corresponding intangible assets of the MoviePass reporting unit as of September 30, 2018. In conjunction with the events occurring in the third quarter of 2018, the Company updated its long-term business plan, which was used as the basis for estimating the future cash flows of its reporting units. That plan considered then current economic conditions and trends, estimated future operating results, the Company’s views of growth rates and then-anticipated future economic and regulatory conditions.

The Company determined that the fair value of the MoviePass reporting unit was below its carrying value. Therefore, the Company conducted step two of the impairment test for the MoviePass reporting unit and determined the carrying value of goodwill in the MoviePass reporting unit exceeded its implied fair value, resulting in an impairment charge of $38,524,016. This was as a result of reduced financial projections for the MoviePass reporting unit, due to, among other things, lower than expected actual financial results from this business due to a lower number of subscribers resulting from changes in the MoviePass service offering, which resulted in diminished financial performance relative to its original expectations. Given the foregoing, the Company determined there was greater uncertainty in achieving its prior financial projections and so applied a higher discount rate for purposes of its goodwill impairment analysis. Additionally, modifications of certain cashflow assumptions to reflect the current economic conditions as well as market participant levels were made. These assumptions along with a higher discount rate negatively affected the fair value of the MoviePass reporting unit.

Generally, fair value is determined using a multiple of earnings, or discounted projected future cash flows, and is compared to the carrying value of a reporting unit for purposes of identifying potential impairment. Projected future cash flows are based on management’s knowledge of the current operating environment and expectations for the future. Goodwill impairment is recognized for any excess of the carrying value of the reporting unit’s goodwill over the its estimated fair value, not to exceed the total amount of goodwill allocated to the reporting unit.

The identification of relevant events and circumstances and how these may impact a reporting unit’s fair value or carrying amount involve significant judgments by management. These judgments include the consideration of the general economic outlook, industry and market considerations, cost factors, overall financial performance, events which are specific to the Company, and trends in the market price of the Company’s common stock. Each factor is assessed to determine whether it impacts the impairment test as well as the magnitude of any such impact.

Intangible Assets, net

Intangible assets consist of customer relationships, technology, trademarks, broker relationships and patents. Applicable long-lived assets are amortized or depreciated on the straight-line method over their useful lives ranging from three to twelve years.

The Company recorded amortization expense of $1,363,638 and $430,716 for the three months ended September 30, 2018 and 2017, respectively, and $3,977,211 and $1,284,018 for the nine months ended September 30, 2018 and 2017, respectively.

The Company monitors the carrying value of long-lived assets for potential impairment each quarter based on whether certain triggering events have occurred. These events include current period losses or a projection of continuing losses or a significant decrease in the market value of an asset. When a triggering event occurs, an impairment calculation is performed, comparing projected undiscounted future cash flows, utilizing current cash flow information and expected growth rates, to the respective carrying value. If the Company identifies impairment for long-lived assets to be held and used because the carrying value is greater than the projected undiscounted cash flows, the Company compares the assets’ current carrying value to the assets’ fair value. Fair value is based on current market values or discounted future cash flows. The Company records impairment when the carrying value exceeds the assets’ fair value. With respect to owned property and equipment held for disposal, the value of the property and equipment is adjusted to reflect recoverable values based on previous efforts to dispose of similar assets and current economic conditions. Impairment is recognized for the excess of the carrying value over the estimated fair market value, reduced by estimated direct costs of disposal.

The Company evaluated the MoviePass intangible assets in connection with the MoviePass impairment analysis and did not record any impairment charges in regard to definite-lived intangible assets for the three and nine months ended September 30, 2018 and 2017.

Research and Development

Research and development costs are charged to operations when incurred and are included in operating expenses.

Stock Based Compensation

The Company follows the fair value recognition provisions in ASC Topic 718, Stock Compensation (“ASC 718”) and the provisions of ASC Topic 505, Equity (“ASC 505”) for stock-based transactions with non-employees. Stock based compensation expense for employees is recognized over the requisite service period based on the estimated grant-date fair value of the awards. The Company accounts for forfeitures as they occur. The grant date is the date at which an employer and employee reach a mutual understanding of the key terms and conditions of a share-based payment award. Stock-based compensation for non-employee stock options is recorded over the vesting period and remeasured at fair value until they vest.

8

HELIOS AND MATHESON ANALYTICS INC.

Notes to Condensed Consolidated Financial Statements

Investment in Films

The Company capitalizes film production costs, including direct costs and production overhead, net of production incentives, for films in production and the cost of acquiring copyright interests in or participation rights to completed but not released films. The Company amortizes film production costs, including the costs to acquire interests or participation rights to direct operating expenses, using the individual film forecast computation method, which amortizes the costs for an individual film in the proportion that the current year’s revenues bear to management’s estimates of the ultimate revenue expected to be recognized from the distribution, exhibition or sale of such film. Ultimate revenue includes estimates over a period not to exceed ten years following the date of initial release of the motion picture. As of September 30, 2018, unamortized capitalized investment in film costs were $13,403,433. This balance represents total capitalized costs for the period of $17,212,981 less $3,809,548 of costs related to amortization and impairments.

Due to the inherent uncertainties involved in making such estimates of ultimate revenues and expenses, these estimates may differ from actual results and are likely to differ to some extent in the future from actual results. In addition, in the normal course of our business, some films and titles are more successful or less successful than anticipated. Management regularly reviews and revises when necessary its ultimate revenue and cost estimates, which may result in a change in the rate of amortization of film costs and/or write-down of all or a portion of the unamortized costs of the film to its estimated fair value. Management estimates the ultimate revenue based on experience with similar titles or title genre, the general public appeal of the cast, actual performance (when available) at the box office or in markets currently being exploited, and other factors such as the quality and acceptance of motion pictures or programs that our competitors release into the marketplace at or near the same time, critical reviews, general economic conditions and other tangible and intangible factors, many of which we do not control and which may change.

An increase in the estimate of ultimate revenue will generally result in a lower amortization rate and, therefore, less film amortization expense, while a decrease in the estimate of ultimate revenue will generally result in a higher amortization rate and, therefore, higher film amortization expense, and could also periodically result in an impairment requiring a write-down of the film cost to the title’s fair value. These write-downs are included in amortization expense within cost of revenues in our consolidated statements of operations.

Investment in films is stated at the lower of amortized cost or estimated fair value. Additional amortization is recorded in the amount by which the unamortized costs exceed the estimated fair value of the film. Estimates of future revenue involve measurement uncertainty and it is therefore possible that reductions in the carrying value of investment in films may be required as a consequence of changes in our future revenue estimates.

Film Production Incentives

The Company has access to various governmental programs that are designed to promote film production within the United States. Tax credits earned with respect to expenditures on qualifying film production activities, including qualifying capital projects, are included as an offset to the related asset or as an offset to production expenses when we have reasonable assurance regarding the realizable amount of the tax credits.

The unamortized balance includes $2,376,451 representing our investment in participation rights in completed and released films and $11,026,982 in film costs for completed and partially completed films that have yet to be released.

9

HELIOS AND MATHESON ANALYTICS INC.

Notes to Condensed Consolidated Financial Statements

Fair Value Measurements

ASC Topic 820, Fair Value Measurement and Disclosures, defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. This topic also establishes a fair value hierarchy which requires classification based on observable and unobservable inputs when measuring fair value. There are three levels of inputs that may be used to measure fair value:

Level 1: Observable inputs such as quoted prices (unadjusted) in an active market for identical assets or liabilities.

Level 2: Inputs other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.

Level 3: Unobservable inputs that are supported by little or no market activity; therefore, the inputs are developed by the Company using estimates and assumptions that the Company expects a market participant would use, including pricing models, discounted cash flow methodologies, or similar techniques.

The carrying value of the Company’s financial instruments, including cash and cash equivalents, accounts receivable and accounts payable and accrued expenses approximate fair value because of the short-term maturity of these financial instruments.

The liabilities in connection with the conversion and make-whole features included within certain of the Company’s convertible notes payable and warrants are each classified as a level 3 liability.

Derivative Instruments

The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates its convertible notes and warrants to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for in accordance with Paragraph 815-10-05-4 of the FASB ASC and Paragraph 815-40-25 of the Codification. The result of this accounting treatment is that the fair value of the embedded derivative is marked-to-market each balance sheet date and recorded as a liability. In the event that the fair value is recorded as a liability, the change in fair value is recorded in the statements of operations as other income or expense. Upon conversion or exercise of a derivative instrument, the instrument is marked to fair value at the conversion date and then that fair value is reclassified to equity.

In circumstances where the embedded conversion option in a convertible instrument is required to be bifurcated and there are also other embedded derivative instruments in the convertible instrument that are required to be bifurcated the bifurcated derivative instruments are accounted for as a single, compound derivative instrument.

The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. Equity instruments that are initially classified as equity that become subject to reclassification are reclassified to liability at the fair value of the instrument on the reclassification date. Derivative instrument liabilities are classified in the balance sheet as current or non-current to correspond with its host instrument.

The Company marks to market the fair value of the embedded derivatives at each balance sheet date and records the change in the fair value of the embedded derivatives as other income or expense in the statements of operations.

10

HELIOS AND MATHESON ANALYTICS INC.

Notes to Condensed Consolidated Financial Statements

The Company utilizes a Monte Carlo Method that values the liability of the debt conversion feature derivative financial instruments and derivative warrants based on a probability of a down round event. The reason the Company selected the lattice binomial model is that in many cases there may be multiple embedded features or the features of the bifurcated derivatives may be so complex that a Black-Scholes valuation does not consider all of the terms of the instrument. Therefore, the fair value may not be appropriately captured by simple models.

Warrant Liability

The Company evaluates its warrants to determine if those contracts qualify as liabilities in accordance with ASC 480-10 and ASC 815-40. The result of this accounting treatment is that the fair value of the warrant liability is marked-to-market each balance sheet date and recorded as a liability, with the change in fair value recorded in the statements of operations as other income or expense. Upon conversion or exercise of a warrant liability, the instrument is marked to fair value at the conversion date and then that fair value is reclassified to equity.

For warrants with a fixed conversion price and a fixed number of shares, the Company utilizes a Black Scholes model for valuation. For warrants with variability in the number of shares or conversion price (such as a down round feature), the Company utilizes the Monte Carlo Method to value the warrant liability. The reason the Company selected the lattice binomial model is that in many cases there may be multiple embedded features or the features may be so complex that a Black-Scholes valuation does not consider all of the terms of the instrument. Therefore, the fair value may not be appropriately captured by simple models.

Recent Accounting Pronouncements

The following accounting standards updates were recently issued and have not yet been adopted. These standards are currently under review to determine their impact on the consolidated balance sheets, consolidated statements of operations and comprehensive loss, or consolidated statements of cash flows.

In February 2016, the FASB issued Accounting Standards Update (“ASU”) 2016-02, Leases, (“ASU 2016-02”), which supersedes FASB ASC 840, Leases and provides principles for the recognition, measurement, presentation and disclosure of leases for both lessees and lessors. The new standard requires lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. This classification will determine whether lease expense is recognized based on an effective interest method or on a straight-line basis over the term of the lease. A lessee is also required to record a right-of-use asset and a lease liability for all leases with a term of greater than twelve months regardless of classification. Leases with a term of twelve months or less will be accounted for similar to existing guidance for operating leases. In July 2018, the FASB issued ASU 2018-10, Codification Improvements to Topic 842 (Leases), and ASU 2018-11, Leases (Topic 842), Targeted Improvements, which provide (i) narrow amendments to clarify how to apply certain aspects of the new lease standard, (ii) entities with an additional transition method to adopt the new standard, and (ii) lessors with a practical expedient for separating components of a contract. The standard is effective for annual and interim periods beginning after December 15, 2018, with early adoption permitted upon issuance. The Company is currently evaluating the method of adoption and the impact of adopting ASU 2016-02 on its results of operations, cash flows and financial position. We expect to adopt the guidance using the modified retrospective method and practical expedients for transition. The practical expedients allow us to largely account for our existing leases consistent with current guidance except for the incremental balance sheet recognition for lessees. We have started an initial evaluation of our leasing contracts and activities. We do not expect a material change to the timing of expense recognition, but we are early in the implementation process and will continue to evaluate the impact. We are evaluating our existing disclosures and may need to provide additional information as a result of adoption of the ASU.

11

HELIOS AND MATHESON ANALYTICS INC.

Notes to Condensed Consolidated Financial Statements

In January 2017, the FASB issued ASU 2017-04 Intangibles-Goodwill and Other (“ASC 350”): Simplifying the Accounting for Goodwill Impairment (“ASU 2017-04”). ASU 2017-04 simplifies the subsequent measurement of goodwill by eliminating Step 2 from the goodwill impairment test. In computing the implied fair value of goodwill under Step 2, an entity had to perform procedures to determine the fair value at the impairment testing date of its assets and liabilities (including unrecognized assets and liabilities) following the procedure that would be required in determining the fair value of assets acquired and liabilities assumed in a business combination. Instead, under ASU 2017-04, an entity should perform its annual or interim goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An entity should recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value; however, the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. Additionally, an entity should consider income tax effects from any tax-deductible goodwill on the carrying amount of the reporting unit when measuring the goodwill impairment loss, if applicable. ASU 2017-04 is effective for annual or any interim goodwill impairment tests for fiscal years beginning after December 15, 2019 and an entity should apply the amendments of ASU 2017-04 on a prospective basis. Early adoption is permitted for interim or annual goodwill impairment tests performed on testing dates after January 1, 2017. The Company is currently evaluating the effects of ASU 2017-04 on its consolidated financial statements.

In July 2017, the FASB issued ASU 2017-11, Earnings Per Share (“ASC 260”), Distinguishing Liabilities from Equity (“ASC 480”), and Derivatives and Hedging (“ASC 815”). ASU 2017-11 is intended to simplify the accounting for financial instruments with characteristics of liabilities and equity. Among the issues addressed are: (i) determining whether an instrument (or embedded feature) is indexed to an entity’s own stock; (ii) distinguishing liabilities from equity for mandatorily redeemable financial instruments of certain nonpublic entities; and (iii) identifying mandatorily redeemable non-controlling interests. ASU 2017-11 is effective for the Company on January 1, 2019. The Company is currently evaluating the potential impact of ASU 2017-11 on the Company’s consolidated financial statements.

In June 2018, the FASB issued ASU 2018-07, Compensation - Stock Compensation (“ASC 718”), Improvements to Nonemployee Share-Based Payment Accounting (“ASU 2018-07”). The amendments in ASU 2018-07 expand the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. ASU 2018-07 is effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption is permitted. The Company has evaluated the impact of ASU 2018-07 on the Company’s consolidated financial statements and determined it will not have a material impact.

In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (“ASC 820”), Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement (“ASU 2018-13”). ASU 2018-13 is intended to improve the effectiveness of fair value measurement disclosures. ASU 2018-13 is effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating the impact of ASU 2018-13 on the Company’s consolidated financial statements. 

4. Going Concern Analysis

In evaluating the Company’s ability to continue as a going concern, management considered the conditions and events that could raise substantial doubt about the Company’s ability to continue as a going concern within twelve months after the Company’s interim financial statements were issued (November 15, 2018). Management considered the Company’s current financial condition and liquidity sources, including current funds available, forecasted future cash flows and the Company’s conditional and unconditional obligations due before November 15, 2019.

The Company is subject to a number of risks similar to those of other big data technology, technology consulting companies and subscription based businesses, including its dependence on outside sources of capital, the Company’s ability to maintain and grow its subscriber base, uncertainty of generation of revenues and positive cash flow, dependence on key individuals, risks associated with research, development, testing, and successful protection of intellectual property, and the Company’s susceptibility to infringement on the proprietary rights of others. The attainment of profitable operations is dependent on future events, including obtaining adequate financing to fulfill the Company’s growth and operating activities and generating a level of revenues adequate to support the Company’s cost structure.

The Company has experienced net losses and significant cash outflows from cash used in operating activities over the past years. As of September 30, 2018, the Company had an accumulated deficit of $377,266,866, a loss from operations for the three and nine months ended September 30, 2018 of $86,414,887 and $320,785,739, respectively, and net cash used in operating activities for the nine months ended September 30, 2018 of $321,093,755.

12

HELIOS AND MATHESON ANALYTICS INC.

Notes to Condensed Consolidated Financial Statements

The Company expects to continue to incur net losses and have significant cash outflows for at least the next twelve months. As of September 30, 2018, the Company had cash and a working capital deficit of $4,850,972 and $15,657,290, respectively, compared to $24,949,393 and $107,097,249 as of December 31, 2017. Of the working capital deficit at September 30, 2018, $60,809 pertained to warrant and derivative liabilities classified on the balance sheet within current liabilities. Management has evaluated the significance of the conditions described above in relation to the Company’s ability to meet its obligations and concluded that, without additional funding, the Company will not have sufficient funds to meet its obligations within one year from the date the condensed consolidated financial statements were issued. While management will look to continue funding operations by raising additional capital from sources such as sales of the Company’s debt or equity securities or loans in order to meet operating cash requirements, there is no assurance that management’s plans will be successful.

The Company obtained convertible debt financing for up to $60,000,000 in gross proceeds on January 11, 2018, of which the Company had received $31,000,000 in gross proceeds as of September 30, 2018, which the Company used (i) to increase the Company’s ownership interests or other rights and interests in MoviePass; (ii) to satisfy certain indebtedness; and (iii) for general corporate purposes and transaction expenses. The Company may also use the proceeds to make other acquisitions. Additionally, during the second and third quarter of 2018, the Company received $58,959,736 in gross proceeds related to the convertible debt financing obtained on November 7, 2017.

On June 26, 2018, the Company obtained preferred stock and convertible debt financing for up to $139,400,000 in gross proceeds, of which the Company had received $20,500,000 in gross proceeds as of September 30, 2018, which the Company used for general corporate purposes and transaction expenses.

As of September 30, 2018, the Company had no outstanding unrestricted principal under the Senior Convertible Notes issued to institutional investors on November 7, 2017 and January 23, 2018, respectively, and there remained $49,388,861 in restricted principal for which a corresponding amount of principal under the investor notes remains to be paid to the Company by the holders of those convertible notes.

In order to facilitate the Company’s further access to capital, in January 2018 the Company filed a shelf registration statement on form S-3 that was declared effective by the SEC on February 9, 2018, which allows the Company to offer and sell up to $400,000,000 of its equity or equity-linked securities. Using the shelf registration statement, the Company completed an underwritten public offering of common stock and warrants for gross proceeds of $105,050,000 on February 13, 2018. The total net proceeds to the Company from the February 2018 public offering were $96,912,380. The Company also completed an underwritten public offering of common stock and warrants for gross proceeds of approximately $30,250,000 on April 23, 2018. The total net proceeds to the Company from the April 2018 public offering were $27,677,558.

On April 18, 2018, the Company entered into an Equity Distribution Agreement (the “Sales Agreement”) with Canaccord Genuity LLC (“Canaccord”) under which the Company could offer and sell under the shelf registration statement up to $150,000,000 of its common stock at prevailing market prices in a continuous at-the market offering (the “ATM Offering”) through its sales agent Canaccord. The Company used the net proceeds from the ATM Offering to increase the Company’s ownership stake in MoviePass and to support the operations of MoviePass and MoviePass Ventures, to satisfy a portion or all of any amounts due and payable in connection with the convertible notes issued on November 7, 2017, January 23, 2018 and June 26, 2018, and for general corporate purposes and transaction expenses. As of September 30, 2018, the Company sold approximately 627,933,083 shares, and received net proceeds of approximately $119,423,879, pursuant to the ATM Offering. The Sales Agreement was terminated on October 1, 2018, and, as a result, no further offers or sales of the Company’s common stock will be made pursuant to the ATM Offering.

Without raising additional capital, there is substantial doubt about the Company’s ability to continue as a going concern through November 15, 2019. The accompanying condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern. This basis of accounting contemplates the recovery of the Company’s assets and the satisfaction of liabilities in the normal course of business. A successful transition to attaining profitable operations is dependent upon achieving a level of positive cash flows adequate to support the Company’s cost structure. 

Notice of Potential Delisting from NASDAQ 

On June 21, 2018, the Company received a deficiency letter from the Nasdaq Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the prior 30 consecutive business days, the closing bid price for the Company’s common stock has closed below a minimum $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (“Rule 5550(a)(2)” or the “Minimum Bid Price Requirement”).

In accordance with Nasdaq Listing Rule 5810(b), the Company has been given 180 calendar days, or until December 18, 2018 to regain compliance with Rule 5550(a)(2).

13

HELIOS AND MATHESON ANALYTICS INC.

Notes to Condensed Consolidated Financial Statements

The Special Meeting of Stockholders scheduled to be held on November 14, 2018 to provide stockholders with an opportunity to vote on the proposed reverse stock split in a ratio of 1 share-for-2 shares up to a ratio of 1 share-for-500 shares has been cancelled. The Company was presenting the reverse stock split proposal in an effort to regain compliance with the Rule 5550(a)(2). Since the Company will not be able to effect a reverse stock split ten business days prior to December 18, 2018, absent an extension by The Nasdaq Capital Market (of which there can be no assurance) the Company believes that our common stock will be subject to delisting from The Nasdaq Capital Market, which would adversely impact the liquidity and marketability of our common stock. The Company intends to monitor the closing bid price of its common stock and consider its available options to resolve its noncompliance with Rule 5550(a)(2).

If the Company does not regain compliance with Rule 5550(a)(2) by December 18, 2018, the Company may be afforded a second 180-calendar day period to regain compliance. To qualify, the Company would be required to meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, except for the Minimum Bid Price Requirement. In addition, the Company would be required to notify Nasdaq of its intent to cure the deficiency during the second compliance period, which may include, if necessary, implementing a reverse stock split. If the Company is afforded additional time to regain compliance (of which there can be no assurance), the Board of Directors of the Company plans to call a special meeting as soon as practicable with a new record date for the Company’s stockholders to vote on a reverse stock split in an effort to regain compliance with Rule 5550(a)(2). Even if the Company is eligible for an additional compliance period, Nasdaq may decline to grant the Company an additional compliance period in its discretion.

If the Company does not regain compliance with Rule 5550(a)(2) by December 18, 2018, and is either not eligible for an additional compliance period at that time or Nasdaq declines to grant the Company an additional compliance period in Nasdaq’s discretion, the Staff will provide notice to the Company that its securities will be subject to delisting. At that time, the Company may appeal the Staff’s delisting determination to a Nasdaq Listing Qualifications Panel (“Panel”). The Company would remain listed pending the Panel’s decision.

On August 25, 2018, Carl J. Schramm resigned from the Board of Directors of the Company and each committee of the Board of Directors which he was a member, including the Audit Committee. As a result, the Company is no longer compliant with Nasdaq Listing Rule 5605(b)(1), which requires that a majority of the Board of Directors of the Company be independent, and Nasdaq Listing Rule 5605(c)(2)(A), which requires that the Audit Committee have at least three independent directors.

In accordance with Nasdaq Listing Rules, on August 27, 2018, the Company notified Nasdaq of Mr. Schramm’s resignation and non-compliance with the above Nasdaq Listing Rules. Nasdaq responded on September 6, 2018 with a notification letter confirming the Company’s non-compliance with Nasdaq’s independent director and audit committee requirements as set forth above. Nasdaq advised that, pursuant to Nasdaq Listing Rules 5605(b)(1)(A) and 5605(c)(4), the Company will have until the following to cure the deficiencies caused by Mr. Schramm’s departure:

● until the earlier of the Company’s next annual shareholders’ meeting or August 25, 2019; or

● if the next annual shareholders’ meeting is held before February 21, 2019, then the Company must evidence compliance no later than February 21, 2019.

The Board of Directors of the Company intends to appoint a new independent director who satisfies the applicable requirements of the Nasdaq Listing Rules to serve on the Company’s Board of Directors and Audit Committee prior to the expiration of the cure period.

5. Acquisitions of MoviePass and Moviefone and the Formation of MoviePass Films

Acquisition of Controlling Interest in MoviePass Inc.

On December 11, 2017, the Company completed its acquisition of a 62.41% majority interest in MoviePass (such acquisition, the “MoviePass Transaction”), for the following consideration: (1) a subordinated convertible promissory note in the principal amount of $12,000,000 (the “Helios Convertible Note”), which is convertible into shares of HMNY’s common stock, as further described below; (2) a $5,000,000 promissory note issued to MoviePass (the “Helios Note”); (3) the exchange of a convertible promissory note issued by MoviePass to HMNY in an aggregate principal amount of $11,500,000 (plus accrued interest thereon); (4) $1,000,000 in cash to purchase outstanding convertible notes of MoviePass, which were converted into shares of MoviePass’ common stock amounting to an additional 2% of the outstanding shares of MoviePass common stock; and (5) $20,000,000 in cash pursuant to the Investment Option Agreement, dated October 11, 2017, between the Company and MoviePass.

The Helios Convertible Note will convert into 16,000 (4,000,000 pre-split) unregistered shares of the Company’s common stock (the “Conversion Shares”) automatically upon the Company’s receipt of approval of its stockholders relating to the issuance of the Conversion Shares as required by and in accordance with Nasdaq Listing Rule 5635. Of that amount, 2,667 (666,667 pre-split) of the Conversion Shares are subject to forfeiture by MoviePass, in the Company’s sole discretion, as MoviePass failed to list its common stock on the Nasdaq Stock Market by March 31, 2018 (as required by the securities purchase agreement between the Company and MoviePass). As of the date of this report, the Company has not made a decision with respect to the disposition of those shares that are subject to forfeiture. 

14

HELIOS AND MATHESON ANALYTICS INC.

Notes to Condensed Consolidated Financial Statements

The Company has valued the Helios Convertible Note as of the acquisition date, including the valuation of the shares subject to forfeiture as noted above, at the fair value on the acquisition date based on a Monte Carlo simulation. The shares subject to forfeiture are contingent consideration and have been valued as a separate component of the Helios Convertible Note. As of the acquisition date the Helios Convertible Note was valued at $29,000,000 and the portion of the Conversion Shares subject to forfeiture was valued at $5,152,446. All of the purchase consideration, with the exception of the $1,000,000 paid for the MoviePass convertible notes which were converted into MoviePass common stock, was retained by MoviePass. Accordingly, the value of the Helios Convertible Note, the Helios Note and the value associated with the Conversion Shares subject to forfeiture are eliminated in consolidation for financial reporting purposes.

Goodwill recognized as part of the MoviePass Transaction is not expected to be tax deductible.

The Company has made a provisional allocation of the purchase price of the MoviePass Transaction to the assets acquired and the liabilities assumed as of the acquisition date. The following table summarizes the provisional purchase price allocations relating to the MoviePass Transaction:

Purchase consideration:	MoviePass
Cash	$	32,671,792
Notes payable (includes Helios Convertible Note and Helios Note)		39,152,446
Fair value of consideration transferred	$	71,824,238
Recognized amounts of identifiable assets and liabilities acquired:
Cash acquired	$	1,106,171
Accounts receivable		9,669,390
Notes receivable		39,152,446
Investment option payment receivable		7,850,000
Prepaid expenses and other current assets		192,180
Property and equipment		39,320
Other assets		8,000
Identifiable intangible assets:
Tradenames and trademarks		19,550,000
Technology		3,800,000
Customer relationships		2,560,000
Liabilities assumed		(9,261,785	)
Deferred revenue		(38,718,397	)
Non-controlling interest		(43,260,264	)
Goodwill		79,137,177
Total purchase price allocation	$	71,824,238

The Company has not completed the valuation studies necessary to finalize the acquisition fair values of the assets acquired and liabilities assumed and related allocation of the purchase price for the MoviePass Transaction. Accordingly, the type and value of the intangible assets and deferred revenue amounts set forth above are preliminary. Once the valuation process is finalized for the MoviePass Transaction, there could be changes to the reported values of the assets acquired and liabilities assumed, including goodwill, intangible assets and deferred revenue and those changes could differ materially from what is presented above.

The Company determined the provisional fair value of the acquired intangible assets through a combination of the market approach and the income approach. The significant assumptions used in certain valuations associated with the MoviePass Transaction include discount rates ranging from 10.0% to 51.0%. In determining the value of tradenames and trademarks the Company observed royalty rates ranging from 0.0% to 100.0%, and utilized a 1.0% rate for MoviePass’s aggregated tradenames and trademarks. Additionally, the Company observed royalty rates related to MoviePass’s technology assets acquired ranging from 0.0% to 50.0%, and used a 1.0% royalty rate in determining the fair value of the acquired technology. In accordance with Emerging Issues Task Force (“EITF”) guidance, the fair value of an acquired liability related to deferred revenue would include the direct and incremental cost of fulfilling the obligation plus a normal profit margin. The Company utilized historical operating results in estimating the direct and incremental costs of fulfilling the acquired deferred revenue obligations. The non-controlling interest in MoviePass was determined based on the fair value of MoviePass less the amounts paid by the Company for its 62.41% controlling interest.

The estimated useful lives of acquired intangible assets are 7 years for customer relationships, 3 years for technology, and 7 years for tradenames and trademarks. Acquired deferred revenue is estimated to be realized based on the length of the subscription, over 12 months from the acquisition date.

15

HELIOS AND MATHESON ANALYTICS INC.

Notes to Condensed Consolidated Financial Statements

Additional MoviePass Subscription Agreements

On March 8, 2018, the Company entered into a Subscription Agreement with MoviePass (the “March 2018 Agreement”), pursuant to which, in lieu of repayment of advances totaling $55,525,000 made by the Company, MoviePass agreed to sell to the Company an amount of MoviePass common stock equal to 18.79% of the total then outstanding shares of MoviePass common stock (excluding shares underlying MoviePass options and warrants) (the “March 2018 MoviePass Purchased Shares”). MoviePass also agreed to issue to the Company, in addition to the March 2018 MoviePass Purchased Shares, without payment of additional consideration by the Company, for purposes of anti-dilution, an amount of shares of MoviePass common stock that caused the Company’s total ownership of the outstanding shares of MoviePass common stock (excluding shares underlying MoviePass options and warrants), together with the March 2018 MoviePass Purchased Shares, to equal 81.2% as of March 8, 2018.

From February 27, 2018 through April 12, 2018, the Company advanced a total of $35,000,000 to MoviePass (the “Second Advance”). On April 16, 2018, the Company entered into an additional Subscription Agreement with MoviePass (the “April 2018 Agreement”), pursuant to which, in lieu of repayment of the Second Advance, MoviePass agreed to sell to the Company an amount of shares of common stock of MoviePass equal to 10.6% of the total then outstanding MoviePass common stock (excluding shares underlying MoviePass options and warrants) (the “April 2018 MoviePass Purchased Shares”), based on a pre-money valuation of MoviePass of $295,525,000 as of March 31, 2018. Pursuant to the April 2018 Agreement, MoviePass also agreed to issue to the Company, in addition to the April 2018 MoviePass Purchased Shares, without payment of additional consideration by the Company, for purposes of anti-dilution, an amount of shares of common stock of MoviePass that caused the Company’s total ownership of the outstanding shares of common stock of MoviePass (excluding shares underlying MoviePass options and warrants), together with the April 2018 MoviePass Purchased Shares, to equal 91.8% as of April 12, 2018.

In addition, from April 16, 2018 through September 30, 2018 the Company has advanced MoviePass, $187,285,000 for operational funding. Such amount remains payable to the Company by MoviePass and has been eliminated in consolidation for financial reporting purposes. 

The Company has accounted for the March 2018 MoviePass Purchased Shares and the April 2018 MoviePass Purchased Shares as an acquisition of a portion of the non-controlling interest in MoviePass. Accordingly, the non-controlling interest at March 8, 2018 and April 12, 2018 was reduced respectively, based on the percentage acquired, and the balance invested in excess of the value of the non-controlling interest acquired was recorded as additional invested capital.

Acquisition of Moviefone Brand

On April 4, 2018, the Company entered into an Asset Purchase Agreement (the “Moviefone Purchase Agreement”) with Oath Inc. (formerly, AOL Inc.), a Delaware corporation and subsidiary of Verizon Communications and certain of its subsidiaries (“Oath”), pursuant to which the Company completed the acquisition from Oath of certain products, rights, technology, contracts, data and other assets related to the Moviefone brand (the “Moviefone Assets”). The acquisition of Moviefone has been accounted for as the acquisition of a business. The historical operational results of Moviefone were not significant for purposes of providing pro forma financial information. The purchase price for the Moviefone Assets consisted of the following: (i) $1.0 million in cash, (ii) the issuance of 10,201 (2,550,154 pre-split) shares of common stock of the Company with a market value of $7.6 million as of the closing date, and (iii) the issuance of warrants to purchase 10,201 (2,550,154 pre-split) shares of common stock of the Company at an exercise price of $1,375 ($5.50 pre-split) per share. In addition, and pursuant to the Moviefone Purchase Agreement, the Company assumed certain specified liabilities incurred after the acquisition date and retained certain employees of Moviefone.

The Company determined the provisional fair value of the acquired intangible assets through a combination of the market approach, cost and the income approach. The significant assumptions used in certain valuations associated with the Moviefone transaction include discount rates ranging from 9.0% to 22.1%. In determining the value of tradenames and trademarks the Company observed royalty rates ranging from 0.0% to 100.0% and utilized a 10.0% rate for Moviefone’s aggregated tradenames and trademarks. Additionally, the Company utilized a cost approach for Moviefone’s technology assets acquired based on man hours to construct in determining the fair value of the acquired technology. The non-compete agreements were analyzed and found to have a de minimis value.

The estimated useful lives of acquired intangible assets are 20 years for tradenames and trademarks, 7 years for customer relationships and 3 years for technology. 

The following table summarizes the consideration paid for Moviefone by the Company, and the amounts of assets acquired, and liabilities assumed and recognized at the acquisition date:

Purchase consideration:	Moviefone
Cash	$	1,000,000
Common shares issued		7,599,459
Warrants for common shares issued		5,475,500
Fair value of consideration transferred	$	14,074,959
Trade names and trademarks	$	4,640,000
Technology		340,000
Customer relationships		560,000
Goodwill		8,534,959
Total purchase price allocation	$	14,074,959

16

HELIOS AND MATHESON ANALYTICS INC.

Notes to Condensed Consolidated Financial Statements

MoviePass Films

On May 23, 2018, the Company entered into the LOI with EFO, pursuant to which EFO acquired a 49% membership interest in MoviePass Films. Pursuant to the LOI, the Company capitalized MoviePass Films with an initial capital contribution of $2,000,000 in cash and retained a 51% interest in MoviePass Films and capitalized MoviePass Films with an additional $4,200,000 as of September 30, 2018, for a total of $6,200,000 capitalized by the Company as of September 30, 2018.. EFO has assigned its rights in a film output agreement of EFO to MoviePass Films. MoviePass Films has begun operations, and the Company and EFO are finalizing the long form agreements that will further define the relative rights and duties of the Company and EFO with respect to MoviePass Films. In accordance with the LOI, as of September 30, 2018, the Company is committed to contribute 16,000 (4,000,000 pre-split) shares of common stock of the Company to EFO.

The Company has not performed the valuation studies required to value film output agreement assigned to MoviePass Films by EFO.

The Company has a 51% membership interest in MoviePass Films and the right to designate three out of five of the members of its board of managers and accordingly has consolidated the results of MoviePass Films with those of the Company.

6. Net Loss Per Share Attributable to Common Stockholders

Earnings per share (“EPS”) is the amount of earnings attributable to each share of common stock. For convenience, the term is used to refer to either earnings or loss per share. EPS is computed pursuant to Section 260-10-45 of the FASB ASC. Pursuant to ASC Paragraphs 260-10-45-10 through 260-10-45-16, basic EPS is computed by dividing income available to common stockholders (the numerator) by the weighted-average number of common shares outstanding (the denominator) during the period. The computation of diluted EPS is similar to the computation of basic EPS except that the denominator is increased to include the number of additional common shares that would have been outstanding if the dilutive potential common shares had been issued during the period to reflect the potential dilution that could occur from common shares issuable through contingent shares issuance arrangements, stock options or warrants.

The following table shows the outstanding dilutive common shares excluded from the diluted net loss per share attributable to common stockholder’s calculation as they were anti-dilutive:

	September 30,		December 31,
	2018		2017
Warrants		67,468		38,526
Conversion features on convertible notes		-		5,482
Total potentially dilutive shares		67,468		44,008

17

HELIOS AND MATHESON ANALYTICS INC.

Notes to Condensed Consolidated Financial Statements

7. Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following as of September 30, 2018 and December 31, 2017:

	September 30, 2018		December 31, 2017
Vendor deposits	$	2,293,641	$	147,533
Tax		105,503		108,433
Deposits		-		230,711
Insurance		167,016		86,181
Professional fees and services		61,359		33,333
Deferred stock compensation		250,333		2,885,278
Rent		-		52,650
Other		591,793		13,692
Total prepaid expenses and other current assets	$	3,469,645	$	3,557,811

8. Intangible Assets, net and Goodwill

The following table sets forth the major categories of the Company’s intangible assets and the estimated useful lives as of September 30, 2018 and December 31, 2017 for those assets that are not already fully amortized: 

				September 30, 2018
	Estimate Useful Life (Years)	Gross Carrying Amount		Acquisitions		Accumulated Amortization			Impairments			Net Book Value
Customer relationships	7	$	2,560,000		560,000		(334,043	)		-			2,785,957
Technology	3		8,070,000		340,000		(3,773,338	)		(1,210	)		4,635,452
Tradenames and trademarks	10-20		19,873,224		4,640,000		(2,013,260	)		-			22,499,964
Patents	12		196,353		-		(20,327	)		-			176,026
		$	30,699,577		5,540,000		(6,140,968	)		(1,210	)		30,097,399

				December 31, 2017
	Estimate Useful Life (Years)	Gross Carrying Amount		Acquisitions		Accumulated Amortization			Impairments			Net Book Value
Customer relationships	7	$	-	$	2,560,000	$	(20,645	)	$	-		$	2,539,355
Technology	3		4,270,000		3,800,000		(1,700,431	)		-			6,369,569
Tradenames and trademarks	10-20		1,977,000		19,550,000		(433,588	)		(1,653,776	)		19,439,636
Broker relationships	5		4,200		-		(962	)		(3,238	)		-
Patents	12		196,353		-		(8,131	)		-			188,222
		$	6,447,553	$	25,910,000	$	(2,163,757	)	$	(1,657,014	)	$	28,536,782

The Company recorded amortization expense of $1,363,638 and $430,716 for the three months ended September 30, 2018 and 2017, respectively, and $3,977,211 and $1,284,018 for the nine months ended September 30, 2018 and 2017, respectively. 

18

HELIOS AND MATHESON ANALYTICS INC.

Notes to Condensed Consolidated Financial Statements

The following table outlines estimated future annual amortization expense for the next five years and thereafter:

September 30,
Remaining 2018	$	1,363,077
2019		5,246,717
2020		3,957,471
2021		2,678,569
2022		2,648,976
Thereafter		14,202,589
	$	30,097,399

Goodwill represents the difference between purchase cost and the fair value of net assets acquired in business acquisitions. Goodwill and indefinite lived intangible assets are tested for impairment annually as of December 31st and more often if a triggering event occurs, by comparing the fair value of each reporting unit to its carrying value. During the third quarter of 2018, due to a significant decline in its MoviePass subscribers resulting primarily from changes made to service offerings during the third quarter, the Company deemed it appropriate to assess goodwill impairment of the MoviePass reporting unit as of September 30, 2018. Due to the complexity and the effort required to estimate the fair value of the reporting units in step one of the impairment test and to estimate the fair value of all assets and liabilities of the reporting units in the second step of the test, the fair value estimates were derived based on preliminary assumptions and analyses that are subject to change. Based on our preliminary analyses, the implied fair value of goodwill was substantially lower than the carrying value of goodwill for the reporting units of the Subscription and Marketing, Promotional Services, and Films segment. As a result, we recorded our best estimate of $38,524,016 for the goodwill impairment charge in the three months ended September 30, 2018, which is included in impairment of goodwill on the condensed consolidated statements of operations and comprehensive income/(loss). Any adjustments to the estimated impairment loss following the completion of the measurement of the impairment will be recorded in the fourth quarter of 2018.

The Company used a discounted cash flow model, to determine the fair value of the reporting unit.  Key assumptions within the analysis included revenue projections, revenue growth assumptions, adjustments for the latest subscriber information, revisions to the current costs of the subscription program including limitations on visits per month and first run movies, revenue growth assumptions, expectations for working capital and capital expenditure needs discount rates, and the effective tax rate that the Company determined to be appropriate. Revenue projections reflected declines in the current and next year, and revenues are expected to moderate to a terminal growth rate of 3%. The discount rate was 49.4% and the effective tax rate was 28%.

Balance as of December 31, 2017	$	79,137,177
Acquisition of Moviefone		8,534,959
Impairment of a portion of MoviePass		(38,524,016	)
Balance as of September 30, 2018	$	49,148,120

19

HELIOS AND MATHESON ANALYTICS INC.

Notes to Condensed Consolidated Financial Statements

9. Accounts Payable and Accrued Expenses

As of September 30, 2018 and December 31, 2017, accounts payable and accrued expenses consisted of the following:

	September 30, 2018		December 31, 2017
Accounts payable	$	5,292,213	$	5,087,060
Accrued ticket expense		1,174,638		4,743,582
Accrued professional fees		1,763,670		597,187
Accrued credit card fees		-		782,670
Accrued payroll expense		4,111,418		312,149
Accrued other expense		3,755,564		852,840
Accrued interest		1,593,757		768,515
Total accounts payable and accrued expenses	$	17,691,260	$	13,144,003

10. Senior Secured Convertible Notes and Warrants and Unit Offerings

February 2017 Notes

On February 8, 2017, the Company issued two Senior Secured Convertible Notes (the “February 2017 Notes”) to an institutional investor (the “Investor”) in the aggregate principal amount of $5,681,818 for consideration consisting of a secured promissory note payable by the Investor to the Company in the principal amount of $5,000,000 (the “February 2017 Investor Note”), which offsets the February 2017 Notes of the same amount. Upon issuance, the initial principal balance of $681,818 of the February 2017 Notes was accounted for as an original issuance discount and accreted into interest expense over the life of the February 2017 Notes. As cash is received from the February 2017 Investor Note, and the related principal amount of the February 2017 Notes increases accordingly, a derivative liability related to the conversion feature embedded within the February 2017 Notes is recorded as a debt discount, and accreted into interest expense over the life of the February 2017 Notes using the effective interest method, and any excess value over the amount of cash received is expensed immediately to interest expense. In addition, February Placement Agent Warrants were also issued (See The Placement Agent Notes and Warrants below), recognized as liabilities pursuant to their terms and recorded as a debt discount, and accreted into interest expense over the life of the February 2017 Notes using the effective interest method, and any excess value over the amount of cash received is expensed immediately to interest expense. The February 2017 Notes had a maturity date of October 8, 2017.

As of December 31, 2017, the Investor had fully funded the February 2017 Investor Note and had subsequently converted the aggregate principal amount due under the February 2017 Notes and approximately $49,000 of interest into 7,411 (1,852,886 pre-split) shares of the Company’s common stock in full payment of the February 2017 Notes. On any principal balance owed by the Company to the Investor, a 6% interest obligation was due quarterly and calculated on a 360-day basis. For the three and nine months ended September 30, 2017, the Company had interest expense of $42,750 and $173,963, respectively. In a letter agreement executed on August 27, 2017, in consideration for the prepayment in the amount of $2,500,000, on the February 2017 Investor Note, which the Investor subsequently made on August 28, 2017, the Investor and the Company agreed that the Investor would have the right, but not the obligation, until December 31, 2017, to effect an exchange (the “Share Exchange”) of 3,365 (841,250 pre-split) shares of the Company’s common stock (the “Exchange Shares”) for one or more senior secured convertible promissory notes in the form of the February Additional Note (the “New Note”), with the right to substitute the alternate conversion price of the New Note with the alternate conversion price of the Company’s Series B Senior Secured Convertible Note (the “Series B Note”) that was issued on August 16, 2017. Any New Note issued was in a principal amount equal to the product of the prepayment amount ($2,500,000) multiplied by a fraction, the numerator of which was the number of the aggregate shares being tendered to the Company in the Share Exchange and the denominator of which was 3,365 (841,250 pre-spilt). The maturity date of any New Note was 45 days following the issuance of the New Note, and the conversion price of the New Notes was $1,125 ($4.50 pre-split), or, at the election of the Investor, the Investor could convert at the Alternate Conversion Price. The Alternate Conversion Price was defined as either (A) the lower of (i) $1,125 ($4.50 pre-split) and (ii) the greater of (I) $1,000 ($4.00 pre-split) and (II) 85% of the quotient of (x) the sum of the volume weighted average price of the common stock for each of the 5 consecutive trading days ending on the trading day immediately preceding the delivery of the Conversion Notice, divided by (y) 5 or (B) that price which shall be the lowest of (i) $750 ($3.00 pre-split) and (ii) the greater of (I) the Floor Price then in effect and (II) 85% of the quotient of (x) the sum of the volume weighted average price of the Company’s common stock for each of the 5 consecutive trading days ending and including the date of the alternate conversion, divided by (y) 5. The Floor Price was defined as $750 ($3.00 pre-split) through October 4, 2017 and $125 ($0.50 pre-split) following October 4, 2017. On October 23, 2017, the Company and the Investor entered into a Third Amendment and Exchange Agreement (the “Third Exchange Agreement”) for the purpose of exchanging the New Note for 3,789 (947,218 pre-split) shares of common stock (the “New Exchange Shares”) and rights (the “Rights”) to receive 2,211 (552,782 pre-split) additional shares of common stock. As partial consideration for the New Exchange Shares and the Rights, the Investor agreed, among other things, to terminate the Investor’s right to exchange the remaining Exchange Shares for New Notes. The termination of these rights is accounted for as financing fees associated with the February 2017 Notes, valued at $19,950,000 based on the trading price of the Company’s stock on the date of the Third Exchange Agreement and recorded as interest expense. 

20

HELIOS AND MATHESON ANALYTICS INC.

Notes to Condensed Consolidated Financial Statements

August 2017 Notes

On August 16, 2017, the Company issued to the Investor three Senior Secured Convertible Notes (the “August 2017 Notes”) in the aggregate principal amount of $10,300,000 and a 5-year warrant for the purchase of 7,572 (1,892,972 pre-split) shares of the Company’s common stock at an exercise price of $812.50 ($3.25 pre-split) per share (the “Investor Warrant”) for consideration consisting of a secured promissory notes payable by the Investor to the Company (the “August 2017 Investor Notes”) in the principal amount of $8,800,000 and $220,000, which offset the August 2017 Notes of the same amount. The August 2017 Notes had a maturity date of April 16, 2018 and the Investor Warrant had an expiration date of April 16, 2022. The $220,000 secured promissory note payable by the Investor was issued in exchange for a $250,000 Senior Secured Convertible Note; therefore, a discount of $30,000 was recognized upon issuance and accreted into interest expense over the life of the note using the effective interest method. Upon issuance, the Investor Warrant, which was determined to be a liability, was recorded at fair value and accounted for as an original issuance discount to the August 2017 Notes. The excess in value of the Investor Warrant over the August 2017 Notes upon issuance was recorded as interest expense, while the initial principal balance was recorded as a debt discount and accreted into interest expense over the life of the August 2017 Notes.

At December 31, 2017, the contracted conversion prices for the August 2017 Notes, which included an Initial Series A Note, an Additional Series A Note and the Series B Note, were $1,000 ($4.00 pre-split) for the Initial Series A Note and the Additional Series A Note and $750 ($3.00 pre-split) for the Series B Note. As of December 31, 2017, the Investor had fully prepaid the August 2017 Investor Note and converted $5,794,560 in principal amount, plus accrued interest, of the August 2017 Notes into 5,931 (1,482,639 pre-split) shares of the Company’s common stock. On any principal balance owed by the Company to the Investor, a 6% interest obligation was due quarterly and calculated on a 360-day basis. For the three and nine months ended September 30, 2018, the Company had $0 and $37,126, respectively, of interest expense pertaining to the unpaid principal amount of the August 2017 Notes. The full outstanding principal balance of $4,677,899 and accrued interest of $37,126 were converted to 4,678 (1,169,475 pre-split) shares of the Company’s common stock on February 20, 2018. As of September 30, 2018, the unpaid principal amount of the August 2017 Notes owed to the Investor was $0.

The Investor Warrant included anti-dilution provisions. The anti-dilution provisions were triggered when the Company issued a new senior convertible note to the Investor in the aggregate principal amount of $697,000 (the “Exchange Note”) in September 2017. Because the Exchange Note had a conversion price of $750 ($3.00 pre-split) per share, which was lower than the Investor Warrant per share exercise price of $812.50 ($3.25 pre-split), the number of shares of the Company’s common stock issuable to the Investor pursuant to the Investor Warrant was increased from 7,572 (1,892,972 pre-split) to 8,203 (2,050,720 pre-split) and the per share exercise price of the Investor Warrant was decreased from $812.50 ($3.25 pre-split) to $750 ($3.00 pre-split). As of December 31, 2017, the Investor had elected, in a cashless transaction, to exercise the Investor Warrant to purchase 6,860 (1,715,006 pre-split) shares of common stock and also paid the Company the sum of $977,142 to exercise the Investor Warrant for an additional 1,303 (325,714 pre-split) shares of common stock. On November 21, 2017 in conjunction with the Fourth Amendment and Exchange Agreement entered into between the Investor and the Company, the remaining 40 (10,000 pre-split) shares of common stock subject to the Investor Warrant were exchanged for a new warrant (the “Exchange Warrant”). The Exchange Warrant, which was determined to be a liability and was recorded at fair value, was in substantially the form of the Investor Warrant, except that: 

● The Exchange Warrant had an exercise price of $3,578 ($14.31 pre-split).

● The expiration date of the Exchange Warrant was November 21, 2022.

● The Exchange Warrant could not be exercised for the purchase of shares of common stock unless the stockholders of the Company approve the issuance in compliance with the rules and regulations of The Nasdaq Capital Market, which stockholder approval was obtained at a special meeting of the Company’s stockholders in October 2017.

● The Exchange Warrant was subject to redemption, refund or alternate cashless exercise after the August 2017 Notes were no longer outstanding (or on or after February 16, 2018 if the Company failed to remain current in its filings or an event of default under the August 2017 Notes occurred).

21

HELIOS AND MATHESON ANALYTICS INC.

Notes to Condensed Consolidated Financial Statements

In March 2018, the Investor exercised the Exchange Warrant by means of a cashless exercise into 17,414 (4,353,581 pre-split) shares of common stock and a cash payment from the Company of $779,219, resulting in a reduction of the warrant liability and corresponding adjustment to Additional Paid in Capital.

With the issuance of the Exchange Warrant, the resulting cash flows of the remaining Investor Warrant were considered to be significantly modified within the context of ASC 470. Accordingly, the incremental change in fair value between the Investor Warrant and the Exchange Warrant was calculated as $12,878,864 and recorded as interest expense. 

November 2017 Notes

On November 7, 2017, the Company issued two Senior Secured Convertible Notes in the aggregate principal amount of $100,000,000 (collectively, the “November 2017 Notes”) to institutional investors. The November 2017 Notes consist of a Senior Secured Convertible Note in the amount of $5,000,000 (the “November Initial Note”) and a Senior Secured Convertible Note in the amount of $95,000,000 (the “November Additional Note”) in exchange for an upfront cash payment of $5,000,000 and a senior secured promissory note of $95,000,000 (the “November 2017 Investor Note”). As of December 31, 2017, purchasers of the November 2017 Notes prepaid $15,650,000 of the November 2017 Investor Note with the remaining principal being subject to master netting agreements between the Company and such holders. In conjunction with the prepayment, the Company was also obligated to pay the holders interest which would have accrued with respect to the outstanding balance for the period from the redemption date through the maturity date (the “Make-Whole Interest”). As cash is received from the November 2017 Investor Note, and the related principal amount of the November 2017 Notes increases accordingly, a derivative liability related to the conversion feature and Make-Whole Interest feature embedded within the November 2017 Notes is recorded as a debt discount, and accreted into interest expense over the life of the November 2017 Notes using the effective interest method, and any excess value over the amount of cash received is expensed immediately to interest expense. In addition, November Placement Agent Warrants are also issued (See The Placement Agent Notes Warrants below), recognized as liabilities pursuant to their terms and recorded as a debt discount, and accreted into interest expense over the life of the November 2017 Notes using the effective interest method, and any excess value over the amount of cash received is expensed immediately to interest expense.

The Company elected to defer payment of the Make-Whole Interest by capitalizing the full balance under the same terms as the original November 2017 Notes. On January 2, 2018, an additional $646,263 of interest was capitalized and added to the principal balance of the November 2017 Notes and on January 26, 2018, investors redeemed principal of $2,894,062 in exchange for cash. On April 2, 2018 and July 2, 2018, an additional $1,028,730 and $714,977 of interest respectively, was capitalized and added to the principal balance of the note. As of September 30, 2018, the entire capitalized balance was converted to shares of the Company’s common stock and the outstanding balance owed on the capitalized Make-Whole Interest was $0.

The November 2017 Notes have a maturity date of November 7, 2019. On any unfunded principal balance of the November 2017 Investor Notes the Company owed to the investors a 5.25% interest obligation which is due quarterly and calculated on a 360-day basis. For the funded portion of the November 2017 Notes the Company has a 10% interest obligation. The initial conversion price for the November 2017 Notes, which includes both the November Initial Note and November Additional Note, was $3,015 ($12.06 pre-split). However, the conversion price may be adjusted upon obtaining stockholder approval in accordance with Nasdaq Listing Rule 5635(d) of the issuance of our common stock at any conversion price below $3,015, which may result from full ratchet conversion price adjustments required by the November 2017 Notes in the event of certain issuances below the initial conversion price. Such stockholder approval was obtained at the stockholders meeting held in February 2018. As a result, during the second and third quarters of 2018, in conjunction with the April 2018 Offering and the sale of shares in the ATM Offering at prices lower than the initial conversion price, the conversion price for the November 2017 Notes has been reduced, and as of September 30, 2018, the conversion price was $0.02.

During the second and third quarters of 2018, the Company received cash prepayments on the November 2017 Investor Notes of $58,959,736, of which $58,959,736 of principal and $8,252,583 of accrued interest, were converted into 612,792 (58,905,544 pre-split) shares of the Company’s common stock during the nine months ended September 30, 2018. As of September 30, 2018, there was no outstanding unrestricted principal under the November 2017 Notes and $20,388,861 in restricted principal outstanding for which there was a corresponding amount due under corresponding November 2017 Investor Notes. For the three and nine months ended September 30, 2018, the Company recognized $261,657 and $5,994,771 of interest expense pertaining to the November 2017 Notes and had $261,657 of accrued interest as of September 30, 2018.

22

HELIOS AND MATHESON ANALYTICS INC.

Notes to Condensed Consolidated Financial Statements

On June 1, 2018, the Company entered into an amendment to the securities purchase agreement between the Company and the institutional investors holding the November 2017 Notes to reduce the number of shares of common stock required to be reserved for issuance under the November 2017 Notes from 200% to 110% of the maximum number of shares of common stock issuable upon conversion of the November 2017 Notes until the earlier of the January 2018 Notes Stockholder Approval Date (as defined below) and August 1, 2018. After such date, the required reserve amount will be increased back to 200%. As more fully described in Note 19 – Subsequent Events, the Securities Purchase Agreement between the Company and certain institutional investors pursuant to which the Company issued the November 2017 Notes was amended to reduce the number of shares of common stock of the Company required to be reserved for issuance under the November 2017 Notes to 100% of the maximum number of shares of common stock of the Company issuable upon conversion of the November 2017 Notes.

MoviePass has guaranteed the obligations arising under the November 2017 Notes.

January 2018 Notes

On January 23, 2018, pursuant to a securities purchase agreement (the “January Securities Purchase Agreement”) entered into by the Company and an institutional investor the Company sold and issued senior convertible notes in the aggregate principal amount of $60,000,000 (collectively, the “January 2018 Notes”), consisting of (i) a Series A-1 Senior Bridge Subordinated Convertible Note in the aggregate principal amount of $25,000,000 (the “Series A-1 Note”) and (ii) a Series B-1 Senior Secured Bridge Convertible Note in the aggregate principal amount of $35,000,000 (the “Series B-1 Note”) for consideration consisting of (i) a cash payment in the aggregate amount of $25,000,000, and (ii) a secured promissory note payable by the buyer to the Company (the “January 2018 Investor Note”) in the aggregate principal amount of $35,000,000 which is subject to a master netting agreement between the Company and the buyer (collectively, the “January 2018 Financing”). In conjunction with the prepayment of the January 2018 Investor Note the Company was also obligated to pay the buyer interest which would have accrued with respect to the outstanding balance for the period from the redemption date through the maturity date (the “January Make-Whole Interest”). As cash is received from the January 2018 Investor Note, and the related principal amount of the January 2018 Notes increases accordingly, a derivative liability related to the conversion feature and the January Make-Whole Interest feature embedded within the January 2018 Notes is recorded as a debt discount and any excess value over the amount of cash received is expensed immediately to interest expense. In addition, January Placement Agent Warrants were also issued (See The Placement Agent Notes and Warrants below), recognized as liabilities pursuant to their terms and recorded as a debt discount, and accreted into interest expense over the life of the January 2018 Notes using the effective interest method, and any excess value over the amount of cash received was expensed immediately to interest expense.

The Company elected to defer payment of the January Make-Whole Interest by capitalizing the full balance under the same terms as the original January 2018 Notes. On April 2, 2018, $352,187 and July 2, 2018, $468,180 of interest, respectively, was capitalized and added to the principal balance of the note. As of September 30, 2018, the entire capitalized was converted to shares of the Company’s common stock and the outstanding balance owed on the capitalized Make-Whole Interest was $0.

Unless earlier converted or redeemed, the January 2018 Notes have a maturity date of January 23, 2020. The Series A-1 Note bears interest at a rate of 10% per annum. Upon issuance, the Series B-1 Note initially consisted entirely of “Restricted Principal” which is defined as that portion of the principal amount of a Series B-1 Note that equals the outstanding principal amount of the corresponding January 2018 Investor Note. The principal amount of the January 2018 Investor Note is subject to reduction through prepayments by the buyer of the January 2018 Investor Note given by the buyer to the Company or, upon maturity or redemption of the Series B-1 Note, by netting the amount owed by the buyer under the January 2018 Investor Note against a corresponding amount of principal to be canceled under the buyer’s Series B-1 Note. Each prepayment under the January 2018 Investor Note will convert a corresponding amount of Restricted Principal under the Series B-1 Note into “Unrestricted Principal” that may be converted into common stock.

The January 2018 Notes have an initial conversion price of $2,860 ($11.44 pre-split) per share. However, pursuant to the January Securities Purchase Agreement, the Company was required to seek stockholder approval in accordance with Nasdaq Listing Rule 5635(d) of the issuance of our common stock at a conversion price per share as low as $1.83 following the occurrence of an event of default or otherwise at any conversion price below $2,860 which may result from full ratchet conversion price adjustments required by the January 2018 Notes in the event of certain issuances below the initial conversion price. Such stockholder approval was obtained on July 23, 2018. As a result, in conjunction with the April 2018 Offering and the sale of shares in the ATM Offering at prices lower than the initial conversion price, the conversion price for the January 2018 Notes has been reduced, and as of September 30, 2018, the conversion price was $0.02.

The Company is required to redeem the January 2018 Notes (i) at the option of the buyer from and after June 7, 2018; (ii) at the option of the buyer if the Company completes a subsequent public or private offering of debt or equity securities, including equity-linked securities (subject to certain excluded issuances); (iii) upon the occurrence of an Event of Default, including a Bankruptcy Event of Default (each, as defined in the January 2018 Notes); or (iv) in the event of a Change of Control (as defined in the January 2018 Notes). With the exception of a redemption required by an Event of Default (as defined in the January 2018 Notes), which may be paid with cash or shares of the Company’s common stock at the election of the buyer, the Company will be required to redeem the January 2018 Notes with cash. All amounts outstanding under the January 2018 Notes are secured by the January 2018 Investor Note and all proceeds therefrom. The January 2018 Notes are not secured by, and the buyer does not have a lien on, any assets of the Company other than the January 2018 Investor Note.

23

HELIOS AND MATHESON ANALYTICS INC.

Notes to Condensed Consolidated Financial Statements

MoviePass has guaranteed the obligations arising under the January 2018 Notes.

Provided there has been no Equity Conditions Failure (as defined in the January 2018 Notes) and, as to the Series A-1 Note, no August 2017 Notes or November 2017 Notes remain outstanding, and as to the Series B-1 Note, no August 2017 Notes, November 2017 Notes, Series A-1 Note or Series B-1 Note with any Unrestricted Principal remain outstanding, the Company will have the right to redeem all, but not less than all, of the Outstanding Amount (as defined in the January 2018 Notes) remaining unpaid under the January 2018 Notes. The portion of the January 2018 Notes subject to redemption can be redeemed by the Company in cash at a price equal to 115% of the amount being redeemed. Under the Series B-1 Note, the Company may reduce, on a dollar for dollar basis, the Restricted Principal by the surrender for cancellation of such portion of the corresponding January 2018 Investor Note equal to the amount of Restricted Principal included in the redemption.

During the third quarter of 2018, the Company received cash payments on the January 2018 Notes of $6,000,000, of which $6,000,000 of principal and $909,021 of accrued interest, were converted into 109,897,912 shares of the Company’s common stock during the third quarter of 2018. Additionally, during the third quarter of 2018, the Company converted principal under the January 2018 Notes in the amount of $820,367, and interest of $128,068 into 1,896,872 shares of the Company’s common stock. As of September 30, 2018, there was no outstanding unrestricted principal on the January Notes. For the three and nine months ended September 30, 2018, the Company recognized $372,167 and $1,182,130 of interest expense pertaining to the January 2018 Notes and had $372,167 of accrued interest as of September 30, 2018.

On June 1, 2018, the Company and the buyer entered into an amendment to the January Securities Purchase Agreement and the January 2018 Notes to reduce the number of shares of common stock required to be reserved for issuance under the January 2018 Notes from 200% to 100% of the maximum number of shares of common stock issuable upon conversion of the January 2018 Notes until the earlier of (1) the date stockholders approve resolutions providing for the issuance of the January 2018 Notes and the shares of common stock issuable upon conversion of the January 2018 Notes (the “January 2018 Notes Stockholder Approval” and the date the Stockholder Approval is obtained, the “January 2018 Notes Stockholder Approval Date”) and (2) August 1, 2018. After such date, the required reserve amount will be increased back to 200%. The amendment to the January Securities Purchase Agreement also extended the date by which the Company must hold the special meeting to obtain the January 2018 Notes Stockholder Approval from June 1, 2018 to August 1, 2018. As more fully described in Note 19 – Subsequent Events, the January Securities Purchase Agreement was amended to reduce the number of shares of common stock of the Company required to be reserved for issuance under the January 2018 Notes to 125% of the maximum number of shares of common stock of the Company issuable upon conversion of the January 2018 Notes.

February 2018 Units Offering

On February 13, 2018, the Company sold an aggregate of approximately $105 million worth of units (the “Units”) of the Company’s securities to Canaccord Genuity Inc., on behalf of itself and as representative of the underwriters (the “Underwriters”), pursuant to which the Company issued and sold to the Underwriters in a best-efforts underwritten public offering (the “Offering”) at a purchase price of $5.192 per Unit with each Unit consisting of (A) 7,425,000 Series A-1 units (the “Series A-1 Units”), with each Series A-1 Unit consisting of (i) 0.004 (one pre-split) share of the Company’s common stock, and (ii) 0.004 (one pre-split) Series A-1 warrant to purchase 0.004 (one pre-split) share of the Company’s common stock (a “Series A-1 Warrant”); and (B) for those purchasers whose purchase of Series A-1 Units would result in the purchaser, together with its affiliates and certain related parties, beneficially owning more than 9.99% of the Company’s outstanding common stock following the consummation of the Offering, 11,675,000 Series B-1 units (the “Series B-1 Units”), consisting of (i) 0.004 (one pre-split) pre-funded Series B-1 warrant to purchase 0.004 (one pre-split) share of common stock (a “Series B-1 Warrant”; and the Series B-1 Warrants, together with the Series A-1 Warrants, the “Warrants”) and (ii) 0.004 (one pre-split) Series A-1 Warrant.

24

HELIOS AND MATHESON ANALYTICS INC.

Notes to Condensed Consolidated Financial Statements

Each Warrant is exercisable at any time on or after the issuance date until the five-year anniversary of the issuance date. Each Series A-1 Warrant is exercisable at a price of $1,625 ($6.50 pre-split) per share of common stock. Each Series B-1 Warrant has an aggregate exercise price of $1,375 ($5.50 pre-split) per share of common stock, all of which were pre-funded except for a nominal exercise price of $0.001 per share of common stock. All Series B-1 Warrants were exercised.

The Company received approximately $96.9 million in net proceeds from the sale of the Units, after deducting underwriting discounts and commissions equal to $5.9 million and estimated offering expenses of approximately $0.5 million, not taking into account any exercise of the Warrants. In addition, Palladium Capital Advisors, LLC acted as financial advisor in connection with the Offering and received a financial advisory fee equal to $1.9 million.

The Warrants were recorded as liabilities and initially recorded at fair value with the residual amount received allocated to the Company’s common stock. The exercise price of and number of shares of the Company’s common stock underlying the Warrants are subject to adjustment upon the issuance by the Company of stock dividends, stock splits, and similar proportionately applied changes affecting the Company’s outstanding common stock. In addition, the Series A-1 Warrants are subject to adjustment of the applicable exercise price then in effect, if, as of December 17, 2018 (the “Adjustment Date”), the quotient determined by dividing the (x) sum of the VWAP (as defined in the Series A-1 Warrant) of the common stock for each trading day during the 10 consecutive trading day period ending and including the trading day immediately preceding the Adjustment Date, divided by (y) 0.4 (10 pre-split) (all such determinations to be appropriately adjusted for any stock dividend, stock split, stock combination or other similar transaction during such period) (the “Adjustment Price”), is less than the applicable exercise price. If the Adjustment Price is less than the applicable exercise price as of the Adjustment Date, then the exercise price shall be automatically adjusted to be equal to the Adjustment Price.

If the Company consummates any merger, consolidation, sale or other reorganization event in which its common stock is converted into or exchanged for securities, cash or other property (“Fundamental Transaction”), then the Company shall pay at the Warrants holder’s option, exercisable at any time commencing on the occurrence or the consummation of a Fundamental Transaction and continuing for 90 days, an amount of cash equal to the value of the remaining unexercised portion of the warrant as determined in accordance with the Black-Scholes option pricing model on the date of such Fundamental Transaction.

April 2018 Units Offering

On April 23, 2018, the Company sold an aggregate of approximately $30 million worth of units (the “April 2018 Units”) of the Company’s securities to Canaccord Genuity Inc., on behalf of itself and as representative of the underwriters (the “April Offering Underwriters”), pursuant to which the Company issued and sold to the April Offering Underwriters in a best-efforts underwritten public offering (the “April 2018 Offering”) at a purchase price of $2.59875 per April 2018 Unit with each April 2018 Unit consisting of (A) 10,500,000 Series A-2 units (the “Series A-2 Units”), with each Series A-2 Unit consisting of (i) 0.004 (one pre-split) share (an “April Share”) of the Company’s common stock, and (ii) 0.004 (one pre-split) Series A-2 warrant to purchase 0.004 (one pre-split) share of common stock (the “Series A-2 Warrants”); and (B) for those purchasers whose purchase of Series A-2 Units would result in the purchaser, together with its affiliates and certain related parties, beneficially owning more than 9.99% of the Company’s outstanding common stock following the consummation of the April 2018 Offering, 500,000 Series B-2 units (the “Series B-2 Units”), consisting of (i) 0.004 (one pre-split) pre-funded Series B-2 warrant to purchase 0.004 (one pre-split) share of common stock (the “Series B-2 Warrants”, and together with the Series A-2 Warrants, the “April Warrants”) and (ii) 0.004 (one pre-split) Series A-2 Warrant. The April Shares, Series A-2 Warrants and Series B-2 Warrants were immediately separable.

25

HELIOS AND MATHESON ANALYTICS INC.

Notes to Condensed Consolidated Financial Statements

Each April Warrant is exercisable at any time on or after the issuance date until the five-year anniversary of the issuance date. Each Series A-2 Warrant is exercisable at a price of $250 ($1.00 pre-split) per share of common stock. Each Series B-2 Warrant had an aggregate exercise price of $687.50 ($2.75 pre-split) per share of common stock, all of which were pre-funded except for a nominal exercise price of $0.001 per share of common stock. All of the Series B-2 Warrants were exercised.

The Company received approximately $27.7 million in net proceeds from the sale of the April 2018 Units, after deducting underwriting discounts and commissions equal to $1.7 million and estimated offering expenses of approximately $1.0 million, not taking into account any exercise of the April Warrants. In addition, Palladium Capital Advisors, LLC acted as financial advisor in connection with the April 2018 Offering and received a financial advisory fee equal to $0.6 million

The April Warrants were recorded as liabilities and initially recorded at fair value with the residual amount received allocated to the Company’s common stock. The exercise price of and number of shares of common stock underlying the April Warrants are subject to adjustment upon the issuance by the Company of stock dividends, stock splits, and similar proportionately applied changes affecting the Company’s outstanding common stock. The Series A-2 Warrants also include “full ratchet” anti-dilution protection provisions (the “Full Ratchet Adjustment”), which provide that if the Company issues any shares of common stock at a price less than the then current exercise price of the Series A-2 Warrants, or if the Company issues any securities convertible into, or exercisable, or exchangeable for, shares of common stock with an exercise or conversion price less than the then current exercise price of the Series A-2 Warrants, then the exercise price of the Series A-2 Warrants will automatically be reduced to the issuance price of the new shares of common stock or the exercise or conversion price of the April Warrants, options or other convertible or exchangeable securities.

The Full Ratchet Adjustment does not apply if the Company issues “Excluded Securities”, including certain (i) option and other equity incentive awards approved by the Company’s Board of Directors to be issued to directors, officers, consultants and employees, (ii) shares of common stock issuable pursuant to existing employment agreements, (iii) shares of common stock issued upon conversion or exercise of convertible securities that were previously issued, (iv) shares of common stock issued pursuant to strategic license agreements, mergers or acquisitions (but does not include a transaction in which the Company is issuing securities primarily for the purpose of raising capital), (v) shares of common stock issued under the ATM Offering after the fifteenth calendar day that the Series A-2 Warrants were issued and (vi) 2,000 (500,000 pre-split) shares granted by the Company’s Board of Directors to Helios & Matheson Information Technology Ltd, a current stockholder of the Company, in exchange for its entry into a 12-month lock-up agreement with the Company.

If the Company consummates any merger, consolidation, sale or other reorganization event in which its common stock is converted into or exchanged for securities, cash or other property (“fundamental transaction”), then the Company shall pay at the holder’s option, exercisable at any time commencing on the occurrence or the consummation of a fundamental transaction and continuing for 90 days, an amount of cash equal to the value of the remaining unexercised portion of the warrant as determined in accordance with the Black-Scholes option pricing model on the date of such fundamental transaction.

June 2018 Convertible Notes and Series A Preferred Stock

On June 26, 2018, pursuant to the Securities Purchase Agreement, dated as of June 21, 2018, by and between the Company and certain institutional investors (the “June Buyers” and such agreement, the “June Securities Purchase Agreement”), the Company issued and sold 20,500 shares of Series A Preferred Stock of the Company (the “Preferred Stock”) and Series B-2 Senior Convertible Notes in the aggregate principal amount of $164,000,000 (which includes an approximate 15.0% original issue discount) (the “June 2018 Convertible Notes”), for total consideration consisting of an aggregate cash payment to the Company of $20,500,000 and secured promissory notes payable by the June Buyers to the Company (the “June 2018 Investor Notes”) in the aggregate principal amount of $139,400,000.

Unless earlier converted or redeemed, the June 2018 Convertible Notes would have matured on June 26, 2020. The maturity date of the June 2018 Investor Notes was June 26, 2060. Upon issuance, (i) $24,600,000 in principal amount of the June 2018 Convertible Notes consisted of “Unrestricted Principal”, which is defined as that portion of the principal amount of June 2018 Convertible Note that may be converted at any time and is not subject to netting  against any June 2018 Investor Notes, and (ii) the balance of the principal amount under the June 2018 Convertible Notes, equal to $139,400,000, consisted entirely of “Restricted Principal”, which is defined as that portion of the principal amount of a June 2018 Convertible Note that equals the outstanding principal amount of a corresponding June 2018 Investor Note. The principal amount of each June 2018 Investor Note was subject to reduction through prepayments by the applicable June Buyer of the applicable June 2018 Investor Note given by the applicable June Buyer to the Company or, upon maturity or redemption of the June 2018 Convertible Notes, by netting the amount owed by the applicable June Buyer under such June 2018 Investor Note against a corresponding amount of Restricted Principal to be canceled under the June 2018 Convertible Note. Each prepayment under the June 2018 Investor Notes would convert a corresponding amount of Restricted Principal under the June 2018 Convertible Notes into “Unrestricted Principal” that could be converted into common stock.

As of September 30, 2018, the June Buyers prepaid $24,600,000 of the June 2018 Investor Notes with the remaining principal being subject to a master netting agreement between the Company and the June Buyers (collectively, the “June 2018 Financing”). In conjunction with the prepayment, the Company was also obligated to pay the June Buyers interest which would have accrued with respect to the outstanding balance for the period from the redemption date through the maturity date (the “June Make-Whole Interest”).

26

HELIOS AND MATHESON ANALYTICS INC.

Notes to Condensed Consolidated Financial Statements

On any unfunded principal balance of the June 2018 Investor Notes the Company owed to the June Buyers a 5.25% interest obligation which was due quarterly and calculated on a 360-day basis. For the funded portion of the June 2018 Notes the Company had a 10% interest obligation.

Interest on the June 2018 Convertible Notes was capitalized on each quarterly interest payment date starting July 1, 2018 by adding the interest to the then outstanding principal amount of the June 2018 Convertible Notes. Interest could also be paid by inclusion in the “Outstanding Amount”, which is defined in the June 2018 Convertible Notes as the principal amount to be converted or redeemed, accrued and unpaid interest with respect to such principal amount, accrued and unpaid late charges, if any, and the “June Make-Whole Amount.” The “June Make-Whole Amount” is defined as the amount of any interest that, but for a conversion or redemption, would have accrued with respect to the Outstanding Amount (as defined in the June 2018 Convertible Notes) of principal being redeemed or converted under the June 2018 Convertible Notes, for the period from the applicable date of conversion or redemption date through the maturity date of the June 2018 Convertible Notes. No June Make-Whole Amount is payable under the June 2018 Convertible Notes with respect to any portion of Restricted Principal after the cancellation of such Restricted Principal pursuant to netting under the June 2018 Convertible Notes, the June 2018 Investor Notes or the Master Netting Agreement (as defined below), as applicable. In the event of an event of default interest under the June 2018 Convertible Notes could be increased to 15% during the first 30 days following the occurrence and continuance of an event of default and to 18% thereafter (the “Default Rate”).

Provided there has been no Equity Conditions Failure (as defined in the June 2018 Convertible Notes) and no November 2017 Notes, January 2018 Notes, or shares of the Preferred Stock remain outstanding and no Unrestricted Principal remains outstanding under the June 2018 Convertible Notes, the Company had the right to redeem all, but not less than all, of the Outstanding Amount remaining unpaid under the June 2018 Convertible Notes. The portion of the June 2018 Convertible Notes subject to redemption could be redeemed by the Company in cash at a price equal to 115% of the amount being redeemed. Under the June 2018 Convertible Notes, the Company could reduce, on a dollar for dollar basis, the Restricted Principal by the surrender for cancellation of such portion of the corresponding June 2018 Investor Notes equal to the amount of Restricted Principal included in the redemption.

The June Buyers had the right to elect, at any time after the Company obtains approval by its stockholders to either increase its authorized shares of common stock or effect a reverse stock split, which approval was obtained on July 23, 2018, to convert the June 2018 Convertible Notes into shares of the Company’s common stock at the Conversion Price, subject to certain beneficial ownership limitations described below. The “Conversion Price” is $250 ($1.00 pre-split) per share (subject to anti-dilution adjustment as described in the June 2018 Convertible Notes). However, pursuant to the June Securities Purchase Agreement, the Company was required to seek stockholder approval in accordance with Nasdaq Listing Rule 5635(d) of the issuance of common stock at a conversion price per share below $250 which may result from the full ratchet conversion price adjustments required by the June 2018 Convertible Notes in the event of certain issuances below the initial conversion price. The Company was required to hold a special meeting of stockholders by November 14, 2018 to obtain such approval. If such stockholder approval was obtained, if the Company issues securities in certain transactions, such as the ATM Offering, at a price lower than the applicable conversion price, then the applicable conversion price for the June 2018 Convertible Notes will be reduced to equal such lower price.

The Preferred Stock was determined to be classified in equity. Accordingly, the June 2018 Convertible Notes and the Preferred Stock were recorded based on their relative fair values. A derivative liability related to the conversion feature and make-whole interest feature embedded within the June 2018 Convertible Notes is recorded as a debt discount, and accreted into interest expense over the life of the June 2018 Convertible Notes using the effective interest method, and any excess value over the amount allocated to the June 2018 Convertible Notes was expensed immediately to interest expense. In addition, June Placement Agent Warrants are also issued (See The Placement Agent Notes and Warrants below), recognized as liabilities pursuant to their terms and recorded as a debt discount, and accreted into interest expense over the life of the June 2018 Convertible Notes using the effective interest method, and any excess value over the amount of cash received is expensed immediately to interest expense.

MoviePass has guaranteed the obligations arising under the June 2018 Convertible Notes.

In connection with the June 2018 Financing, Theodore Farnsworth, the Chief Executive Officer and Chairman of the Board of the Company, and Helios & Matheson Information Technology Ltd, of which Muralikrishna Gadiyaram, a director of the Company, is the chief executive officer, and its wholly-owned subsidiary, Helios & Matheson Inc., who collectively owned approximately 1.5% of the Company’s issued and outstanding common stock as of the closing of the June 2018 Financing, entered into Voting and Lockup Agreements with the Company. In addition, the Company entered into separate Buyer Voting Agreements with each of the June Buyers with terms consistent with the June 2018 Amendment and Exchange Agreements (see Exchange of Warrants for Common Shares below).

27

HELIOS AND MATHESON ANALYTICS INC.

Notes to Condensed Consolidated Financial Statements

As of September 30, 2018, there was no unrestricted principal balance of the June 2018 Convertible Notes outstanding and restricted principal outstanding was $74,800,000 for which there was a corresponding amount due under the June 2018 Investor Notes. For the three and nine months ended September 30, 2018, the Company recognized $959,933 and $965,233, respectively, of interest expense pertaining to the June 2018 Convertible Notes and had $959,933 of accrued interest as of September 30, 2018.

On October 4, 2018, the Company entered into an Amendment and Exchange Agreement (the “October Exchange Agreement”) with the holder of a June 2018 Convertible Note having an outstanding principal amount of $68,882,583 for the purpose of (i) netting the June 2018 Investor Note issued by such holder to the Company having an aggregate principal amount of $68,000,000 against such holder’s June 2018 Convertible Note and (ii) following such netting transaction, exchanging the remaining outstanding amount payable under such holder’s June 2018 Convertible Note for a new non-convertible Senior Note issued by the Company to such holder (the “New Non-Convertible Note”) in an aggregate principal amount of $20,400,000, subject to reduction as provided in the New Non-Convertible Note. As a result, such holder’s June 2018 Convertible Note and the corresponding June 2018 Investor Note issued by such holder were each cancelled and became null and void.

Following the consummation of the transactions contemplated by the October Exchange Agreement and the netting of the other June 2018 Investor Notes by the other holders of the June 2018 Investor Notes against their corresponding June 2018 Convertible Notes, all of the June 2018 Convertible Notes have been cancelled.

Exchange of Warrants for Common Shares

On June 28, 2018, the Company entered into separate June 2018 Amendment and Exchange Agreements (each, an “Exchange Agreement”) with the holders (each, a “Holder” and collectively, the “Holders”) of certain warrants to purchase shares of the Company’s common stock for the purpose of exchanging outstanding warrants to purchase an aggregate of 106,437 (26,609,269 pre-split) shares of common stock (the “June Exchange Warrants”) for an aggregate of 90,472 (22,617,879 pre-split) shares of common stock (collectively, the “June Exchange Shares”), based on a ratio of 0.85 June Exchange Shares for each warrant share. As a result, the June Exchange Warrants have been cancelled.

On June 28, 2018, each Holder that was not a party to the June Securities Purchase Agreement entered into a voting agreement with the Company (each, a “Voting Agreement” and collectively, the “Voting Agreements”). Pursuant to the Voting Agreements, each Holder agreed to vote the June Exchange Shares and any shares of common stock the Holder owns or may acquire (collectively, the “Holder Securities”) at any meeting of stockholders of the Company: (a) in favor of (i) approval of resolutions providing for the January 2018 Notes Stockholder Approval, (ii) an increase in the authorized shares of the Company and (iii) a reverse stock split of the common stock; and (b) against any proposal or any other corporate action or agreement that would result in a breach of any covenant, representation or warranty or any other obligation or agreement of the Company under the Transaction Documents (as defined in the June Securities Purchase Agreement) or the Transaction Documents (as defined in the January Securities Purchase Agreement) or which could result in any of the conditions to the Company’s obligations under the Transaction Documents (as defined in the June Securities Purchase Agreement) or the Transaction Documents (as defined in the January Securities Purchase Agreement), as applicable, not being fulfilled. The agreements to vote the Holder Securities described above terminate immediately following the occurrence of the January 2018 Notes Stockholder Approval described above.

The Voting Agreements also required that, at any time on or prior to the record date for the meeting of stockholders of the Company at which the Company obtained the January 2018 Notes Stockholder Approval, each Holder would not sell or transfer any of the June Exchange Shares. However, the Holders (or their designees, as applicable) were not prohibited from (i) using their Holder Securities to cover the Holders’ or their respective affiliates’ Short Sales (as defined in SEC Regulation SHO) outstanding as of the date of the Voting Agreement, (ii) lending any of their Holder Securities to any person, or (iii) pledging any of the Holder Securities to any person.

In connection with the Exchange Agreements, on June 28, 2018, each Holder entered into a leak-out agreement with the Company (each a “Leak-Out Agreement” and collectively, the “Leak-Out Agreements”), which restricted each Holder from selling the June Exchange Shares during certain periods. Pursuant to the Leak-Out Agreements, for a period ending on the earlier of (x) July 23, 2018 and (y) the Stock Split Stockholder Approval Date (as defined in the June Securities Purchase Agreement) (such earlier date, the “Lock-Up End Date”), the Holder was not, after the date of the Leak-Out Agreement, to sell any of the June Exchange Shares. However, the Holders (or their designees, as applicable) were not prohibited from (i) using their Holder Securities to cover the Holders’ or their respective affiliates’ Short Sales (as defined in SEC Regulation SHO) outstanding as of the date of the Leak-Out Agreement, (ii) lending any of their Holder Securities to any person, or (iii) pledging any of their Holder Securities to any person. In addition, subject to certain exclusions, Holders and any Trading Affiliates (as defined in the Leak-Out Agreements) were restricted from selling specified amounts of their June Exchange Shares for up to fifteen calendar days after the Lock-Up End Date, unless certain events, as described in the Leak-Out Agreements, earlier terminated such restrictions.

28

HELIOS AND MATHESON ANALYTICS INC.

Notes to Condensed Consolidated Financial Statements

On June 28, 2018, the Company and the Required Holder (as defined in the June Securities Purchase Agreement), entered into an amendment to the June Securities Purchase Agreement (“Amendment No. 1 to Securities Purchase Agreement”), pursuant to which the Stockholder Meeting Deadline (as defined in the June Securities Purchase Agreement) was amended from July 18, 2018 to July 23, 2018.

The collective June Exchange Warrants which were exchanged in this transaction, were all recorded as liabilities at fair value upon issuance, and marked to market at each balance sheet date. The June Exchange Warrants were valued through the date of exchange, June 28, 2018, based upon the original terms of the agreements with changes in fair value recorded in the as gain/loss on warrant liability. The June Exchange Warrants were then valued on the same day based on the fair value of the common shares into which they were converted (0.85 June Exchange Shares for each warrant), and the difference in the fair value between the two instruments was recorded as gain/loss on exchange of warrant. The fair value determined on June 28, 2018 then became the consideration received for the issuance of the common stock. The excess of the consideration received over the par value of the common stock was recorded as Additional Paid in Capital. Accordingly, the incremental change in fair value between the Investor Warrant and the Exchange Warrant is calculated as $301,500 and recorded as Gain on Exchange of Warrants.

Waiver Agreements

On July 10, 2018, the Company entered into a Waiver Agreement (the “July Waiver Agreement”) with a holder of the November 2017 Notes, January 2018 Notes and June 2018 Convertible Notes (collectively, the “Existing Notes”).

Pursuant to the July Waiver Agreement, such holder, in its capacity as the Required Holder under the Securities Purchase Agreements pursuant to which the Existing Notes were issued: (i) waived any obligation by the Company to effect any redemption of the Existing Notes as a result of the consummation of a proposed public offering of securities by the Company (the “New Proposed Offering”), (ii) reduced the aggregate number of shares required to be reserved for issuance upon conversion of the November 2017 Notes and the January 2018 Notes, (iii) deferred the right that the holders of the Existing Notes may have to adjust the Conversion Price (as defined in the applicable Existing Note) of such Existing Notes solely as a result of the issuance of securities in the New Proposed Offering until the fourth trading day after the time of the pricing of the New Proposed Offering, (iv) consented to the New Proposed Offering, and (v) waived any prohibition with respect to the issuance of the securities in the New Proposed Offering.

On July 13, 2018, the Company entered into an amendment (the “Amendment”) to the July Waiver Agreement. The Amendment revised the July Waiver Agreement as follows: (i) the waiver of the Company’s obligation to effect any redemption of the Existing Notes as a result of the consummation of a New Proposed Offering (as defined in the July Waiver Agreement) applies only to the extent the redemption right arises from the occurrence of a Financing (as defined in the June 2018 Convertible Notes) occurring between July 11, 2018 and July 17, 2018; (ii) the number of shares permitted to be offered in the New Proposed Offering was reduced; (iii) the number of shares required to be reserved for issuance upon conversion of the November 2017 Notes was increased; (iv) the reduction in the number of shares required to be reserved upon conversion of the November 2017 Notes (the “Reduction Shares”) ends when stockholders approve either an increase in the authorized shares of common stock or a reverse stock split of the common stock, and if the Reduction Shares are not issued prior to close of market on July 17, 2018, the Reduction Shares that were not issued would be restored to (and increase) the reserve for the November 2017 Notes; and (v) the deferral of the right that the holders of the Existing Notes may have to adjust the Conversion Price (as defined in the applicable Existing Note) of such Existing Notes solely as a result of the issuance of securities in the New Proposed Offering until the fourth trading day after the time of the pricing of the New Proposed Offering provided in the July Waiver Agreement was eliminated.

July 13, 2018 Demand Note

On July 13, 2018 the Company issued a demand note (the “July 13 Demand Note”) in the principal amount of $6,806,850, which included $5.0 million in cash borrowed by the Company from the holder and $1,806,850 required to be paid by the Company to the holder pursuant to a partial redemption of the June 2018 Convertible Notes held by the holder. The July 13 Demand Note bore interest on the unpaid principal amount at the rate of 10.0% per year. The holder could make a demand for full payment of the July 13 Demand Note from and after July 17, 2018. The Company was required to use all proceeds received by the Company under its ATM Offering to repay the July 13 Demand Note. The July 13 Demand Note and all accrued interest could be prepaid by the Company without penalty. With the agreement of the holder, principal and interest accrued on the July 13 Demand Note could be applied to all, or any part, of the purchase price of securities to be issued upon the consummation, after July 13, 2018, of an offering of securities by the Company to the holder. Any amount of principal or other amounts due which is not paid when due would result in a late charge being incurred and payable by the Company to the holder in an amount equal to interest on such amount at the rate of 15% per year from the date such amount was due until the same is paid in full. 

29

HELIOS AND MATHESON ANALYTICS INC.

Notes to Condensed Consolidated Financial Statements

The $5,000,000 cash proceeds received from the July 13 Demand Note were used by the Company to pay the Company’s merchant and fulfillment processors. 

MoviePass executed a guaranty (the “MoviePass July 13 Demand Note Guaranty”) pursuant to which MoviePass guaranteed the punctual payment of the July 13 Demand Note, including, without limitation, all principal, interest and other amounts that accrue after the commencement of any insolvency proceeding of the Company or MoviePass, whether or not the payment of such interest and/or other amounts are enforceable or are allowable and agreed to pay any and all costs and expenses (including counsel fees and expenses) incurred by the holder in enforcing any rights under the MoviePass July 13 Demand Note Guaranty or the July 13 Demand Note.

On July 31, 2018, the Company paid in full the $6,800,000 outstanding under the July 13 Demand Note.

July 27, 2018 Demand Note

On July 27, 2018, the Company issued a demand note (the “July 27 Demand Note”) in the principal amount of $6,200,000, which included $5.0 million in cash borrowed by the Company from the holder and $1.2 million of original issue discount. The holder could make a demand for full payment of the July 27 Demand Note from and after (x) with respect to up to $3,100,000 of the principal outstanding under the July 27 Demand Note (the “Initial Principal”), August 1, 2018 or (y) with respect to any other amounts then outstanding under the July 27 Demand Note, August 5, 2018. The Company was required to use all proceeds received by the Company on or after July 31, 2018 from sales of common stock under its ATM Offering against any Initial Principal until no Initial Principal remains outstanding, and thereafter, against any remaining amounts due under the July 27 Demand Note. The July 27 Demand Note’s principal, together with accrued and unpaid late charges could be prepaid by the Company without penalty. With the agreement of the holder, principal and accrued and unpaid late charges on the July 27 Demand Note could be applied to all, or any part, of the purchase price of securities to be issued upon the consummation, after July 27, 2018, of an offering of securities by the Company to the holder. Any amount of principal or other amounts due which is not paid when due (a “Payment Default”) would result in a late charge being incurred and payable by the Company to the holder in an amount equal to interest on such amount as the rate of 15% per year from the date such amount was due until the same was paid in full. If a Payment Default remained outstanding for a period of 48 hours, the holder could require the Company to redeem all or a portion of the July 27 Demand Note at a redemption price of 130%.

The $5,000,000 cash proceeds received from the July 27 Demand Note were used by the Company to pay the Company’s merchant and fulfillment processors. If the Company is unable to make required payments to its merchant and fulfillment processors, the merchant and fulfillment processors may cease processing payments for MoviePass, which would cause a MoviePass service interruption. Such a service interruption occurred on July 26, 2018. Any future service interruptions could have a further material adverse effect on MoviePass’ ability to retain its subscribers. This would have an adverse effect on the Company’s financial position and results of operations.

MoviePass executed a guaranty (the “MoviePass July 27 Demand Note Guaranty”) pursuant to which MoviePass guaranteed the punctual payment of the July 27 Demand Note, including, without limitation, all principal, interest and other amounts that accrue after the commencement of any insolvency proceeding of the Company or MoviePass, whether or not the payment of such interest and/or other amounts are enforceable or are allowable, and agreed to pay any and all costs and expenses (including counsel fees and expenses) incurred by the holder in enforcing any rights under the MoviePass July 27 Demand Note Guaranty or the July 27 Demand Note.

On July 31, 2018, the Company paid in full the $6,200,000 outstanding under the July 27 Demand Note.

30

HELIOS AND MATHESON ANALYTICS INC.

Notes to Condensed Consolidated Financial Statements

The Placement Agent Notes and Warrants

The Company entered into an agreement with a placement agent (the “Placement Agent”) for assistance with the placement of the February 2017 Notes. The Placement Agent accepted from the Company a 5-year warrant (each, a “February Placement Agent Warrant”) as partial payment for the Placement Agent’s services. The February Placement Agent Warrants allow the purchase of up to 8% of the number of shares of the Company’s common stock into which the unrestricted principal of the February 2017 Notes may be converted. Through the first nine months of 2017, the Company received $5,000,000 of cash payments for the February 2017 Notes, resulting in the issuance of February Placement Agent Warrants for the purchase of 533 (133,334 pre-split) shares of common stock at an exercise price of $750 ($3.00 pre-split) per share. As of September 30, 2018, the Placement Agent has not elected to exercise any February Placement Agent Warrants. 

The Company entered into an agreement with the Placement Agent for assistance with the placement of the August 2017 Notes and Investor Warrant. The Placement Agent accepted from the Company a 5-year warrant (each, an “August Placement Agent Warrant”) as partial payment for the Placement Agent’s services. The August Placement Agent Warrants allow the purchase of up to 8% of the number of shares of the Company’s common stock into which the unrestricted principal of the Additional Series A Note and the Series B Note in the combined principal amount of $9,050,000 becomes convertible at an exercise price equal to the greater of the exercise price of the August 2017 Notes and the consolidated closing bid price of the Company’s common stock on the date that the Placement Agent becomes entitled to the August Placement Agent Warrants. During the period ended December 31, 2017, the Company received $8,800,000 of cash payments in conjunction with the August 2017 Notes and issued August Placement Agent Warrants for the purchase of 704 (176,000 pre-split) shares of common stock at exercise price of $750 ($3.00 pre-split) and $3,568 ($14.27 pre-split) per share. As of September 30, 2018, the Placement Agent has not elected to exercise any August Placement Agent Warrants. 

The Company entered into an agreement with the Placement Agent for assistance with the placement of the November 2017 Notes. The Placement Agent accepted from the Company a 5-year warrant (each, a “November Placement Agent Warrant”) as partial payment for the Placement Agent’s services. The November Placement Agent Warrants allow the purchase of up to 8% of the number of shares of the Company’s common stock into which the unrestricted principal of the November Series A Note and the November 2017 Notes in the combined principal amount of $100,000,000 becomes convertible at an exercise price equal to the greater of the exercise price of the November 2017 Notes and the consolidated closing bid price of the Company’s common stock on the date that the Placement Agent becomes entitled to the November Placement Agent Warrants. During the nine months ended September 30, 2018, the Company received $58,959,736 of cash payments for the November 2017 Notes resulting in the issuance of 751 (187,711 pre-split) warrants at an exercise price of $3,015 ($12.06 pre-split) per share. As of September 30, 2018, the Placement Agent has not elected to exercise any November Placement Agent Warrants.

The Company entered into an agreement with the Placement Agent for assistance with the placement of the January 2018 Notes. The Placement Agent accepted from the Company a 5-year warrant (each, a “January Placement Agent Warrant”) as partial payment for the Placement Agent’s services. The January Placement Agent Warrants allow the purchase of up to 8% of the number of shares of the Company’s common stock into which the unrestricted principal of the Series A-1 Note and the Series B-1 Note in the combined principal amount of $0 becomes convertible at an exercise price equal to the greater of the exercise price of the January 2018 Notes and the consolidated closing bid price of the Company’s common stock on the date that the Placement Agent becomes entitled to the January Placement Agent Warrants. During the nine months ended September 30, 2018, the Company received $31,000,000 of cash payments for the January 2018 Notes resulting in the issuances of 867 (216,786 pre-split) warrants at an exercise price of $2,860 ($11.44 pre-split) per share. As of September 30, 2018, the Placement Agent has not elected to exercise any January Placement Agent Warrants.

The Company entered into an agreement with the Placement Agent for assistance with the placement of the June 2018 Financing. The Placement Agent accepted from the Company a 5-year warrant (each, a “June Placement Agent Warrant”) as partial payment for the Placement Agent’s services. The June Placement Agent Warrants allow the purchase of up to 8% of the number of shares of the Company’s common stock determined by dividing the aggregate purchase price of the Preferred Stock purchased by the Conversion Price of the June 2018 Convertible Notes in effect as of the Subscription Date (as defined in the June Placement Agent Warrant) and eight percent (8%) of the number of shares of common stock into which any Unrestricted Principal of the June 2018 Convertible Notes purchased is initially convertible at the Conversion Price in effect as of the Subscription Date, at an exercise price equal to the Conversion Price of the June 2018 Convertible Notes in effect as of the Subscription Date, without regard to any adjustment of the Conversion Price resulting from the anti-dilution provision of the June 2018 Convertible Notes, other than proportionate adjustments to the Conversion Price resulting from stock splits or combinations or similar proportionately applied changes to the Company’s outstanding common stock. During the nine months ended September 30, 2018, the Company issued 3,200 (800,000 pre-split) warrants at an exercise price of $250 ($1.00 pre-split) per share. As of September 30, 2018, the Placement Agent has not elected to exercise any June Placement Agent Warrants. 

31

HELIOS AND MATHESON ANALYTICS INC.

Notes to Condensed Consolidated Financial Statements

Note Activity:

MoviePass Films Senior Notes consist of the following:

	September 30, 2018		December 31, 2017
GFF79 loan from SSS Entertainment	$	150,000	$	-
A Vigilante loan from Film Science, LLC (See Note 16)		2,625,000		-
10 Minutes Gone loan from City National Bank		5,923,250		-
Balance at period end	$	8,698,250	$	-

On September 10, 2018, MoviePass Films entered into a note payable for $7.2 million with annual interest equal to either a) 3.5% plus the prime rate plus 0.25% or b) the greater of (i) 3.5% and (ii) the LIBOR rate plus 2.75%. The note can be prepaid at anytime without penalty through the earlier of the abandonment of the production of the 10 Minutes Gone films or March 15, 2020.

Senior Secured Convertible Notes consist of the following:

	September 30, 2018		December 31, 2017
August 2017 Notes	$	-	$	2,061,072
November 2017 Notes		-		1,550,555
Balance at period end	$	-	$	3,611,627

Under ASC 210-20-45-1, management offset the Senior Secured Convertible Notes by the corresponding investor notes payable to the Company that the Company received as partial payment for the Senior Secured Convertible Notes (collectively, the “Investor Notes”) yet to be funded. As of September 30, 2018, the unfunded portion of the Investor Notes remaining was $49,390,264.

The carrying value of the Senior Secured Convertible Notes is comprised of the following:

	September 30, 2018		December 31, 2017
August 2017 Notes	$	-	$	4,505,440
November 2017 Notes		-		2,943,069
Unamortized discounts				(3,836,882	)
Balance at period end	$	-	$	3,611,627

During the three months ended September 30, 2018, the Investor has converted a total of $40,756,847 in principal and $5,537,785 in interest into 728,934,054 (including 361,245 shares which were split affected (90,311,250 pre-split)) shares of the Company’s common stock and for the nine months ended September 30, 2018, the Investor has converted a total of $64,959,736 in principal and $9,161,604 in interest into 729,185,600 (including 612,792 shares which were split affected (153,198,000 pre-split)) shares of the Company’s common stock.

Warrant Liabilities Activity:

The following is a summary of the Company’s warrant activity during the nine months ended September 30, 2018:

	Warrant Shares			Weighted Average Exercise Price		Weighted Average Remaining Contractual Life Years
Outstanding/exercisable – December 31, 2017		38,526		$	6.04		4.86
Granted		180,819			3.84		4.44
Exercised		(151,877	)		7.17		4.40
Forfeited/cancelled		-			-		-
Outstanding/exercisable – September 30, 2018		67,468			5.43		4.46

32

HELIOS AND MATHESON ANALYTICS INC.

Notes to Condensed Consolidated Financial Statements

11. Common and Preferred Stock

Common Stock

On February 5, 2018, the Company’s stockholders approved an amendment to the Company’s Certificate of Incorporation to increase the number of authorized shares of common stock from 100,000,000 to 500,000,000 shares (the “Charter Amendment”). Following stockholder approval of the Charter Amendment, a Certificate of Amendment to the Company’s Certificate of Incorporation was filed with the Secretary of State of the State of Delaware on February 8, 2018, at which time the Charter Amendment became effective.

On July 23, 2018, the Company’s stockholders approved an amendment to the Company’s Certificate of Incorporation to increase the number of authorized shares of common stock from 500,000,000 to 5,000,000,000 shares and to increase the total number of authorized shares of capital stock from 502,000,000 to 5,002,000,000 (the “Authorized Share Increase”), of which 2,000,000 shares with a par value of one cent ($0.01) per share shall be designated as “Preferred Stock” and 5,000,000,000 shares with a par value of one cent ($0.01) per share shall be designated as “Common Stock.” Following the stockholder approval, a Certificate of Amendment to the Company’s Certificate of Incorporation was filed with the Secretary of State of the State of Delaware on July 23, 2018, at which time the Authorized Share Increase became effective.

Reverse Stock Split

On July 23, 2018, the Board of Directors approved the Reverse Stock Split and the filing of a Certificate of Amendment to the Certificate of Incorporation of the Company to effectuate the Reverse Stock Split.

A Certificate of Amendment to the Company’s Certificate of Incorporation authorizing the Reverse Stock Split was filed with the Secretary of State of the State of Delaware on July 24, 2018, and the Reverse Stock Split became effective in accordance with the terms of the Certificate of Amendment on July 24, 2018.

The Reverse Stock Split did not affect the number of authorized shares of common stock, which (following the Authorized Share Increase) is 5,000,000,000 shares. A proportionate adjustment was made to (i) the per share exercise price and the number of shares issuable upon the exercise or conversion of the Company’s outstanding equity awards, options and warrants to purchase shares of common stock and outstanding convertible notes and (ii) the number of shares reserved for issuance pursuant to the Company’s 2014 Equity Incentive Plan. Fractional shares were not issued as a result of the Reverse Stock Split; instead, the Board of Directors, determined to effect an issuance of shares to holders that would otherwise be entitled to a fractional share such that any fractional shares were rounded up to the nearest whole number.

33

HELIOS AND MATHESON ANALYTICS INC.

Notes to Condensed Consolidated Financial Statements

Preferred Stock

On June 25, 2018, the Company filed an amended Certificate of Incorporation in the State of Delaware to designate 20,500 shares of preferred stock as the Preferred Stock.

The following is a description of the Preferred Stock:

Dividends

The Preferred Stock does not accrue dividends.

Conversion

The Preferred Stock is not convertible into common stock.

Voting Rights

Each share of Preferred Stock is entitled to 3,205 votes per share on all matters on which holders of common stock are entitled to vote. However, the amount of votes with respect to the Preferred Stock held by any holder, when aggregated with any other voting securities of the Company held by such holder, cannot exceed 19.9% of the Company’s outstanding voting power calculated as of June 21, 2018 (or such greater percentage allowed by Nasdaq without any stockholder approval requirements).

Redemption

From and after the time when the first 15% of the aggregate principal amount of any June 2018 Convertible Notes is paid or converted in accordance with the terms of the June 2018 Convertible Notes, the Company will have the right to redeem all or a portion of the Preferred Stock at a price per share equal to $0.01, payable, at the Company’s option with cash or shares of common stock or, if required by certain beneficial ownership limitations, rights to receive common stock.

Transfer

The shares of Preferred Stock are transferable, subject to limitations, as defined, and applicable securities laws.

Liquidation Preference

Upon any liquidation, dissolution or winding up of the Company, the holders of the shares of Preferred Stock will be entitled to receive in cash out of the assets of the Company, before any amount is paid to the holders of any junior stock, including common stock of the Company, an amount per share of Preferred Stock equal to 100% of the stated value per share (which is equal to $1,000) plus $0.01.

The Certificate of Designations also includes covenants restricting the Company’s ability to take certain actions without the approval of at least a majority of the outstanding shares of the Preferred Stock.

34

HELIOS AND MATHESON ANALYTICS INC.

Notes to Condensed Consolidated Financial Statements

12. Fair Value of Financial Assets and Liabilities Measured on a Recurring Basis

Financial assets and liabilities measured at fair value on a recurring basis are summarized below and disclosed on the Company’s consolidated balance sheets as of September 30, 2018 and December 31, 2017:

	Amount at		Fair Value Measurement Using
	Fair Value		Level 1		Level 2		Level 3
September 30, 2018
Liabilities
Derivative liability – warrants	$	60,809	$	-	$	-	$	60,809
Total	$	60,809	$	-	$	-	$	60,809
December 31, 2017
Liabilities
Derivative liability – warrants	$	67,288,800	$	-	$	-	$	67,288,800
Derivative liability – conversion feature		4,834,462		-		-		4,834,462
Total	$	72,123,262	$	-	$	-	$	72,123,262

The table below provides a summary of the changes in fair value, including net transfers in and/or out, of all financial assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the nine months ended September 30, 2018:

	Amount
Balance at December 31, 2017	$	72,123,262
Issuances to debt discount		105,223,694
Issuances to interest expense		40,734,226
Reclass from APIC to derivative - February offering		158,944,798
Reclass from APIC to derivative - April offering		33,997,600
Warrants issued in acquisition of Moviefone		5,475,500
Gain on exchange of warrants		(301,487	)
Settlement of warrant liability for March warrant exchange		(12,894,165	)
Settlement of warrant liability for June warrant exchange		(5,202,100	)
Gain on March exchange (cash paid)		(781,195	)
Conversion to paid-in capital		(134,365,641	)
Gain on extinguishment		(60,524,508	)
Change in FMV warrant		(194,058,069	)
Change in FMV derivative		(8,311,106	)
Balance at September 30, 2018	$	60,809

The fair value of the derivative conversion features and warrant liabilities as of September 30, 2018 and December 31, 2017 were calculated using a Monte Carlo option model valued with the following weighted average assumptions:

	September 30, 2018			December 31, 2017
	Amount			Amount
Dividend yield	0%	-	0%		0%
Expected volatility	165%	-	280%	45%	-	270%
Risk free interest rate	2.40%	-	2.93%	1.06%	-	2.20%
Contractual term (in years)	1.14	-	4.55%	0.19	-	5.00
Exercise price	$0.01	-	$1,812.50	$0.25 ($0.001 pre-split)	-	$3,577.50 ($14.310 pre-split)

Changes in the observable input values would likely cause material changes in the fair value of the Company’s Level 3 financial instruments. The significant unobservable input (probability of a down round event) used in the fair value measurement is the estimation of the likelihood of the occurrence of a change in the contractual terms of the financial instruments. A significant increase (decrease) in this likelihood would result in a higher (lower) fair value measurement.

35

HELIOS AND MATHESON ANALYTICS INC.

Notes to Condensed Consolidated Financial Statements

13. Stock Based Compensation

The Company has a stock-based compensation plan, which is described as follows:

On March 3, 2014, the Board of Directors approved and adopted the Helios and Matheson Analytics Inc. 2014 Equity Incentive Plan (the “2014 Plan”) which the Company’s stockholders approved at the annual stockholders’ meeting on May 5, 2014. The 2014 Plan as amended set aside and reserved 12,000 (3,000,000 pre-split) shares of the Company’s common stock for grant and issuance in accordance with its terms and conditions. Persons eligible to receive awards from the 2014 Plan include employees (including officers and directors) of the Company and its affiliates, consultants who provide significant services to the Company or its affiliates, and directors who are not employees of the Company or its affiliates (the “Participants”). The 2014 Plan permits the Company to issue to Participants qualified and/or non-qualified options to purchase the Company’s common stock, restricted common stock, performance units, and performance shares. The 2014 Plan will terminate on March 3, 2024. The Company’s Board of Directors is responsible for administration of the 2014 Plan and has the sole discretion to determine which Participants will be granted awards and the terms and conditions of the awards granted. The 2014 Plan also provides for an annual automatic increase in the number of shares of common stock authorized for issuance thereunder by the lesser of (A) 12,000 (3,000,000 pre-split) shares of the Company’s common stock or the equivalent of such number of shares after the administrator of the 2014 Plan, in its sole discretion, has interpreted the effect of any stock split, stock dividend, combination, recapitalization or similar transaction; (B) a number of shares of common stock equal to 5% of the Company’s common stock outstanding on January 2nd of each year, and (C) an amount determined by the Company’s Board of Directors. A total of 10,440 (2,610,000 pre-split) shares of common stock remained available for issuance as of September 30, 2018.

As of September 30, 2018, there have not been any stock option grants made pursuant to the 2014 Plan.

From time to time the Board of Directors has also authorized the issuance of shares of common stock outside of the 2014 Plan to consultants and employees for services rendered. During the three and nine months ended September 30, 2018 the Company awarded 0 and 2,027 (506,750 pre-split) shares, respectively, to consultants who provided services to the Company. In connection with such awards (including awards granted in 2017) the Company recorded stock compensation expense of $232,188 and $5,913,349, which is included in selling, general and administrative expenses for the three and nine months ended September 30, 2018, respectively. Unamortized stock compensation costs related to these awards at September 30, 2018 of $250,333 will be recognized over the anticipated service period during the balance of 2018. The Company issued 0 and 4,809 (1,202,167 pre-split) shares of common stock to employees and consultants for services provided during 2017 during the three and nine months ended September 30, 2018, respectively. The Company recognized expense in 2017 of $15,631,605, with respect to such awards, and also recorded a liability on the balance sheet at December 31, 2017, related to these costs which were settled in shares.

The shares historically issued both pursuant to the 2014 Plan and outside the 2014 Plan have been fully vested in certain cases and subject to vesting conditions in other cases; they generally contain resale or transfer restrictions pursuant to lock up agreements ranging from 18 to 24 months from the award date. 

The Company generally recognizes stock compensation expense on the grant date and over the period of vesting or period that services will be provided. Compensation associated with shares issued or to be issued to consultants and other non-employees is recognized over the expected service period beginning on the measurement date which is generally the time the Company and the service provider enter into a commitment whereby the Company agrees to grant shares in exchange for the services to be provided. 

36

HELIOS AND MATHESON ANALYTICS INC.

Notes to Condensed Consolidated Financial Statements

MoviePass, Inc.

MoviePass maintained the 2011 Equity Incentive Plan (the “2011 Plan”) during the nine months ended September 30, 2018. The 2011 Plan provides for the grant of up to 95,000,000 shares of common stock for issuance as non-statutory or incentive stock options, stock appreciation rights, restricted stock and restricted stock units to the employees, officers, directors, or consultants of MoviePass. The 2011 Plan is administered by the Board of Directors of MoviePass, which selects the individuals to whom options will be granted, and determines the number of options to be granted and the term and exercise price of each option. Stock options granted pursuant to the terms of the 2011 Plan generally cannot be granted with an exercise price of less than 100% of the fair market value on the date of grant. The term of the options granted under the 2011 Plan cannot be greater than 10 years. Options vest at varying rates generally over three to five years along with performance-based options.

For the nine months ended September 30, 2018, MoviePass granted 39,809,175 stock options at an exercise price of $0.43 per share.

The following table summarizes stock option activity under the MoviePass share-based plan for the nine months ended September 30, 2018:

			Weighted Average
	Options for				Remaining		Aggregate
	Common Shares		Exercise Price		Contractual Term		Intrinsic Value
Outstanding as of December 31, 2017		28,396,428	$	0.14		9.13	$	8,313,684
Granted		39,809,175		0.43
Exercised		-
Forfeited, cancelled, expired		-
Outstanding as of September 30, 2018		68,205,603	$	0.31		8.93	$	6,760,947
Vested and exercisable at September 30, 2018		27,476,989	$	0.20		8.58	$	5,042,235

The weighted average grant date fair value per share of stock options granted during the nine months ended September 30, 2018 was $0.16. No options were exercised during the nine months ended September 30, 2018.

The Company recognized share-based payment expense associated with stock options of $1,170,726 and $4,257,970 for the three and nine months ended September 30, 2018, respectively.

The following table summarizes the weighted-average assumptions used to compute the fair value of options granted to employees:

	Nine months ended
	September 30, 2018
Risk-free interest rate		2.50	%
Expected life of options – years		5.79
Expected stock price volatility		37.20	%
Expected dividend yield		0.00	%

There were no options granted to the Company’s Board of Directors or third parties during the nine months ended September 30, 2018.

37

HELIOS AND MATHESON ANALYTICS INC.

Notes to Condensed Consolidated Financial Statements

14. Concentration of Credit Risk

Consulting

For the three months ended September 30, 2018 and September 30, 2017, respectively, 3 customers accounted for 85.0% and 4 customers accounted for 92.8% of consulting revenues.

For the nine months ended September 30, 2018 and September 30, 2017, respectively, 4 customers accounted for 92.3% and 4 customers accounted for 88.9% of consulting revenues.

As of September 30, 2018 and December 31, 2017, respectively, 7 customers accounted for 100.0% and 4 customers accounted for 62.6% of consulting accounts receivables.

As of September 30, 2018 and December 31, 2017, respectively, 5 vendors accounted for 90.8% and 3 vendors accounted for 82.7% of consulting accounts payables.

Technology

As of September 30, 2018 and December 31, 2017, respectively, 5 vendors accounted for 82.3% and 3 vendors accounted for 60.8% of technology accounts payables.

Subscription and Marketing, Promotional Services, and Films

As of September 30, 2018 and December 31, 2017, respectively, 4 customers accounted for 96.7% of subscription and marketing, promotional services, and films accounts receivables and 2 customers accounted for 100.0% of subscription and marketing, promotional services, and films accounts receivables.

As of September 30, 2018 and December 31, 2017, respectively, 6 vendors accounted for 51.8% subscription and marketing, promotional services, and films accounts payables and 1 vendor accounted for 41.0% of subscription and marketing, promotional services, and films accounts payables.

15. Commitments and Contingencies

The Company’s operating lease commitments as of September 30, 2018 are comprised of the following:

	Payments due by period
Less than 1 year	$	74,094
1 to 3 years		548,808
3 to 5 years		347,985
Thereafter		-
Total	$	970,887

The Company’s executive office is located at the Empire State Building, 350 Fifth Avenue, Suite 7520, New York, New York 10118. The Company’s executive office is located in a leased facility with a term expiring on June 30, 2022. Zone leases office space at 444 Brickell Avenue, Miami Florida with a term expiring on April 30, 2020. Prior to August 1, 2018, MoviePass leased space at WeWork on a month to month basis at 175 Varick Street New York, NY 10014. As of August 1, 2018, MoviePass has relocated to WeWork at 135 Madison Avenue New York, NY 10016 under a one-year lease agreement effective July 9, 2018. In addition, the Company’s Indian subsidiary has an office in Bangalore, India at a leased facility located at 3rd Floor, Beta Block, Number 7 Sigma Tech Park, Varthur Kodi, Bangalore 560066. This lease was amended on September 26, 2017 to extend the duration of the lease until September 30, 2019.

38

HELIOS AND MATHESON ANALYTICS INC.

Notes to Condensed Consolidated Financial Statements

The Company’s executive office lease is subject to escalations based on increases in real estate taxes and operating expenses, all of which are charged to rent expense. Rent expense for the three months ended September 30, 2018 and 2017 was approximately $585,702 and $81,051, respectively, and $1,046,790 and $215,068 for the nine months ended September 30, 2018 and 2017, respectively. 

In April 2017, Zone signed a three-year lease agreement for office space at 444 Brickell Avenue, Miami Florida. The lease term began in May 2017 and expires in April 2020 and requires a monthly rent payment of $5,026 for the first 12 months, $5,177 for the next 12 months, and $5,332 for the last 12 months of the lease.

As of September 30, 2018, the Company does not have any “Off Balance Sheet Arrangements”.

Legal Proceeding:

On August 2, 2018, Jeffrey Chang, acting on behalf of himself and a putative class of persons who purchased or otherwise acquired the Company’s common stock between August 15, 2017, and July 26, 2018, filed a class action complaint in the U.S. District Court for the Southern District of New York against the Company and two of its executive officers, Theodore Farnsworth and Stuart Benson (the “August 2, 2018 Complaint”). Jeffrey Chang v. Helios and Matheson Analytics Inc., et. al., Case No. 1:18-cv-6965. The August 2, 2018 Complaint alleges, among other things, that the Company’s statements to the market were materially false or misleading. The plaintiffs assert claims under Sections 10(b) and 20(a) of the Exchange Act and Rule 10b-5.

On August 13, 2018, Jeffrey Braxton, acting on behalf of himself and a putative class of persons who purchased or otherwise acquired the Company’s common stock between August 15, 2017, and July 26, 2018, filed a class action complaint in the U.S. District Court for the Southern District of New York against the Company and two of its executive officers, Theodore Farnsworth and Stuart Benson (the “August 13, 2018 Complaint”). Jeffrey Braxton v. Helios and Matheson Analytics, Inc. et al., Case No. 1:18-cv-07242-UA. The August 13, 2018 Complaint makes substantially identical allegations as the August 2, 2018 Complaint.

Motions have been filed to consolidate the cases and for the appointment of lead plaintiff and lead plaintiffs’ counsel. The motions are scheduled to be argued November 16, 2018. The Company intends to vigorously defend these matters and believes that they are without merit. Given the preliminary status of the litigation, it is difficult to predict the likelihood of an adverse outcome or estimate the amount or range of any reasonably possible losses, if any.

On September 20, 2018, Yu Chen, a purported stockholder of the Company, filed a complaint in the Supreme Court of the State of New York, County of New York, Index No. 654686/2018, derivatively on behalf of the Company against Theodore Farnsworth, Stuart Benson, Muralikrishna Gadiyaram, Prathap Singh, Gavriel Ralbag, and Carl Schramm, and the Company as a nominal defendant (the “September 20, 2018 Complaint”). The September 20, 2018 Complaint alleges claims for breach of fiduciary duty and unjust enrichment against the individual defendants. The Plaintiff has agreed to stay the action pending a decision on an anticipated motion to dismiss the consolidated complaint that is expected to be filed in the securities actions discussed above.

16. Transactions with Related Parties

Gadiyaram Agreements

On October 5, 2017, the Company entered into a consulting agreement (the “Consulting Agreement”) with Mr. Muralikrishna Gadiyaram (the “Consultant”), a director of the Company, for a period of two years from the agreement date (the “Consulting Term”). The Consulting Agreement formalized, on a compensatory basis, the arrangement that was in place for performance without compensation by the Consultant for consulting services since the acquisition of Zone in November of 2016. Mr. Gadiyaram will continue to provide guidance to the Company and Zone relating to the further development of their respective businesses and technologies. In addition to the aforementioned services, if requested by the Company, Mr. Gadiyaram will provide guidance with respect to the development of any businesses or technologies that the Company or Zone may acquire during the Consulting Term, including, but not limited to, MoviePass. Pursuant to the Consulting Agreement, the Consultant will receive fees in the amount of $18,750 per month in cash. Such fees have been accrued and paid by the Company since January 1, 2017. The amount payable to Mr. Gadiyaram as of September 30, 2018 was approximately $18,750.

On May 22, 2018, the Company and Helios and Matheson Information Technology, Ltd (“HMIT”), an Indian corporation, owned and controlled by Mr. Muralikrishna Gadiyaram, a director of the Company executed a letter agreement whereby HMIT agreed not to sell HMNY shares held by HMIT until after April 15, 2019 (the “Lockup Agreement”). In exchange for such Lockup Agreement the Company agreed to issue to HMIT 2,000 (500,000 pre-split) shares of HMNY stock. As of September 30, 2018, the shares issuable to HMIT had not yet been issued and accordingly, the Company accrued $225,000 with respect thereto, representing the value of the shares on May 22, 2018. 

39

HELIOS AND MATHESON ANALYTICS INC.

Notes to Condensed Consolidated Financial Statements

Emmett Furla Oasis Films  (“EFO”)

On July 27, 2018, the Company entered into an assignment agreement with Georgia Film Fund 50, LLC, a company owned and operated by EFO, for the assignment of the rights, title and interest in the film The Row in exchange for a payment in the amount of $525,000. At September 30, 2018, $400,000 of the payment due in connection with the assignment agreement was included in amounts due to related parties on the balance sheet.

On August 28, 2018, MoviePass Films entered into an assignment agreement with Georgia Film Fund 56, LLC, a company owned and operated by EFO, for all of the rights, title and interest in the film A Vigilante, including all rights associated with distribution agreements in connection therewith. MoviePass Films agreed to pay $3,499,400 in connection with the assignment of the rights granted, in satisfaction of obligations of EFO with respect to the film. The terms of the related note payable provide for annual interest of 20% and the amounts are due in September 2020.  As of September 30, 2018, $2,625,000 remains payable with respect thereto and is included in notes payable on the balance sheet.

On September 25, 2018, Randall Emmett, Co-CEO of MoviePass Films advanced to MoviePass Films $100,000, which is included in due to related parties on the balance sheet at September 30, 2018. On October 4^, 2018 this amount was repaid in full.

In September 2018, George Furla and Randall Emmett, Co-CEO’s of MoviePass Films, entered into equity finance agreements with Georgia Film Fund 79, LLC, a wholly owned subsidiary of MoviePass Films, for the partial funding of the production of the film 10 Minutes Gone, in the amounts of $400,000 and $250,000, respectively. These amounts are included in due to related parties on the balance sheet at September 30, 2018. The principal amounts are repayable from the proceeds of the film plus interest at 20% per annum. The maximum interest payable with respect to these equity finance agreements is subject to a two year cap.

17. Provision for Income Taxes

The Company had a tax provision for the three months ended September 30, 2018 and 2017 of $10,283 and $(2,747), respectively, and $46,953 and $39,110 for the nine months ended September 30, 2018 and 2017, respectively. Tax for both the nine months ended September 30, 2018 and 2017 was comprised of minimum state taxes and a provision for tax in respect to taxes incurred by the Company’s Indian subsidiary.

The Company’s provision for income taxes for the nine months ended September 30, 2018 and 2017 is based on the estimated annual effective tax rate method prescribed by ASC 740-270, plus discrete items. The difference between the Company’s effective tax rates for the nine months ended September 30, 2018 and 2017 and the US statutory tax rates of 21% and 35%, respectively, primarily relates to changes in the valuation allowances against deferred tax assets, non-deductible expenses, state income taxes (net of federal income tax benefit), the effect of taxes on foreign earnings, and changes to provisional amounts recorded for certain aspects of the Act. 

In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that either some portion or the entire deferred tax asset will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income, tax-planning strategies, and available carry-back capacity in making this assessment, therefore, the Company has recorded a valuation allowance on its net domestic deferred tax assets, excluding deferred tax liabilities that are not expected to serve as a source of income for the recognition of deferred tax assets due to their indefinite reversal period (tax amortization of goodwill). 

As of September 30, 2018, the Company did not record any tax liabilities for uncertain income tax positions and concluded that all of its tax positions are either certain or are not material to the Company’s financial statements. The Company is currently not under audit in any jurisdiction in which it conducts business.

18. Segment Reporting

Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker, or decision–making group, in deciding how to allocate resources and in assessing performance. The Company’s chief operating decision–making group is composed of the Chief Executive Officer and Chief Financial Officer. The Company operates in three segments, Consulting, Technology, and Subscription and Marketing, Promotional Services, and Film. During the three and nine months ended September 30, 2018, the Company reported three segments. The Company allocates corporate expenses to the segments for purposes of individually measuring operating segments. Corporate expenses are allocated on the basis of each segment’s relative earnings prior to the allocation.

40

HELIOS AND MATHESON ANALYTICS INC.

Notes to Condensed Consolidated Financial Statements

The Company evaluates performance of its operating segments based on revenue and operating loss. The following table summarizes the Company’s segment information for the following balance sheet dates presented, and for the three and nine months ended September 30, 2018 and 2017:

	For the Nine Months Ended September 30,
	2018			2017
Consulting
Revenue	$	2,471,223		$	3,672,036
Cost of revenue		2,023,707			2,969,357
Gross margin		447,516			702,679
Total operating expenses		19,908,946			6,280,032
Income/(loss) from operations		(19,461,430	)		(5,577,353	)
Total other income/(expense)		73,915,297			(44,914,576	)
Provision for income taxes		(8,826	)		39,110
Total net income/(loss)	$	54,445,041		$	(50,531,039	)
Technology
Revenue	$	-		$	-
Cost of revenue		-			-
Gross margin		-			-
Total operating expenses		2,871,608			4,601,330
Income/(loss) from operations		(2,871,608	)		(4,601,330	)
Total other income/(expense)		70			(47,220	)
Provision for income taxes		-			-
Total net income/(loss)	$	(2,871,538	)	$	(4,648,550	)
Subscription and Marketing, Promotional Services, and Films
Revenue		202,479,613			-
Cost of revenue		422,347,371			-
Gross margin		(219,867,758	)		-
Loss on goodwill		38,524,016
Total other operating expenses		40,060,927			-
Income/(loss) from operations		(298,452,701	)		-
Total other income/(expense)		-			-
Provision for income taxes		(38,127	)		-
Total net income/(loss)	$	(298,490,828	)	$	-

41

HELIOS AND MATHESON ANALYTICS INC.

Notes to Condensed Consolidated Financial Statements

	As of September 30,		As of December 31,
	2018		2017
Consulting
Cash and cash equivalents	$	3,674,904	$	569,886
Accounts receivable	$	290,561	$	332,753
Prepaid expenses and other current assets	$	638,522	$	3,382,127
Property and equipment	$	151,379	$	96,464
Intangible assets	$	805,482	$	-
Goodwill	$	-	$	-
Deposits and other assets	$	128,232	$	129,119
Accounts payable and accrued expenses	$	4,475,771	$	2,088,867
Liabilities to be settled in stock	$	5,669,263	$	20,875,045
Convertible notes payable	$	-	$	3,611,627
Warrant liability	$	60,809	$	67,288,800
Derivative liability	$	-	$	4,834,462
Technology
Cash and cash equivalents	$	160,124	$	21,933,765
Accounts receivable	$	-	$	-
Unbilled receivables	$	-	$	-
Prepaid expenses and other current assets	$	3,333	$	21,666
Property and equipment	$	81,613	$	95,301
Intangible assets	$	1,748,388	$	2,829,295
Goodwill	$	-	$	-
Deposits and other assets	$	10,052	$	10,052
Accounts payable and accrued expenses	$	164,447	$	607,622
Liabilities to be settled in stock	$	319,100	$	445,660
Convertible notes payable	$	-	$	-
Warrant liability	$	-	$	-
Derivative liability	$	-	$	-
Deferred revenue	$	-	$	-
Subscription and Marketing, Promotional Services, and Films
Cash and cash equivalents	$	1,015,944	$	2,445,742
Accounts receivable	$	30,432,024	$	27,137,466
Unbilled receivables	$	-	$	-
Prepaid expenses and other current assets	$	2,827,790	$	154,018
Property and equipment	$	146,674	$	42,270
Intangible assets	$	27,543,529	$	25,707,487
Goodwill	$	49,148,120	$	79,137,177
Deposits and other assets	$	496,888	$	8,000
Accounts payable and accrued expenses	$	13,051,042	$	10,447,514
Liabilities to be settled in stock	$	-	$	-
Note Payable	$	8,698,250
Convertible notes payable	$	-	$	-
Warrant liability	$	-	$	-
Derivative liability	$	-	$	-
Deferred revenue	$	27,035,060	$	54,425,630
Due to Related Parties	$	1,150,000	$	-
Investment in films	$	13,403,433	$	-

42

HELIOS AND MATHESON ANALYTICS INC.

Notes to Condensed Consolidated Financial Statements

19. Subsequent Events

October Amendment and Exchange Agreement

On October 4, 2018, the Company entered into the October Exchange Agreement, with the holder of a June 2018 Convertible Note having an outstanding principal amount of approximately $68,750,000 for the purpose of (i) netting the June 2018 Investor Note issued by such holder to the Company having an aggregate principal amount of approximately $68,000,000 against such holder’s June 2018 Convertible Note and (ii) following such netting transaction, exchanging the remaining outstanding amount payable under such holder’s June 2018 Convertible Note for a new non-convertible Senior Note issued by the Company to such holder (the “New Non-Convertible Note”) in an aggregate principal amount of $20,400,000, subject to reduction as provided in the New Non-Convertible Note. As a result such holder’s June 2018 Convertible Note and the corresponding June 2018 Investor Note issued by such holder were each cancelled and became null and void.

Following the consummation of the transactions contemplated by the October Exchange Agreement and the netting of the other June 2018 Investor Notes by the other holders of the June 2018 Investor Notes against their corresponding June 2018 Convertible Notes, all of the June 2018 Convertible Notes have been cancelled.

Under the October Exchange Agreement, at any time on or prior to the later of (i) the date that the New Non-Convertible Note no longer remains outstanding and (ii) the first anniversary of the date of the October Exchange Agreement, the Company and its subsidiaries may not effect any Subsequent Placement (as defined in the November Securities Purchase Agreement (as defined below)) unless the Company first offers to issue and sell to, or exchange with, the holder of the New Non-Convertible Note, at least 25% of the securities offered in the Subsequent Placement, subject to the terms and conditions of the October Exchange Agreement.

Amendment to November Securities Purchase Agreement

Pursuant to the October Exchange Agreement, the Securities Purchase Agreement between the Company and certain institutional investors pursuant to which the Company issued the November 2017 Notes (the “November Securities Purchase Agreement”) was amended to reduce the number of shares of common stock of the Company required to be reserved for issuance under the November 2017 Notes to 100% of the maximum number of shares of common stock of the Company issuable upon conversion of the November 2017 Notes.

Amendment to January Securities Purchase Agreement

Pursuant to the October Exchange Agreement, the January Securities Purchase Agreement was amended to reduce the number of shares of common stock of the Company required to be reserved for issuance under the January 2018 Notes to 125% of the maximum number of shares of common stock of the Company issuable upon conversion of the January 2018 Notes.

43

HELIOS AND MATHESON ANALYTICS INC.

Notes to Condensed Consolidated Financial Statements

New Non-Convertible Note

On October 4, 2018, the Company issued the New Non-Convertible Note. The New Non-Convertible Note bears interest at a rate of 3% per annum, capitalized quarterly. The New Non-Convertible Note is unsecured and not convertible into equity securities of the Company. Unless earlier redeemed, the New Non-Convertible Note will mature on May 29, 2020.

As long as no Event of Default (as defined in the New Non-Convertible Note) has occurred, the Company has the right to redeem the New Non-Convertible Note at any time on or prior to the nine-month anniversary of the issuance of the New Non-Convertible Note for 50% of the principal being redeemed and 100% of the accrued and unpaid interest and late charges, if any. After the nine-month anniversary of the issuance of the New Non-Convertible Note, the Company has the right to redeem the New Non-Convertible Note at any time for 100% of the principal being redeemed and 100% of the accrued and unpaid interest and late charges, if any. If the Company does not redeem the New Non-Convertible Note within such nine-month period, the New Non-Convertible Note will amortize monthly in cash for, from June 28, 2019, four monthly payments of $850,000 per month (plus accrued and unpaid interest, including any capitalized interest) and, commencing on October 30, 2019, eight monthly payments of $2,125,000 (plus accrued and unpaid interest, including any capitalized interest). Upon an Event of Default, the Company must redeem the New Non-Convertible Note in cash at a price equal to, if the Event of Default occurs on or prior to the nine-month anniversary of the issuance of the New Non-Convertible Note, and there is neither a Primary Covenant Event of Default nor a Bankruptcy Default (each as defined in the New Non-Convertible Note), 50% of the principal being redeemed and 100% of the accrued and unpaid interest and late charges, if any, in each case, multiplied by a redemption premium. If the Event of Default occurs after the nine-month anniversary of the issuance of the New Non-Convertible Note, or there exists either a Primary Covenant Event of Default or a Bankruptcy Default, then the Company must redeem the New Non-Convertible Note in cash at a price equal to 100% of the principal being redeemed and 100% of the accrued and unpaid interest and late charges, if any, in each case, multiplied by a redemption premium.

If the holder of the New Non-Convertible Note participates in a subsequent offering by the Company or prepays the January 2018 Investor Notes or November 2017 Investor Notes issued by such holder to the Company, then 14.5% of the cash proceeds paid (or payable) by such holder in such applicable transaction will be used to pay down the New Non-Convertible Note on a dollar-for-dollar basis. Each such payment amount will reduce the scheduled amortization payments on a reverse basis (i.e. last amortization reduced first).

Special Meeting of Stockholders

The Special Meeting of Stockholders scheduled to be held on November 14, 2018 to provide stockholders with an opportunity to vote on the proposed reverse stock split in a ratio of 1 share-for-2 shares up to a ratio of 1 share-for-500 shares has been cancelled. The Company was presenting the reverse stock split proposal in an effort to regain compliance with Rule 5550(a)(2). Since the Company will not be able to effect a reverse stock split ten business days prior to December 18, 2018, absent an extension by The Nasdaq Capital Market (of which there can be no assurance) the Company believes that our common stock will be subject to delisting from The Nasdaq Capital Market, which would adversely impact the liquidity and marketability of our common stock.

If the Company does not regain compliance with Rule 5550(a)(2) by December 18, 2018, the Company may be afforded a second 180-calendar day period to regain compliance. To qualify, the Company would be required to meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, except for the Minimum Bid Price Requirement. In addition, the Company would be required to notify Nasdaq of its intent to cure the deficiency during the second compliance period, which may include, if necessary, implementing a reverse stock split. If the Company is afforded additional time to regain compliance (of which there can be no assurance), the Board of Directors of the Company plans to call a special meeting as soon as practicable with a new record date for the Company’s stockholders to vote on a reverse stock split in an effort to regain compliance with Rule 5550(a)(2). Even if the Company is eligible for an additional compliance period, Nasdaq may decline to grant the Company an additional compliance period in its discretion.

If the Company does not regain compliance with Rule 5550(a)(2) by December 18, 2018, and is either not eligible for an additional compliance period at that time or Nasdaq declines to grant the Company an additional compliance period in Nasdaq’s discretion, the Staff will provide notice to the Company that its securities will be subject to delisting. At that time, the Company may appeal the Staff’s delisting determination to Panel. The Company would remain listed pending the Panel’s decision.

44

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Forward-Looking Statements

This report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 throughout and in particular in the discussion at Item 2 titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations”. These are statements regarding financial and operating performance results and other statements that are not historical facts. The words “expect,” “project,” “estimate,” “believe,” “anticipate,” “intend,” “plan,” “forecast,” and similar expressions are intended to identify forward-looking statements. Certain important risks, including those discussed in the risk factors set forth in Item 1A of this Form 10-Q and Item 1A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2017, which have been incorporated into this report by reference, could cause results to differ materially from those anticipated by some of the forward-looking statements. Some, but not all, of these risks include, among other things:

● the Company’s ability to successfully develop the business model of MoviePass, Moviefone, MoviePass Films and MoviePass Ventures;

● the Company’s capital requirements and whether the Company will be able to raise capital as needed;

● the Company’s ability to fulfill its payment obligations to its merchant processors in a timely manner to prevent MoviePass service interruptions;

● the Company’s ability to integrate the operations of MoviePass, Moviefone, MoviePass Films and MoviePass Ventures and other acquired businesses into its operation;

● changes in local, state or federal regulations that will adversely affect the Company’s business;

● the Company’s ability to retain its existing subscribers and market and sell its services to new subscribers;

● the success of our cost-reduction and subscription revenue increase measures and the Company’s ability to continue to generate non-subscription revenue;

● the impact of legal proceedings or governmental action against the Company;

● the Company’s ability to satisfy Nasdaq listing criteria deficiencies and whether Nasdaq may conclude the delisting of our common stock is in the public interest;

● The Company’s ability to attract brokers and investors who do not trade in lower priced stock;

● the risk that the conditions to the completion of the creation of MoviePass Entertainment are not satisfied, including the inability of MoviePass Entertainment to complete the necessary audited financial statements and to file and have its registration statement on Form S-1 declared effective by the SEC, and the risk that the Company may not have the required surplus or cash flow solvency under Delaware law to effect a distribution of shares of MoviePass Entertainment to the Company’s securities holders;

● whether the Company will continue to receive the services of certain officers and directors;

● the Company’s ability to protect its intellectual property and operate its business without infringing upon the intellectual property rights of others;

● the Company’s ability to effectively react to other risks and uncertainties described from time to time in the Company’s filings with the SEC, such as fluctuation of quarterly financial results, reliance on third party consultants, litigation or other proceedings and stock price volatility; and

● other uncertainties, all of which are difficult to predict and many of which are beyond the Company’s control.

The Company does not intend to update forward-looking statements. You should refer to and carefully review the information in future documents that the Company files with the SEC.

The following discussion and analysis of significant factors affecting the Company’s operating results and liquidity and capital resources should be read in conjunction with the accompanying condensed consolidated financial statements and related Notes.

Unless expressly indicated or the context requires otherwise, the terms “Helios”, the “Company”, “we”, “us, and “our” refer to Helios and Matheson Analytics Inc.

45

Business Overview

We provide high quality information technology, or IT, services and solutions including a range of technology platforms focusing on big data, business intelligence, and consumer-centric technology. More recently, to provide greater value to stockholders, the Company has sought to expand its business primarily through acquisitions that leverage its capabilities and expertise.

As of September 30, 2018, the Company owned, and as of the date of this report the Company owns, 91.8% of the outstanding shares of MoviePass (excluding outstanding MoviePass options and warrants), 100% of the outstanding membership interests in MoviePass Ventures and 51% of the outstanding membership interests in MoviePass films. MoviePass is the premiere movie theater subscription service in the United States that allows its subscribers to see up to three movies a month, from a schedule of select movies, in theaters nationwide, for a low fixed price and additional movies at a discounted price. 

In March 2018, MoviePass Ventures acquired a stake in the now award winning film American Animals by Bart Layton.  In April 2018, MoviePass Ventures acquired a stake in the movie Gotti.  The Company believes that by utilizing the MoviePass subscriber base to drive a positive impact at the box office, MoviePass Ventures can then leverage the higher box office to obtain additional downstream revenues, such as international distribution rights, streaming rights, DVD rights, transactional rights (iTunes), on demand and foreign movie rights.

MoviePass Films is dedicated to supporting independent filmmakers and distributors by collaborating with creators and acquiring stakes in films. MoviePass Films has already acquired stakes in several films, including 10 Minutes Gone in August 2018, Monsters and Men and Border in September 2018, and In Search of Greatness in the fourth quarter of 2018. The Company believes that the MoviePass marketing ability and MoviePass subscription base will help contribute to the success and revenue generation of these films.

During the third quarter of 2018, MoviePass made changes to the business strategy in order to reduce cash burn, lower total expenses and move towards profitability. As a result, MoviePass incurred a loss of subscribers resulting primarily from the change in service offerings during the third quarter.  MoviePass deemed it more appropriate to assess goodwill impairment of the MoviePass reporting unit as of September 30, 2018. In conjunction with the events occurring in the third quarter of 2018, the Company updated its long-term business plan, which was used as the basis for estimating the future cash flows of its reporting units. That plan considered then current economic conditions and trends, estimated future operating results, the Company’s views of growth rates and then-anticipated future economic and regulatory conditions.

MoviePass has implemented several elements of a long-term growth plan which the Company believes will reduce the monthly cash deficit and improve profitability. In April 2018, MoviePass implemented certain measures to promote the fair use of the MoviePass subscription product. These measures included a technological enhancement which prevents MoviePass subscribers from sharing their accounts with non-subscribers and allowing subscribers to see a movie title only once per subscriber using the MoviePass subscription. From July 2018 through August 2018, MoviePass implemented several cost-reduction measures including changing its monthly subscription plan to the current three-movies-per-month plan, at a price of $9.95 per month. In August 2018, MoviePass Inc. began to convert subscribers on an annual subscription plan to the three-movies-per-month subscription plan, by giving annual subscribers the option to either cancel or refund their annual subscription or continue on the new three-movies-per-month subscription plan.

The Company believes that MoviePass’s move to a curated programming model, which limited title selection on a daily basis, reduced its cash burn significantly from the second quarter of 2018 to the third quarter of 2018. The Company believes that the curated programming model also enhanced its ability to increase non-subscription revenue. The Company believes this is in large measure due to the expectation that distributors of independent films are willing to spend money to market their films as a result of the efficacy this strategy had on driving attendance to their films.

Since moving to this curated programming model, MoviePass has spent a higher percentage of its weekly allocated spend on promoted titles (over non-promoted titles), including independent films for which it has marketing agreements. This shift in the programming model has helped move MoviePass towards a new business model.

On October 23, 2018, the Company issued a press release announcing that its Board of Directors preliminarily approved a plan to create a new subsidiary named MoviePass Entertainment Holdings Inc. (“MoviePass Entertainment”) that would take ownership of the shares of MoviePass and other film related assets held by the Company. If permitted under Delaware law and subject to other conditions, the Company plans to distribute a minority of the outstanding shares of MoviePass Entertainment common stock as a dividend to stockholders of the Company as of a record date that is yet to be determined, with the Company retaining control of MoviePass Entertainment upon any such distribution.

46

Results of Operations

The following table sets forth period over period change in the percentage of revenues of certain items included in the Company’s Statements of Operations:

	For the Three Months Ended September 30,						Change
	2018			2017			Dollars			% Change
Consulting	$	802,114			1,173,023			(370,909	)		(32	)%
Subscription		78,921,951			-			78,921,951			100	%
Marketing, promotional services, and films		1,615,177			-			1,615,177			100	%
Total revenues		81,339,242			1,173,023			80,166,219			6,834	%
Cost of revenues		109,635,383			946,308			108,689,075			11,486	%
Gross (loss)/profit		(28,296,141	)		226,715			(28,522,856	)		(12,581	)%
Loss on impairment of MoviePass goodwill		38,524,016			-			38,524,016			100	%
Operating expenses		19,594,730			3,302,979			16,291,751			493	%
Loss from operations		(86,414,887	)		(3,076,264	)		(83,338,623	)		(2,709	)%
Other income (expense), net		(50,770,628	)		(40,386,701	)		(10,383,927	)		(26	)%
Income tax provision		10,283			(2,747	)		13,030			(474	)%
Net loss	$	(137,195,798	)		(43,460,218	)		(93,735,580	)		(216	)%
Loss per share	$	(0.20	)		(5.79	)		5.59			96	%

	For the Nine months ended September 30,						Change
	2018			2017			Dollars			% Change
Consulting	$	2,471,223			3,672,036			(1,200,813	)		(33	)%
Subscription		198,488,038			-			198,488,038			100	%
Marketing, promotional services, and films		3,991,575			-			3,991,575			100	%
Total revenues		204,950,836			3,672,036			201,278,800			5,481	%
Cost of revenues		424,371,078			2,969,357			421,401,721			14,192	%
Gross (loss)/profit		(219,420,242	)		702,679			(220,122,921	)		(31,326	)%
Loss on impairment of MoviePass goodwill		38,524,016			-			38,524,016			100	%
Operating expenses		62,841,481			10,881,362			51,960,119			478	%
Loss from operations		(320,785,739	)		(10,178,683	)		(310,607,056	)		(3,052	)%
Other income (expense), net		73,915,367			(44,961,796	)		118,877,163			(264	)%
Income tax provision		46,953			39,110			7,843			20	%
Net loss	$	(246,917,325	)		(55,179,589	)		(191,737,736	)		(347	)%
Loss per share	$	(0.87	)		(8.35	)		7.47			89	%

47

Comparison of the Three Months Ended September 30, 2018 to the Three Months Ended September 30, 2017

Revenues. Revenues for the three months ended September 30, 2018 were approximately $81.3 million as compared to revenues of approximately $1.2 million for the three months ended September 30, 2017. The increase was primarily due to the revenues of MoviePass which were offset by a decrease in consulting revenues in the three months ended September 30, 2018.

Gross (Loss) / Profit. The resulting gross loss for the three months ended September 30, 2018 was approximately $28.3 million as compared to a gross profit of approximately $0.2 million for the three months ended September 30, 2017. The decrease is primarily due to operating expenses of MoviePass.

Operating Expenses. Non-research and development operating expenses for the three months ended September 30, 2018 were approximately $19.5 million as compared to approximately $2.7 million for the three months ended September 30, 2017. The increase was primarily due to the acquisitions of MoviePass, the Moviefone Assets and the forming of MoviePass Ventures and MoviePass Films.

Impairment of MoviePass Goodwill. Impairment of goodwill expense for the three months ended September 30, 2018 of approximately $38.5 million relates to a portion of the MoviePass reporting unit as a result of reduced financial projections for the MoviePass reporting unit, due to, among other things, lower than expected actual financial results from this business due to a lower number of subscribers resulting from changes in the MoviePass service offering, described above, which resulted in diminished financial performance relative to its original expectations.

Research and Development. Research and development expenses for the three months ended September 30, 2018 were approximately $0.09 million as compared to $0.6 million for the three months ended September 30, 2017. Research and development expenses relate to the development of the RedZone Map app.

Taxes. The Company had income tax provision of $10,283 and compared to an income tax benefit of $2,747 for the three months ended September 30, 2018 and 2017, respectively. Tax for the three months ended September 30, 2018 was comprised of minimum state taxes and a provision reconciliation of an over estimate of the tax accrual for the Company’s Indian subsidiary’s audit.

Other Income/(Expense). In order to both fund its operations, including the development of the RedZone Map app, to obtain the funds necessary to purchase additional shares in MoviePass, and to fund the operations of MoviePass, the Company issued and sold to several investors Senior Secured Convertible Promissory Notes in September 2016, December 2016, February 2017, August 2017, November 2017, January 2018, and June 2018 having a total principal amount of approximately $352.5 million. As a result of these securities offerings, during the three months ended September 30, 2018, the Company incurred (i) a loss of approximately $0.7 million resulting from the change in market value of derivative and warrant liabilities, (ii) interest expense of approximately $95.6 million, (iii) a gain on the extinguishment of indebtedness of approximately $45.5 million and (iv) interest income of approximately $0.004 million. For the three months ended September 30, 2017, the Company incurred (i) a loss of approximately $28.2 million resulting from the change in market value of derivative and warrant liabilities, (ii) interest expense of approximately $11.6 million, and (iii) interest income of approximately $0.014 million.

Net Loss. The Company had a net loss attributable to Helios and Matheson Analytics Inc. of approximately $129.6 million or $0.20 loss per basic and diluted share for the three months ended September 30, 2018 as compared to a net loss attributable to Helios and Matheson Analytics Inc. of approximately $43.5 million or $5.79 loss per basic and diluted share for the three months ended September 30, 2017. The increase in the Company’s net loss is primarily due to the acquisitions of MoviePass, the Moviefone Assets and the forming of MoviePass Ventures and MoviePass Films, including the associated financing costs incurred with the issuance of our senior convertible notes, offset by a gain on the extinguishment of debt.

Comparison of the Nine Months Ended September 30, 2018 to the Nine Months Ended September 30, 2017

Revenues. Revenues for the nine months ended September 30, 2018 were approximately $205.0 million as compared to revenues of approximately $3.7 million for the nine months ended September 30, 2017. The increase was primarily due to the revenues of MoviePass which were partially offset by a decrease in consulting revenues in the nine months ended September 30, 2018. 

Gross (Loss) / Profit. The resulting gross loss for the nine months ended September 30, 2018 was approximately $219.4 million as compared to a gross profit of approximately $0.7 million for the nine months ended September 30, 2017. The decrease is primarily due to operating expenses of MoviePass.

48

Operating Expenses. Non-research and development operating expenses for the nine months ended September 30, 2018 were approximately $62.4 million as compared to approximately $9.3 million for the nine months ended September 30, 2017. The increase was primarily due to the acquisitions of MoviePass, the Moviefone Assets and the forming of MoviePass Ventures and MoviePass Films.

Impairment of MoviePass Goodwill. Impairment of goodwill expense for the nine months ended September 30, 2018 of approximately $38.5 million relates to a portion of the MoviePass reporting unit as a result of reduced financial projections for the MoviePass reporting unit, due to, among other things, lower than expected actual financial results from this business due to a lower number of subscribers resulting from changes in the MoviePass service offering, described above, which resulted in diminished financial performance relative to its original expectations.

Research and Development. Research and development expenses for the nine months ended September 30, 2018 were approximately $0.5 million as compared to $1.6 million for the nine months ended September 30, 2017. Research and development expenses relate to the development of the RedZone Map app.

Taxes. The Company had income tax provision of $46,953 and $39,110 for the nine months ended September 30, 2018 and 2017, respectively. Tax for the nine months ended September 30, 2018 was comprised of minimum state taxes and a provision reconciliation of an over estimate of the tax accrual for the Company’s India subsidiary’s audit.

Other Income/(Expense). In order to both fund its operations, including the development of the RedZone Map app, to obtain the funds necessary to purchase additional shares in MoviePass, and to fund the operations of MoviePass the Company issued and sold to several investors Senior Secured Convertible Promissory Notes in September 2016, December 2016, February 2017, August 2017, November 2017, January 2018, and June 2018 having a total principal amount of approximately $352.5 million. As a result of these securities offerings, during the nine months ended September 30, 2018, the Company incurred (i) a gain of approximately $202.4 million resulting from the change in market value of derivative and warrant liabilities, (ii) interest expense of approximately $189.3 million, (iii) a gain on the extinguishment of debt of approximately $60.5 million, (iv) a gain on the exchange of warrants of approximately $0.3 million and (iv) interest income of approximately $0.03 million. For the nine months ended September 30, 2017, the Company incurred (i) a gain of approximately $27.5 million resulting from the change in market value of derivative and warrant liabilities, (ii) interest expense of approximately $16.9 million, and (iii) interest income of approximately $0.05 million.

Net Loss. The Company had a net loss attributable to Helios and Matheson Analytics Inc. of approximately $187.8 million or $0.87 loss per basic and diluted share for the nine months ended September 30, 2018 as compared to a net loss attributable to Helios and Matheson Analytics Inc. of approximately $55.2 million or $8.35 loss per basic and diluted share for the nine months ended September 30, 2017. The increase in the Company’s net loss is primarily due to the acquisitions of MoviePass, the Moviefone Assets and the forming of MoviePass Ventures and MoviePass Films, including the associated financing costs incurred with the issuance of our senior convertible notes, offset by favorable adjustments to the Company’s derivative liabilities, and a gain on the extinguishment of debt.

49

Liquidity and Capital Resources

The following table presents a summary of the cash flow activity for the periods set forth below:

	Nine months ended September 30,
	2018			2017
Net cash (used in) operating activities	$	(321,093,755	)		(7,644,296	)
Net cash (used in) investing activities	$	(53,491	)		(5,302,999	)
Net cash provided by financing activities	$	301,101,244			11,870,000
Net(decrease) in cash and cash equivalents	$	(20,046,002	)		(1,077,295	)
Cash and cash equivalents, beginning of period	$	24,949,393			2,747,240
Cash and cash equivalents, end of period	$	4,850,972			1,663,879

Cash Flows Used in Operating Activities

Cash used in operating activities was $321.1 million in the nine months ended September 30, 2018 compared to $7.6 million of cash used in operating activities in the nine months ended September 30, 2017. Our consolidated net loss in September 30, 2018 of $246.9 million, included non-cash items of approximately $46.6 million. Non-cash items affecting our net loss included; change in the fair market value of warrant liabilities and derivative liabilities of $194.1 million and $8.3 million, respectively, loss on extinguishment of debt of $60.5 million, impairment of goodwill of $38.5 million, shares issued in exchange for services of $10.2 million, approximately $173.0 million related to accretion and interest expense incurred from derivative instruments, amortization of deferred revenue of $13.3 million, amortization and impairment of film costs of $3.8 million and depreciation and amortization of $4.0 million. The net change in working capital items affecting operating cash flow was $27.6 million, representing a decrease in cash provided by operating activities. In the nine months ended September 30, 2017 our net loss was $55.2 million and included net non-cash items of $48.6 million, consisting primarily of $16.9 million related to interest expense incurred from derivative instruments, change in fair market value of warrant liabilities and derivative liabilities of $17.0 million and $10.4 million, respectively, shares issued in exchange for services of $2.3 million and depreciation and amortization of $1.3 million. In the nine months ended September 30, 2017, net working capital changes affecting operating cash flow consisted of a $1.0 million cash used in operating activities. 

Cash Flows Used in Investing Activities

Cash used in investing activities of $0.05 million in the nine months ended September 30, 2018 consisted primarily of cash advanced from related parties of $1.2 million and cash used towards the purchase of the Moviefone Assets of $1.0 million. Cash used in investing activities of $5.3 million in the nine months ended September 30, 2017 consisted primarily of cash used to acquired patents and to purchase equipment.

Cash Flows Provided by Financing Activities

Cash provided by financing activities of $301.1 million consists of proceeds from public offerings and other equity raises in the amount of $244.0 million (net of transaction costs), proceeds from convertible notes payable of $108.7 million, proceeds from the issuance of a note payable and preferred shares of $20.2 million, payment for make-whole interest of $5.0 million and payment of deferred financing fees of $2.2 million, less redemptions of convertible notes payable of $63.9 million.

50

Future Liquidity and Capital Resources

Our primary sources of liquidity are cash on hand, proceeds from subscription revenues, proceeds from our equity offerings and prepayments of investor notes payable to us that we received as partial payment for our outstanding convertible notes. As of September 30, 2018, we had cash on hand of $4.9 million and approximately $30.7 million in accounts receivable mostly related to reserve funds held by our merchant processors related to subscription revenues. In addition, in the nine months ended September 30, 2018 we issued common stock and warrant units and received proceeds of approximately $244.0 million, net of associated expenses. We filed with the SEC, and the SEC declared effective, a universal shelf registration statement of up to $400 million worth of registered equity securities, of which we utilized approximately $135 million in offerings in February and April of 2018, and approximately $125 million in the ATM Offering. Under this effective registration statement, we may issue registered securities, from time to time, in one or more separate offerings or other transactions with the size, price and terms to be determined at the time of issuance. In April 2018, we entered into the Sales Agreement with Canaccord pursuant to which we could issue and sell from time to time shares of common stock having aggregate sales proceeds of up to $150.0 million through the ATM Offering under which Canaccord acted as our sales agent. We paid Canaccord a commission of 4% of the gross proceeds from the sale of shares of common stock under the Sales Agreement. For the quarter ended September 30, 2018, we sold approximately 627,933,083 shares shares in the ATM Offering, received $68.3 million net proceeds and paid Canaccord $2.8 million. The Sales Agreement was terminated on October 1, 2018, and as a result, no further sales of shares of common stock can be sold in the ATM Offering. On July 2, 2018, our second universal shelf registration was declared effective under which we may offer for sale up to $1.2 billion of equity securities or debt securities.

For the nine months ended September 30, 2018, we received gross cash proceeds of approximately $33.9 million with respect to prepayments under the November 2017 Investor Notes and issued 705.8 million (23,362 million pre-split) shares with respect to the conversion of the November 2017 Notes, including shares related to the make-whole interest provisions of those notes. From September 30, 2018 through November 14, 2018, we received gross cash proceeds of approximately $4.1 million with respect to prepayments under the November 2017 and January 2018 Investor Notes and issued an additional 233.1 million shares with respect to the conversion of the November 2017 Notes and January 2018 Notes. We used the proceeds from the prepayments of such investor notes to redeem approximately $24,600,000 of the unrestricted principal of our June 2018 Convertible Notes. As a result of such redemptions, as of November 13, 2018, there was approximately $0 million of unrestricted principal (including make-whole interest) outstanding under the June 2018 Convertible Notes. Following the consummation of the transactions contemplated by the October Exchange Agreement and the netting of the other June 2018 Investor Notes by the other holders of the June 2018 Investor Notes against their corresponding June 2018 Convertible Notes, all of the June 2018 Convertible Notes have been cancelled.

We will continue to require significant proceeds from sales of our debt or equity securities, including conversions of unrestricted principal and make-whole interest under our outstanding convertible notes following payments by investors under investor notes payable to us, each of which will continue to have a significant dilutive effect on our stockholders. If we are unable to obtain sufficient amounts of additional capital, we may be required to reduce the scope of our planned growth or otherwise further alter our business model, objectives and operations, which could harm our business, financial condition and operating results. As of November 13, 2018 there remained $41.9  in restricted principal for which a corresponding amount of principal under the investor notes remains to be paid to the Company by the holders of those convertible notes.

As of September 30, 2018, the Company had approximately $26.7 million in deferred revenue related to subscriptions of its MoviePass service. Deferred revenue represents funds received for monthly, quarterly, semi- annual and annual subscriptions plus amounts associated with gift card purchases. MoviePass has experienced service costs over and above subscription revenue in the fulfillment of subscription services mainly for ticketing and related service fees. Included in the deferred revenue balance is approximately $2.8 million of funds resulting from the acquisition of MoviePass and allocated to service future ticket fulfillment associated with deferred revenue on the acquisition date.

The Company maintains relationships with several payment processing vendors. Our primary merchant processor maintains a reserve fund of a portion of the payments received for annual and other extended term subscription plans. As of September 30, 2018, the amount on deposit with our merchant processor was approximately $25.6 million. This amount is classified as accounts receivable on our balance sheet and is expected to be disbursed to the Company during the course of 2018. The Company intends to use these funds for ticket fulfillment and other general operating costs.

During the nine months ended September 30, 2018 and 2017, the Company has received $39.9 million and $4.0 million, respectively, from complex convertible notes containing derivative features associated with conversion rights and stock purchase warrants. In addition, the convertible notes provided for interest to be paid on borrowed and or committed funds as the case may be, generally for minimum periods even when such funds are not outstanding. During the nine months ended September 30, 2018, the Company has recognized derivative gain of $8.3 million associated with these securities which in many cases are valued based on the underlying equity securities required to satisfy such derivative features upon exercise or conversion. Additionally, during the nine months ended September 30, 2018 and September 30, 2017, the Company has recognized non-cash interest expense of $173.0 million and $16.9 million, respectively, associated with these convertible notes and committed funds which have predominantly been settled through the issuance of shares of the Company’s stock. In addition, the Company incurred approximately $17.5 million, in cash paid for interest associated with outstanding notes and committed funds during the nine months ended September 30, 2018.

At September 30, 2018, there were no amounts outstanding of unrestricted principal of convertible notes with respect to convertible notes payable and derivative liability balances.

51

The Company has experienced net losses and significant cash outflows from cash used in operating activities over periods presented in this report. As of September 30, 2018, the Company had an accumulated deficit of $377,266,866, a loss from operations for the three and nine months ended September 30, 2018 of $86,414,887 and $320,785,739, respectively, and net cash used in operating activities for the nine months ended September 30, 2018 of $321,093,755.

If the Company is unable to make required payments to its merchant and fulfillment processors, the merchant and fulfillment processors may cease processing payments for MoviePass, which would cause a MoviePass service interruption. Such a service interruption occurred on July 26, 2018. Any future service interruptions could have a further material adverse effect on MoviePass’ ability to retain its subscribers. This would have an adverse effect on the Company’s financial position and results of operations.

The Company expects to continue to incur net losses and have significant cash outflows for at least the next twelve months. The attainment of profitable operations is dependent on future events, including obtaining adequate financing to fulfill the Company’s growth and operating activities and generating a level of revenues adequate to support the Company’s cost structure. Management has evaluated the significance of the conditions described above in relation to the Company’s ability to meet its obligations and concluded that, without additional funding, the Company will not have sufficient funds to meet its obligations within one year from the date the condensed consolidated financial statements were issued. These factors raise substantial doubt about the Company’s ability to continue as a going concern. While management plans to raise additional capital from sources such as sales of the Company’s debt or equity securities or loans in order to meet operating cash requirements, there is no assurance that management’s plans will be successful.

The Company also has goodwill of approximately $40.6 million, related to the acquisition of MoviePass in December 2017 and $8.5 million related to the acquisition of Moviefone in April 2018, which is included in the Subscription and Marketing, Promotional Services, and Films operating segment, which may be susceptible to impairment as a result of changes in various factors or conditions. Other identifiable intangible assets, including customer relationships, technology and tradenames and trademarks, aggregating to approximately $30.1 million, are amortized on a straight-line basis over their estimated useful lives. The Company assesses the potential impairment of goodwill and our finite-lived intangible assets on an annual basis, as well as whenever events or changes in circumstances indicate that the carrying value may not be recoverable. As of September 30, 2018, the Company evaluated whether any triggering events for goodwill, as defined in ASC 350-35-3C, were deemed to be more likely than not and determined that as of September 30, 2018 they were.

During the third quarter of 2018, due to a significant decline in its MoviePass subscribers resulting primarily from changes made to our service offerings substantially during the third quarter, the Company deemed it more appropriate to assess goodwill impairment of the MoviePass reporting unit as of September 30, 2018. In conjunction with the events occurring in the third quarter of 2018, the Company updated its long-term business plan, which was used as the basis for estimating the future cash flows of its reporting units. That plan considered then current economic conditions and trends, estimated future operating results, the Company’s views of growth rates and then-anticipated future economic and regulatory conditions.

The Company determined that the fair value of the MoviePass reporting unit was below its carrying value. Therefore, the Company conducted step two of the impairment test for the MoviePass reporting unit and determined the carrying value of goodwill in the MoviePass reporting unit exceeded its implied fair value, resulting in an impairment charge of $38.5 million. This was as a result of reduced financial projections for the MoviePass reporting unit, due to, among other things, lower than expected actual financial results from this business due to a lower number of subscribers resulting from changes in the MoviePass service offering, which resulted in diminished financial performance relative to its original expectations. Given the foregoing, the Company determined there was greater uncertainty in achieving its prior financial projections and so applied a slightly higher discount rate for purposes of its goodwill impairment analysis. Additionally, modifications of certain cashflow assumptions to reflect the current economic conditions as well as market participant levels were made. These assumptions along with a higher discount rate negatively affected the fair value of the MoviePass reporting unit.

The Company expects to continue to be required to raise capital to support these initiatives. There can be no assurance that the Company will be able to raise capital on favorable terms, or at all. Future adverse changes in these or other unforeseeable factors could result in an impairment charge that would impact our results of operations and financial position in the reporting period identified.

Off Balance Sheet Arrangements

As of September 30, 2018, the Company does not have any off-balance sheet arrangements.

Contractual Cash Commitments

For a discussion of our “Contractual Cash Commitments”, refer to Note 15 of our unaudited condensed consolidated financial statements in Part I, Item 1 of this Quarterly Report on Form 10-Q.

Related Party Transactions

For a discussion of “Related Party Transactions”, refer to Note 16 of our unaudited condensed consolidated financial statements in Part I, Item 1 of this Quarterly Report on Form 10-Q. 

52

Critical Accounting Policies and Estimates

For a discussion of our “Critical Accounting Policies and Estimates”, refer to “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the year ended December 31, 2017. There have been no material changes to our critical accounting policies and estimates since December 31, 2017.

We adopted the new revenue standard using the modified retrospective method by recognizing the cumulative effect of initially applying the new revenue standard to all non-completed contracts as of January 1, 2018 as an adjustment to opening Accumulated deficit in the period of adoption. For more information regarding the adoption of the new revenue standard, refer to Note 3 in our unaudited condensed consolidated financial statements in Part I, Item 1 of this Quarterly Report on Form 10-Q.

Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not required.

Item 4. Controls and Procedures

As of September 30, 2018, the Company carried out an evaluation, under the supervision of and with the participation of our Principal Executive Officer and our Principal Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)). Disclosure controls and procedures are designed to ensure that information required to be disclosed in the reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Principal Executive Officer and Principal Financial Officer, to all timely decisions regarding required disclosures. Based on that evaluation, our Principal Executive Officer and Principal Financial Officer have concluded that, as of September 30, 2018, our disclosure controls and procedures were not effective due to the existence of the material weakness identified by management at year end December 31, 2017, and as disclosed in our Form 10-K, that we are still in the process of remediating.

Changes in internal control over financial reporting

The MoviePass Inc. acquisition on December 11, 2017 and the post-acquisition integration related activities represents a material change in our internal control over financial reporting. We are in the process of evaluating the impact of the acquisition on our internal control over financial reporting as well as the necessary controls and procedures to be implemented.

During the quarter covered by this report, there were no other changes in our internal control over financial reporting (as defined in Rule 13a-15(f) of the Exchange Act) that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

53

Part II. Other Information

Item 1. Legal Proceedings

On August 2, 2018, Jeffrey Chang, acting on behalf of himself and a putative class of persons who purchased or otherwise acquired the Company’s common stock between August 15, 2017, and July 26, 2018, filed a class action complaint in the U.S. District Court for the Southern District of New York against the Company and two of its executive officers, Theodore Farnsworth and Stuart Benson (the “August 2, 2018 Complaint”). Jeffrey Chang v. Helios and Matheson Analytics Inc., et. al., Case No. 1:18-cv-6965. The August 2, 2018 Complaint alleges, among other things, that the Company’s statements to the market were materially false or misleading. The plaintiffs assert claims under Sections 10(b) and 20(a) of the Exchange Act and Rule 10b-5.

On August 13, 2018, Jeffrey Braxton, acting on behalf of himself and a putative class of persons who purchased or otherwise acquired the Company’s common stock between August 15, 2017, and July 26, 2018, filed a class action complaint in the U.S. District Court for the Southern District of New York against the Company and two of its executive officers, Theodore Farnsworth and Stuart Benson (the “August 13, 2018 Complaint”). Jeffrey Braxton v. Helios and Matheson Analytics, Inc. et al., Case No. 1:18-cv-07242-UA. The August 13, 2018 Complaint makes substantially identical allegations as the August 2, 2018 Complaint.

Motions have been filed to consolidate the cases and for the appointment of lead plaintiff and lead plaintiffs’ counsel. The motions are scheduled to be argued November 16, 2018. The Company intends to vigorously defend these matters and believes that they are without merit. Given the preliminary status of the litigation, it is difficult to predict the likelihood of an adverse outcome or estimate the amount or range of any reasonably possible losses, if any.

On September 20, 2018, Yu Chen, a purported stockholder of the Company, filed a complaint in the Supreme Court of the State of New York, County of New York, Index No. 654686/2018, derivatively on behalf of the Company against Theodore Farnsworth, Stuart Benson, Muralikrishna Gadiyaram, Prathap Singh, Gavriel Ralbag, and Carl Schramm, and the Company as a nominal defendant (the “September 20, 2018 Complaint”). The September 20, 2018 Complaint alleges claims for breach of fiduciary duty and unjust enrichment against the individual defendants. The Plaintiff has agreed to stay the action pending a decision on an anticipated motion to dismiss the consolidated complaint that is expected to be filed in the securities actions discussed above.

Item 1A. Risk Factors 

Our cash and cash equivalents, may not be sufficient to fund our operations for the near future and we may not be able to obtain additional financing.

As of November 12, 2018, we had approximately $6.2 million in available cash and approximately $23.3 million on deposit with our merchant processors for a total of approximately $29.5 million. The funds held by these processors represent a portion of the payments received for annual and other extended term MoviePass subscription plans and future ticket fulfillment, which we classify as current assets on our balance sheet and which we expect to be disbursed to us or utilized during 2018. Historically, our monthly cash deficit has been significant, and as we continue to fund MoviePass’ operations, and increase our investments in movies through MoviePass Ventures and MoviePass Films, and make other acquisitions, our monthly cash deficit will continue to increase in the coming months.

Our cash and cash equivalents may not be sufficient to fund our operations for the near future and we may not be able to obtain additional financing. We will continue to require significant proceeds from sales of our debt or equity securities, However, we no longer have access to funds from the sale of shares of common stock in the ATM Offering and we will need to seek other sources of capital, of which there can be no assurance. Furthermore, to the extent we use any net proceeds from sales of our securities for acquisitions of other businesses or financial interests in additional movies (through our subsidiaries, MoviePass Ventures or MoviePass Films), we will need additional capital to offset our monthly cash deficit to the extent resulting from those further investments.

We will continue to require significant proceeds from sales of our debt or equity securities, including conversions of unrestricted principal and make-whole interest under our outstanding convertible notes following payments by investors under investor notes payable to us, each of which will continue to have a significant dilutive effect on our stockholders. If we are unable to obtain sufficient amounts of additional capital, we may be required to reduce the scope of our planned growth or otherwise further alter our business model, objectives and operations, which could harm our business, financial condition and operating results.

A failure to make required payments to our merchant and fulfillment processors, could result in a MoviePass service interruption, which could cause a material adverse effect on our financial position and results of operations.

If we are unable to make required payments to our merchant and fulfillment processors, the merchant and fulfillment processors may cease processing payments for MoviePass, which would cause a MoviePass service interruption. Such a service interruption occurred on July 26, 2018. Any future service interruptions could have a further material adverse effect on MoviePass’ ability to retain its subscribers. This would have a material adverse effect on our financial position and results of operations.

54

Our common stock may be subject to delisting from The Nasdaq Capital Market.

On June 21, 2018, we received a deficiency letter from the Nasdaq Listing Qualifications Department notifying us that, for the prior thirty consecutive business days, the closing bid price for our common stock had closed below the minimum $1.00 per share requirement for continued listing on The Nasdaq Capital Market pursuant to the Minimum Bid Price Requirement. In accordance with Nasdaq Listing Rules, we have been given 180 calendar days, or until December 18, 2018 to regain compliance with the Minimum Bid Price Requirement. If we are not in compliance with the Minimum Bid Price Requirement by December 18, 2018, we may be afforded a second 180 calendar day grace period. To qualify, we would be required to meet the continued listing requirements for market value of publicly held shares and all initial listing standards for The Nasdaq Capital Market, except for the Minimum Bid Price Requirement. In addition, we would be required to notify Nasdaq of our intent to cure the deficiency during the second compliance period, which may include, if necessary implementing a reverse stock split.

To regain compliance with the Minimum Bid Price Requirement, effective July 23, 2018, we effected the Reverse Stock Split of our common stock at a ratio of 1 share-for-250 shares. However, since the effectiveness of the Reverse Stock Split, the per share market price of our common stock has fallen below $1.00 and as of November 14, 2018, the closing price was $0.017. As a result, we are not in compliance with the Minimum Bid Price Requirement Further, the Special Meeting of Stockholders scheduled to be held on November 14, 2018 to provide stockholders with an opportunity to vote on the proposed reverse stock split in a ratio of 1 share-for-2 shares up to a ratio of 1 share-for-500 shares has been cancelled. The Company was presenting the reverse stock split proposal in an effort to regain compliance with the Minimum Bid Price Requirement. Since the Company will not be able to effect a reverse stock split ten business days prior to December 18, 2018, absent an extension by The Nasdaq Capital Market (of which there can be no assurance) the Company believes that our common stock will be subject to delisting from The Nasdaq Capital Market, which would adversely impact the liquidity and marketability of our common stock.

If we do not regain compliance with the Minimum Bid Price Requirement by December 18, 2018 and we are not eligible for an additional compliance period at that time, the Staff will provide written notification to us that our common stock may be delisted. At that time, we may appeal the Staff’s decision to the Panel. We would remain listed pending the Panel’s decision. There can be no assurance that, if we do appeal a subsequent delisting determination by the Staff to the Panel, that such an appeal would be successful.

On August 25, 2018, Carl J. Schramm resigned from the Board of Directors of the Company and each committee of the Board of Directors which he was a member, including the Audit Committee. As a result, the Company is no longer compliant with Nasdaq Listing Rule 5605(b)(1), which requires that a majority of the Board of Directors of the Company be independent, and Nasdaq Listing Rule 5605(c)(2)(A), which requires that the Audit Committee have at least three independent directors.

In accordance with Nasdaq Listing Rules, on August 27, 2018, the Company notified Nasdaq of Mr. Schramm’s resignation and non-compliance with the above Nasdaq Listing Rules. Nasdaq responded on September 6, 2018 with a notification letter confirming the Company’s non-compliance with Nasdaq’s independent director and audit committee requirements as set forth above. Nasdaq advised that, pursuant to Nasdaq Listing Rules 5605(b)(1)(A) and 5605(c)(4), the Company will have until the following to cure the deficiencies caused by Mr. Schramm’s departure:

● until the earlier of the Company’s next annual shareholders’ meeting or August 25, 2019; or

● if the next annual shareholders’ meeting is held before February 21, 2019, then the Company must evidence compliance no later than February 21, 2019.

The Board of Directors of the Company intends to appoint a new independent director who satisfies the applicable requirements of the Nasdaq Listing Rules to serve on the Company’s Board of Directors and Audit Committee prior to the expiration of the cure period, but no assurances can be given that the Company will appoint a new independent director who satisfies the applicable requirements of the Nasdaq Listing Rules to serve on the Company’s Board of Directors and Audit Committee prior to the expiration of the cure period.

If we are not able to regain compliance with the Minimum Bid Price Requirement or appoint a new independent director who satisfies the applicable requirements of the Nasdaq Listing Rules to serve on the Company’s Board of Directors and Audit Committee prior to the expiration of the cure period, our common stock could be traded on the over the counter market maintained by OTC Markets Group, Inc. In such event, it would become more difficult to dispose of, or obtain accurate price quotations for, our common stock, and there would likely be a reduction in our coverage by security analysts and the news media, which could cause the price of our common stock to decline further. Additionally, the sale or purchase of our common stock would likely be made more difficult and the trading volume and liquidity of our common stock would likely decline. A delisting from The Nasdaq Capital Market would also result in negative publicly and would negatively impact our ability to raise capital in the future.

55

The sale of a substantial amount of our common stock in the public market, and the issuance of shares reserved for consultants and the future conversion of convertible instruments, could adversely affect the prevailing market price of our common stock.

As of November 9, 2018, we had 1,612,561,916 shares of common stock issued and outstanding and the closing sale price of our common stock on November 14, 2018 was $0.017.

The issuances of convertible notes in December 2016 and the February 2017 Notes, the August 2017 Notes, the November 2017 Notes, the January 2018 Notes and the June 2018 Convertible Notes (collectively, the “Notes”) and the subsequent transactions, resulted in a high volume of activity for our securities. We may engage in similar transactions, which transactions may include registration rights. The issuance of such additional securities and the potential for high volume trades of our common stock in connection with these financings may continue to have a downward effect on our market price. In addition, in connection with the Notes, we issued five-year warrants to a financial advisor, of which 6,381 (1,595,250 pre-split) are currently exercisable, and warrants in public offerings, of which 61,087 (16,117,000 pre-split) are currently exercisable. Future issuance of our common stock upon exercise of these warrants may have a further negative impact on our stock price.

Further, as of November 14, 2018, as a result of the issuance of the November 2017 Notes and, the January 2018 Notes, 2.8billion shares of our common stock may be issuable upon conversion of such outstanding debt. Further, this number of shares may increase significantly if there are further conversion price reductions resulting from the full ratchet conversion price adjustment provisions of the November 2017 Notes and the January 2018 Notes, which provide that if we issue securities in certain transactions at a price lower than the applicable conversion price of the November 2017 Notes and the January 2018 Notes, then the applicable conversion price of the November 2017 Notes and the January 2018 Notes, will be reduced to equal such lower price, resulting in additional shares issuable upon conversion of the November 2017 Notes and the January 2018 Notes. As of November 14, 2018, the Company owes approximately $262,471 of make-whole interest under the November 2017 Notes and the January 2018 Notes. As such, all of the shares noted above represent shares issuable upon conversion of restricted principal under such convertible debt for which an equivalent amount owed to us under the corresponding investor notes has not yet been paid. Such restricted principal may not, as of the date of this Quarterly Report on Form 10-Q, be converted into any shares of our common stock. However, if holders of these convertible Notes provide additional payments to us under the corresponding investor notes, an amount equal to such payment will become unrestricted principal under these convertible notes that may be converted to our common stock at the election of the holders of these Notes.

The issuance of shares we are obligated to issue and the issuance of shares we may issue in connection with conversion or exercise of our outstanding convertible instruments may result in a higher volume trading of our securities, which may increase dilution of existing investors and further depress the market price of our common stock, which may negatively affect our stockholders’ equity and our ability to raise capital on terms acceptable to us in the future.

Impairment of our intangible assets could result in significant charges that would adversely impact our future operating results.

The Company has goodwill of approximately $40.6 million, related to the acquisition of MoviePass in December 2017 and $8.5 million related to the acquisition of Moviefone in April 2018, which is included in the Subscription and Marketing, Promotional Services, and Films operating segment, which may be susceptible to impairment as a result of changes in various factors or conditions. Other identifiable intangible assets, including customer relationships, technology and tradenames and trademarks, aggregating to approximately $30.1 million, are amortized on a straight-line basis over their estimated useful lives. The Company assesses the potential impairment of goodwill and our finite-lived intangible assets on an annual basis, as well as whenever events or changes in circumstances indicate that the carrying value may not be recoverable. As of September 30, 2018, the Company evaluated whether any triggering events for goodwill, as defined in ASC 350-35-3C, were deemed to be more likely than not and determined that as of September 30, 2018 they were.

During the third quarter of 2018, due to a significant decline in its MoviePass subscribers resulting primarily from changes made to our service offerings substantially during the third quarter, the Company deemed it more appropriate to assess goodwill impairment of the MoviePass reporting unit as of September 30, 2018. In conjunction with the events occurring in the third quarter of 2018, the Company updated its long-term business plan, which was used as the basis for estimating the future cash flows of its reporting units. That plan considered then current economic conditions and trends, estimated future operating results, the Company’s views of growth rates and then-anticipated future economic and regulatory conditions.

56

The Company determined that the fair value of the MoviePass reporting unit was below its carrying value. Therefore, the Company conducted step two of the impairment test for the MoviePass reporting unit and determined the carrying value of goodwill in the MoviePass reporting unit exceeded its implied fair value, resulting in an impairment charge of $38.5 million. This was as a result of reduced financial projections for the MoviePass reporting unit, due to, among other things, lower than expected actual financial results from this business due to a lower number of subscribers resulting from changes in the MoviePass service offering, which resulted in diminished financial performance relative to its original expectations. Given the foregoing, the Company determined there was greater uncertainty in achieving its prior financial projections and so applied a slightly higher discount rate for purposes of its goodwill impairment analysis. Additionally, modifications of certain cashflow assumptions to reflect the current economic conditions as well as market participant levels were made. These assumptions along with a higher discount rate negatively affected the fair value of the MoviePass reporting unit.

The Company has implemented several changes to the services offered under the MoviePass subscription plans with the goal of reducing the costs associated with providing the related services. The Company expects to continue raise capital to support these initiatives. Future adverse changes in these or other unforeseeable factors could result in an impairment charge that would impact our results of operations and financial position in the reporting period identified.

We could be subject to liability, penalties and other restrictive sanctions and adverse consequences arising out of certain private proceedings and governmental matters.

We are, and in the future may become, subject to various lawsuits and legal proceedings. For example, we are a named defendant in several lawsuits described under “Legal Proceedings.” In addition, we have received requests for information from regulators and governmental authorities. We cannot predict the outcome or impact of any ongoing matters.

There can be no assurance that additional lawsuits or legal proceedings by a regulator or governmental authority will not be filed against us. There also can be no assurance that any such lawsuits or proceedings will not have a disruptive impact upon the operation of our business, and that the defense of such lawsuits or proceedings will not consume the time and attention of our senior management and financial resources or that the resolution of any such litigation will not have a material adverse effect on our business, financial condition and results of operations. Further, should the government decide to pursue an enforcement action, there exists the possibility of a material adverse effect on our business, financial condition and results of operations.

Due to recent changes to our subscription plans, the number of our subscribers has decreased, and we may continue to lose subscribers or fail to attract new subscribers. 

In an effort to reduce our monthly deficit and improve profitability, we recently changed our monthly subscription plan to the current three-movies-per-month plan, at a price of $9.95 per month and limited the available movies to those listed on a schedule. In August 2018, we began to convert subscribers on an annual subscription plan to the three-movies-per-month subscription plan, by giving annual subscribers the option to either cancel or refund their annual subscription or continue on the new three-movies-per-month subscription plan. As a result of these changes, we have experienced subscriber losses. We may continue to lose subscribers, or fail to attract new subscribers, and our business and operating results could be adversely affected. Future changes to our subscription plan may not be favorably received by customers and we may not be able to attract or retain subscribers, and as a result, our revenue and results of operations may be affected adversely. The number of recent changes to our subscription plans may also make competitors’ subscription plans more attractive to customers, and we may be unable to successfully compete with current and new competitors.

57

We are at risk of attempts at unauthorized or improper use of our services, and failure to effectively prevent and remediate such attempts could have an adverse impact on our business, operating results and financial condition.

Our terms of use prohibit subscribers from sharing their accounts with non-subscribers or reselling tickets purchased through their account to non-subscribers. We have in the past been, and continue to be, impacted by attempts by subscribers and other persons to violate our terms of use by sharing accounts with non-subscribers or reselling tickets to non-subscribers. We have implemented certain measures to promote the fair use of our MoviePass subscription product, including a technological enhancement allowing subscribers to log in on only one mobile device, a policy allowing subscribers to see a movie title only once per subscriber and new ticket verification software, which have reduced suspected abuse. Despite these measures, we cannot guarantee that such unauthorized sharing of accounts or reselling of tickets or other violations of our terms of use will not occur or that these measures will continue to reduce or eliminate suspected abuse. If in the future we fail to successfully prevent subscribers from sharing their accounts with non-subscribers or reselling tickets purchased through their account to non-subscribers, we may incur losses as a result and may not achieve profitability.

Our success depends on our ability to maintain the value of our brand. As a result of changes to our subscription plan, there has been some damage to our brand, and if future events further damage our brand, our business and financial results may be harmed.

Our success depends on our ability to maintain the value of our brand. As a result of recent changes to our subscription plan, there has been adverse press and complaints from users about MoviePass, which has resulted in damage to the MoviePass brand. This harm to the MoviePass brand has resulted in a loss of existing subscribers and a slower growth of new subscribers, which has had an adverse effect on our revenues. Improving, promoting and positioning the MoviePass brand will depend largely on the success of our marketing efforts and our ability to provide consistent, high quality products and services through our applications. The MoviePass brand could be further harmed if we fail to achieve these objectives or if our public image or brand were to be tarnished by additional negative publicity. Our reputation and brand may also be harmed if we fail to maintain a consistently high level of customer service. Executing the strategies necessary to maintain the value of our brand may require us to make substantial investments, and these investments may not be successful. Such failures may adversely affect our business, financial condition and operating results.

We depend on motion picture production and performance and may be susceptible to fluctuations in motion picture production and performance.

Our success depends in part on the performance of the motion picture production industry. Although our monthly subscription model stabilizes and reduces exposure to short-term volatility, our business may still be affected by fluctuations in the performance of the motion picture production industry. Additionally, our business may be affected by a shortage of motion picture programming attractive to our subscribers, though we do not anticipate such a shortage. Further, the diversity and stability of our subscribers reduces exposure to the effect of any shortage of motion picture programming.

An increase in the use of alternative film delivery methods or other forms of entertainment may drive down subscribers and moviegoer attendance.

The movie industry faces continuing disruption resulting from the proliferation of alternative film delivery methods. The availability and increased use of alternative film delivery methods, such as online movie streaming services, or other forms of entertainment may drive down moviegoer attendance and subscribers to the MoviePass service, which may affect our business.

Increased regulatory scrutiny, in particular, related to privacy and security issues may negatively impact our business.

Although we are not aware of any current or proposed federal, state or local laws or regulations that would have a material detrimental effect on us, there may be increased legal and regulatory scrutiny on our data sources, technologies to process data and other aspects of the MoviePass service. The increased legal and regulatory scrutiny may require us to make modifications or improvements to the current technologies we use or may otherwise increase our compliance costs, which may adversely affect our business.

In particular, the regulatory framework for privacy and security issues is evolving worldwide and is likely to remain in flux for the foreseeable future. Various government and consumer agencies have also called for new regulation and changes in industry practices. Practices regarding the collection, processing, storage, sharing, disclosure, use and security of personal and other information by companies offering online or mobile services is under increased public scrutiny. Our business, including our ability to operate and expand in the United States and internationally or on new technology platforms, could be adversely affected if legislation or regulations are adopted, interpreted or implemented in a manner that is inconsistent with our current business practices and that require changes to these practices, the design of our website, mobile applications, products, features or our privacy policy. In particular, the success of our business will be driven by our ability to responsibly use the data that we collect from our users, key suppliers and other sources. Therefore, our business could be harmed by any significant change to applicable laws, regulations or industry standards or practices regarding the storage, use or disclosure of data we collect, or regarding the manner in which the express or implied consent of relevant persons for such use and disclosure is obtained. Such changes may require us to modify our products and features, possibly in a material manner, and may limit our ability to develop new products and features that make use of the data that we collect.

58

We could be subject to consumer protection claims, lawsuits and other proceedings that may result in adverse outcomes.

Although we are committed to providing MoviePass’s services as high in quality as we are capable while striving to comply with applicable consumer protection laws and regulations, there is no assurance that we will not be the subject of claims, lawsuits or other proceedings arising from our technologies, products or services, especially if any new laws or regulations are promulgated which may greatly increase the risk of litigation by users or third parties. In particular, in the ordinary course of business, we have received notices from state consumer protection bureaus of individual complaints filed against us by subscribers and may continue to receive such complaints, particularly as we make changes to our subscription plans. We are also subject to investigations or inquiries from state or federal consumer protection agencies and face regulatory scrutiny with respect to consumer protection issues.

Responding to investigations or litigation are costly and could divert us from focusing on our business operations.  If any investigation or litigation results in an adverse outcome, it could negatively impact our public image and brand and have a detrimental effect on our financial position and operating results.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Not Applicable.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosure

Not Applicable.

Item 5. Other Information

On October 23, 2018, the Company issued a press release announcing that its Board of Directors preliminarily approved a plan to create a new subsidiary named MoviePass Entertainment Holdings Inc. (“MoviePass Entertainment”) that would take ownership of the shares of MoviePass and other film related assets held by the Company. If permitted under Delaware law and subject to other conditions, the Company plans to distribute a minority of the outstanding shares of MoviePass Entertainment common stock as a dividend to stockholders of the Company as of a record date that is yet to be determined, with the Company retaining control of MoviePass Entertainment upon any such distribution.

On October 24, 2018, Christopher Kelly and Maria Stipp advised MoviePass of their resignations from the board of directors of MoviePass. Prior to his resignation, Mr. Kelly was Chairman of the board of directors of MoviePass. Mr. Kelly had served as a member of the board of directors of MoviePass since June 24, 2014, and as Chairman of the board of directors of MoviePass since June 24, 2014. Ms. Stipp had served as a member of the board of directors of MoviePass since January 2018. Both Mr. Kelly and Ms. Stipp expressed their belief that they had not received sufficient access to information regarding the Company’s preliminary approval of a plan to create MoviePass Entertainment and potential distribution of MoviePass Entertainment common stock to the Company’s stockholders.

Our Board of Directors has determined that it intends to hold the Company’s Annual Meeting of Stockholders (the “2018 Annual Meeting”) on December 27, 2018, at a time and location to be specified in the Company’s proxy statement for the 2018 Annual Meeting.

Because the date of the 2018 Annual Meeting has been changed by more than 30 days from the anniversary of the Company’s 2017 Annual Meeting of Stockholders, pursuant to Rule 14a-8 (“Rule 14a-8”) under the Exchange Act, stockholders of the Company who wish to have a proposal considered for inclusion in the Company’s proxy materials for the 2018 Annual Meeting pursuant to Rule 14a-8 must ensure that their proposal is received by the Secretary of the Company at Helios and Matheson Analytics Inc., Empire State Building, 350 5th Avenue, Suite 7520, New York, NY 10118, Attn: Stuart Benson, Secretary, by November 26, 2018, which the Company has determined to be a reasonable time before it expects to begin to print and send its proxy materials. Rule 14a-8 proposals must also comply with the requirements of Rule 14a-8 and other applicable laws in order to be eligible for inclusion in the Company’s proxy materials for the 2018 Annual Meeting. The November 26, 2018 deadline will also apply in determining whether notice of a stockholder proposal is timely for purposes of exercising discretionary voting authority with respect to proxies under Rule 14a-4(c) under the Exchange Act.

59

Item 6. Exhibits

The following exhibits are either filed herewith or incorporated herein by reference: 

Exhibit Number	Description
3.1.1	Certificate of Incorporation of the Company (incorporated by reference to Exhibit 3.1 to the Company’s Annual Report on Form 10-K for the year ended December 31, 2009 filed with the SEC on March 31, 2010).
3.1.2	Certificate of Amendment of Certificate of Incorporation of the Company (incorporated by reference to Exhibit 3.3 to the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2011 filed with the SEC on May 13, 2011).
3.1.3	Certificate of Amendment of Certificate of Incorporation of the Company (incorporated by reference to Exhibit 3.4 to the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2011 filed with the SEC on August 15, 2011).
3.1.4	Certificate of Amendment of Certificate of Incorporation of the Company (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed with the SEC on February 8, 2018).
3.1.5	Certificate of Designations, Preferences and Rights of the Series A Preferred Stock of the Company (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed with the SEC on June 26, 2018).
3.1.6	Certificate of Amendment of Certificate of Incorporation of the Company (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed with the SEC on July 24, 2018).
3.1.7	Certificate of Amendment of Certificate of Incorporation of the Company (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed with the SEC on July 25, 2018).
3.2	Bylaws of the Company (incorporated by reference to Exhibit 3.2 to the Company’s Annual Report on Form 10-K for the year ended December 31, 2009 filed with the SEC on March 31, 2010).
4.1	Form of A-2 Warrant issued by the Company in favor of the holder thereof (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed with the SEC on April 19, 2018).
4.2	Form of B-2 Warrant issued by the Company in favor of the holder thereof (incorporated by reference to Exhibit 4.2 to the Company’s Current Report on Form 8-K filed with the SEC on April 19, 2018).
4.3	Form of Series B-2 Senior Secured Bridge Convertible Note issued by the Company in favor of the holder thereof (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed with the SEC on June 21, 2018).
4.4	Form of Secured Promissory Note issued by the investors in favor of the Company (incorporated by reference to Exhibit 4.2 to the Company’s Current Report on Form 8-K filed with the SEC on June 21, 2018).
4.5	Form of Senior Note issued by the Company in favor of Hudson Bay Master Fund Ltd (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed with the SEC on October 4, 2018).
10.1	Asset Purchase Agreement, dated as of April 4, 2018, by and between the Company and Oath Inc. (incorporated by reference to Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2018, filed with the SEC on August 14, 2018).
10.2	Registration Rights Agreement, dated April 4, 2018, by and between the Company and Oath Inc. (incorporated by reference to Exhibit 10.2 to the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2018, filed with the SEC on August 14, 2018).
10.3	Lock-Up Agreement, dated as of April 4, 2018, by and between the Company and Oath Inc. (incorporated by reference to Exhibit 10.3 to the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2018, filed with the SEC on August 14, 2018).
10.4	Warrant to Purchase Common Stock, dated April 4, 2108, issued by the Company in favor of Oath Inc. (incorporated by reference to Exhibit 10.4 to the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2018, filed with the SEC on August 14, 2018).
10.5	Equity Distribution Agreement, dated April 18, 2018, by and between the Company and Canaccord Genuity LLC. (incorporated by reference to Exhibit 10.5 to the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2018, filed with the SEC on August 14, 2018).
10.6	Subscription Agreement, dated April 16, 2018, by and between MoviePass Inc. and the Company (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on April 20, 2018).
10.7	Amendment No. 1 to November Securities Purchase Agreement and Convertible Notes, entered into as of June 1, 2018, by and between the Company and the investor signatory thereto (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on June 4, 2018).
10.8	Amendment No. 2 to January Securities Purchase Agreement and Convertible Notes, entered into as of June 1, 2018, by and between the Company and the investor signatory thereto (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed with the SEC on June 4, 2018).
10.9	Form of Securities Purchase Agreement, dated as of June 21, 2018, by and between the Company and the investors listed therein (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on June 21, 2018).
10.10	Form of Note Purchase Agreement, by and between the Company and the investor signatory thereto (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed with the SEC on June 21, 2018).
10.11	Form of Master Netting Agreement, by and among the Company and the investor signatory thereto (incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K filed with the SEC on June 21, 2018).
10.12	Form of Guaranty made by MoviePass, Inc. and each direct and indirect subsidiary of MoviePass, Inc. (incorporated by reference to Exhibit 10.4 to the Company’s Current Report on Form 8-K filed with the SEC on June 21, 2018).
10.13	Form of Voting and Lockup Agreement, by and between the Company and Theodore Farnsworth (incorporated by reference to Exhibit 10.5 to the Company’s Current Report on Form 8-K filed with the SEC on June 21, 2018).
10.14	Form of Voting and Lockup Agreement, by and between the Company and Helios & Matheson Information Technology, Ltd. and Helios & Matheson Inc. (incorporated by reference to Exhibit 10.6 to the Company’s Current Report on Form 8-K filed with the SEC on June 21, 2018).

60

Exhibit Number	Description
10.15	Form of Common Stock Purchase Warrant issued to Palladium Capital Advisors, LLC by the Company (incorporated by reference to Exhibit 4.2 to the Company’s Current Report on Form 8-K filed with the SEC on October 5, 2017).
10.16	Form of Voting Agreement by and between the Company and the stockholder signatory thereto (incorporated by reference to Exhibit 10.8 to the Company’s Current Report on Form 8-K filed with the SEC on June 21, 2018).
10.17	Form of Amendment and Exchange Agreement, dated June 28, 2018, by and between the Company and the holder signatory thereto (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on June 28, 2018).
10.18	Form of Voting Agreement, dated June 28, 2018, by and between the Company and the stockholder signatory thereto (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed with the SEC on June 28, 2018).
10.19	Form of Leak-Out Agreement by and between the Company and the signatory thereto (incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K filed with the SEC on June 28, 2018).
10.20	Amendment No. 1 to the Securities Purchase Agreement, dated as of June 28, 2018, by and between the Company and Hudson Bay Master Fund Ltd. (incorporated by reference to Exhibit 10.4 to the Company’s Current Report on Form 8-K filed with the SEC on June 28, 2018).
10.21	October 2018 Amendment and Exchange Agreement, dated as of October 4, 2018, by and between the Company and Hudson Bay Master Fund Ltd. (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on October 4, 2018).
31.1	Certification of Principal Executive Officer pursuant to Section 302 of Sarbanes-Oxley Act of 2002.
31.2	Certification of Principal Financial Officer pursuant to Section 302 of Sarbanes-Oxley Act of 2002.
32.1	Certification of the Principal Executive Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2	Certification of the Principal Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101	The following financial statements from the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2018 formatted in XBRL (eXtensible Business Reporting Language): (i) Condensed Consolidated Balance Sheets; (ii) Condensed Consolidated Statements of Operations and Comprehensive Loss; (iii) Condensed Consolidated Statement of Change in Stockholders’ Deficit; (iv) Condensed Consolidated Statements of Cash Flows; and (v) the Notes to the Consolidated Financial Statements.

61

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	HELIOS AND MATHESON ANALYTICS INC.
Date: November 15, 2018	By:	/s/ Theodore Farnsworth
		Theodore Farnsworth
		Chief Executive Officer (Principal Executive Officer)

	HELIOS AND MATHESON ANALYTICS INC.
Date: November 15, 2018	By:	/s/ Stuart Benson
		Stuart Benson
		Chief Financial and Accounting Officer (Principal Financial Officer)

62

EX-31.1

Exhibit 31.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

I, Theodore Farnsworth, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Helios and Matheson Analytics Inc.;

2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 15, 2018	By:	/s/ Theodore Farnsworth
		Theodore Farnsworth
		Chief Executive Officer (Principal Executive Officer)

EX-31.2

Exhibit 31.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

I, Stuart Benson, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Helios and Matheson Analytics Inc.;

2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 15, 2018	By:	/s/ Stuart Benson
		Stuart Benson
		Chief Financial and Accounting Officer (Principal Financial and Accounting Officer)

EX-32.1

Exhibit 32.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350

In connection with the accompanying Quarterly Report on Form 10-Q of Helios and Matheson Analytics Inc. for the quarter ended September 30, 2018, I, Theodore Farnsworth, the Principal Executive Officer of Helios and Matheson Analytics Inc., hereby certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:

(1) such Quarterly Report on Form 10-Q for the quarter ended September 30, 2018 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in such Quarterly Report on Form 10-Q for the period ended September 30, 2018 fairly presents, in all material respects, the financial condition and results of operations of Helios and Matheson Analytics Inc. on a consolidated basis.

Date: November 15, 2018	By:	/s/ Theodore Farnsworth
		Theodore Farnsworth
		Chief Executive Officer (Principal Executive Officer)

A signed original of this written statement required by §906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

The foregoing certification is being furnished solely pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code) and is not being filed as part of the Form 10-Q or as a separate disclosure document

EX-32.2

Exhibit 32.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350

In connection with the accompanying Quarterly Report on Form 10-Q of Helios and Matheson Analytics Inc. for the quarter ended September 30, 2018, I, Stuart Benson, the Principal Financial Officer of Helios and Matheson Analytics Inc., hereby certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:

(1) such Quarterly Report on Form 10-Q for the quarter ended September 30, 2018 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in such Quarterly Report on Form 10-Q for the period ended September 30, 2018 fairly presents, in all material respects, the financial condition and results of operations of Helios and Matheson Analytics Inc., on a consolidated basis.

Date: November 15, 2018	By:	/s/ Stuart Benson
		Stuart Benson
		Chief Financial and Accounting Officer (Principal Financial and Accounting Officer)

A signed original of this written statement required by §906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

The foregoing certification is being furnished solely pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code) and is not being filed as part of the Form 10-Q or as a separate disclosure document

XML

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2018	Nov. 09, 2018
Document and Entity Information [Abstract]
Entity Registrant Name	Helios & Matheson Analytics Inc.
Entity Central Index Key	0001040792
Trading Symbol	HMNY
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Type	10-Q
Document Period End Date	Sep. 30, 2018
Document Fiscal Year Focus	2018
Document Fiscal Period Focus	Q3
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Ex Transition Period	false
Entity Common Stock, Shares Outstanding		1,612,561,916

XML

Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2018	Dec. 31, 2017
Current assets:
Cash and cash equivalents	$ 4,850,972	$ 24,949,393
Accounts receivable - less allowance for doubtful accounts of $61,614 and $72,335 at September 30, 2018 and December 31, 2017, respectively	30,722,585	27,470,219
Prepaid expenses and other current assets	3,469,645	3,557,811
Total current assets	39,043,202	55,977,423
Property and equipment, net of accumulated depreciation of $332,447 and $274,587 at September 30, 2018 and December 31, 2017, respectively	379,666	234,035
Intangible assets, net	30,097,399	28,536,782
Goodwill	49,148,120	79,137,177
Investment in films	13,403,433
Deposits and other assets	635,172	147,171
Total assets	132,706,992	164,032,588
Current liabilities:
Accounts payable and accrued expenses	17,691,260	13,144,003
Deferred revenue	27,035,060	54,425,630
Due to related parties	1,150,000
Liabilities to be settled in stock	5,988,363	21,320,705
Convertible notes payable, net of debt discount of $0 and $2,444,368 at September 30, 2018 and December 31, 2017, respectively		2,061,072
Warrant liability	60,809	67,288,800
Derivative liability		4,834,462
Notes payable	2,775,000
Total current liabilities	54,700,492	163,074,672
Convertible notes payable, net of current portion and debt discount of $0 and $1,392,514 at September 30, 2018 and December 31, 2017, respectively		1,550,555
Notes payable, net of current portion	5,923,250
Total liabilities	60,623,742	164,625,227
Commitments and Contingencies
Stockholders' equity/(deficit):
Preferred stock, $0.01 par value; 2,000,000 shares authorized; 20,500 and 0 shares issued and outstanding as of September 30, 2018 and December 31, 2017, respectively	205
Common stock, $0.01 par value; 5,000,000,000 shares authorized; 1,357,590,536 issued and outstanding as of September 30, 2018; 100,000,000 shares authorized; 95,925 issued and outstanding as of December 31, 2017	13,575,906	959
Paid-in capital	461,370,934	150,595,611
Accumulated other comprehensive loss - foreign currency translation	(156,399)	(103,980)
Accumulated deficit	(377,266,866)	(189,495,185)
Total Helios and Matheson Analytics Inc. stockholders' equity/(deficit)	97,523,780	(39,002,595)
Noncontrolling interest	(25,440,530)	38,409,956
Total stockholders' equity/(deficit)	72,083,250	(592,639)
Total liabilities and stockholders' equity/(deficit)	$ 132,706,992	$ 164,032,588

XML

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)	Sep. 30, 2018	Dec. 31, 2017
Statement of Financial Position [Abstract]
Allowance for doubtful accounts	$ 61,614	$ 72,335
Property and equipment, net of depreciation	332,447	274,587
Convertible notes payable, debt discount - current	0	2,444,368
Convertible notes payable, debt discount - long term	$ 0	$ 1,392,514
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, shares authorized	2,000,000	2,000,000
Preferred stock, shares issued	20,500	0
Preferred stock, shares outstanding	20,500	0
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	5,000,000,000	100,000,000
Common stock, shares issued	1,357,590,536	95,925
Common stock, shares outstanding	1,357,590,536	95,925

XML

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Revenues:
Consulting	$ 802,114	$ 1,173,023	$ 2,471,223	$ 3,672,036
Subscription	78,921,951		198,488,038
Marketing, promotional services, and film revenue	1,615,177		3,991,575
Total revenues	81,339,242	1,173,023	204,950,836	3,672,036
Cost of revenue	109,635,383	946,308	424,371,078	2,969,357
Gross (loss)/profit	(28,296,141)	226,715	(219,420,242)	702,679
Operating expenses:
Selling, general & administrative	18,121,681	2,243,440	58,340,040	8,023,886
Research and development	85,943	621,754	465,407	1,555,095
Loss on impairment of goodwill	38,524,016		38,524,016
Depreciation & amortization	1,387,106	437,785	4,036,034	1,302,381
Total operating expenses	58,118,746	3,302,979	101,365,497	10,881,362
Loss from operations	(86,414,887)	(3,076,264)	(320,785,739)	(10,178,683)
Other income/(expense):
Change in fair market value - derivative liabilities	(4,933,938)	(11,115,463)	8,311,106	(10,434,611)
Change in fair market value - warrant liabilities	4,217,981	(17,038,711)	194,058,069	(17,038,711)
Gain/(loss) on the extinguishment of debt	45,516,809	(683,885)	60,524,508	(683,885)
Gain on exchange of warrants			301,487
Interest expense	(95,575,954)	(11,563,078)	(189,305,904)	(16,856,284)
Interest income	4,474	14,436	26,101	51,695
Total other income/(expense)	(50,770,628)	(40,386,701)	73,915,367	(44,961,796)
Loss before income taxes	(137,185,515)	(43,462,965)	(246,870,372)	(55,140,479)
Provision for income taxes	10,283	(2,747)	46,953	39,110
Net loss	(137,195,798)	(43,460,218)	(246,917,325)	(55,179,589)
Net loss attributable to the noncontrolling interest	7,583,015		59,145,644
Net loss attributable to Helios and Matheson Analytics Inc.	(129,612,783)	(43,460,218)	(187,771,681)	(55,179,589)
Other comprehensive loss - foreign currency adjustment	(23,699)	(7,355)	(52,419)	(6,066)
Comprehensive loss	$ (129,636,482)	$ (43,467,573)	$ (187,824,100)	$ (55,185,655)
Basic and diluted loss per share:
Net loss per share attributable to common stockholders - basic and diluted	$ (0.2)	$ (5.79)	$ (0.87)	$ (8.35)
Weighted average shares - basic and diluted	642,704,390	7,500,558	216,795,141	6,607,149

XML

Condensed Consolidated Statements of Stockholders' Equity/(Deficit) (Unaudited) - 9 months ended Sep. 30, 2018 - USD ($)	Total	Preferred Stock	Common Stock	Additional Paid-In Capital	Accumulated other comprehensive income	Accumulated Deficit	Noncontrolling Interest
Balance at Dec. 31, 2017	$ (592,639)		$ 959	$ 150,595,611	$ (103,980)	$ (189,495,185)	$ 38,409,956
Balance, shares at Dec. 31, 2017			95,925
Settlement of warrant liability for March warrant exchange	12,894,165		$ 182	12,893,983
Settlement of warrant liability for March warrant exchange, shares			18,186
Settlement of warrant liability for June warrant exchange	5,202,100		$ 905	5,201,195
Settlement of warrant liability for June warrant exchange, shares			90,472
Warrant liability which ceases to exist	53,998,650			53,998,650
Conversion of convertible notes and interest to shares of common stock	82,545,844		$ 7,291,856	75,253,988
Conversion of convertible notes and interest to shares of common stock, shares			729,185,600
Shares issued for settlement of a liability	15,670,686		$ 49	15,670,637
Shares issued for settlement of a liability, shares			4,909
MoviePass shares issued in advance of services	324,369			324,369
Share based compensation	7,198,705		$ 718	7,197,987
Share based compensation, shares			71,760
Derivative liability which ceases to exist	80,366,991			80,366,991
Equity raise, net of transaction fees	119,423,879		$ 6,279,931	113,143,948
Equity raise, net of transaction fees, shares			627,993,083
Shares issued for February public offering	96,912,380		$ 764	96,911,616
Shares issued for February public offering, shares			76,400
Reclassification of February public offering to derivative liability	(158,944,798)			(158,944,798)
Shares issued for April public offering	27,677,558		$ 440	27,677,118
Shares issued for April public offering, shares			44,000
Reclassification of April public offering to warrant liability	(33,997,600)			(33,997,600)
Preferred shares issued in conjunction with June notes	2,773,246	$ 205		2,773,041
Preferred shares issued in conjunction with June notes, shares		20,500
Shares issued in connection with Moviefone acquisition	7,599,458		$ 102	7,599,356
Shares issued in connection with Moviefone acquisition, shares			10,201
Adjustment of noncontrolling interest in connection with the MoviePass Acquisition				4,704,842			(4,704,842)
Net loss	(246,917,325)					(187,771,681)	(59,145,644)
Foreign exchange translation	(52,419)				(52,419)
Balance at Sep. 30, 2018	$ 72,083,250	$ 205	$ 13,575,906	$ 461,370,934	$ (156,399)	$ (377,266,866)	$ (25,440,530)
Balance, shares at Sep. 30, 2018		20,500	1,357,590,536

XML

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (246,917,325)	$ (55,179,589)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	4,036,034	1,302,381
Gain on exchange of warrants	(301,487)
Change in fair market value - derivative liabilities	(8,311,106)	10,434,611
Change in fair market value - warrant liabilities	(194,058,069)	17,038,711
(Gain)/loss on extinguishment of debt	(60,524,508)	683,885
Provision for doubtful accounts	(10,721)	8,005
Non-cash interest expense	173,022,046	16,856,284
Impairment of Goodwill	38,524,016
Share based compensation in exchange for services	10,186,007	2,251,115
Amortization and impairment of film costs	3,809,548
Amortization of deferred revenue	(13,308,643)
Shares issued in advance of services	324,369
Change in operating assets and liabilities:
Accounts receivable	(3,241,645)	147,171
Prepaid expenses and other current assets	(2,871,148)	(110,697)
Unbilled receivables		(3,388)
Deposits and other assets	(488,001)	(79,823)
Investment in films	(17,212,981)
Accounts payable and accrued expenses	10,331,786	(992,962)
Deferred revenue	(14,081,927)
Net cash used in operating activities	(321,093,755)	(7,644,296)
CASH FLOWS FROM INVESTING ACTIVITIES:
Sale of property and equipment		1,929
Advanced from related parties	1,150,000
Purchases of equipment	(203,491)	(109,785)
Acquisition of intangible asset		(195,143)
Payments for acquisition of business net of cash acquired	(1,000,000)	(5,000,000)
Net cash used in investing activities	(53,491)	(5,302,999)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from convertible notes payable	108,657,986	11,950,000
Redemption of convertible notes payable	(63,856,937)
Payment of deferred financing fees	(2,170,328)
Payment of Make-Whole Interest	(5,000,000)
Payment for exchange warrants	(779,219)
Proceeds from equity raises, net of transaction fees	244,013,817
Proceeds from issuance of June notes and preferred shares, net of transaction fees	20,235,925
Extinguishment of September Placement note		(80,000)
Net cash provided by financing activities	301,101,244	11,870,000
Net change in cash	(20,046,002)	(1,077,295)
Effect of foreign currency exchange rate changes on cash and cash equivalents	(52,419)	(6,066)
Cash, beginning of period	24,949,393	2,747,240
Cash, end of period	4,850,972	1,663,879
Supplemental disclosure of cash and non-cash transactions:
Cash paid during the period for interest	16,283,858	253,407
Cash paid for income taxes		5,975
Non-cash investing and financing activities
Conversion of convertible notes and interest to shares of common stock	82,546,858	10,297,936
Exercise of investor warrants to shares of common stock	18,875,484
Warrant liability which ceases to exist	53,998,650
Change in carrying value of convertible common stock equity		152,763
Debt discount for derivative and warrant liability	(118,080,530)
Derivative ceases to exist - reclassified to paid in capital	(80,366,991)	4,674,682
Increase in debt for new original issue discount	27,606,850	7,827,984
Reclassification of warrant from public offering to derivative liability	(158,944,798)
Reclassification of April public offering to warrant liability	(33,997,600)
Non-cash fees relating to public offering	(19,100)
Issuance of warrants in public offering	192,942,398
Interest capitalized as debt	3,345,670
Non-cash consideration for Moviefone acquisition	$ (13,074,959)

XML

General

9 Months Ended

Sep. 30, 2018

General [Abstract]

General

1. General

The accompanying unaudited condensed interim consolidated financial statements (“interim statements”) of Helios and Matheson Analytics Inc. (“Helios and Matheson”, “HMNY” or the “Company”) have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X of the Securities and Exchange Commission (the “SEC”). Accordingly, they do not include all the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments and disclosures necessary for a fair presentation of these interim statements have been included. The results reported in these interim statements are not necessarily indicative of the results that may be reported for the entire year. The consolidated balance sheet as of December 31, 2017 was derived from the audited consolidated financial statements as of and for the year ended December 31, 2017. These interim statements should be read in conjunction with the Company’s consolidated financial statements for the year ended December 31, 2017.

XML

Business and Basis of Presentation

9 Months Ended

Sep. 30, 2018

Business and Basis of Presentation [Abstract]

Business and Basis of Presentation

2. Business and Basis of Presentation

Business

Since 1983, the Company has provided high quality information technology, or IT, services and solutions including a range of technology platforms focusing on big data, business intelligence, and consumer-centric technology. More recently, to provide greater value to stockholders, the Company has sought to expand its business primarily through acquisitions that leverage its capabilities and expertise.

On November 9, 2016, the Company acquired Zone Technologies, Inc., a Nevada corporation (“Zone”), a state-of-the-art mapping and spatial analysis company. On December 11, 2017, the Company acquired a majority interest in MoviePass Inc., a Delaware corporation (“MoviePass”), whose primary product offering is MoviePass™, the nation’s premier movie theater subscription service. MoviePass allows its subscribers to see up to three movies a month, from a schedule of select movies, in theaters nationwide, for a low fixed price and additional movies at a discounted price.

In January 2018, the Company formed the Company’s wholly-owned subsidiary, MoviePass Ventures LLC, a Delaware limited liability company (“MoviePass Ventures”), which aims to collaborate with film distributors to share in film revenues while using the data analytics that MoviePass offers for marketing and targeting services reaching MoviePass’ paying subscribers using the platform.

In April 2018, the Company acquired the Moviefone brand and related assets (“Moviefone”). Moviefone is an entertainment information and marketing service which provides its users with access to the entire entertainment ecosystem. Moviefone delivers movie show times and tickets, trailers, TV schedules, streaming information, cast and crew interviews, photo galleries and more. Moviefone’s editorial coverage includes up-to-date entertainment news, trailers and clips, red-carpet coverage and celebrity features.

On May 15, 2018, the Company formed MoviePass Films LLC, a Delaware limited liability company (“MoviePass Films”), to focus on studio-driven content and new film production for theatrical release and other distribution channels. On May 23, 2018, the Company executed a binding letter of intent (the “LOI”) with Emmett Furla Oasis Films LLC (“EFO”) pursuant to which EFO acquired a 49% membership interest in MoviePass Films.

On July 16, 2018, the Company formed 10 Minutes Gone, LLC, a Delaware limited liability company (“10 Minutes Gone”), for the purpose of engaging in the production and distribution of the film 10 Minutes Gone.

On July 16, 2018, 100% of the membership interests in Georgia Film Fund 79, LLC, a Delaware limited liability company (“GFF79”), formed on January 16, 2018 by EFO, for the purpose of engaging in motion picture production was transferred to 10 Minutes Gone.

Basis of Presentation

The Company’s condensed consolidated financial statements have been prepared in accordance with U.S. GAAP. The condensed consolidated financial statements include all accounts of the Company and its wholly owned and majority owned subsidiaries. The Company consolidates entities in which it owns more than 50% of the voting equity interests and controls operations. All intercompany transactions and balances among consolidated subsidiaries have been eliminated. The Company consolidated the operations of MoviePass as of December 11, 2017, Moviefone as of April 4, 2018, MoviePass Ventures as of January 2018 and MoviePass Films as of May 15, 2018.

Reverse Stock-Split

On July 24, 2018, the Company effected a reverse stock-split of its issued and outstanding common stock at a ratio of one-for-250 (“Reverse Stock Split”). The Company filed a Certificate of Amendment to its Certificate of Incorporation with the Secretary of State of the State of Delaware effecting the Reverse Stock Split. The Reverse Stock Split did not affect the number of authorized shares of common stock, which, following the increase in authorized shares effected on July 23, 2018 discussed in Note 11, remains at 5,000,000,000 shares. A proportionate adjustment was made to (i) the per share exercise price and the number of shares issuable upon the exercise or conversion of the Company’s outstanding equity awards, options and warrants to purchase shares of common stock and outstanding convertible notes and (ii) the number of shares reserved for issuance pursuant to the Company’s 2014 Equity Incentive Plan. The accompanying condensed consolidated financial statements and notes give retroactive effect to the Reverse Stock Split for all periods presented.

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Significant estimates made by management include, but are not limited to, allowance for doubtful accounts, purchase accounting allocations, recoverability and useful lives of property, plant and equipment, identifiable intangibles and goodwill, warrant liabilities, derivative liabilities, the valuation allowance of deferred taxes, contingencies and equity compensation. Actual results could differ from those estimates.

Reclassification

Certain prior period amounts have been reclassified to conform to current period presentation.

XML

Summary of Significant Accounting Policies

9 Months Ended

Sep. 30, 2018

Summary of Significant Accounting Policies [Abstract]

Summary of Significant Accounting Policies

3. Summary of Significant Accounting Policies

Revenue Recognition

ASC 606 Revenue from Contracts with Customers (“ASC 606”)

The Company adopted the new revenue standard, ASC 606, using the modified retrospective method with respect to all non-completed contracts as of January 1, 2018. This method required retrospective application of the new accounting standard to all unfulfilled contracts that were outstanding as of January 1, 2018. Revenues and contract assets and liabilities for contracts completed prior to January 1, 2018 are presented in accordance with ASC 605.

The Company has determined that there were no adjustments required with respect to the adoption of ASC 606 with respect to any prior periods.

Disaggregation of Revenue

	Three Months Ended September 30,				Nine Months Ended  September 30,
	2018		2017		2018		2017
	(Unaudited)		(Unaudited)		(Unaudited)		(Unaudited)
Revenues:
Consulting	$	802,114	$	1,173,023	$	2,471,223	$	3,672,036
Subscription		78,921,951		-		198,488,038		-
Marketing, promotional services, and films		1,615,177		-		3,991,575		-
Total revenues	$	81,339,242	$	1,173,023	$	204,950,836	$	3,672,036

The following is a description of the principal activities from which the Company generates revenue, including from consulting customers and subscribers.

Consulting Revenue

Consulting revenues are recognized as services are provided. The Company primarily provides consulting services under time and material contracts, whereby revenue is recognized as hours and costs are incurred. Clients for consulting revenues are billed on a weekly or monthly basis. Revenues from fixed fee contracts are recorded when work is performed on the basis of the proportionate performance method, which is based on costs incurred to date relative to total estimated costs. Any anticipated contract losses are estimated and accrued at the time they become known and estimable. Unbilled accounts receivables represent amounts recognized as revenue based on services performed in advance of customer billings. Revenue from sales of software licenses is recognized upon delivery of the software to a customer because future obligations associated with such revenue are insignificant.

Subscription Revenue

Subscription revenue consists primarily of subscription fees for monthly, quarterly, semi-annual or annual subscriptions. Revenue from subscriptions is recognized on a straight-line basis when the performance obligations to provide each service for the period are satisfied, which is over time as subscription services can be used by subscribers at any time. Consumers purchasing subscriptions generally pay on an annual or monthly basis, and any prepaid amounts for subscription services are recorded as deferred revenue and amortized to revenue evenly over the service period which begins once a subscriber has activated his or her subscription.

Marketing, Promotional Services, and Films

The Company also generates revenue from marketing services primarily related to major motion picture releases. Marketing revenue is generated through e-mail and digital advertising to the Company’s subscriber base and pursuant to a contract for such services with the movie distributor. Such agreements are short-term and are generally represented by a fully executed customer agreement. Revenue is recognized as performance obligations are satisfied which generally occurs within a month of the date the contract begins. Payment terms on marketing agreements vary and payment is generally due once the performance obligations have been satisfied. Revenue from our participation in the theatrical release of feature films is recognized as earned based on our share of the ultimate expected revenue.

Deferred Revenue

Subscription fees are generally paid in advance by credit card through merchant processors. Subscription fees received in advance of completion of the performance obligations are recorded as deferred revenue until such time the services are provided to the customer.

Goodwill

The Company reviews goodwill for impairment, typically during the fourth quarter of each year, and periodically analyzes whether any indicators of impairment have occurred. The Company performs reviews of each of its reporting units that have goodwill balances. During the third quarter of 2018, due to a significant decline in its MoviePass subscribers resulting primarily from substantial changes made to our service offerings during the third quarter, the Company deemed it more appropriate to assess impairment of goodwill and corresponding intangible assets of the MoviePass reporting unit as of September 30, 2018. In conjunction with the events occurring in the third quarter of 2018, the Company updated its long-term business plan, which was used as the basis for estimating the future cash flows of its reporting units. That plan considered then current economic conditions and trends, estimated future operating results, the Company’s views of growth rates and then-anticipated future economic and regulatory conditions.

The Company determined that the fair value of the MoviePass reporting unit was below its carrying value. Therefore, the Company conducted step two of the impairment test for the MoviePass reporting unit and determined the carrying value of goodwill in the MoviePass reporting unit exceeded its implied fair value, resulting in an impairment charge of $38,524,016. This was as a result of reduced financial projections for the MoviePass reporting unit, due to, among other things, lower than expected actual financial results from this business due to a lower number of subscribers resulting from changes in the MoviePass service offering, which resulted in diminished financial performance relative to its original expectations. Given the foregoing, the Company determined there was greater uncertainty in achieving its prior financial projections and so applied a higher discount rate for purposes of its goodwill impairment analysis. Additionally, modifications of certain cashflow assumptions to reflect the current economic conditions as well as market participant levels were made. These assumptions along with a higher discount rate negatively affected the fair value of the MoviePass reporting unit.

Generally, fair value is determined using a multiple of earnings, or discounted projected future cash flows, and is compared to the carrying value of a reporting unit for purposes of identifying potential impairment. Projected future cash flows are based on management’s knowledge of the current operating environment and expectations for the future. Goodwill impairment is recognized for any excess of the carrying value of the reporting unit’s goodwill over the its estimated fair value, not to exceed the total amount of goodwill allocated to the reporting unit.

The identification of relevant events and circumstances and how these may impact a reporting unit’s fair value or carrying amount involve significant judgments by management. These judgments include the consideration of the general economic outlook, industry and market considerations, cost factors, overall financial performance, events which are specific to the Company, and trends in the market price of the Company’s common stock. Each factor is assessed to determine whether it impacts the impairment test as well as the magnitude of any such impact.

Intangible Assets, net

Intangible assets consist of customer relationships, technology, trademarks, broker relationships and patents. Applicable long-lived assets are amortized or depreciated on the straight-line method over their useful lives ranging from three to twelve years.

The Company recorded amortization expense of $1,363,638 and $430,716 for the three months ended September 30, 2018 and 2017, respectively, and $3,977,211 and $1,284,018 for the nine months ended September 30, 2018 and 2017, respectively.

The Company monitors the carrying value of long-lived assets for potential impairment each quarter based on whether certain triggering events have occurred. These events include current period losses or a projection of continuing losses or a significant decrease in the market value of an asset. When a triggering event occurs, an impairment calculation is performed, comparing projected undiscounted future cash flows, utilizing current cash flow information and expected growth rates, to the respective carrying value. If the Company identifies impairment for long-lived assets to be held and used because the carrying value is greater than the projected undiscounted cash flows, the Company compares the assets’ current carrying value to the assets’ fair value. Fair value is based on current market values or discounted future cash flows. The Company records impairment when the carrying value exceeds the assets’ fair value. With respect to owned property and equipment held for disposal, the value of the property and equipment is adjusted to reflect recoverable values based on previous efforts to dispose of similar assets and current economic conditions. Impairment is recognized for the excess of the carrying value over the estimated fair market value, reduced by estimated direct costs of disposal.

The Company evaluated the MoviePass intangible assets in connection with the MoviePass impairment analysis and did not record any impairment charges in regard to definite-lived intangible assets for the three and nine months ended September 30, 2018 and 2017.

Research and Development

Research and development costs are charged to operations when incurred and are included in operating expenses.

Stock Based Compensation

The Company follows the fair value recognition provisions in ASC Topic 718, Stock Compensation (“ASC 718”) and the provisions of ASC Topic 505, Equity (“ASC 505”) for stock-based transactions with non-employees. Stock based compensation expense for employees is recognized over the requisite service period based on the estimated grant-date fair value of the awards. The Company accounts for forfeitures as they occur. The grant date is the date at which an employer and employee reach a mutual understanding of the key terms and conditions of a share-based payment award. Stock-based compensation for non-employee stock options is recorded over the vesting period and remeasured at fair value until they vest.

Investment in Films

The Company capitalizes film production costs, including direct costs and production overhead, net of production incentives, for films in production and the cost of acquiring copyright interests in or participation rights to completed but not released films. The Company amortizes film production costs, including the costs to acquire interests or participation rights to direct operating expenses, using the individual film forecast computation method, which amortizes the costs for an individual film in the proportion that the current year’s revenues bear to management’s estimates of the ultimate revenue expected to be recognized from the distribution, exhibition or sale of such film. Ultimate revenue includes estimates over a period not to exceed ten years following the date of initial release of the motion picture. As of September 30, 2018, unamortized capitalized investment in film costs were $13,403,433. This balance represents total capitalized costs for the period of $17,212,981 less $3,809,548 of costs related to amortization and impairments.

Due to the inherent uncertainties involved in making such estimates of ultimate revenues and expenses, these estimates may differ from actual results and are likely to differ to some extent in the future from actual results. In addition, in the normal course of our business, some films and titles are more successful or less successful than anticipated. Management regularly reviews and revises when necessary its ultimate revenue and cost estimates, which may result in a change in the rate of amortization of film costs and/or write-down of all or a portion of the unamortized costs of the film to its estimated fair value. Management estimates the ultimate revenue based on experience with similar titles or title genre, the general public appeal of the cast, actual performance (when available) at the box office or in markets currently being exploited, and other factors such as the quality and acceptance of motion pictures or programs that our competitors release into the marketplace at or near the same time, critical reviews, general economic conditions and other tangible and intangible factors, many of which we do not control and which may change.

An increase in the estimate of ultimate revenue will generally result in a lower amortization rate and, therefore, less film amortization expense, while a decrease in the estimate of ultimate revenue will generally result in a higher amortization rate and, therefore, higher film amortization expense, and could also periodically result in an impairment requiring a write-down of the film cost to the title’s fair value. These write-downs are included in amortization expense within cost of revenues in our consolidated statements of operations.

Investment in films is stated at the lower of amortized cost or estimated fair value. Additional amortization is recorded in the amount by which the unamortized costs exceed the estimated fair value of the film. Estimates of future revenue involve measurement uncertainty and it is therefore possible that reductions in the carrying value of investment in films may be required as a consequence of changes in our future revenue estimates.

Film Production Incentives

The Company has access to various governmental programs that are designed to promote film production within the United States. Tax credits earned with respect to expenditures on qualifying film production activities, including qualifying capital projects, are included as an offset to the related asset or as an offset to production expenses when we have reasonable assurance regarding the realizable amount of the tax credits.

The unamortized balance includes $2,376,451 representing our investment in participation rights in completed and released films and $11,026,982 in film costs for completed and partially completed films that have yet to be released.

Fair Value Measurements

ASC Topic 820, Fair Value Measurement and Disclosures, defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. This topic also establishes a fair value hierarchy which requires classification based on observable and unobservable inputs when measuring fair value. There are three levels of inputs that may be used to measure fair value:

Level 1: Observable inputs such as quoted prices (unadjusted) in an active market for identical assets or liabilities.

Level 2: Inputs other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.

Level 3: Unobservable inputs that are supported by little or no market activity; therefore, the inputs are developed by the Company using estimates and assumptions that the Company expects a market participant would use, including pricing models, discounted cash flow methodologies, or similar techniques.

The carrying value of the Company’s financial instruments, including cash and cash equivalents, accounts receivable and accounts payable and accrued expenses approximate fair value because of the short-term maturity of these financial instruments.

The liabilities in connection with the conversion and make-whole features included within certain of the Company’s convertible notes payable and warrants are each classified as a level 3 liability.

Derivative Instruments

The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates its convertible notes and warrants to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for in accordance with Paragraph 815-10-05-4 of the FASB ASC and Paragraph 815-40-25 of the Codification. The result of this accounting treatment is that the fair value of the embedded derivative is marked-to-market each balance sheet date and recorded as a liability. In the event that the fair value is recorded as a liability, the change in fair value is recorded in the statements of operations as other income or expense. Upon conversion or exercise of a derivative instrument, the instrument is marked to fair value at the conversion date and then that fair value is reclassified to equity.

In circumstances where the embedded conversion option in a convertible instrument is required to be bifurcated and there are also other embedded derivative instruments in the convertible instrument that are required to be bifurcated the bifurcated derivative instruments are accounted for as a single, compound derivative instrument.

The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. Equity instruments that are initially classified as equity that become subject to reclassification are reclassified to liability at the fair value of the instrument on the reclassification date. Derivative instrument liabilities are classified in the balance sheet as current or non-current to correspond with its host instrument.

The Company marks to market the fair value of the embedded derivatives at each balance sheet date and records the change in the fair value of the embedded derivatives as other income or expense in the statements of operations.

The Company utilizes a Monte Carlo Method that values the liability of the debt conversion feature derivative financial instruments and derivative warrants based on a probability of a down round event. The reason the Company selected the lattice binomial model is that in many cases there may be multiple embedded features or the features of the bifurcated derivatives may be so complex that a Black-Scholes valuation does not consider all of the terms of the instrument. Therefore, the fair value may not be appropriately captured by simple models.

Warrant Liability

The Company evaluates its warrants to determine if those contracts qualify as liabilities in accordance with ASC 480-10 and ASC 815-40. The result of this accounting treatment is that the fair value of the warrant liability is marked-to-market each balance sheet date and recorded as a liability, with the change in fair value recorded in the statements of operations as other income or expense. Upon conversion or exercise of a warrant liability, the instrument is marked to fair value at the conversion date and then that fair value is reclassified to equity.

For warrants with a fixed conversion price and a fixed number of shares, the Company utilizes a Black Scholes model for valuation. For warrants with variability in the number of shares or conversion price (such as a down round feature), the Company utilizes the Monte Carlo Method to value the warrant liability. The reason the Company selected the lattice binomial model is that in many cases there may be multiple embedded features or the features may be so complex that a Black-Scholes valuation does not consider all of the terms of the instrument. Therefore, the fair value may not be appropriately captured by simple models.

Recent Accounting Pronouncements

The following accounting standards updates were recently issued and have not yet been adopted. These standards are currently under review to determine their impact on the consolidated balance sheets, consolidated statements of operations and comprehensive loss, or consolidated statements of cash flows.

In February 2016, the FASB issued Accounting Standards Update (“ASU”) 2016-02, Leases, (“ASU 2016-02”), which supersedes FASB ASC 840, Leases and provides principles for the recognition, measurement, presentation and disclosure of leases for both lessees and lessors. The new standard requires lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. This classification will determine whether lease expense is recognized based on an effective interest method or on a straight-line basis over the term of the lease. A lessee is also required to record a right-of-use asset and a lease liability for all leases with a term of greater than twelve months regardless of classification. Leases with a term of twelve months or less will be accounted for similar to existing guidance for operating leases. In July 2018, the FASB issued ASU 2018-10, Codification Improvements to Topic 842 (Leases), and ASU 2018-11, Leases (Topic 842), Targeted Improvements, which provide (i) narrow amendments to clarify how to apply certain aspects of the new lease standard, (ii) entities with an additional transition method to adopt the new standard, and (ii) lessors with a practical expedient for separating components of a contract. The standard is effective for annual and interim periods beginning after December 15, 2018, with early adoption permitted upon issuance. The Company is currently evaluating the method of adoption and the impact of adopting ASU 2016-02 on its results of operations, cash flows and financial position. We expect to adopt the guidance using the modified retrospective method and practical expedients for transition. The practical expedients allow us to largely account for our existing leases consistent with current guidance except for the incremental balance sheet recognition for lessees. We have started an initial evaluation of our leasing contracts and activities. We do not expect a material change to the timing of expense recognition, but we are early in the implementation process and will continue to evaluate the impact. We are evaluating our existing disclosures and may need to provide additional information as a result of adoption of the ASU.

In January 2017, the FASB issued ASU 2017-04 Intangibles-Goodwill and Other (“ASC 350”): Simplifying the Accounting for Goodwill Impairment (“ASU 2017-04”). ASU 2017-04 simplifies the subsequent measurement of goodwill by eliminating Step 2 from the goodwill impairment test. In computing the implied fair value of goodwill under Step 2, an entity had to perform procedures to determine the fair value at the impairment testing date of its assets and liabilities (including unrecognized assets and liabilities) following the procedure that would be required in determining the fair value of assets acquired and liabilities assumed in a business combination. Instead, under ASU 2017-04, an entity should perform its annual or interim goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An entity should recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value; however, the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. Additionally, an entity should consider income tax effects from any tax-deductible goodwill on the carrying amount of the reporting unit when measuring the goodwill impairment loss, if applicable. ASU 2017-04 is effective for annual or any interim goodwill impairment tests for fiscal years beginning after December 15, 2019 and an entity should apply the amendments of ASU 2017-04 on a prospective basis. Early adoption is permitted for interim or annual goodwill impairment tests performed on testing dates after January 1, 2017. The Company is currently evaluating the effects of ASU 2017-04 on its consolidated financial statements.

In July 2017, the FASB issued ASU 2017-11, Earnings Per Share (“ASC 260”), Distinguishing Liabilities from Equity (“ASC 480”), and Derivatives and Hedging (“ASC 815”). ASU 2017-11 is intended to simplify the accounting for financial instruments with characteristics of liabilities and equity. Among the issues addressed are: (i) determining whether an instrument (or embedded feature) is indexed to an entity’s own stock; (ii) distinguishing liabilities from equity for mandatorily redeemable financial instruments of certain nonpublic entities; and (iii) identifying mandatorily redeemable non-controlling interests. ASU 2017-11 is effective for the Company on January 1, 2019. The Company is currently evaluating the potential impact of ASU 2017-11 on the Company’s consolidated financial statements.

In June 2018, the FASB issued ASU 2018-07, Compensation - Stock Compensation (“ASC 718”), Improvements to Nonemployee Share-Based Payment Accounting (“ASU 2018-07”). The amendments in ASU 2018-07 expand the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. ASU 2018-07 is effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption is permitted. The Company has evaluated the impact of ASU 2018-07 on the Company’s consolidated financial statements and determined it will not have a material impact.

In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (“ASC 820”), Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement (“ASU 2018-13”). ASU 2018-13 is intended to improve the effectiveness of fair value measurement disclosures. ASU 2018-13 is effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating the impact of ASU 2018-13 on the Company’s consolidated financial statements.

XML

Going Concern Analysis

9 Months Ended

Sep. 30, 2018

Going Concern Analysis [Abstract]

Going Concern Analysis

4. Going Concern Analysis

In evaluating the Company’s ability to continue as a going concern, management considered the conditions and events that could raise substantial doubt about the Company’s ability to continue as a going concern within twelve months after the Company’s interim financial statements were issued (November 15, 2018). Management considered the Company’s current financial condition and liquidity sources, including current funds available, forecasted future cash flows and the Company’s conditional and unconditional obligations due before November 15, 2019.

The Company is subject to a number of risks similar to those of other big data technology, technology consulting companies and subscription based businesses, including its dependence on outside sources of capital, the Company’s ability to maintain and grow its subscriber base, uncertainty of generation of revenues and positive cash flow, dependence on key individuals, risks associated with research, development, testing, and successful protection of intellectual property, and the Company’s susceptibility to infringement on the proprietary rights of others. The attainment of profitable operations is dependent on future events, including obtaining adequate financing to fulfill the Company’s growth and operating activities and generating a level of revenues adequate to support the Company’s cost structure.

The Company has experienced net losses and significant cash outflows from cash used in operating activities over the past years. As of September 30, 2018, the Company had an accumulated deficit of $377,266,866, a loss from operations for the three and nine months ended September 30, 2018 of $86,414,887 and $320,785,739, respectively, and net cash used in operating activities for the nine months ended September 30, 2018 of $321,093,755.

The Company expects to continue to incur net losses and have significant cash outflows for at least the next twelve months. As of September 30, 2018, the Company had cash and a working capital deficit of $4,850,972 and $15,657,290, respectively, compared to $24,949,393 and $107,097,249 as of December 31, 2017. Of the working capital deficit at September 30, 2018, $60,809 pertained to warrant and derivative liabilities classified on the balance sheet within current liabilities. Management has evaluated the significance of the conditions described above in relation to the Company’s ability to meet its obligations and concluded that, without additional funding, the Company will not have sufficient funds to meet its obligations within one year from the date the condensed consolidated financial statements were issued. While management will look to continue funding operations by raising additional capital from sources such as sales of the Company’s debt or equity securities or loans in order to meet operating cash requirements, there is no assurance that management’s plans will be successful.

The Company obtained convertible debt financing for up to $60,000,000 in gross proceeds on January 11, 2018, of which the Company had received $31,000,000 in gross proceeds as of September 30, 2018, which the Company used (i) to increase the Company’s ownership interests or other rights and interests in MoviePass; (ii) to satisfy certain indebtedness; and (iii) for general corporate purposes and transaction expenses. The Company may also use the proceeds to make other acquisitions. Additionally, during the second and third quarter of 2018, the Company received $58,959,736 in gross proceeds related to the convertible debt financing obtained on November 7, 2017.

On June 26, 2018, the Company obtained preferred stock and convertible debt financing for up to $139,400,000 in gross proceeds, of which the Company had received $20,500,000 in gross proceeds as of September 30, 2018, which the Company used for general corporate purposes and transaction expenses.

As of September 30, 2018, the Company had no outstanding unrestricted principal under the Senior Convertible Notes issued to institutional investors on November 7, 2017 and January 23, 2018, respectively, and there remained $49,388,861 in restricted principal for which a corresponding amount of principal under the investor notes remains to be paid to the Company by the holders of those convertible notes.

In order to facilitate the Company’s further access to capital, in January 2018 the Company filed a shelf registration statement on form S-3 that was declared effective by the SEC on February 9, 2018, which allows the Company to offer and sell up to $400,000,000 of its equity or equity-linked securities. Using the shelf registration statement, the Company completed an underwritten public offering of common stock and warrants for gross proceeds of $105,050,000 on February 13, 2018. The total net proceeds to the Company from the February 2018 public offering were $96,912,380. The Company also completed an underwritten public offering of common stock and warrants for gross proceeds of approximately $30,250,000 on April 23, 2018. The total net proceeds to the Company from the April 2018 public offering were $27,677,558.

On April 18, 2018, the Company entered into an Equity Distribution Agreement (the “Sales Agreement”) with Canaccord Genuity LLC (“Canaccord”) under which the Company could offer and sell under the shelf registration statement up to $150,000,000 of its common stock at prevailing market prices in a continuous at-the market offering (the “ATM Offering”) through its sales agent Canaccord. The Company used the net proceeds from the ATM Offering to increase the Company’s ownership stake in MoviePass and to support the operations of MoviePass and MoviePass Ventures, to satisfy a portion or all of any amounts due and payable in connection with the convertible notes issued on November 7, 2017, January 23, 2018 and June 26, 2018, and for general corporate purposes and transaction expenses. As of September 30, 2018, the Company sold approximately 627,933,083 shares, and received net proceeds of approximately $119,423,879, pursuant to the ATM Offering. The Sales Agreement was terminated on October 1, 2018, and, as a result, no further offers or sales of the Company’s common stock will be made pursuant to the ATM Offering.

Without raising additional capital, there is substantial doubt about the Company’s ability to continue as a going concern through November 15, 2019. The accompanying condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern. This basis of accounting contemplates the recovery of the Company’s assets and the satisfaction of liabilities in the normal course of business. A successful transition to attaining profitable operations is dependent upon achieving a level of positive cash flows adequate to support the Company’s cost structure. 

Notice of Potential Delisting from NASDAQ 

On June 21, 2018, the Company received a deficiency letter from the Nasdaq Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the prior 30 consecutive business days, the closing bid price for the Company’s common stock has closed below a minimum $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (“Rule 5550(a)(2)” or the “Minimum Bid Price Requirement”).

In accordance with Nasdaq Listing Rule 5810(b), the Company has been given 180 calendar days, or until December 18, 2018 to regain compliance with Rule 5550(a)(2).

The Special Meeting of Stockholders scheduled to be held on November 14, 2018 to provide stockholders with an opportunity to vote on the proposed reverse stock split in a ratio of 1 share-for-2 shares up to a ratio of 1 share-for-500 shares has been cancelled. The Company was presenting the reverse stock split proposal in an effort to regain compliance with the Rule 5550(a)(2). Since the Company will not be able to effect a reverse stock split ten business days prior to December 18, 2018, absent an extension by The Nasdaq Capital Market (of which there can be no assurance) the Company believes that our common stock will be subject to delisting from The Nasdaq Capital Market, which would adversely impact the liquidity and marketability of our common stock. The Company intends to monitor the closing bid price of its common stock and consider its available options to resolve its noncompliance with Rule 5550(a)(2).

If the Company does not regain compliance with Rule 5550(a)(2) by December 18, 2018, the Company may be afforded a second 180-calendar day period to regain compliance. To qualify, the Company would be required to meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, except for the Minimum Bid Price Requirement. In addition, the Company would be required to notify Nasdaq of its intent to cure the deficiency during the second compliance period, which may include, if necessary, implementing a reverse stock split. If the Company is afforded additional time to regain compliance (of which there can be no assurance), the Board of Directors of the Company plans to call a special meeting as soon as practicable with a new record date for the Company’s stockholders to vote on a reverse stock split in an effort to regain compliance with Rule 5550(a)(2). Even if the Company is eligible for an additional compliance period, Nasdaq may decline to grant the Company an additional compliance period in its discretion.

If the Company does not regain compliance with Rule 5550(a)(2) by December 18, 2018, and is either not eligible for an additional compliance period at that time or Nasdaq declines to grant the Company an additional compliance period in Nasdaq’s discretion, the Staff will provide notice to the Company that its securities will be subject to delisting. At that time, the Company may appeal the Staff’s delisting determination to a Nasdaq Listing Qualifications Panel (“Panel”). The Company would remain listed pending the Panel’s decision.

On August 25, 2018, Carl J. Schramm resigned from the Board of Directors of the Company and each committee of the Board of Directors which he was a member, including the Audit Committee. As a result, the Company is no longer compliant with Nasdaq Listing Rule 5605(b)(1), which requires that a majority of the Board of Directors of the Company be independent, and Nasdaq Listing Rule 5605(c)(2)(A), which requires that the Audit Committee have at least three independent directors.

In accordance with Nasdaq Listing Rules, on August 27, 2018, the Company notified Nasdaq of Mr. Schramm’s resignation and non-compliance with the above Nasdaq Listing Rules. Nasdaq responded on September 6, 2018 with a notification letter confirming the Company’s non-compliance with Nasdaq’s independent director and audit committee requirements as set forth above. Nasdaq advised that, pursuant to Nasdaq Listing Rules 5605(b)(1)(A) and 5605(c)(4), the Company will have until the following to cure the deficiencies caused by Mr. Schramm’s departure:

● until the earlier of the Company’s next annual shareholders’ meeting or August 25, 2019; or

● if the next annual shareholders’ meeting is held before February 21, 2019, then the Company must evidence compliance no later than February 21, 2019.

The Board of Directors of the Company intends to appoint a new independent director who satisfies the applicable requirements of the Nasdaq Listing Rules to serve on the Company’s Board of Directors and Audit Committee prior to the expiration of the cure period.

XML

Acquisitions of MoviePass and Moviefone and the Formation of MoviePass Films

9 Months Ended

Sep. 30, 2018

Acquisitions of MoviePass and Moviefone and the Formation of MoviePass Films [Abstract]

Acquisitions of MoviePass and Moviefone and the Formation of MoviePass Films

5. Acquisitions of MoviePass and Moviefone and the Formation of MoviePass Films

Acquisition of Controlling Interest in MoviePass Inc.

On December 11, 2017, the Company completed its acquisition of a 62.41% majority interest in MoviePass (such acquisition, the “MoviePass Transaction”), for the following consideration: (1) a subordinated convertible promissory note in the principal amount of $12,000,000 (the “Helios Convertible Note”), which is convertible into shares of HMNY’s common stock, as further described below; (2) a $5,000,000 promissory note issued to MoviePass (the “Helios Note”); (3) the exchange of a convertible promissory note issued by MoviePass to HMNY in an aggregate principal amount of $11,500,000 (plus accrued interest thereon); (4) $1,000,000 in cash to purchase outstanding convertible notes of MoviePass, which were converted into shares of MoviePass’ common stock amounting to an additional 2% of the outstanding shares of MoviePass common stock; and (5) $20,000,000 in cash pursuant to the Investment Option Agreement, dated October 11, 2017, between the Company and MoviePass.

The Helios Convertible Note will convert into 16,000 (4,000,000 pre-split) unregistered shares of the Company’s common stock (the “Conversion Shares”) automatically upon the Company’s receipt of approval of its stockholders relating to the issuance of the Conversion Shares as required by and in accordance with Nasdaq Listing Rule 5635. Of that amount, 2,667 (666,667 pre-split) of the Conversion Shares are subject to forfeiture by MoviePass, in the Company’s sole discretion, as MoviePass failed to list its common stock on the Nasdaq Stock Market by March 31, 2018 (as required by the securities purchase agreement between the Company and MoviePass). As of the date of this report, the Company has not made a decision with respect to the disposition of those shares that are subject to forfeiture. 

The Company has valued the Helios Convertible Note as of the acquisition date, including the valuation of the shares subject to forfeiture as noted above, at the fair value on the acquisition date based on a Monte Carlo simulation. The shares subject to forfeiture are contingent consideration and have been valued as a separate component of the Helios Convertible Note. As of the acquisition date the Helios Convertible Note was valued at $29,000,000 and the portion of the Conversion Shares subject to forfeiture was valued at $5,152,446. All of the purchase consideration, with the exception of the $1,000,000 paid for the MoviePass convertible notes which were converted into MoviePass common stock, was retained by MoviePass. Accordingly, the value of the Helios Convertible Note, the Helios Note and the value associated with the Conversion Shares subject to forfeiture are eliminated in consolidation for financial reporting purposes.

Goodwill recognized as part of the MoviePass Transaction is not expected to be tax deductible.

The Company has made a provisional allocation of the purchase price of the MoviePass Transaction to the assets acquired and the liabilities assumed as of the acquisition date. The following table summarizes the provisional purchase price allocations relating to the MoviePass Transaction:

Purchase consideration:	MoviePass
Cash	$	32,671,792
Notes payable (includes Helios Convertible Note and Helios Note)		39,152,446
Fair value of consideration transferred	$	71,824,238
Recognized amounts of identifiable assets and liabilities acquired:
Cash acquired	$	1,106,171
Accounts receivable		9,669,390
Notes receivable		39,152,446
Investment option payment receivable		7,850,000
Prepaid expenses and other current assets		192,180
Property and equipment		39,320
Other assets		8,000
Identifiable intangible assets:
Tradenames and trademarks		19,550,000
Technology		3,800,000
Customer relationships		2,560,000
Liabilities assumed		(9,261,785	)
Deferred revenue		(38,718,397	)
Non-controlling interest		(43,260,264	)
Goodwill		79,137,177
Total purchase price allocation	$	71,824,238

The Company has not completed the valuation studies necessary to finalize the acquisition fair values of the assets acquired and liabilities assumed and related allocation of the purchase price for the MoviePass Transaction. Accordingly, the type and value of the intangible assets and deferred revenue amounts set forth above are preliminary. Once the valuation process is finalized for the MoviePass Transaction, there could be changes to the reported values of the assets acquired and liabilities assumed, including goodwill, intangible assets and deferred revenue and those changes could differ materially from what is presented above.

The Company determined the provisional fair value of the acquired intangible assets through a combination of the market approach and the income approach. The significant assumptions used in certain valuations associated with the MoviePass Transaction include discount rates ranging from 10.0% to 51.0%. In determining the value of tradenames and trademarks the Company observed royalty rates ranging from 0.0% to 100.0%, and utilized a 1.0% rate for MoviePass’s aggregated tradenames and trademarks. Additionally, the Company observed royalty rates related to MoviePass’s technology assets acquired ranging from 0.0% to 50.0%, and used a 1.0% royalty rate in determining the fair value of the acquired technology. In accordance with Emerging Issues Task Force (“EITF”) guidance, the fair value of an acquired liability related to deferred revenue would include the direct and incremental cost of fulfilling the obligation plus a normal profit margin. The Company utilized historical operating results in estimating the direct and incremental costs of fulfilling the acquired deferred revenue obligations. The non-controlling interest in MoviePass was determined based on the fair value of MoviePass less the amounts paid by the Company for its 62.41% controlling interest.

The estimated useful lives of acquired intangible assets are 7 years for customer relationships, 3 years for technology, and 7 years for tradenames and trademarks. Acquired deferred revenue is estimated to be realized based on the length of the subscription, over 12 months from the acquisition date.

Additional MoviePass Subscription Agreements

On March 8, 2018, the Company entered into a Subscription Agreement with MoviePass (the “March 2018 Agreement”), pursuant to which, in lieu of repayment of advances totaling $55,525,000 made by the Company, MoviePass agreed to sell to the Company an amount of MoviePass common stock equal to 18.79% of the total then outstanding shares of MoviePass common stock (excluding shares underlying MoviePass options and warrants) (the “March 2018 MoviePass Purchased Shares”). MoviePass also agreed to issue to the Company, in addition to the March 2018 MoviePass Purchased Shares, without payment of additional consideration by the Company, for purposes of anti-dilution, an amount of shares of MoviePass common stock that caused the Company’s total ownership of the outstanding shares of MoviePass common stock (excluding shares underlying MoviePass options and warrants), together with the March 2018 MoviePass Purchased Shares, to equal 81.2% as of March 8, 2018.

From February 27, 2018 through April 12, 2018, the Company advanced a total of $35,000,000 to MoviePass (the “Second Advance”). On April 16, 2018, the Company entered into an additional Subscription Agreement with MoviePass (the “April 2018 Agreement”), pursuant to which, in lieu of repayment of the Second Advance, MoviePass agreed to sell to the Company an amount of shares of common stock of MoviePass equal to 10.6% of the total then outstanding MoviePass common stock (excluding shares underlying MoviePass options and warrants) (the “April 2018 MoviePass Purchased Shares”), based on a pre-money valuation of MoviePass of $295,525,000 as of March 31, 2018. Pursuant to the April 2018 Agreement, MoviePass also agreed to issue to the Company, in addition to the April 2018 MoviePass Purchased Shares, without payment of additional consideration by the Company, for purposes of anti-dilution, an amount of shares of common stock of MoviePass that caused the Company’s total ownership of the outstanding shares of common stock of MoviePass (excluding shares underlying MoviePass options and warrants), together with the April 2018 MoviePass Purchased Shares, to equal 91.8% as of April 12, 2018.

In addition, from April 16, 2018 through September 30, 2018 the Company has advanced MoviePass, $187,285,000 for operational funding. Such amount remains payable to the Company by MoviePass and has been eliminated in consolidation for financial reporting purposes. 

The Company has accounted for the March 2018 MoviePass Purchased Shares and the April 2018 MoviePass Purchased Shares as an acquisition of a portion of the non-controlling interest in MoviePass. Accordingly, the non-controlling interest at March 8, 2018 and April 12, 2018 was reduced respectively, based on the percentage acquired, and the balance invested in excess of the value of the non-controlling interest acquired was recorded as additional invested capital.

Acquisition of Moviefone Brand

On April 4, 2018, the Company entered into an Asset Purchase Agreement (the “Moviefone Purchase Agreement”) with Oath Inc. (formerly, AOL Inc.), a Delaware corporation and subsidiary of Verizon Communications and certain of its subsidiaries (“Oath”), pursuant to which the Company completed the acquisition from Oath of certain products, rights, technology, contracts, data and other assets related to the Moviefone brand (the “Moviefone Assets”). The acquisition of Moviefone has been accounted for as the acquisition of a business. The historical operational results of Moviefone were not significant for purposes of providing pro forma financial information. The purchase price for the Moviefone Assets consisted of the following: (i) $1.0 million in cash, (ii) the issuance of 10,201 (2,550,154 pre-split) shares of common stock of the Company with a market value of $7.6 million as of the closing date, and (iii) the issuance of warrants to purchase 10,201 (2,550,154 pre-split) shares of common stock of the Company at an exercise price of $1,375 ($5.50 pre-split) per share. In addition, and pursuant to the Moviefone Purchase Agreement, the Company assumed certain specified liabilities incurred after the acquisition date and retained certain employees of Moviefone.

The Company determined the provisional fair value of the acquired intangible assets through a combination of the market approach, cost and the income approach. The significant assumptions used in certain valuations associated with the Moviefone transaction include discount rates ranging from 9.0% to 22.1%. In determining the value of tradenames and trademarks the Company observed royalty rates ranging from 0.0% to 100.0% and utilized a 10.0% rate for Moviefone’s aggregated tradenames and trademarks. Additionally, the Company utilized a cost approach for Moviefone’s technology assets acquired based on man hours to construct in determining the fair value of the acquired technology. The non-compete agreements were analyzed and found to have a de minimis value.

The estimated useful lives of acquired intangible assets are 20 years for tradenames and trademarks, 7 years for customer relationships and 3 years for technology. 

The following table summarizes the consideration paid for Moviefone by the Company, and the amounts of assets acquired, and liabilities assumed and recognized at the acquisition date:

Purchase consideration:	Moviefone
Cash	$	1,000,000
Common shares issued		7,599,459
Warrants for common shares issued		5,475,500
Fair value of consideration transferred	$	14,074,959
Trade names and trademarks	$	4,640,000
Technology		340,000
Customer relationships		560,000
Goodwill		8,534,959
Total purchase price allocation	$	14,074,959

MoviePass Films

On May 23, 2018, the Company entered into the LOI with EFO, pursuant to which EFO acquired a 49% membership interest in MoviePass Films. Pursuant to the LOI, the Company capitalized MoviePass Films with an initial capital contribution of $2,000,000 in cash and retained a 51% interest in MoviePass Films and capitalized MoviePass Films with an additional $4,200,000 as of September 30, 2018, for a total of $6,200,000 capitalized by the Company as of September 30, 2018.. EFO has assigned its rights in a film output agreement of EFO to MoviePass Films. MoviePass Films has begun operations, and the Company and EFO are finalizing the long form agreements that will further define the relative rights and duties of the Company and EFO with respect to MoviePass Films. In accordance with the LOI, as of September 30, 2018, the Company is committed to contribute 16,000 (4,000,000 pre-split) shares of common stock of the Company to EFO.

The Company has not performed the valuation studies required to value film output agreement assigned to MoviePass Films by EFO.

The Company has a 51% membership interest in MoviePass Films and the right to designate three out of five of the members of its board of managers and accordingly has consolidated the results of MoviePass Films with those of the Company.

XML

Net Loss Per Share Attributable to Common Stockholders

9 Months Ended

Sep. 30, 2018

Net Loss Per Share Attributable to Common Stockholders [Abstract]

Net Loss Per Share Attributable to Common Stockholders

6. Net Loss Per Share Attributable to Common Stockholders

Earnings per share (“EPS”) is the amount of earnings attributable to each share of common stock. For convenience, the term is used to refer to either earnings or loss per share. EPS is computed pursuant to Section 260-10-45 of the FASB ASC. Pursuant to ASC Paragraphs 260-10-45-10 through 260-10-45-16, basic EPS is computed by dividing income available to common stockholders (the numerator) by the weighted-average number of common shares outstanding (the denominator) during the period. The computation of diluted EPS is similar to the computation of basic EPS except that the denominator is increased to include the number of additional common shares that would have been outstanding if the dilutive potential common shares had been issued during the period to reflect the potential dilution that could occur from common shares issuable through contingent shares issuance arrangements, stock options or warrants.

The following table shows the outstanding dilutive common shares excluded from the diluted net loss per share attributable to common stockholder’s calculation as they were anti-dilutive:

	September 30,		December 31,
	2018		2017
Warrants		67,468		38,526
Conversion features on convertible notes		-		5,482
Total potentially dilutive shares		67,468		44,008

XML

Prepaid Expenses and Other Current Assets

9 Months Ended

Sep. 30, 2018

Prepaid Expenses and Other Current Assets [Abstract]

Prepaid Expenses and Other Current Assets

7. Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following as of September 30, 2018 and December 31, 2017:

	September 30, 2018		December 31, 2017
Vendor deposits	$	2,293,641	$	147,533
Tax		105,503		108,433
Deposits		-		230,711
Insurance		167,016		86,181
Professional fees and services		61,359		33,333
Deferred stock compensation		250,333		2,885,278
Rent		-		52,650
Other		591,793		13,692
Total prepaid expenses and other current assets	$	3,469,645	$	3,557,811

XML

Intangible Assets, net and Goodwill

9 Months Ended

Sep. 30, 2018

Intangible Assets, net and Goodwill [Abstract]

Intangible Assets, net and Goodwill

8. Intangible Assets, net and Goodwill

The following table sets forth the major categories of the Company’s intangible assets and the estimated useful lives as of September 30, 2018 and December 31, 2017 for those assets that are not already fully amortized: 

				September 30, 2018
	Estimate Useful Life (Years)	Gross Carrying Amount		Acquisitions		Accumulated Amortization			Impairments			Net Book Value
Customer relationships	7	$	2,560,000		560,000		(334,043	)		-			2,785,957
Technology	3		8,070,000		340,000		(3,773,338	)		(1,210	)		4,635,452
Tradenames and trademarks	10-20		19,873,224		4,640,000		(2,013,260	)		-			22,499,964
Patents	12		196,353		-		(20,327	)		-			176,026
		$	30,699,577		5,540,000		(6,140,968	)		(1,210	)		30,097,399

				December 31, 2017
	Estimate Useful Life (Years)	Gross  Carrying Amount		Acquisitions		Accumulated Amortization			Impairments			Net Book Value
Customer relationships	7	$	-	$	2,560,000	$	(20,645	)	$	-		$	2,539,355
Technology	3		4,270,000		3,800,000		(1,700,431	)		-			6,369,569
Tradenames and trademarks	10-20		1,977,000		19,550,000		(433,588	)		(1,653,776	)		19,439,636
Broker relationships	5		4,200		-		(962	)		(3,238	)		-
Patents	12		196,353		-		(8,131	)		-			188,222
		$	6,447,553	$	25,910,000	$	(2,163,757	)	$	(1,657,014	)	$	28,536,782

The Company recorded amortization expense of $1,363,638 and $430,716 for the three months ended September 30, 2018 and 2017, respectively, and $3,977,211 and $1,284,018 for the nine months ended September 30, 2018 and 2017, respectively. 

The following table outlines estimated future annual amortization expense for the next five years and thereafter:

September 30,
Remaining 2018	$	1,363,077
2019		5,246,717
2020		3,957,471
2021		2,678,569
2022		2,648,976
Thereafter		14,202,589
	$	30,097,399

Goodwill represents the difference between purchase cost and the fair value of net assets acquired in business acquisitions. Goodwill and indefinite lived intangible assets are tested for impairment annually as of December 31st and more often if a triggering event occurs, by comparing the fair value of each reporting unit to its carrying value. During the third quarter of 2018, due to a significant decline in its MoviePass subscribers resulting primarily from changes made to service offerings during the third quarter, the Company deemed it appropriate to assess goodwill impairment of the MoviePass reporting unit as of September 30, 2018. Due to the complexity and the effort required to estimate the fair value of the reporting units in step one of the impairment test and to estimate the fair value of all assets and liabilities of the reporting units in the second step of the test, the fair value estimates were derived based on preliminary assumptions and analyses that are subject to change. Based on our preliminary analyses, the implied fair value of goodwill was substantially lower than the carrying value of goodwill for the reporting units of the Subscription and Marketing, Promotional Services, and Films segment. As a result, we recorded our best estimate of $38,524,016 for the goodwill impairment charge in the three months ended September 30, 2018, which is included in impairment of goodwill on the condensed consolidated statements of operations and comprehensive income/(loss). Any adjustments to the estimated impairment loss following the completion of the measurement of the impairment will be recorded in the fourth quarter of 2018.

The Company used a discounted cash flow model, to determine the fair value of the reporting unit.  Key assumptions within the analysis included revenue projections, revenue growth assumptions, adjustments for the latest subscriber information, revisions to the current costs of the subscription program including limitations on visits per month and first run movies, revenue growth assumptions, expectations for working capital and capital expenditure needs discount rates, and the effective tax rate that the Company determined to be appropriate. Revenue projections reflected declines in the current and next year, and revenues are expected to moderate to a terminal growth rate of 3%. The discount rate was 49.4% and the effective tax rate was 28%.

Balance as of December 31, 2017	$	79,137,177
Acquisition of Moviefone		8,534,959
Impairment of a portion of MoviePass		(38,524,016	)
Balance as of September 30, 2018	$	49,148,120

XML

Accounts Payable and Accrued Expenses

9 Months Ended

Sep. 30, 2018

Accounts Payable and Accrued Expenses [Abstract]

Accounts Payable and Accrued Expenses

9. Accounts Payable and Accrued Expenses

As of September 30, 2018 and December 31, 2017, accounts payable and accrued expenses consisted of the following:

	September 30, 2018		December 31, 2017
Accounts payable	$	5,292,213	$	5,087,060
Accrued ticket expense		1,174,638		4,743,582
Accrued professional fees		1,763,670		597,187
Accrued credit card fees		-		782,670
Accrued payroll expense		4,111,418		312,149
Accrued other expense		3,755,564		852,840
Accrued interest		1,593,757		768,515
Total accounts payable and accrued expenses	$	17,691,260	$	13,144,003

XML

Senior Secured Convertible Notes and Warrants and Unit Offerings

9 Months Ended

Sep. 30, 2018

Senior Secured Convertible Notes and Warrants and Unit Offerings [Abstract]

Senior Secured Convertible Notes and Warrants and Unit Offerings

10. Senior Secured Convertible Notes and Warrants and Unit Offerings

February 2017 Notes

On February 8, 2017, the Company issued two Senior Secured Convertible Notes (the “February 2017 Notes”) to an institutional investor (the “Investor”) in the aggregate principal amount of $5,681,818 for consideration consisting of a secured promissory note payable by the Investor to the Company in the principal amount of $5,000,000 (the “February 2017 Investor Note”), which offsets the February 2017 Notes of the same amount. Upon issuance, the initial principal balance of $681,818 of the February 2017 Notes was accounted for as an original issuance discount and accreted into interest expense over the life of the February 2017 Notes. As cash is received from the February 2017 Investor Note, and the related principal amount of the February 2017 Notes increases accordingly, a derivative liability related to the conversion feature embedded within the February 2017 Notes is recorded as a debt discount, and accreted into interest expense over the life of the February 2017 Notes using the effective interest method, and any excess value over the amount of cash received is expensed immediately to interest expense. In addition, February Placement Agent Warrants were also issued (See The Placement Agent Notes and Warrants below), recognized as liabilities pursuant to their terms and recorded as a debt discount, and accreted into interest expense over the life of the February 2017 Notes using the effective interest method, and any excess value over the amount of cash received is expensed immediately to interest expense. The February 2017 Notes had a maturity date of October 8, 2017.

As of December 31, 2017, the Investor had fully funded the February 2017 Investor Note and had subsequently converted the aggregate principal amount due under the February 2017 Notes and approximately $49,000 of interest into 7,411 (1,852,886 pre-split) shares of the Company’s common stock in full payment of the February 2017 Notes. On any principal balance owed by the Company to the Investor, a 6% interest obligation was due quarterly and calculated on a 360-day basis. For the three and nine months ended September 30, 2017, the Company had interest expense of $42,750 and $173,963, respectively. In a letter agreement executed on August 27, 2017, in consideration for the prepayment in the amount of $2,500,000, on the February 2017 Investor Note, which the Investor subsequently made on August 28, 2017, the Investor and the Company agreed that the Investor would have the right, but not the obligation, until December 31, 2017, to effect an exchange (the “Share Exchange”) of 3,365 (841,250 pre-split) shares of the Company’s common stock (the “Exchange Shares”) for one or more senior secured convertible promissory notes in the form of the February Additional Note (the “New Note”), with the right to substitute the alternate conversion price of the New Note with the alternate conversion price of the Company’s Series B Senior Secured Convertible Note (the “Series B Note”) that was issued on August 16, 2017. Any New Note issued was in a principal amount equal to the product of the prepayment amount ($2,500,000) multiplied by a fraction, the numerator of which was the number of the aggregate shares being tendered to the Company in the Share Exchange and the denominator of which was 3,365 (841,250 pre-spilt). The maturity date of any New Note was 45 days following the issuance of the New Note, and the conversion price of the New Notes was $1,125 ($4.50 pre-split), or, at the election of the Investor, the Investor could convert at the Alternate Conversion Price. The Alternate Conversion Price was defined as either (A) the lower of (i) $1,125 ($4.50 pre-split) and (ii) the greater of (I) $1,000 ($4.00 pre-split) and (II) 85% of the quotient of (x) the sum of the volume weighted average price of the common stock for each of the 5 consecutive trading days ending on the trading day immediately preceding the delivery of the Conversion Notice, divided by (y) 5 or (B) that price which shall be the lowest of (i) $750 ($3.00 pre-split) and (ii) the greater of (I) the Floor Price then in effect and (II) 85% of the quotient of (x) the sum of the volume weighted average price of the Company’s common stock for each of the 5 consecutive trading days ending and including the date of the alternate conversion, divided by (y) 5. The Floor Price was defined as $750 ($3.00 pre-split) through October 4, 2017 and $125 ($0.50 pre-split) following October 4, 2017. On October 23, 2017, the Company and the Investor entered into a Third Amendment and Exchange Agreement (the “Third Exchange Agreement”) for the purpose of exchanging the New Note for 3,789 (947,218 pre-split) shares of common stock (the “New Exchange Shares”) and rights (the “Rights”) to receive 2,211 (552,782 pre-split) additional shares of common stock. As partial consideration for the New Exchange Shares and the Rights, the Investor agreed, among other things, to terminate the Investor’s right to exchange the remaining Exchange Shares for New Notes. The termination of these rights is accounted for as financing fees associated with the February 2017 Notes, valued at $19,950,000 based on the trading price of the Company’s stock on the date of the Third Exchange Agreement and recorded as interest expense. 

August 2017 Notes

On August 16, 2017, the Company issued to the Investor three Senior Secured Convertible Notes (the “August 2017 Notes”) in the aggregate principal amount of $10,300,000 and a 5-year warrant for the purchase of 7,572 (1,892,972 pre-split) shares of the Company’s common stock at an exercise price of $812.50 ($3.25 pre-split) per share (the “Investor Warrant”) for consideration consisting of a secured promissory notes payable by the Investor to the Company (the “August 2017 Investor Notes”) in the principal amount of $8,800,000 and $220,000, which offset the August 2017 Notes of the same amount. The August 2017 Notes had a maturity date of April 16, 2018 and the Investor Warrant had an expiration date of April 16, 2022. The $220,000 secured promissory note payable by the Investor was issued in exchange for a $250,000 Senior Secured Convertible Note; therefore, a discount of $30,000 was recognized upon issuance and accreted into interest expense over the life of the note using the effective interest method. Upon issuance, the Investor Warrant, which was determined to be a liability, was recorded at fair value and accounted for as an original issuance discount to the August 2017 Notes. The excess in value of the Investor Warrant over the August 2017 Notes upon issuance was recorded as interest expense, while the initial principal balance was recorded as a debt discount and accreted into interest expense over the life of the August 2017 Notes.

At December 31, 2017, the contracted conversion prices for the August 2017 Notes, which included an Initial Series A Note, an Additional Series A Note and the Series B Note, were $1,000 ($4.00 pre-split) for the Initial Series A Note and the Additional Series A Note and $750 ($3.00 pre-split) for the Series B Note. As of December 31, 2017, the Investor had fully prepaid the August 2017 Investor Note and converted $5,794,560 in principal amount, plus accrued interest, of the August 2017 Notes into 5,931 (1,482,639 pre-split) shares of the Company’s common stock. On any principal balance owed by the Company to the Investor, a 6% interest obligation was due quarterly and calculated on a 360-day basis. For the three and nine months ended September 30, 2018, the Company had $0 and $37,126, respectively, of interest expense pertaining to the unpaid principal amount of the August 2017 Notes. The full outstanding principal balance of $4,677,899 and accrued interest of $37,126 were converted to 4,678 (1,169,475 pre-split) shares of the Company’s common stock on February 20, 2018. As of September 30, 2018, the unpaid principal amount of the August 2017 Notes owed to the Investor was $0.

The Investor Warrant included anti-dilution provisions. The anti-dilution provisions were triggered when the Company issued a new senior convertible note to the Investor in the aggregate principal amount of $697,000 (the “Exchange Note”) in September 2017. Because the Exchange Note had a conversion price of $750 ($3.00 pre-split) per share, which was lower than the Investor Warrant per share exercise price of $812.50 ($3.25 pre-split), the number of shares of the Company’s common stock issuable to the Investor pursuant to the Investor Warrant was increased from 7,572 (1,892,972 pre-split) to 8,203 (2,050,720 pre-split) and the per share exercise price of the Investor Warrant was decreased from $812.50 ($3.25 pre-split) to $750 ($3.00 pre-split). As of December 31, 2017, the Investor had elected, in a cashless transaction, to exercise the Investor Warrant to purchase 6,860 (1,715,006 pre-split) shares of common stock and also paid the Company the sum of $977,142 to exercise the Investor Warrant for an additional 1,303 (325,714 pre-split) shares of common stock. On November 21, 2017 in conjunction with the Fourth Amendment and Exchange Agreement entered into between the Investor and the Company, the remaining 40 (10,000 pre-split) shares of common stock subject to the Investor Warrant were exchanged for a new warrant (the “Exchange Warrant”). The Exchange Warrant, which was determined to be a liability and was recorded at fair value, was in substantially the form of the Investor Warrant, except that: 

● The Exchange Warrant had an exercise price of $3,578 ($14.31 pre-split).

● The expiration date of the Exchange Warrant was November 21, 2022.

● The Exchange Warrant could not be exercised for the purchase of shares of common stock unless the stockholders of the Company approve the issuance in compliance with the rules and regulations of The Nasdaq Capital Market, which stockholder approval was obtained at a special meeting of the Company’s stockholders in October 2017.

● The Exchange Warrant was subject to redemption, refund or alternate cashless exercise after the August 2017 Notes were no longer outstanding (or on or after February 16, 2018 if the Company failed to remain current in its filings or an event of default under the August 2017 Notes occurred).

In March 2018, the Investor exercised the Exchange Warrant by means of a cashless exercise into 17,414 (4,353,581 pre-split) shares of common stock and a cash payment from the Company of $779,219, resulting in a reduction of the warrant liability and corresponding adjustment to Additional Paid in Capital.

With the issuance of the Exchange Warrant, the resulting cash flows of the remaining Investor Warrant were considered to be significantly modified within the context of ASC 470. Accordingly, the incremental change in fair value between the Investor Warrant and the Exchange Warrant was calculated as $12,878,864 and recorded as interest expense. 

November 2017 Notes

On November 7, 2017, the Company issued two Senior Secured Convertible Notes in the aggregate principal amount of $100,000,000 (collectively, the “November 2017 Notes”) to institutional investors. The November 2017 Notes consist of a Senior Secured Convertible Note in the amount of $5,000,000 (the “November Initial Note”) and a Senior Secured Convertible Note in the amount of $95,000,000 (the “November Additional Note”) in exchange for an upfront cash payment of $5,000,000 and a senior secured promissory note of $95,000,000 (the “November 2017 Investor Note”). As of December 31, 2017, purchasers of the November 2017 Notes prepaid $15,650,000 of the November 2017 Investor Note with the remaining principal being subject to master netting agreements between the Company and such holders. In conjunction with the prepayment, the Company was also obligated to pay the holders interest which would have accrued with respect to the outstanding balance for the period from the redemption date through the maturity date (the “Make-Whole Interest”). As cash is received from the November 2017 Investor Note, and the related principal amount of the November 2017 Notes increases accordingly, a derivative liability related to the conversion feature and Make-Whole Interest feature embedded within the November 2017 Notes is recorded as a debt discount, and accreted into interest expense over the life of the November 2017 Notes using the effective interest method, and any excess value over the amount of cash received is expensed immediately to interest expense. In addition, November Placement Agent Warrants are also issued (See The Placement Agent Notes Warrants below), recognized as liabilities pursuant to their terms and recorded as a debt discount, and accreted into interest expense over the life of the November 2017 Notes using the effective interest method, and any excess value over the amount of cash received is expensed immediately to interest expense.

The Company elected to defer payment of the Make-Whole Interest by capitalizing the full balance under the same terms as the original November 2017 Notes. On January 2, 2018, an additional $646,263 of interest was capitalized and added to the principal balance of the November 2017 Notes and on January 26, 2018, investors redeemed principal of $2,894,062 in exchange for cash. On April 2, 2018 and July 2, 2018, an additional $1,028,730 and $714,977 of interest respectively, was capitalized and added to the principal balance of the note. As of September 30, 2018, the entire capitalized balance was converted to shares of the Company’s common stock and the outstanding balance owed on the capitalized Make-Whole Interest was $0.

The November 2017 Notes have a maturity date of November 7, 2019. On any unfunded principal balance of the November 2017 Investor Notes the Company owed to the investors a 5.25% interest obligation which is due quarterly and calculated on a 360-day basis. For the funded portion of the November 2017 Notes the Company has a 10% interest obligation. The initial conversion price for the November 2017 Notes, which includes both the November Initial Note and November Additional Note, was $3,015 ($12.06 pre-split). However, the conversion price may be adjusted upon obtaining stockholder approval in accordance with Nasdaq Listing Rule 5635(d) of the issuance of our common stock at any conversion price below $3,015, which may result from full ratchet conversion price adjustments required by the November 2017 Notes in the event of certain issuances below the initial conversion price. Such stockholder approval was obtained at the stockholders meeting held in February 2018. As a result, during the second and third quarters of 2018, in conjunction with the April 2018 Offering and the sale of shares in the ATM Offering at prices lower than the initial conversion price, the conversion price for the November 2017 Notes has been reduced, and as of September 30, 2018, the conversion price was $0.02.

During the second and third quarters of 2018, the Company received cash prepayments on the November 2017 Investor Notes of $58,959,736, of which $58,959,736 of principal and $8,252,583 of accrued interest, were converted into 612,792 (58,905,544 pre-split) shares of the Company’s common stock during the nine months ended September 30, 2018. As of September 30, 2018, there was no outstanding unrestricted principal under the November 2017 Notes and $20,388,861 in restricted principal outstanding for which there was a corresponding amount due under corresponding November 2017 Investor Notes. For the three and nine months ended September 30, 2018, the Company recognized $261,657 and $5,994,771 of interest expense pertaining to the November 2017 Notes and had $261,657 of accrued interest as of September 30, 2018.

On June 1, 2018, the Company entered into an amendment to the securities purchase agreement between the Company and the institutional investors holding the November 2017 Notes to reduce the number of shares of common stock required to be reserved for issuance under the November 2017 Notes from 200% to 110% of the maximum number of shares of common stock issuable upon conversion of the November 2017 Notes until the earlier of the January 2018 Notes Stockholder Approval Date (as defined below) and August 1, 2018. After such date, the required reserve amount will be increased back to 200%. As more fully described in Note 19 – Subsequent Events, the Securities Purchase Agreement between the Company and certain institutional investors pursuant to which the Company issued the November 2017 Notes was amended to reduce the number of shares of common stock of the Company required to be reserved for issuance under the November 2017 Notes to 100% of the maximum number of shares of common stock of the Company issuable upon conversion of the November 2017 Notes.

MoviePass has guaranteed the obligations arising under the November 2017 Notes.

January 2018 Notes

On January 23, 2018, pursuant to a securities purchase agreement (the “January Securities Purchase Agreement”) entered into by the Company and an institutional investor the Company sold and issued senior convertible notes in the aggregate principal amount of $60,000,000 (collectively, the “January 2018 Notes”), consisting of (i) a Series A-1 Senior Bridge Subordinated Convertible Note in the aggregate principal amount of $25,000,000 (the “Series A-1 Note”) and (ii) a Series B-1 Senior Secured Bridge Convertible Note in the aggregate principal amount of $35,000,000 (the “Series B-1 Note”) for consideration consisting of (i) a cash payment in the aggregate amount of $25,000,000, and (ii) a secured promissory note payable by the buyer to the Company (the “January 2018 Investor Note”) in the aggregate principal amount of $35,000,000 which is subject to a master netting agreement between the Company and the buyer (collectively, the “January 2018 Financing”). In conjunction with the prepayment of the January 2018 Investor Note the Company was also obligated to pay the buyer interest which would have accrued with respect to the outstanding balance for the period from the redemption date through the maturity date (the “January Make-Whole Interest”). As cash is received from the January 2018 Investor Note, and the related principal amount of the January 2018 Notes increases accordingly, a derivative liability related to the conversion feature and the January Make-Whole Interest feature embedded within the January 2018 Notes is recorded as a debt discount and any excess value over the amount of cash received is expensed immediately to interest expense. In addition, January Placement Agent Warrants were also issued (See The Placement Agent Notes and Warrants below), recognized as liabilities pursuant to their terms and recorded as a debt discount, and accreted into interest expense over the life of the January 2018 Notes using the effective interest method, and any excess value over the amount of cash received was expensed immediately to interest expense.

The Company elected to defer payment of the January Make-Whole Interest by capitalizing the full balance under the same terms as the original January 2018 Notes. On April 2, 2018, $352,187 and July 2, 2018, $468,180 of interest, respectively, was capitalized and added to the principal balance of the note. As of September 30, 2018, the entire capitalized was converted to shares of the Company’s common stock and the outstanding balance owed on the capitalized Make-Whole Interest was $0.

Unless earlier converted or redeemed, the January 2018 Notes have a maturity date of January 23, 2020. The Series A-1 Note bears interest at a rate of 10% per annum. Upon issuance, the Series B-1 Note initially consisted entirely of “Restricted Principal” which is defined as that portion of the principal amount of a Series B-1 Note that equals the outstanding principal amount of the corresponding January 2018 Investor Note. The principal amount of the January 2018 Investor Note is subject to reduction through prepayments by the buyer of the January 2018 Investor Note given by the buyer to the Company or, upon maturity or redemption of the Series B-1 Note, by netting the amount owed by the buyer under the January 2018 Investor Note against a corresponding amount of principal to be canceled under the buyer’s Series B-1 Note. Each prepayment under the January 2018 Investor Note will convert a corresponding amount of Restricted Principal under the Series B-1 Note into “Unrestricted Principal” that may be converted into common stock.

The January 2018 Notes have an initial conversion price of $2,860 ($11.44 pre-split) per share. However, pursuant to the January Securities Purchase Agreement, the Company was required to seek stockholder approval in accordance with Nasdaq Listing Rule 5635(d) of the issuance of our common stock at a conversion price per share as low as $1.83 following the occurrence of an event of default or otherwise at any conversion price below $2,860 which may result from full ratchet conversion price adjustments required by the January 2018 Notes in the event of certain issuances below the initial conversion price. Such stockholder approval was obtained on July 23, 2018. As a result, in conjunction with the April 2018 Offering and the sale of shares in the ATM Offering at prices lower than the initial conversion price, the conversion price for the January 2018 Notes has been reduced, and as of September 30, 2018, the conversion price was $0.02.

The Company is required to redeem the January 2018 Notes (i) at the option of the buyer from and after June 7, 2018; (ii) at the option of the buyer if the Company completes a subsequent public or private offering of debt or equity securities, including equity-linked securities (subject to certain excluded issuances); (iii) upon the occurrence of an Event of Default, including a Bankruptcy Event of Default (each, as defined in the January 2018 Notes); or (iv) in the event of a Change of Control (as defined in the January 2018 Notes). With the exception of a redemption required by an Event of Default (as defined in the January 2018 Notes), which may be paid with cash or shares of the Company’s common stock at the election of the buyer, the Company will be required to redeem the January 2018 Notes with cash. All amounts outstanding under the January 2018 Notes are secured by the January 2018 Investor Note and all proceeds therefrom. The January 2018 Notes are not secured by, and the buyer does not have a lien on, any assets of the Company other than the January 2018 Investor Note.

MoviePass has guaranteed the obligations arising under the January 2018 Notes.

Provided there has been no Equity Conditions Failure (as defined in the January 2018 Notes) and, as to the Series A-1 Note, no August 2017 Notes or November 2017 Notes remain outstanding, and as to the Series B-1 Note, no August 2017 Notes, November 2017 Notes, Series A-1 Note or Series B-1 Note with any Unrestricted Principal remain outstanding, the Company will have the right to redeem all, but not less than all, of the Outstanding Amount (as defined in the January 2018 Notes) remaining unpaid under the January 2018 Notes. The portion of the January 2018 Notes subject to redemption can be redeemed by the Company in cash at a price equal to 115% of the amount being redeemed. Under the Series B-1 Note, the Company may reduce, on a dollar for dollar basis, the Restricted Principal by the surrender for cancellation of such portion of the corresponding January 2018 Investor Note equal to the amount of Restricted Principal included in the redemption.

During the third quarter of 2018, the Company received cash payments on the January 2018 Notes of $6,000,000, of which $6,000,000 of principal and $909,021 of accrued interest, were converted into 109,897,912 shares of the Company’s common stock during the third quarter of 2018. Additionally, during the third quarter of 2018, the Company converted principal under the January 2018 Notes in the amount of $820,367, and interest of $128,068 into 1,896,872 shares of the Company’s common stock. As of September 30, 2018, there was no outstanding unrestricted principal on the January Notes. For the three and nine months ended September 30, 2018, the Company recognized $372,167 and $1,182,130 of interest expense pertaining to the January 2018 Notes and had $372,167 of accrued interest as of September 30, 2018.

On June 1, 2018, the Company and the buyer entered into an amendment to the January Securities Purchase Agreement and the January 2018 Notes to reduce the number of shares of common stock required to be reserved for issuance under the January 2018 Notes from 200% to 100% of the maximum number of shares of common stock issuable upon conversion of the January 2018 Notes until the earlier of (1) the date stockholders approve resolutions providing for the issuance of the January 2018 Notes and the shares of common stock issuable upon conversion of the January 2018 Notes (the “January 2018 Notes Stockholder Approval” and the date the Stockholder Approval is obtained, the “January 2018 Notes Stockholder Approval Date”) and (2) August 1, 2018. After such date, the required reserve amount will be increased back to 200%. The amendment to the January Securities Purchase Agreement also extended the date by which the Company must hold the special meeting to obtain the January 2018 Notes Stockholder Approval from June 1, 2018 to August 1, 2018. As more fully described in Note 19 – Subsequent Events, the January Securities Purchase Agreement was amended to reduce the number of shares of common stock of the Company required to be reserved for issuance under the January 2018 Notes to 125% of the maximum number of shares of common stock of the Company issuable upon conversion of the January 2018 Notes.

February 2018 Units Offering

On February 13, 2018, the Company sold an aggregate of approximately $105 million worth of units (the “Units”) of the Company’s securities to Canaccord Genuity Inc., on behalf of itself and as representative of the underwriters (the “Underwriters”), pursuant to which the Company issued and sold to the Underwriters in a best-efforts underwritten public offering (the “Offering”) at a purchase price of $5.192 per Unit with each Unit consisting of (A) 7,425,000 Series A-1 units (the “Series A-1 Units”), with each Series A-1 Unit consisting of (i) 0.004 (one pre-split) share of the Company’s common stock, and (ii) 0.004 (one pre-split) Series A-1 warrant to purchase 0.004 (one pre-split) share of the Company’s common stock (a “Series A-1 Warrant”); and (B) for those purchasers whose purchase of Series A-1 Units would result in the purchaser, together with its affiliates and certain related parties, beneficially owning more than 9.99% of the Company’s outstanding common stock following the consummation of the Offering, 11,675,000 Series B-1 units (the “Series B-1 Units”), consisting of (i) 0.004 (one pre-split) pre-funded Series B-1 warrant to purchase 0.004 (one pre-split) share of common stock (a “Series B-1 Warrant”; and the Series B-1 Warrants, together with the Series A-1 Warrants, the “Warrants”) and (ii) 0.004 (one pre-split) Series A-1 Warrant.

Each Warrant is exercisable at any time on or after the issuance date until the five-year anniversary of the issuance date. Each Series A-1 Warrant is exercisable at a price of $1,625 ($6.50 pre-split) per share of common stock. Each Series B-1 Warrant has an aggregate exercise price of $1,375 ($5.50 pre-split) per share of common stock, all of which were pre-funded except for a nominal exercise price of $0.001 per share of common stock. All Series B-1 Warrants were exercised.

The Company received approximately $96.9 million in net proceeds from the sale of the Units, after deducting underwriting discounts and commissions equal to $5.9 million and estimated offering expenses of approximately $0.5 million, not taking into account any exercise of the Warrants. In addition, Palladium Capital Advisors, LLC acted as financial advisor in connection with the Offering and received a financial advisory fee equal to $1.9 million.

The Warrants were recorded as liabilities and initially recorded at fair value with the residual amount received allocated to the Company’s common stock. The exercise price of and number of shares of the Company’s common stock underlying the Warrants are subject to adjustment upon the issuance by the Company of stock dividends, stock splits, and similar proportionately applied changes affecting the Company’s outstanding common stock. In addition, the Series A-1 Warrants are subject to adjustment of the applicable exercise price then in effect, if, as of December 17, 2018 (the “Adjustment Date”), the quotient determined by dividing the (x) sum of the VWAP (as defined in the Series A-1 Warrant) of the common stock for each trading day during the 10 consecutive trading day period ending and including the trading day immediately preceding the Adjustment Date, divided by (y) 0.4 (10 pre-split) (all such determinations to be appropriately adjusted for any stock dividend, stock split, stock combination or other similar transaction during such period) (the “Adjustment Price”), is less than the applicable exercise price. If the Adjustment Price is less than the applicable exercise price as of the Adjustment Date, then the exercise price shall be automatically adjusted to be equal to the Adjustment Price.

If the Company consummates any merger, consolidation, sale or other reorganization event in which its common stock is converted into or exchanged for securities, cash or other property (“Fundamental Transaction”), then the Company shall pay at the Warrants holder’s option, exercisable at any time commencing on the occurrence or the consummation of a Fundamental Transaction and continuing for 90 days, an amount of cash equal to the value of the remaining unexercised portion of the warrant as determined in accordance with the Black-Scholes option pricing model on the date of such Fundamental Transaction.

April 2018 Units Offering

On April 23, 2018, the Company sold an aggregate of approximately $30 million worth of units (the “April 2018 Units”) of the Company’s securities to Canaccord Genuity Inc., on behalf of itself and as representative of the underwriters (the “April Offering Underwriters”), pursuant to which the Company issued and sold to the April Offering Underwriters in a best-efforts underwritten public offering (the “April 2018 Offering”) at a purchase price of $2.59875 per April 2018 Unit with each April 2018 Unit consisting of (A) 10,500,000 Series A-2 units (the “Series A-2 Units”), with each Series A-2 Unit consisting of (i) 0.004 (one pre-split) share (an “April Share”) of the Company’s common stock, and (ii) 0.004 (one pre-split) Series A-2 warrant to purchase 0.004 (one pre-split) share of common stock (the “Series A-2 Warrants”); and (B) for those purchasers whose purchase of Series A-2 Units would result in the purchaser, together with its affiliates and certain related parties, beneficially owning more than 9.99% of the Company’s outstanding common stock following the consummation of the April 2018 Offering, 500,000 Series B-2 units (the “Series B-2 Units”), consisting of (i) 0.004 (one pre-split) pre-funded Series B-2 warrant to purchase 0.004 (one pre-split) share of common stock (the “Series B-2 Warrants”, and together with the Series A-2 Warrants, the “April Warrants”) and (ii) 0.004 (one pre-split) Series A-2 Warrant. The April Shares, Series A-2 Warrants and Series B-2 Warrants were immediately separable.

Each April Warrant is exercisable at any time on or after the issuance date until the five-year anniversary of the issuance date. Each Series A-2 Warrant is exercisable at a price of $250 ($1.00 pre-split) per share of common stock. Each Series B-2 Warrant had an aggregate exercise price of $687.50 ($2.75 pre-split) per share of common stock, all of which were pre-funded except for a nominal exercise price of $0.001 per share of common stock. All of the Series B-2 Warrants were exercised.

The Company received approximately $27.7 million in net proceeds from the sale of the April 2018 Units, after deducting underwriting discounts and commissions equal to $1.7 million and estimated offering expenses of approximately $1.0 million, not taking into account any exercise of the April Warrants. In addition, Palladium Capital Advisors, LLC acted as financial advisor in connection with the April 2018 Offering and received a financial advisory fee equal to $0.6 million

The April Warrants were recorded as liabilities and initially recorded at fair value with the residual amount received allocated to the Company’s common stock. The exercise price of and number of shares of common stock underlying the April Warrants are subject to adjustment upon the issuance by the Company of stock dividends, stock splits, and similar proportionately applied changes affecting the Company’s outstanding common stock. The Series A-2 Warrants also include “full ratchet” anti-dilution protection provisions (the “Full Ratchet Adjustment”), which provide that if the Company issues any shares of common stock at a price less than the then current exercise price of the Series A-2 Warrants, or if the Company issues any securities convertible into, or exercisable, or exchangeable for, shares of common stock with an exercise or conversion price less than the then current exercise price of the Series A-2 Warrants, then the exercise price of the Series A-2 Warrants will automatically be reduced to the issuance price of the new shares of common stock or the exercise or conversion price of the April Warrants, options or other convertible or exchangeable securities.

The Full Ratchet Adjustment does not apply if the Company issues “Excluded Securities”, including certain (i) option and other equity incentive awards approved by the Company’s Board of Directors to be issued to directors, officers, consultants and employees, (ii) shares of common stock issuable pursuant to existing employment agreements, (iii) shares of common stock issued upon conversion or exercise of convertible securities that were previously issued, (iv) shares of common stock issued pursuant to strategic license agreements, mergers or acquisitions (but does not include a transaction in which the Company is issuing securities primarily for the purpose of raising capital), (v) shares of common stock issued under the ATM Offering after the fifteenth calendar day that the Series A-2 Warrants were issued and (vi) 2,000 (500,000 pre-split) shares granted by the Company’s Board of Directors to Helios & Matheson Information Technology Ltd, a current stockholder of the Company, in exchange for its entry into a 12-month lock-up agreement with the Company.

If the Company consummates any merger, consolidation, sale or other reorganization event in which its common stock is converted into or exchanged for securities, cash or other property (“fundamental transaction”), then the Company shall pay at the holder’s option, exercisable at any time commencing on the occurrence or the consummation of a fundamental transaction and continuing for 90 days, an amount of cash equal to the value of the remaining unexercised portion of the warrant as determined in accordance with the Black-Scholes option pricing model on the date of such fundamental transaction.

June 2018 Convertible Notes and Series A Preferred Stock

On June 26, 2018, pursuant to the Securities Purchase Agreement, dated as of June 21, 2018, by and between the Company and certain institutional investors (the “June Buyers” and such agreement, the “June Securities Purchase Agreement”), the Company issued and sold 20,500 shares of Series A Preferred Stock of the Company (the “Preferred Stock”) and Series B-2 Senior Convertible Notes in the aggregate principal amount of $164,000,000 (which includes an approximate 15.0% original issue discount) (the “June 2018 Convertible Notes”), for total consideration consisting of an aggregate cash payment to the Company of $20,500,000 and secured promissory notes payable by the June Buyers to the Company (the “June 2018 Investor Notes”) in the aggregate principal amount of $139,400,000.

Unless earlier converted or redeemed, the June 2018 Convertible Notes would have matured on June 26, 2020. The maturity date of the June 2018 Investor Notes was June 26, 2060. Upon issuance, (i) $24,600,000 in principal amount of the June 2018 Convertible Notes consisted of “Unrestricted Principal”, which is defined as that portion of the principal amount of June 2018 Convertible Note that may be converted at any time and is not subject to netting  against any June 2018 Investor Notes, and (ii) the balance of the principal amount under the June 2018 Convertible Notes, equal to $139,400,000, consisted entirely of “Restricted Principal”, which is defined as that portion of the principal amount of a June 2018 Convertible Note that equals the outstanding principal amount of a corresponding June 2018 Investor Note. The principal amount of each June 2018 Investor Note was subject to reduction through prepayments by the applicable June Buyer of the applicable June 2018 Investor Note given by the applicable June Buyer to the Company or, upon maturity or redemption of the June 2018 Convertible Notes, by netting the amount owed by the applicable June Buyer under such June 2018 Investor Note against a corresponding amount of Restricted Principal to be canceled under the June 2018 Convertible Note. Each prepayment under the June 2018 Investor Notes would convert a corresponding amount of Restricted Principal under the June 2018 Convertible Notes into “Unrestricted Principal” that could be converted into common stock.

As of September 30, 2018, the June Buyers prepaid $24,600,000 of the June 2018 Investor Notes with the remaining principal being subject to a master netting agreement between the Company and the June Buyers (collectively, the “June 2018 Financing”). In conjunction with the prepayment, the Company was also obligated to pay the June Buyers interest which would have accrued with respect to the outstanding balance for the period from the redemption date through the maturity date (the “June Make-Whole Interest”).

On any unfunded principal balance of the June 2018 Investor Notes the Company owed to the June Buyers a 5.25% interest obligation which was due quarterly and calculated on a 360-day basis. For the funded portion of the June 2018 Notes the Company had a 10% interest obligation.

Interest on the June 2018 Convertible Notes was capitalized on each quarterly interest payment date starting July 1, 2018 by adding the interest to the then outstanding principal amount of the June 2018 Convertible Notes. Interest could also be paid by inclusion in the “Outstanding Amount”, which is defined in the June 2018 Convertible Notes as the principal amount to be converted or redeemed, accrued and unpaid interest with respect to such principal amount, accrued and unpaid late charges, if any, and the “June Make-Whole Amount.” The “June Make-Whole Amount” is defined as the amount of any interest that, but for a conversion or redemption, would have accrued with respect to the Outstanding Amount (as defined in the June 2018 Convertible Notes) of principal being redeemed or converted under the June 2018 Convertible Notes, for the period from the applicable date of conversion or redemption date through the maturity date of the June 2018 Convertible Notes. No June Make-Whole Amount is payable under the June 2018 Convertible Notes with respect to any portion of Restricted Principal after the cancellation of such Restricted Principal pursuant to netting under the June 2018 Convertible Notes, the June 2018 Investor Notes or the Master Netting Agreement (as defined below), as applicable. In the event of an event of default interest under the June 2018 Convertible Notes could be increased to 15% during the first 30 days following the occurrence and continuance of an event of default and to 18% thereafter (the “Default Rate”).

Provided there has been no Equity Conditions Failure (as defined in the June 2018 Convertible Notes) and no November 2017 Notes, January 2018 Notes, or shares of the Preferred Stock remain outstanding and no Unrestricted Principal remains outstanding under the June 2018 Convertible Notes, the Company had the right to redeem all, but not less than all, of the Outstanding Amount remaining unpaid under the June 2018 Convertible Notes. The portion of the June 2018 Convertible Notes subject to redemption could be redeemed by the Company in cash at a price equal to 115% of the amount being redeemed. Under the June 2018 Convertible Notes, the Company could reduce, on a dollar for dollar basis, the Restricted Principal by the surrender for cancellation of such portion of the corresponding June 2018 Investor Notes equal to the amount of Restricted Principal included in the redemption.

The June Buyers had the right to elect, at any time after the Company obtains approval by its stockholders to either increase its authorized shares of common stock or effect a reverse stock split, which approval was obtained on July 23, 2018, to convert the June 2018 Convertible Notes into shares of the Company’s common stock at the Conversion Price, subject to certain beneficial ownership limitations described below. The “Conversion Price” is $250 ($1.00 pre-split) per share (subject to anti-dilution adjustment as described in the June 2018 Convertible Notes). However, pursuant to the June Securities Purchase Agreement, the Company was required to seek stockholder approval in accordance with Nasdaq Listing Rule 5635(d) of the issuance of common stock at a conversion price per share below $250 which may result from the full ratchet conversion price adjustments required by the June 2018 Convertible Notes in the event of certain issuances below the initial conversion price. The Company was required to hold a special meeting of stockholders by November 14, 2018 to obtain such approval. If such stockholder approval was obtained, if the Company issues securities in certain transactions, such as the ATM Offering, at a price lower than the applicable conversion price, then the applicable conversion price for the June 2018 Convertible Notes will be reduced to equal such lower price.

The Preferred Stock was determined to be classified in equity. Accordingly, the June 2018 Convertible Notes and the Preferred Stock were recorded based on their relative fair values. A derivative liability related to the conversion feature and make-whole interest feature embedded within the June 2018 Convertible Notes is recorded as a debt discount, and accreted into interest expense over the life of the June 2018 Convertible Notes using the effective interest method, and any excess value over the amount allocated to the June 2018 Convertible Notes was expensed immediately to interest expense. In addition, June Placement Agent Warrants are also issued (See The Placement Agent Notes and Warrants below), recognized as liabilities pursuant to their terms and recorded as a debt discount, and accreted into interest expense over the life of the June 2018 Convertible Notes using the effective interest method, and any excess value over the amount of cash received is expensed immediately to interest expense.

MoviePass has guaranteed the obligations arising under the June 2018 Convertible Notes.

In connection with the June 2018 Financing, Theodore Farnsworth, the Chief Executive Officer and Chairman of the Board of the Company, and Helios & Matheson Information Technology Ltd, of which Muralikrishna Gadiyaram, a director of the Company, is the chief executive officer, and its wholly-owned subsidiary, Helios & Matheson Inc., who collectively owned approximately 1.5% of the Company’s issued and outstanding common stock as of the closing of the June 2018 Financing, entered into Voting and Lockup Agreements with the Company. In addition, the Company entered into separate Buyer Voting Agreements with each of the June Buyers with terms consistent with the June 2018 Amendment and Exchange Agreements (see Exchange of Warrants for Common Shares below).

As of September 30, 2018, there was no unrestricted principal balance of the June 2018 Convertible Notes outstanding and restricted principal outstanding was $74,800,000 for which there was a corresponding amount due under the June 2018 Investor Notes. For the three and nine months ended September 30, 2018, the Company recognized $959,933 and $965,233, respectively, of interest expense pertaining to the June 2018 Convertible Notes and had $959,933 of accrued interest as of September 30, 2018.

On October 4, 2018, the Company entered into an Amendment and Exchange Agreement (the “October Exchange Agreement”) with the holder of a June 2018 Convertible Note having an outstanding principal amount of $68,882,583 for the purpose of (i) netting the June 2018 Investor Note issued by such holder to the Company having an aggregate principal amount of $68,000,000 against such holder’s June 2018 Convertible Note and (ii) following such netting transaction, exchanging the remaining outstanding amount payable under such holder’s June 2018 Convertible Note for a new non-convertible Senior Note issued by the Company to such holder (the “New Non-Convertible Note”) in an aggregate principal amount of $20,400,000, subject to reduction as provided in the New Non-Convertible Note. As a result, such holder’s June 2018 Convertible Note and the corresponding June 2018 Investor Note issued by such holder were each cancelled and became null and void.

Following the consummation of the transactions contemplated by the October Exchange Agreement and the netting of the other June 2018 Investor Notes by the other holders of the June 2018 Investor Notes against their corresponding June 2018 Convertible Notes, all of the June 2018 Convertible Notes have been cancelled.

Exchange of Warrants for Common Shares

On June 28, 2018, the Company entered into separate June 2018 Amendment and Exchange Agreements (each, an “Exchange Agreement”) with the holders (each, a “Holder” and collectively, the “Holders”) of certain warrants to purchase shares of the Company’s common stock for the purpose of exchanging outstanding warrants to purchase an aggregate of 106,437 (26,609,269 pre-split) shares of common stock (the “June Exchange Warrants”) for an aggregate of 90,472 (22,617,879 pre-split) shares of common stock (collectively, the “June Exchange Shares”), based on a ratio of 0.85 June Exchange Shares for each warrant share. As a result, the June Exchange Warrants have been cancelled.

On June 28, 2018, each Holder that was not a party to the June Securities Purchase Agreement entered into a voting agreement with the Company (each, a “Voting Agreement” and collectively, the “Voting Agreements”). Pursuant to the Voting Agreements, each Holder agreed to vote the June Exchange Shares and any shares of common stock the Holder owns or may acquire (collectively, the “Holder Securities”) at any meeting of stockholders of the Company: (a) in favor of (i) approval of resolutions providing for the January 2018 Notes Stockholder Approval, (ii) an increase in the authorized shares of the Company and (iii) a reverse stock split of the common stock; and (b) against any proposal or any other corporate action or agreement that would result in a breach of any covenant, representation or warranty or any other obligation or agreement of the Company under the Transaction Documents (as defined in the June Securities Purchase Agreement) or the Transaction Documents (as defined in the January Securities Purchase Agreement) or which could result in any of the conditions to the Company’s obligations under the Transaction Documents (as defined in the June Securities Purchase Agreement) or the Transaction Documents (as defined in the January Securities Purchase Agreement), as applicable, not being fulfilled. The agreements to vote the Holder Securities described above terminate immediately following the occurrence of the January 2018 Notes Stockholder Approval described above.

The Voting Agreements also required that, at any time on or prior to the record date for the meeting of stockholders of the Company at which the Company obtained the January 2018 Notes Stockholder Approval, each Holder would not sell or transfer any of the June Exchange Shares. However, the Holders (or their designees, as applicable) were not prohibited from (i) using their Holder Securities to cover the Holders’ or their respective affiliates’ Short Sales (as defined in SEC Regulation SHO) outstanding as of the date of the Voting Agreement, (ii) lending any of their Holder Securities to any person, or (iii) pledging any of the Holder Securities to any person.

In connection with the Exchange Agreements, on June 28, 2018, each Holder entered into a leak-out agreement with the Company (each a “Leak-Out Agreement” and collectively, the “Leak-Out Agreements”), which restricted each Holder from selling the June Exchange Shares during certain periods. Pursuant to the Leak-Out Agreements, for a period ending on the earlier of (x) July 23, 2018 and (y) the Stock Split Stockholder Approval Date (as defined in the June Securities Purchase Agreement) (such earlier date, the “Lock-Up End Date”), the Holder was not, after the date of the Leak-Out Agreement, to sell any of the June Exchange Shares. However, the Holders (or their designees, as applicable) were not prohibited from (i) using their Holder Securities to cover the Holders’ or their respective affiliates’ Short Sales (as defined in SEC Regulation SHO) outstanding as of the date of the Leak-Out Agreement, (ii) lending any of their Holder Securities to any person, or (iii) pledging any of their Holder Securities to any person. In addition, subject to certain exclusions, Holders and any Trading Affiliates (as defined in the Leak-Out Agreements) were restricted from selling specified amounts of their June Exchange Shares for up to fifteen calendar days after the Lock-Up End Date, unless certain events, as described in the Leak-Out Agreements, earlier terminated such restrictions.

On June 28, 2018, the Company and the Required Holder (as defined in the June Securities Purchase Agreement), entered into an amendment to the June Securities Purchase Agreement (“Amendment No. 1 to Securities Purchase Agreement”), pursuant to which the Stockholder Meeting Deadline (as defined in the June Securities Purchase Agreement) was amended from July 18, 2018 to July 23, 2018.

The collective June Exchange Warrants which were exchanged in this transaction, were all recorded as liabilities at fair value upon issuance, and marked to market at each balance sheet date. The June Exchange Warrants were valued through the date of exchange, June 28, 2018, based upon the original terms of the agreements with changes in fair value recorded in the as gain/loss on warrant liability. The June Exchange Warrants were then valued on the same day based on the fair value of the common shares into which they were converted (0.85 June Exchange Shares for each warrant), and the difference in the fair value between the two instruments was recorded as gain/loss on exchange of warrant. The fair value determined on June 28, 2018 then became the consideration received for the issuance of the common stock. The excess of the consideration received over the par value of the common stock was recorded as Additional Paid in Capital. Accordingly, the incremental change in fair value between the Investor Warrant and the Exchange Warrant is calculated as $301,500 and recorded as Gain on Exchange of Warrants.

Waiver Agreements

On July 10, 2018, the Company entered into a Waiver Agreement (the “July Waiver Agreement”) with a holder of the November 2017 Notes, January 2018 Notes and June 2018 Convertible Notes (collectively, the “Existing Notes”).

Pursuant to the July Waiver Agreement, such holder, in its capacity as the Required Holder under the Securities Purchase Agreements pursuant to which the Existing Notes were issued: (i) waived any obligation by the Company to effect any redemption of the Existing Notes as a result of the consummation of a proposed public offering of securities by the Company (the “New Proposed Offering”), (ii) reduced the aggregate number of shares required to be reserved for issuance upon conversion of the November 2017 Notes and the January 2018 Notes, (iii) deferred the right that the holders of the Existing Notes may have to adjust the Conversion Price (as defined in the applicable Existing Note) of such Existing Notes solely as a result of the issuance of securities in the New Proposed Offering until the fourth trading day after the time of the pricing of the New Proposed Offering, (iv) consented to the New Proposed Offering, and (v) waived any prohibition with respect to the issuance of the securities in the New Proposed Offering.

On July 13, 2018, the Company entered into an amendment (the “Amendment”) to the July Waiver Agreement. The Amendment revised the July Waiver Agreement as follows: (i) the waiver of the Company’s obligation to effect any redemption of the Existing Notes as a result of the consummation of a New Proposed Offering (as defined in the July Waiver Agreement) applies only to the extent the redemption right arises from the occurrence of a Financing (as defined in the June 2018 Convertible Notes) occurring between July 11, 2018 and July 17, 2018; (ii) the number of shares permitted to be offered in the New Proposed Offering was reduced; (iii) the number of shares required to be reserved for issuance upon conversion of the November 2017 Notes was increased; (iv) the reduction in the number of shares required to be reserved upon conversion of the November 2017 Notes (the “Reduction Shares”) ends when stockholders approve either an increase in the authorized shares of common stock or a reverse stock split of the common stock, and if the Reduction Shares are not issued prior to close of market on July 17, 2018, the Reduction Shares that were not issued would be restored to (and increase) the reserve for the November 2017 Notes; and (v) the deferral of the right that the holders of the Existing Notes may have to adjust the Conversion Price (as defined in the applicable Existing Note) of such Existing Notes solely as a result of the issuance of securities in the New Proposed Offering until the fourth trading day after the time of the pricing of the New Proposed Offering provided in the July Waiver Agreement was eliminated.

July 13, 2018 Demand Note

On July 13, 2018 the Company issued a demand note (the “July 13 Demand Note”) in the principal amount of $6,806,850, which included $5.0 million in cash borrowed by the Company from the holder and $1,806,850 required to be paid by the Company to the holder pursuant to a partial redemption of the June 2018 Convertible Notes held by the holder. The July 13 Demand Note bore interest on the unpaid principal amount at the rate of 10.0% per year. The holder could make a demand for full payment of the July 13 Demand Note from and after July 17, 2018. The Company was required to use all proceeds received by the Company under its ATM Offering to repay the July 13 Demand Note. The July 13 Demand Note and all accrued interest could be prepaid by the Company without penalty. With the agreement of the holder, principal and interest accrued on the July 13 Demand Note could be applied to all, or any part, of the purchase price of securities to be issued upon the consummation, after July 13, 2018, of an offering of securities by the Company to the holder. Any amount of principal or other amounts due which is not paid when due would result in a late charge being incurred and payable by the Company to the holder in an amount equal to interest on such amount at the rate of 15% per year from the date such amount was due until the same is paid in full. 

The $5,000,000 cash proceeds received from the July 13 Demand Note were used by the Company to pay the Company’s merchant and fulfillment processors. 

MoviePass executed a guaranty (the “MoviePass July 13 Demand Note Guaranty”) pursuant to which MoviePass guaranteed the punctual payment of the July 13 Demand Note, including, without limitation, all principal, interest and other amounts that accrue after the commencement of any insolvency proceeding of the Company or MoviePass, whether or not the payment of such interest and/or other amounts are enforceable or are allowable and agreed to pay any and all costs and expenses (including counsel fees and expenses) incurred by the holder in enforcing any rights under the MoviePass July 13 Demand Note Guaranty or the July 13 Demand Note.

On July 31, 2018, the Company paid in full the $6,800,000 outstanding under the July 13 Demand Note.

July 27, 2018 Demand Note

On July 27, 2018, the Company issued a demand note (the “July 27 Demand Note”) in the principal amount of $6,200,000, which included $5.0 million in cash borrowed by the Company from the holder and $1.2 million of original issue discount. The holder could make a demand for full payment of the July 27 Demand Note from and after (x) with respect to up to $3,100,000 of the principal outstanding under the July 27 Demand Note (the “Initial Principal”), August 1, 2018 or (y) with respect to any other amounts then outstanding under the July 27 Demand Note, August 5, 2018. The Company was required to use all proceeds received by the Company on or after July 31, 2018 from sales of common stock under its ATM Offering against any Initial Principal until no Initial Principal remains outstanding, and thereafter, against any remaining amounts due under the July 27 Demand Note. The July 27 Demand Note’s principal, together with accrued and unpaid late charges could be prepaid by the Company without penalty. With the agreement of the holder, principal and accrued and unpaid late charges on the July 27 Demand Note could be applied to all, or any part, of the purchase price of securities to be issued upon the consummation, after July 27, 2018, of an offering of securities by the Company to the holder. Any amount of principal or other amounts due which is not paid when due (a “Payment Default”) would result in a late charge being incurred and payable by the Company to the holder in an amount equal to interest on such amount as the rate of 15% per year from the date such amount was due until the same was paid in full. If a Payment Default remained outstanding for a period of 48 hours, the holder could require the Company to redeem all or a portion of the July 27 Demand Note at a redemption price of 130%.

The $5,000,000 cash proceeds received from the July 27 Demand Note were used by the Company to pay the Company’s merchant and fulfillment processors. If the Company is unable to make required payments to its merchant and fulfillment processors, the merchant and fulfillment processors may cease processing payments for MoviePass, which would cause a MoviePass service interruption. Such a service interruption occurred on July 26, 2018. Any future service interruptions could have a further material adverse effect on MoviePass’ ability to retain its subscribers. This would have an adverse effect on the Company’s financial position and results of operations.

MoviePass executed a guaranty (the “MoviePass July 27 Demand Note Guaranty”) pursuant to which MoviePass guaranteed the punctual payment of the July 27 Demand Note, including, without limitation, all principal, interest and other amounts that accrue after the commencement of any insolvency proceeding of the Company or MoviePass, whether or not the payment of such interest and/or other amounts are enforceable or are allowable, and agreed to pay any and all costs and expenses (including counsel fees and expenses) incurred by the holder in enforcing any rights under the MoviePass July 27 Demand Note Guaranty or the July 27 Demand Note.

On July 31, 2018, the Company paid in full the $6,200,000 outstanding under the July 27 Demand Note.

The Placement Agent Notes and Warrants

The Company entered into an agreement with a placement agent (the “Placement Agent”) for assistance with the placement of the February 2017 Notes. The Placement Agent accepted from the Company a 5-year warrant (each, a “February Placement Agent Warrant”) as partial payment for the Placement Agent’s services. The February Placement Agent Warrants allow the purchase of up to 8% of the number of shares of the Company’s common stock into which the unrestricted principal of the February 2017 Notes may be converted. Through the first nine months of 2017, the Company received $5,000,000 of cash payments for the February 2017 Notes, resulting in the issuance of February Placement Agent Warrants for the purchase of 533 (133,334 pre-split) shares of common stock at an exercise price of $750 ($3.00 pre-split) per share. As of September 30, 2018, the Placement Agent has not elected to exercise any February Placement Agent Warrants. 

The Company entered into an agreement with the Placement Agent for assistance with the placement of the August 2017 Notes and Investor Warrant. The Placement Agent accepted from the Company a 5-year warrant (each, an “August Placement Agent Warrant”) as partial payment for the Placement Agent’s services. The August Placement Agent Warrants allow the purchase of up to 8% of the number of shares of the Company’s common stock into which the unrestricted principal of the Additional Series A Note and the Series B Note in the combined principal amount of $9,050,000 becomes convertible at an exercise price equal to the greater of the exercise price of the August 2017 Notes and the consolidated closing bid price of the Company’s common stock on the date that the Placement Agent becomes entitled to the August Placement Agent Warrants. During the period ended December 31, 2017, the Company received $8,800,000 of cash payments in conjunction with the August 2017 Notes and issued August Placement Agent Warrants for the purchase of 704 (176,000 pre-split) shares of common stock at exercise price of $750 ($3.00 pre-split) and $3,568 ($14.27 pre-split) per share. As of September 30, 2018, the Placement Agent has not elected to exercise any August Placement Agent Warrants. 

The Company entered into an agreement with the Placement Agent for assistance with the placement of the November 2017 Notes. The Placement Agent accepted from the Company a 5-year warrant (each, a “November Placement Agent Warrant”) as partial payment for the Placement Agent’s services. The November Placement Agent Warrants allow the purchase of up to 8% of the number of shares of the Company’s common stock into which the unrestricted principal of the November Series A Note and the November 2017 Notes in the combined principal amount of $100,000,000 becomes convertible at an exercise price equal to the greater of the exercise price of the November 2017 Notes and the consolidated closing bid price of the Company’s common stock on the date that the Placement Agent becomes entitled to the November Placement Agent Warrants. During the nine months ended September 30, 2018, the Company received $58,959,736 of cash payments for the November 2017 Notes resulting in the issuance of 751 (187,711 pre-split) warrants at an exercise price of $3,015 ($12.06 pre-split) per share. As of September 30, 2018, the Placement Agent has not elected to exercise any November Placement Agent Warrants.

The Company entered into an agreement with the Placement Agent for assistance with the placement of the January 2018 Notes. The Placement Agent accepted from the Company a 5-year warrant (each, a “January Placement Agent Warrant”) as partial payment for the Placement Agent’s services. The January Placement Agent Warrants allow the purchase of up to 8% of the number of shares of the Company’s common stock into which the unrestricted principal of the Series A-1 Note and the Series B-1 Note in the combined principal amount of $0 becomes convertible at an exercise price equal to the greater of the exercise price of the January 2018 Notes and the consolidated closing bid price of the Company’s common stock on the date that the Placement Agent becomes entitled to the January Placement Agent Warrants. During the nine months ended September 30, 2018, the Company received $31,000,000 of cash payments for the January 2018 Notes resulting in the issuances of 867 (216,786 pre-split) warrants at an exercise price of $2,860 ($11.44 pre-split) per share. As of September 30, 2018, the Placement Agent has not elected to exercise any January Placement Agent Warrants.

The Company entered into an agreement with the Placement Agent for assistance with the placement of the June 2018 Financing. The Placement Agent accepted from the Company a 5-year warrant (each, a “June Placement Agent Warrant”) as partial payment for the Placement Agent’s services. The June Placement Agent Warrants allow the purchase of up to 8% of the number of shares of the Company’s common stock determined by dividing the aggregate purchase price of the Preferred Stock purchased by the Conversion Price of the June 2018 Convertible Notes in effect as of the Subscription Date (as defined in the June Placement Agent Warrant) and eight percent (8%) of the number of shares of common stock into which any Unrestricted Principal of the June 2018 Convertible Notes purchased is initially convertible at the Conversion Price in effect as of the Subscription Date, at an exercise price equal to the Conversion Price of the June 2018 Convertible Notes in effect as of the Subscription Date, without regard to any adjustment of the Conversion Price resulting from the anti-dilution provision of the June 2018 Convertible Notes, other than proportionate adjustments to the Conversion Price resulting from stock splits or combinations or similar proportionately applied changes to the Company’s outstanding common stock. During the nine months ended September 30, 2018, the Company issued 3,200 (800,000 pre-split) warrants at an exercise price of $250 ($1.00 pre-split) per share. As of September 30, 2018, the Placement Agent has not elected to exercise any June Placement Agent Warrants. 

Note Activity:

MoviePass Films Senior Notes consist of the following:

	September 30, 2018		December 31, 2017
GFF79 loan from SSS Entertainment	$	150,000	$	-
A Vigilante loan from Film Science, LLC (See Note 16)		2,625,000		-
10 Minutes Gone loan from City National Bank		5,923,250		-
Balance at period end	$	8,698,250	$	-

On September 10, 2018, MoviePass Films entered into a note payable for $7.2 million with annual interest equal to either a) 3.5% plus the prime rate plus 0.25% or b) the greater of (i) 3.5% and (ii) the LIBOR rate plus 2.75%. The note can be prepaid at anytime without penalty through the earlier of the abandonment of the production of the 10 Minutes Gone films or March 15, 2020.

Senior Secured Convertible Notes consist of the following:

	September 30, 2018		December 31, 2017
August 2017 Notes	$	-	$	2,061,072
November 2017 Notes		-		1,550,555
Balance at period end	$	-	$	3,611,627

Under ASC 210-20-45-1, management offset the Senior Secured Convertible Notes by the corresponding investor notes payable to the Company that the Company received as partial payment for the Senior Secured Convertible Notes (collectively, the “Investor Notes”) yet to be funded. As of September 30, 2018, the unfunded portion of the Investor Notes remaining was $49,390,264.

The carrying value of the Senior Secured Convertible Notes is comprised of the following:

	September 30, 2018		December 31, 2017
August 2017 Notes	$	-	$	4,505,440
November 2017 Notes		-		2,943,069
Unamortized discounts				(3,836,882	)
Balance at period end	$	-	$	3,611,627

During the three months ended September 30, 2018, the Investor has converted a total of $40,756,847 in principal and $5,537,785 in interest into 728,934,054 (including 361,245 shares which were split affected (90,311,250 pre-split)) shares of the Company’s common stock and for the nine months ended September 30, 2018, the Investor has converted a total of $64,959,736 in principal and $9,161,604 in interest into 729,185,600 (including 612,792 shares which were split affected (153,198,000 pre-split)) shares of the Company’s common stock.

Warrant Liabilities Activity:

The following is a summary of the Company’s warrant activity during the nine months ended September 30, 2018:

	Warrant Shares			Weighted Average Exercise Price		Weighted Average Remaining Contractual Life Years
Outstanding/exercisable – December 31, 2017		38,526		$	6.04		4.86
Granted		180,819			3.84		4.44
Exercised		(151,877	)		7.17		4.40
Forfeited/cancelled		-			-		-
Outstanding/exercisable – September 30, 2018		67,468			5.43		4.46

XML

Common and Preferred Stock

9 Months Ended

Sep. 30, 2018

Common and Preferred Stock [Abstract]

Common and Preferred Stock

11. Common and Preferred Stock

Common Stock

On February 5, 2018, the Company’s stockholders approved an amendment to the Company’s Certificate of Incorporation to increase the number of authorized shares of common stock from 100,000,000 to 500,000,000 shares (the “Charter Amendment”). Following stockholder approval of the Charter Amendment, a Certificate of Amendment to the Company’s Certificate of Incorporation was filed with the Secretary of State of the State of Delaware on February 8, 2018, at which time the Charter Amendment became effective.

On July 23, 2018, the Company’s stockholders approved an amendment to the Company’s Certificate of Incorporation to increase the number of authorized shares of common stock from 500,000,000 to 5,000,000,000 shares and to increase the total number of authorized shares of capital stock from 502,000,000 to 5,002,000,000 (the “Authorized Share Increase”), of which 2,000,000 shares with a par value of one cent ($0.01) per share shall be designated as “Preferred Stock” and 5,000,000,000 shares with a par value of one cent ($0.01) per share shall be designated as “Common Stock.” Following the stockholder approval, a Certificate of Amendment to the Company’s Certificate of Incorporation was filed with the Secretary of State of the State of Delaware on July 23, 2018, at which time the Authorized Share Increase became effective.

Reverse Stock Split

On July 23, 2018, the Board of Directors approved the Reverse Stock Split and the filing of a Certificate of Amendment to the Certificate of Incorporation of the Company to effectuate the Reverse Stock Split.

A Certificate of Amendment to the Company’s Certificate of Incorporation authorizing the Reverse Stock Split was filed with the Secretary of State of the State of Delaware on July 24, 2018, and the Reverse Stock Split became effective in accordance with the terms of the Certificate of Amendment on July 24, 2018.

The Reverse Stock Split did not affect the number of authorized shares of common stock, which (following the Authorized Share Increase) is 5,000,000,000 shares. A proportionate adjustment was made to (i) the per share exercise price and the number of shares issuable upon the exercise or conversion of the Company’s outstanding equity awards, options and warrants to purchase shares of common stock and outstanding convertible notes and (ii) the number of shares reserved for issuance pursuant to the Company’s 2014 Equity Incentive Plan. Fractional shares were not issued as a result of the Reverse Stock Split; instead, the Board of Directors, determined to effect an issuance of shares to holders that would otherwise be entitled to a fractional share such that any fractional shares were rounded up to the nearest whole number.

Preferred Stock

On June 25, 2018, the Company filed an amended Certificate of Incorporation in the State of Delaware to designate 20,500 shares of preferred stock as the Preferred Stock.

The following is a description of the Preferred Stock:

Dividends

The Preferred Stock does not accrue dividends.

Conversion

The Preferred Stock is not convertible into common stock.

Voting Rights

Each share of Preferred Stock is entitled to 3,205 votes per share on all matters on which holders of common stock are entitled to vote. However, the amount of votes with respect to the Preferred Stock held by any holder, when aggregated with any other voting securities of the Company held by such holder, cannot exceed 19.9% of the Company’s outstanding voting power calculated as of June 21, 2018 (or such greater percentage allowed by Nasdaq without any stockholder approval requirements).

Redemption

From and after the time when the first 15% of the aggregate principal amount of any June 2018 Convertible Notes is paid or converted in accordance with the terms of the June 2018 Convertible Notes, the Company will have the right to redeem all or a portion of the Preferred Stock at a price per share equal to $0.01, payable, at the Company’s option with cash or shares of common stock or, if required by certain beneficial ownership limitations, rights to receive common stock.

Transfer

The shares of Preferred Stock are transferable, subject to limitations, as defined, and applicable securities laws.

Liquidation Preference

Upon any liquidation, dissolution or winding up of the Company, the holders of the shares of Preferred Stock will be entitled to receive in cash out of the assets of the Company, before any amount is paid to the holders of any junior stock, including common stock of the Company, an amount per share of Preferred Stock equal to 100% of the stated value per share (which is equal to $1,000) plus $0.01.

The Certificate of Designations also includes covenants restricting the Company’s ability to take certain actions without the approval of at least a majority of the outstanding shares of the Preferred Stock.

XML

Fair Value of Financial Assets and Liabilities Measured on a Recurring Basis

9 Months Ended

Sep. 30, 2018

Fair Value of Financial Assets and Liabilities Measured on a Recurring Basis [Abstract]

Fair Value of Financial Assets and Liabilities Measured on a Recurring Basis

12. Fair Value of Financial Assets and Liabilities Measured on a Recurring Basis

Financial assets and liabilities measured at fair value on a recurring basis are summarized below and disclosed on the Company’s consolidated balance sheets as of September 30, 2018 and December 31, 2017:

	Amount at		Fair Value Measurement Using
	Fair Value		Level 1		Level 2		Level 3
September 30, 2018
Liabilities
Derivative liability – warrants	$	60,809	$	-	$	-	$	60,809
Total	$	60,809	$	-	$	-	$	60,809
December 31, 2017
Liabilities
Derivative liability – warrants	$	67,288,800	$	-	$	-	$	67,288,800
Derivative liability – conversion feature		4,834,462		-		-		4,834,462
Total	$	72,123,262	$	-	$	-	$	72,123,262

The table below provides a summary of the changes in fair value, including net transfers in and/or out, of all financial assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the nine months ended September 30, 2018:

	Amount
Balance at December 31, 2017	$	72,123,262
Issuances to debt discount		105,223,694
Issuances to interest expense		40,734,226
Reclass from APIC to derivative - February offering		158,944,798
Reclass from APIC to derivative - April offering		33,997,600
Warrants issued in acquisition of Moviefone		5,475,500
Gain on exchange of warrants		(301,487	)
Settlement of warrant liability for March warrant exchange		(12,894,165	)
Settlement of warrant liability for June warrant exchange		(5,202,100	)
Gain on March exchange (cash paid)		(781,195	)
Conversion to paid-in capital		(134,365,641	)
Gain on extinguishment		(60,524,508	)
Change in FMV warrant		(194,058,069	)
Change in FMV derivative		(8,311,106	)
Balance at September 30, 2018	$	60,809

The fair value of the derivative conversion features and warrant liabilities as of September 30, 2018 and December 31, 2017 were calculated using a Monte Carlo option model valued with the following weighted average assumptions:

	September 30, 2018			December 31, 2017
	Amount			Amount
Dividend yield	0%	-	0%		0%
Expected volatility	165%	-	280%	45%	-	270%
Risk free interest rate	2.40%	-	2.93%	1.06%	-	2.20%
Contractual term (in years)	1.14	-	4.55%	0.19	-	5.00
Exercise price	$0.01	-	$1,812.50	$0.25 ($0.001 pre-split)	-	$3,577.50 ($14.310 pre-split)

Changes in the observable input values would likely cause material changes in the fair value of the Company’s Level 3 financial instruments. The significant unobservable input (probability of a down round event) used in the fair value measurement is the estimation of the likelihood of the occurrence of a change in the contractual terms of the financial instruments. A significant increase (decrease) in this likelihood would result in a higher (lower) fair value measurement.

XML

Stock Based Compensation

9 Months Ended

Sep. 30, 2018

Stock Based Compensation [Abstract]

Stock Based Compensation

13. Stock Based Compensation

The Company has a stock-based compensation plan, which is described as follows:

On March 3, 2014, the Board of Directors approved and adopted the Helios and Matheson Analytics Inc. 2014 Equity Incentive Plan (the “2014 Plan”) which the Company’s stockholders approved at the annual stockholders’ meeting on May 5, 2014. The 2014 Plan as amended set aside and reserved 12,000 (3,000,000 pre-split) shares of the Company’s common stock for grant and issuance in accordance with its terms and conditions. Persons eligible to receive awards from the 2014 Plan include employees (including officers and directors) of the Company and its affiliates, consultants who provide significant services to the Company or its affiliates, and directors who are not employees of the Company or its affiliates (the “Participants”). The 2014 Plan permits the Company to issue to Participants qualified and/or non-qualified options to purchase the Company’s common stock, restricted common stock, performance units, and performance shares. The 2014 Plan will terminate on March 3, 2024. The Company’s Board of Directors is responsible for administration of the 2014 Plan and has the sole discretion to determine which Participants will be granted awards and the terms and conditions of the awards granted. The 2014 Plan also provides for an annual automatic increase in the number of shares of common stock authorized for issuance thereunder by the lesser of (A) 12,000 (3,000,000 pre-split) shares of the Company’s common stock or the equivalent of such number of shares after the administrator of the 2014 Plan, in its sole discretion, has interpreted the effect of any stock split, stock dividend, combination, recapitalization or similar transaction; (B) a number of shares of common stock equal to 5% of the Company’s common stock outstanding on January 2nd of each year, and (C) an amount determined by the Company’s Board of Directors. A total of 10,440 (2,610,000 pre-split) shares of common stock remained available for issuance as of September 30, 2018.

As of September 30, 2018, there have not been any stock option grants made pursuant to the 2014 Plan.

From time to time the Board of Directors has also authorized the issuance of shares of common stock outside of the 2014 Plan to consultants and employees for services rendered. During the three and nine months ended September 30, 2018 the Company awarded 0 and 2,027 (506,750 pre-split) shares, respectively, to consultants who provided services to the Company. In connection with such awards (including awards granted in 2017) the Company recorded stock compensation expense of $232,188 and $5,913,349, which is included in selling, general and administrative expenses for the three and nine months ended September 30, 2018, respectively. Unamortized stock compensation costs related to these awards at September 30, 2018 of $250,333 will be recognized over the anticipated service period during the balance of 2018. The Company issued 0 and 4,809 (1,202,167 pre-split) shares of common stock to employees and consultants for services provided during 2017 during the three and nine months ended September 30, 2018, respectively. The Company recognized expense in 2017 of $15,631,605, with respect to such awards, and also recorded a liability on the balance sheet at December 31, 2017, related to these costs which were settled in shares.

The shares historically issued both pursuant to the 2014 Plan and outside the 2014 Plan have been fully vested in certain cases and subject to vesting conditions in other cases; they generally contain resale or transfer restrictions pursuant to lock up agreements ranging from 18 to 24 months from the award date. 

The Company generally recognizes stock compensation expense on the grant date and over the period of vesting or period that services will be provided. Compensation associated with shares issued or to be issued to consultants and other non-employees is recognized over the expected service period beginning on the measurement date which is generally the time the Company and the service provider enter into a commitment whereby the Company agrees to grant shares in exchange for the services to be provided. 

MoviePass, Inc.

MoviePass maintained the 2011 Equity Incentive Plan (the “2011 Plan”) during the nine months ended September 30, 2018. The 2011 Plan provides for the grant of up to 95,000,000 shares of common stock for issuance as non-statutory or incentive stock options, stock appreciation rights, restricted stock and restricted stock units to the employees, officers, directors, or consultants of MoviePass. The 2011 Plan is administered by the Board of Directors of MoviePass, which selects the individuals to whom options will be granted, and determines the number of options to be granted and the term and exercise price of each option. Stock options granted pursuant to the terms of the 2011 Plan generally cannot be granted with an exercise price of less than 100% of the fair market value on the date of grant. The term of the options granted under the 2011 Plan cannot be greater than 10 years. Options vest at varying rates generally over three to five years along with performance-based options.

For the nine months ended September 30, 2018, MoviePass granted 39,809,175 stock options at an exercise price of $0.43 per share.

The following table summarizes stock option activity under the MoviePass share-based plan for the nine months ended September 30, 2018:

			Weighted Average
	Options for				Remaining		Aggregate
	Common Shares		Exercise Price		Contractual Term		Intrinsic Value
Outstanding as of December 31, 2017		28,396,428	$	0.14		9.13	$	8,313,684
Granted		39,809,175		0.43
Exercised		-
Forfeited, cancelled, expired		-
Outstanding as of September 30, 2018		68,205,603	$	0.31		8.93	$	6,760,947
Vested and exercisable at September 30, 2018		27,476,989	$	0.20		8.58	$	5,042,235

The weighted average grant date fair value per share of stock options granted during the nine months ended September 30, 2018 was $0.16. No options were exercised during the nine months ended September 30, 2018.

The Company recognized share-based payment expense associated with stock options of $1,170,726 and $4,257,970 for the three and nine months ended September 30, 2018, respectively.

The following table summarizes the weighted-average assumptions used to compute the fair value of options granted to employees:

	Nine months ended
	September 30, 2018
Risk-free interest rate		2.50	%
Expected life of options – years		5.79
Expected stock price volatility		37.20	%
Expected dividend yield		0.00	%

There were no options granted to the Company’s Board of Directors or third parties during the nine months ended September 30, 2018.

XML

Concentration of Credit Risk

9 Months Ended

Sep. 30, 2018

Concentration of Credit Risk [Abstract]

Concentration of Credit Risk

14. Concentration of Credit Risk

Consulting

For the three months ended September 30, 2018 and September 30, 2017, respectively, 3 customers accounted for 85.0% and 4 customers accounted for 92.8% of consulting revenues.

For the nine months ended September 30, 2018 and September 30, 2017, respectively, 4 customers accounted for 92.3% and 4 customers accounted for 88.9% of consulting revenues.

As of September 30, 2018 and December 31, 2017, respectively, 7 customers accounted for 100.0% and 4 customers accounted for 62.6% of consulting accounts receivables.

As of September 30, 2018 and December 31, 2017, respectively, 5 vendors accounted for 90.8% and 3 vendors accounted for 82.7% of consulting accounts payables.

Technology

As of September 30, 2018 and December 31, 2017, respectively, 5 vendors accounted for 82.3% and 3 vendors accounted for 60.8% of technology accounts payables.

Subscription and Marketing, Promotional Services, and Films

As of September 30, 2018 and December 31, 2017, respectively, 4 customers accounted for 96.7% of subscription and marketing, promotional services, and films accounts receivables and 2 customers accounted for 100.0% of subscription and marketing, promotional services, and films accounts receivables.

As of September 30, 2018 and December 31, 2017, respectively, 6 vendors accounted for 51.8% subscription and marketing, promotional services, and films accounts payables and 1 vendor accounted for 41.0% of subscription and marketing, promotional services, and films accounts payables.

XML

Commitments and Contingencies

9 Months Ended

Sep. 30, 2018

Commitments and Contingencies [Abstract]

Commitments and Contingencies

15. Commitments and Contingencies

The Company’s operating lease commitments as of September 30, 2018 are comprised of the following:

	Payments due by period
Less than 1 year	$	74,094
1 to 3 years		548,808
3 to 5 years		347,985
Thereafter		-
Total	$	970,887

The Company’s executive office is located at the Empire State Building, 350 Fifth Avenue, Suite 7520, New York, New York 10118. The Company’s executive office is located in a leased facility with a term expiring on June 30, 2022. Zone leases office space at 444 Brickell Avenue, Miami Florida with a term expiring on April 30, 2020. Prior to August 1, 2018, MoviePass leased space at WeWork on a month to month basis at 175 Varick Street New York, NY 10014. As of August 1, 2018, MoviePass has relocated to WeWork at 135 Madison Avenue New York, NY 10016 under a one-year lease agreement effective July 9, 2018. In addition, the Company’s Indian subsidiary has an office in Bangalore, India at a leased facility located at 3rd Floor, Beta Block, Number 7 Sigma Tech Park, Varthur Kodi, Bangalore 560066. This lease was amended on September 26, 2017 to extend the duration of the lease until September 30, 2019.

The Company’s executive office lease is subject to escalations based on increases in real estate taxes and operating expenses, all of which are charged to rent expense. Rent expense for the three months ended September 30, 2018 and 2017 was approximately $585,702 and $81,051, respectively, and $1,046,790 and $215,068 for the nine months ended September 30, 2018 and 2017, respectively. 

In April 2017, Zone signed a three-year lease agreement for office space at 444 Brickell Avenue, Miami Florida. The lease term began in May 2017 and expires in April 2020 and requires a monthly rent payment of $5,026 for the first 12 months, $5,177 for the next 12 months, and $5,332 for the last 12 months of the lease.

As of September 30, 2018, the Company does not have any “Off Balance Sheet Arrangements”.

Legal Proceeding:

On August 2, 2018, Jeffrey Chang, acting on behalf of himself and a putative class of persons who purchased or otherwise acquired the Company’s common stock between August 15, 2017, and July 26, 2018, filed a class action complaint in the U.S. District Court for the Southern District of New York against the Company and two of its executive officers, Theodore Farnsworth and Stuart Benson (the “August 2, 2018 Complaint”). Jeffrey Chang v. Helios and Matheson Analytics Inc., et. al., Case No. 1:18-cv-6965. The August 2, 2018 Complaint alleges, among other things, that the Company’s statements to the market were materially false or misleading. The plaintiffs assert claims under Sections 10(b) and 20(a) of the Exchange Act and Rule 10b-5.

On August 13, 2018, Jeffrey Braxton, acting on behalf of himself and a putative class of persons who purchased or otherwise acquired the Company’s common stock between August 15, 2017, and July 26, 2018, filed a class action complaint in the U.S. District Court for the Southern District of New York against the Company and two of its executive officers, Theodore Farnsworth and Stuart Benson (the “August 13, 2018 Complaint”). Jeffrey Braxton v. Helios and Matheson Analytics, Inc. et al., Case No. 1:18-cv-07242-UA. The August 13, 2018 Complaint makes substantially identical allegations as the August 2, 2018 Complaint.

Motions have been filed to consolidate the cases and for the appointment of lead plaintiff and lead plaintiffs’ counsel. The motions are scheduled to be argued November 16, 2018. The Company intends to vigorously defend these matters and believes that they are without merit. Given the preliminary status of the litigation, it is difficult to predict the likelihood of an adverse outcome or estimate the amount or range of any reasonably possible losses, if any.

On September 20, 2018, Yu Chen, a purported stockholder of the Company, filed a complaint in the Supreme Court of the State of New York, County of New York, Index No. 654686/2018, derivatively on behalf of the Company against Theodore Farnsworth, Stuart Benson, Muralikrishna Gadiyaram, Prathap Singh, Gavriel Ralbag, and Carl Schramm, and the Company as a nominal defendant (the “September 20, 2018 Complaint”). The September 20, 2018 Complaint alleges claims for breach of fiduciary duty and unjust enrichment against the individual defendants. The Plaintiff has agreed to stay the action pending a decision on an anticipated motion to dismiss the consolidated complaint that is expected to be filed in the securities actions discussed above.

XML

Transactions with Related Parties

9 Months Ended

Sep. 30, 2018

Transactions with Related Parties [Abstract]

Transactions with Related Parties

16. Transactions with Related Parties

Gadiyaram Agreements

On October 5, 2017, the Company entered into a consulting agreement (the “Consulting Agreement”) with Mr. Muralikrishna Gadiyaram (the “Consultant”), a director of the Company, for a period of two years from the agreement date (the “Consulting Term”). The Consulting Agreement formalized, on a compensatory basis, the arrangement that was in place for performance without compensation by the Consultant for consulting services since the acquisition of Zone in November of 2016. Mr. Gadiyaram will continue to provide guidance to the Company and Zone relating to the further development of their respective businesses and technologies. In addition to the aforementioned services, if requested by the Company, Mr. Gadiyaram will provide guidance with respect to the development of any businesses or technologies that the Company or Zone may acquire during the Consulting Term, including, but not limited to, MoviePass. Pursuant to the Consulting Agreement, the Consultant will receive fees in the amount of $18,750 per month in cash. Such fees have been accrued and paid by the Company since January 1, 2017. The amount payable to Mr. Gadiyaram as of September 30, 2018 was approximately $18,750.

On May 22, 2018, the Company and Helios and Matheson Information Technology, Ltd (“HMIT”), an Indian corporation, owned and controlled by Mr. Muralikrishna Gadiyaram, a director of the Company executed a letter agreement whereby HMIT agreed not to sell HMNY shares held by HMIT until after April 15, 2019 (the “Lockup Agreement”). In exchange for such Lockup Agreement the Company agreed to issue to HMIT 2,000 (500,000 pre-split) shares of HMNY stock. As of September 30, 2018, the shares issuable to HMIT had not yet been issued and accordingly, the Company accrued $225,000 with respect thereto, representing the value of the shares on May 22, 2018. 

Emmett Furla Oasis Films  (“EFO”)

On July 27, 2018, the Company entered into an assignment agreement with Georgia Film Fund 50, LLC, a company owned and operated by EFO, for the assignment of the rights, title and interest in the film The Row in exchange for a payment in the amount of $525,000. At September 30, 2018, $400,000 of the payment due in connection with the assignment agreement was included in amounts due to related parties on the balance sheet.

On August 28, 2018, MoviePass Films entered into an assignment agreement with Georgia Film Fund 56, LLC, a company owned and operated by EFO, for all of the rights, title and interest in the film A Vigilante, including all rights associated with distribution agreements in connection therewith. MoviePass Films agreed to pay $3,499,400 in connection with the assignment of the rights granted, in satisfaction of obligations of EFO with respect to the film. The terms of the related note payable provide for annual interest of 20% and the amounts are due in September 2020.  As of September 30, 2018, $2,625,000 remains payable with respect thereto and is included in notes payable on the balance sheet.

On September 25, 2018, Randall Emmett, Co-CEO of MoviePass Films advanced to MoviePass Films $100,000, which is included in due to related parties on the balance sheet at September 30, 2018. On October 4^, 2018 this amount was repaid in full.

In September 2018, George Furla and Randall Emmett, Co-CEO’s of MoviePass Films, entered into equity finance agreements with Georgia Film Fund 79, LLC, a wholly owned subsidiary of MoviePass Films, for the partial funding of the production of the film 10 Minutes Gone, in the amounts of $400,000 and $250,000, respectively. These amounts are included in due to related parties on the balance sheet at September 30, 2018. The principal amounts are repayable from the proceeds of the film plus interest at 20% per annum. The maximum interest payable with respect to these equity finance agreements is subject to a two year cap.

XML

Provision for Income Taxes

9 Months Ended

Sep. 30, 2018

Provision for Income Taxes [Abstract]

Provision for Income Taxes

17. Provision for Income Taxes

The Company had a tax provision for the three months ended September 30, 2018 and 2017 of $10,283 and $(2,747), respectively, and $46,953 and $39,110 for the nine months ended September 30, 2018 and 2017, respectively. Tax for both the nine months ended September 30, 2018 and 2017 was comprised of minimum state taxes and a provision for tax in respect to taxes incurred by the Company’s Indian subsidiary.

The Company’s provision for income taxes for the nine months ended September 30, 2018 and 2017 is based on the estimated annual effective tax rate method prescribed by ASC 740-270, plus discrete items. The difference between the Company’s effective tax rates for the nine months ended September 30, 2018 and 2017 and the US statutory tax rates of 21% and 35%, respectively, primarily relates to changes in the valuation allowances against deferred tax assets, non-deductible expenses, state income taxes (net of federal income tax benefit), the effect of taxes on foreign earnings, and changes to provisional amounts recorded for certain aspects of the Act. 

In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that either some portion or the entire deferred tax asset will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income, tax-planning strategies, and available carry-back capacity in making this assessment, therefore, the Company has recorded a valuation allowance on its net domestic deferred tax assets, excluding deferred tax liabilities that are not expected to serve as a source of income for the recognition of deferred tax assets due to their indefinite reversal period (tax amortization of goodwill). 

As of September 30, 2018, the Company did not record any tax liabilities for uncertain income tax positions and concluded that all of its tax positions are either certain or are not material to the Company’s financial statements. The Company is currently not under audit in any jurisdiction in which it conducts business.

XML

Segment Reporting

9 Months Ended

Sep. 30, 2018

Segment Reporting [Abstract]

Segment Reporting

18. Segment Reporting

Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker, or decision–making group, in deciding how to allocate resources and in assessing performance. The Company’s chief operating decision–making group is composed of the Chief Executive Officer and Chief Financial Officer. The Company operates in three segments, Consulting, Technology, and Subscription and Marketing, Promotional Services, and Film. During the three and nine months ended September 30, 2018, the Company reported three segments. The Company allocates corporate expenses to the segments for purposes of individually measuring operating segments. Corporate expenses are allocated on the basis of each segment’s relative earnings prior to the allocation.

The Company evaluates performance of its operating segments based on revenue and operating loss. The following table summarizes the Company’s segment information for the following balance sheet dates presented, and for the three and nine months ended September 30, 2018 and 2017:

	For the Nine Months Ended September 30,
	2018			2017
Consulting
Revenue	$	2,471,223		$	3,672,036
Cost of revenue		2,023,707			2,969,357
Gross margin		447,516			702,679
Total operating expenses		19,908,946			6,280,032
Income/(loss) from operations		(19,461,430	)		(5,577,353	)
Total other income/(expense)		73,915,297			(44,914,576	)
Provision for income taxes		(8,826	)		39,110
Total net income/(loss)	$	54,445,041		$	(50,531,039	)
Technology
Revenue	$	-		$	-
Cost of revenue		-			-
Gross margin		-			-
Total operating expenses		2,871,608			4,601,330
Income/(loss) from operations		(2,871,608	)		(4,601,330	)
Total other income/(expense)		70			(47,220	)
Provision for income taxes		-			-
Total net income/(loss)	$	(2,871,538	)	$	(4,648,550	)
Subscription and Marketing, Promotional Services, and Films
Revenue		202,479,613			-
Cost of revenue		422,347,371			-
Gross margin		(219,867,758	)		-
Loss on goodwill		38,524,016
Total other operating expenses		40,060,927			-
Income/(loss) from operations		(298,452,701	)		-
Total other income/(expense)		-			-
Provision for income taxes		(38,127	)		-
Total net income/(loss)	$	(298,490,828	)	$	-

	As of September 30,		As of  December 31,
	2018		2017
Consulting
Cash and cash equivalents	$	3,674,904	$	569,886
Accounts receivable	$	290,561	$	332,753
Prepaid expenses and other current assets	$	638,522	$	3,382,127
Property and equipment	$	151,379	$	96,464
Intangible assets	$	805,482	$	-
Goodwill	$	-	$	-
Deposits and other assets	$	128,232	$	129,119
Accounts payable and accrued expenses	$	4,475,771	$	2,088,867
Liabilities to be settled in stock	$	5,669,263	$	20,875,045
Convertible notes payable	$	-	$	3,611,627
Warrant liability	$	60,809	$	67,288,800
Derivative liability	$	-	$	4,834,462
Technology
Cash and cash equivalents	$	160,124	$	21,933,765
Accounts receivable	$	-	$	-
Unbilled receivables	$	-	$	-
Prepaid expenses and other current assets	$	3,333	$	21,666
Property and equipment	$	81,613	$	95,301
Intangible assets	$	1,748,388	$	2,829,295
Goodwill	$	-	$	-
Deposits and other assets	$	10,052	$	10,052
Accounts payable and accrued expenses	$	164,447	$	607,622
Liabilities to be settled in stock	$	319,100	$	445,660
Convertible notes payable	$	-	$	-
Warrant liability	$	-	$	-
Derivative liability	$	-	$	-
Deferred revenue	$	-	$	-
Subscription and Marketing, Promotional Services, and Films
Cash and cash equivalents	$	1,015,944	$	2,445,742
Accounts receivable	$	30,432,024	$	27,137,466
Unbilled receivables	$	-	$	-
Prepaid expenses and other current assets	$	2,827,790	$	154,018
Property and equipment	$	146,674	$	42,270
Intangible assets	$	27,543,529	$	25,707,487
Goodwill	$	49,148,120	$	79,137,177
Deposits and other assets	$	496,888	$	8,000
Accounts payable and accrued expenses	$	13,051,042	$	10,447,514
Liabilities to be settled in stock	$	-	$	-
Note Payable	$	8,698,250
Convertible notes payable	$	-	$	-
Warrant liability	$	-	$	-
Derivative liability	$	-	$	-
Deferred revenue	$	27,035,060	$	54,425,630
Due to Related Parties	$	1,150,000	$	-
Investment in films	$	13,403,433	$	-

XML

Subsequent Events

9 Months Ended

Sep. 30, 2018

Subsequent Events [Abstract]

Subsequent Events

19. Subsequent Events

October Amendment and Exchange Agreement

On October 4, 2018, the Company entered into the October Exchange Agreement, with the holder of a June 2018 Convertible Note having an outstanding principal amount of approximately $68,750,000 for the purpose of (i) netting the June 2018 Investor Note issued by such holder to the Company having an aggregate principal amount of approximately $68,000,000 against such holder’s June 2018 Convertible Note and (ii) following such netting transaction, exchanging the remaining outstanding amount payable under such holder’s June 2018 Convertible Note for a new non-convertible Senior Note issued by the Company to such holder (the “New Non-Convertible Note”) in an aggregate principal amount of $20,400,000, subject to reduction as provided in the New Non-Convertible Note. As a result such holder’s June 2018 Convertible Note and the corresponding June 2018 Investor Note issued by such holder were each cancelled and became null and void.

Following the consummation of the transactions contemplated by the October Exchange Agreement and the netting of the other June 2018 Investor Notes by the other holders of the June 2018 Investor Notes against their corresponding June 2018 Convertible Notes, all of the June 2018 Convertible Notes have been cancelled.

Under the October Exchange Agreement, at any time on or prior to the later of (i) the date that the New Non-Convertible Note no longer remains outstanding and (ii) the first anniversary of the date of the October Exchange Agreement, the Company and its subsidiaries may not effect any Subsequent Placement (as defined in the November Securities Purchase Agreement (as defined below)) unless the Company first offers to issue and sell to, or exchange with, the holder of the New Non-Convertible Note, at least 25% of the securities offered in the Subsequent Placement, subject to the terms and conditions of the October Exchange Agreement.

Amendment to November Securities Purchase Agreement

Pursuant to the October Exchange Agreement, the Securities Purchase Agreement between the Company and certain institutional investors pursuant to which the Company issued the November 2017 Notes (the “November Securities Purchase Agreement”) was amended to reduce the number of shares of common stock of the Company required to be reserved for issuance under the November 2017 Notes to 100% of the maximum number of shares of common stock of the Company issuable upon conversion of the November 2017 Notes.

Amendment to January Securities Purchase Agreement

Pursuant to the October Exchange Agreement, the January Securities Purchase Agreement was amended to reduce the number of shares of common stock of the Company required to be reserved for issuance under the January 2018 Notes to 125% of the maximum number of shares of common stock of the Company issuable upon conversion of the January 2018 Notes.

New Non-Convertible Note

On October 4, 2018, the Company issued the New Non-Convertible Note. The New Non-Convertible Note bears interest at a rate of 3% per annum, capitalized quarterly. The New Non-Convertible Note is unsecured and not convertible into equity securities of the Company. Unless earlier redeemed, the New Non-Convertible Note will mature on May 29, 2020.

As long as no Event of Default (as defined in the New Non-Convertible Note) has occurred, the Company has the right to redeem the New Non-Convertible Note at any time on or prior to the nine-month anniversary of the issuance of the New Non-Convertible Note for 50% of the principal being redeemed and 100% of the accrued and unpaid interest and late charges, if any. After the nine-month anniversary of the issuance of the New Non-Convertible Note, the Company has the right to redeem the New Non-Convertible Note at any time for 100% of the principal being redeemed and 100% of the accrued and unpaid interest and late charges, if any. If the Company does not redeem the New Non-Convertible Note within such nine-month period, the New Non-Convertible Note will amortize monthly in cash for, from June 28, 2019, four monthly payments of $850,000 per month (plus accrued and unpaid interest, including any capitalized interest) and, commencing on October 30, 2019, eight monthly payments of $2,125,000 (plus accrued and unpaid interest, including any capitalized interest). Upon an Event of Default, the Company must redeem the New Non-Convertible Note in cash at a price equal to, if the Event of Default occurs on or prior to the nine-month anniversary of the issuance of the New Non-Convertible Note, and there is neither a Primary Covenant Event of Default nor a Bankruptcy Default (each as defined in the New Non-Convertible Note), 50% of the principal being redeemed and 100% of the accrued and unpaid interest and late charges, if any, in each case, multiplied by a redemption premium. If the Event of Default occurs after the nine-month anniversary of the issuance of the New Non-Convertible Note, or there exists either a Primary Covenant Event of Default or a Bankruptcy Default, then the Company must redeem the New Non-Convertible Note in cash at a price equal to 100% of the principal being redeemed and 100% of the accrued and unpaid interest and late charges, if any, in each case, multiplied by a redemption premium.

If the holder of the New Non-Convertible Note participates in a subsequent offering by the Company or prepays the January 2018 Investor Notes or November 2017 Investor Notes issued by such holder to the Company, then 14.5% of the cash proceeds paid (or payable) by such holder in such applicable transaction will be used to pay down the New Non-Convertible Note on a dollar-for-dollar basis. Each such payment amount will reduce the scheduled amortization payments on a reverse basis (i.e. last amortization reduced first).

Special Meeting of Stockholders

The Special Meeting of Stockholders scheduled to be held on November 14, 2018 to provide stockholders with an opportunity to vote on the proposed reverse stock split in a ratio of 1 share-for-2 shares up to a ratio of 1 share-for-500 shares has been cancelled. The Company was presenting the reverse stock split proposal in an effort to regain compliance with Rule 5550(a)(2). Since the Company will not be able to effect a reverse stock split ten business days prior to December 18, 2018, absent an extension by The Nasdaq Capital Market (of which there can be no assurance) the Company believes that our common stock will be subject to delisting from The Nasdaq Capital Market, which would adversely impact the liquidity and marketability of our common stock.

If the Company does not regain compliance with Rule 5550(a)(2) by December 18, 2018, the Company may be afforded a second 180-calendar day period to regain compliance. To qualify, the Company would be required to meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, except for the Minimum Bid Price Requirement. In addition, the Company would be required to notify Nasdaq of its intent to cure the deficiency during the second compliance period, which may include, if necessary, implementing a reverse stock split. If the Company is afforded additional time to regain compliance (of which there can be no assurance), the Board of Directors of the Company plans to call a special meeting as soon as practicable with a new record date for the Company’s stockholders to vote on a reverse stock split in an effort to regain compliance with Rule 5550(a)(2). Even if the Company is eligible for an additional compliance period, Nasdaq may decline to grant the Company an additional compliance period in its discretion.

If the Company does not regain compliance with Rule 5550(a)(2) by December 18, 2018, and is either not eligible for an additional compliance period at that time or Nasdaq declines to grant the Company an additional compliance period in Nasdaq’s discretion, the Staff will provide notice to the Company that its securities will be subject to delisting. At that time, the Company may appeal the Staff’s delisting determination to Panel. The Company would remain listed pending the Panel’s decision.

XML

Summary of Significant Accounting Policies (Policies)

9 Months Ended

Sep. 30, 2018

Summary of Significant Accounting Policies [Abstract]

Revenue Recognition

Revenue Recognition

ASC 606 Revenue from Contracts with Customers (“ASC 606”)

The Company adopted the new revenue standard, ASC 606, using the modified retrospective method with respect to all non-completed contracts as of January 1, 2018. This method required retrospective application of the new accounting standard to all unfulfilled contracts that were outstanding as of January 1, 2018. Revenues and contract assets and liabilities for contracts completed prior to January 1, 2018 are presented in accordance with ASC 605.

The Company has determined that there were no adjustments required with respect to the adoption of ASC 606 with respect to any prior periods.

Disaggregation of Revenue

	Three Months Ended September 30,				Nine Months Ended  September 30,
	2018		2017		2018		2017
	(Unaudited)		(Unaudited)		(Unaudited)		(Unaudited)
Revenues:
Consulting	$	802,114	$	1,173,023	$	2,471,223	$	3,672,036
Subscription		78,921,951		-		198,488,038		-
Marketing, promotional services, and films		1,615,177		-		3,991,575		-
Total revenues	$	81,339,242	$	1,173,023	$	204,950,836	$	3,672,036

The following is a description of the principal activities from which the Company generates revenue, including from consulting customers and subscribers.

Consulting Revenue

Consulting revenues are recognized as services are provided. The Company primarily provides consulting services under time and material contracts, whereby revenue is recognized as hours and costs are incurred. Clients for consulting revenues are billed on a weekly or monthly basis. Revenues from fixed fee contracts are recorded when work is performed on the basis of the proportionate performance method, which is based on costs incurred to date relative to total estimated costs. Any anticipated contract losses are estimated and accrued at the time they become known and estimable. Unbilled accounts receivables represent amounts recognized as revenue based on services performed in advance of customer billings. Revenue from sales of software licenses is recognized upon delivery of the software to a customer because future obligations associated with such revenue are insignificant.

Subscription Revenue

Subscription revenue consists primarily of subscription fees for monthly, quarterly, semi-annual or annual subscriptions. Revenue from subscriptions is recognized on a straight-line basis when the performance obligations to provide each service for the period are satisfied, which is over time as subscription services can be used by subscribers at any time. Consumers purchasing subscriptions generally pay on an annual or monthly basis, and any prepaid amounts for subscription services are recorded as deferred revenue and amortized to revenue evenly over the service period which begins once a subscriber has activated his or her subscription.

Marketing, Promotional Services, and Films

The Company also generates revenue from marketing services primarily related to major motion picture releases. Marketing revenue is generated through e-mail and digital advertising to the Company’s subscriber base and pursuant to a contract for such services with the movie distributor. Such agreements are short-term and are generally represented by a fully executed customer agreement. Revenue is recognized as performance obligations are satisfied which generally occurs within a month of the date the contract begins. Payment terms on marketing agreements vary and payment is generally due once the performance obligations have been satisfied. Revenue from our participation in the theatrical release of feature films is recognized as earned based on our share of the ultimate expected revenue.

Deferred Revenue

Subscription fees are generally paid in advance by credit card through merchant processors. Subscription fees received in advance of completion of the performance obligations are recorded as deferred revenue until such time the services are provided to the customer.

Goodwill

Goodwill

The Company reviews goodwill for impairment, typically during the fourth quarter of each year, and periodically analyzes whether any indicators of impairment have occurred. The Company performs reviews of each of its reporting units that have goodwill balances. During the third quarter of 2018, due to a significant decline in its MoviePass subscribers resulting primarily from substantial changes made to our service offerings during the third quarter, the Company deemed it more appropriate to assess impairment of goodwill and corresponding intangible assets of the MoviePass reporting unit as of September 30, 2018. In conjunction with the events occurring in the third quarter of 2018, the Company updated its long-term business plan, which was used as the basis for estimating the future cash flows of its reporting units. That plan considered then current economic conditions and trends, estimated future operating results, the Company’s views of growth rates and then-anticipated future economic and regulatory conditions.

The Company determined that the fair value of the MoviePass reporting unit was below its carrying value. Therefore, the Company conducted step two of the impairment test for the MoviePass reporting unit and determined the carrying value of goodwill in the MoviePass reporting unit exceeded its implied fair value, resulting in an impairment charge of $38,524,016. This was as a result of reduced financial projections for the MoviePass reporting unit, due to, among other things, lower than expected actual financial results from this business due to a lower number of subscribers resulting from changes in the MoviePass service offering, which resulted in diminished financial performance relative to its original expectations. Given the foregoing, the Company determined there was greater uncertainty in achieving its prior financial projections and so applied a higher discount rate for purposes of its goodwill impairment analysis. Additionally, modifications of certain cashflow assumptions to reflect the current economic conditions as well as market participant levels were made. These assumptions along with a higher discount rate negatively affected the fair value of the MoviePass reporting unit.

Generally, fair value is determined using a multiple of earnings, or discounted projected future cash flows, and is compared to the carrying value of a reporting unit for purposes of identifying potential impairment. Projected future cash flows are based on management’s knowledge of the current operating environment and expectations for the future. Goodwill impairment is recognized for any excess of the carrying value of the reporting unit’s goodwill over the its estimated fair value, not to exceed the total amount of goodwill allocated to the reporting unit.

The identification of relevant events and circumstances and how these may impact a reporting unit’s fair value or carrying amount involve significant judgments by management. These judgments include the consideration of the general economic outlook, industry and market considerations, cost factors, overall financial performance, events which are specific to the Company, and trends in the market price of the Company’s common stock. Each factor is assessed to determine whether it impacts the impairment test as well as the magnitude of any such impact.

Intangible Assets, net

Intangible Assets, net

Intangible assets consist of customer relationships, technology, trademarks, broker relationships and patents. Applicable long-lived assets are amortized or depreciated on the straight-line method over their useful lives ranging from three to twelve years.

The Company recorded amortization expense of $1,363,638 and $430,716 for the three months ended September 30, 2018 and 2017, respectively, and $3,977,211 and $1,284,018 for the nine months ended September 30, 2018 and 2017, respectively.

The Company monitors the carrying value of long-lived assets for potential impairment each quarter based on whether certain triggering events have occurred. These events include current period losses or a projection of continuing losses or a significant decrease in the market value of an asset. When a triggering event occurs, an impairment calculation is performed, comparing projected undiscounted future cash flows, utilizing current cash flow information and expected growth rates, to the respective carrying value. If the Company identifies impairment for long-lived assets to be held and used because the carrying value is greater than the projected undiscounted cash flows, the Company compares the assets’ current carrying value to the assets’ fair value. Fair value is based on current market values or discounted future cash flows. The Company records impairment when the carrying value exceeds the assets’ fair value. With respect to owned property and equipment held for disposal, the value of the property and equipment is adjusted to reflect recoverable values based on previous efforts to dispose of similar assets and current economic conditions. Impairment is recognized for the excess of the carrying value over the estimated fair market value, reduced by estimated direct costs of disposal.

The Company evaluated the MoviePass intangible assets in connection with the MoviePass impairment analysis and did not record any impairment charges in regard to definite-lived intangible assets for the three and nine months ended September 30, 2018 and 2017.

Research and Development

Research and Development

Research and development costs are charged to operations when incurred and are included in operating expenses.

Stock Based Compensation

Stock Based Compensation

The Company follows the fair value recognition provisions in ASC Topic 718, Stock Compensation (“ASC 718”) and the provisions of ASC Topic 505, Equity (“ASC 505”) for stock-based transactions with non-employees. Stock based compensation expense for employees is recognized over the requisite service period based on the estimated grant-date fair value of the awards. The Company accounts for forfeitures as they occur. The grant date is the date at which an employer and employee reach a mutual understanding of the key terms and conditions of a share-based payment award. Stock-based compensation for non-employee stock options is recorded over the vesting period and remeasured at fair value until they vest.

Investment in Films

Investment in Films

The Company capitalizes film production costs, including direct costs and production overhead, net of production incentives, for films in production and the cost of acquiring copyright interests in or participation rights to completed but not released films. The Company amortizes film production costs, including the costs to acquire interests or participation rights to direct operating expenses, using the individual film forecast computation method, which amortizes the costs for an individual film in the proportion that the current year’s revenues bear to management’s estimates of the ultimate revenue expected to be recognized from the distribution, exhibition or sale of such film. Ultimate revenue includes estimates over a period not to exceed ten years following the date of initial release of the motion picture. As of September 30, 2018, unamortized capitalized investment in film costs were $13,403,433. This balance represents total capitalized costs for the period of $17,212,981 less $3,809,548 of costs related to amortization and impairments.

Due to the inherent uncertainties involved in making such estimates of ultimate revenues and expenses, these estimates may differ from actual results and are likely to differ to some extent in the future from actual results. In addition, in the normal course of our business, some films and titles are more successful or less successful than anticipated. Management regularly reviews and revises when necessary its ultimate revenue and cost estimates, which may result in a change in the rate of amortization of film costs and/or write-down of all or a portion of the unamortized costs of the film to its estimated fair value. Management estimates the ultimate revenue based on experience with similar titles or title genre, the general public appeal of the cast, actual performance (when available) at the box office or in markets currently being exploited, and other factors such as the quality and acceptance of motion pictures or programs that our competitors release into the marketplace at or near the same time, critical reviews, general economic conditions and other tangible and intangible factors, many of which we do not control and which may change.

An increase in the estimate of ultimate revenue will generally result in a lower amortization rate and, therefore, less film amortization expense, while a decrease in the estimate of ultimate revenue will generally result in a higher amortization rate and, therefore, higher film amortization expense, and could also periodically result in an impairment requiring a write-down of the film cost to the title’s fair value. These write-downs are included in amortization expense within cost of revenues in our consolidated statements of operations.

Investment in films is stated at the lower of amortized cost or estimated fair value. Additional amortization is recorded in the amount by which the unamortized costs exceed the estimated fair value of the film. Estimates of future revenue involve measurement uncertainty and it is therefore possible that reductions in the carrying value of investment in films may be required as a consequence of changes in our future revenue estimates.

Film Production Incentives

Film Production Incentives

The Company has access to various governmental programs that are designed to promote film production within the United States. Tax credits earned with respect to expenditures on qualifying film production activities, including qualifying capital projects, are included as an offset to the related asset or as an offset to production expenses when we have reasonable assurance regarding the realizable amount of the tax credits.

The unamortized balance includes $2,376,451 representing our investment in participation rights in completed and released films and $11,026,982 in film costs for completed and partially completed films that have yet to be released.

Fair Value Measurements

Fair Value Measurements

ASC Topic 820, Fair Value Measurement and Disclosures, defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. This topic also establishes a fair value hierarchy which requires classification based on observable and unobservable inputs when measuring fair value. There are three levels of inputs that may be used to measure fair value:

Level 1: Observable inputs such as quoted prices (unadjusted) in an active market for identical assets or liabilities.

Level 2: Inputs other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.

Level 3: Unobservable inputs that are supported by little or no market activity; therefore, the inputs are developed by the Company using estimates and assumptions that the Company expects a market participant would use, including pricing models, discounted cash flow methodologies, or similar techniques.

The carrying value of the Company’s financial instruments, including cash and cash equivalents, accounts receivable and accounts payable and accrued expenses approximate fair value because of the short-term maturity of these financial instruments.

The liabilities in connection with the conversion and make-whole features included within certain of the Company’s convertible notes payable and warrants are each classified as a level 3 liability.

Derivative Instruments

Derivative Instruments

The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates its convertible notes and warrants to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for in accordance with Paragraph 815-10-05-4 of the FASB ASC and Paragraph 815-40-25 of the Codification. The result of this accounting treatment is that the fair value of the embedded derivative is marked-to-market each balance sheet date and recorded as a liability. In the event that the fair value is recorded as a liability, the change in fair value is recorded in the statements of operations as other income or expense. Upon conversion or exercise of a derivative instrument, the instrument is marked to fair value at the conversion date and then that fair value is reclassified to equity.

In circumstances where the embedded conversion option in a convertible instrument is required to be bifurcated and there are also other embedded derivative instruments in the convertible instrument that are required to be bifurcated the bifurcated derivative instruments are accounted for as a single, compound derivative instrument.

The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. Equity instruments that are initially classified as equity that become subject to reclassification are reclassified to liability at the fair value of the instrument on the reclassification date. Derivative instrument liabilities are classified in the balance sheet as current or non-current to correspond with its host instrument.

The Company marks to market the fair value of the embedded derivatives at each balance sheet date and records the change in the fair value of the embedded derivatives as other income or expense in the statements of operations.

The Company utilizes a Monte Carlo Method that values the liability of the debt conversion feature derivative financial instruments and derivative warrants based on a probability of a down round event. The reason the Company selected the lattice binomial model is that in many cases there may be multiple embedded features or the features of the bifurcated derivatives may be so complex that a Black-Scholes valuation does not consider all of the terms of the instrument. Therefore, the fair value may not be appropriately captured by simple models.

Warrant Liability

Warrant Liability

The Company evaluates its warrants to determine if those contracts qualify as liabilities in accordance with ASC 480-10 and ASC 815-40. The result of this accounting treatment is that the fair value of the warrant liability is marked-to-market each balance sheet date and recorded as a liability, with the change in fair value recorded in the statements of operations as other income or expense. Upon conversion or exercise of a warrant liability, the instrument is marked to fair value at the conversion date and then that fair value is reclassified to equity.

For warrants with a fixed conversion price and a fixed number of shares, the Company utilizes a Black Scholes model for valuation. For warrants with variability in the number of shares or conversion price (such as a down round feature), the Company utilizes the Monte Carlo Method to value the warrant liability. The reason the Company selected the lattice binomial model is that in many cases there may be multiple embedded features or the features may be so complex that a Black-Scholes valuation does not consider all of the terms of the instrument. Therefore, the fair value may not be appropriately captured by simple models.

Recent Accounting Pronouncements

Recent Accounting Pronouncements

The following accounting standards updates were recently issued and have not yet been adopted. These standards are currently under review to determine their impact on the consolidated balance sheets, consolidated statements of operations and comprehensive loss, or consolidated statements of cash flows.

In February 2016, the FASB issued Accounting Standards Update (“ASU”) 2016-02, Leases, (“ASU 2016-02”), which supersedes FASB ASC 840, Leases and provides principles for the recognition, measurement, presentation and disclosure of leases for both lessees and lessors. The new standard requires lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. This classification will determine whether lease expense is recognized based on an effective interest method or on a straight-line basis over the term of the lease. A lessee is also required to record a right-of-use asset and a lease liability for all leases with a term of greater than twelve months regardless of classification. Leases with a term of twelve months or less will be accounted for similar to existing guidance for operating leases. In July 2018, the FASB issued ASU 2018-10, Codification Improvements to Topic 842 (Leases), and ASU 2018-11, Leases (Topic 842), Targeted Improvements, which provide (i) narrow amendments to clarify how to apply certain aspects of the new lease standard, (ii) entities with an additional transition method to adopt the new standard, and (ii) lessors with a practical expedient for separating components of a contract. The standard is effective for annual and interim periods beginning after December 15, 2018, with early adoption permitted upon issuance. The Company is currently evaluating the method of adoption and the impact of adopting ASU 2016-02 on its results of operations, cash flows and financial position. We expect to adopt the guidance using the modified retrospective method and practical expedients for transition. The practical expedients allow us to largely account for our existing leases consistent with current guidance except for the incremental balance sheet recognition for lessees. We have started an initial evaluation of our leasing contracts and activities. We do not expect a material change to the timing of expense recognition, but we are early in the implementation process and will continue to evaluate the impact. We are evaluating our existing disclosures and may need to provide additional information as a result of adoption of the ASU.

In January 2017, the FASB issued ASU 2017-04 Intangibles-Goodwill and Other (“ASC 350”): Simplifying the Accounting for Goodwill Impairment (“ASU 2017-04”). ASU 2017-04 simplifies the subsequent measurement of goodwill by eliminating Step 2 from the goodwill impairment test. In computing the implied fair value of goodwill under Step 2, an entity had to perform procedures to determine the fair value at the impairment testing date of its assets and liabilities (including unrecognized assets and liabilities) following the procedure that would be required in determining the fair value of assets acquired and liabilities assumed in a business combination. Instead, under ASU 2017-04, an entity should perform its annual or interim goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An entity should recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value; however, the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. Additionally, an entity should consider income tax effects from any tax-deductible goodwill on the carrying amount of the reporting unit when measuring the goodwill impairment loss, if applicable. ASU 2017-04 is effective for annual or any interim goodwill impairment tests for fiscal years beginning after December 15, 2019 and an entity should apply the amendments of ASU 2017-04 on a prospective basis. Early adoption is permitted for interim or annual goodwill impairment tests performed on testing dates after January 1, 2017. The Company is currently evaluating the effects of ASU 2017-04 on its consolidated financial statements.

In July 2017, the FASB issued ASU 2017-11, Earnings Per Share (“ASC 260”), Distinguishing Liabilities from Equity (“ASC 480”), and Derivatives and Hedging (“ASC 815”). ASU 2017-11 is intended to simplify the accounting for financial instruments with characteristics of liabilities and equity. Among the issues addressed are: (i) determining whether an instrument (or embedded feature) is indexed to an entity’s own stock; (ii) distinguishing liabilities from equity for mandatorily redeemable financial instruments of certain nonpublic entities; and (iii) identifying mandatorily redeemable non-controlling interests. ASU 2017-11 is effective for the Company on January 1, 2019. The Company is currently evaluating the potential impact of ASU 2017-11 on the Company’s consolidated financial statements.

In June 2018, the FASB issued ASU 2018-07, Compensation - Stock Compensation (“ASC 718”), Improvements to Nonemployee Share-Based Payment Accounting (“ASU 2018-07”). The amendments in ASU 2018-07 expand the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. ASU 2018-07 is effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption is permitted. The Company has evaluated the impact of ASU 2018-07 on the Company’s consolidated financial statements and determined it will not have a material impact.

In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (“ASC 820”), Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement (“ASU 2018-13”). ASU 2018-13 is intended to improve the effectiveness of fair value measurement disclosures. ASU 2018-13 is effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating the impact of ASU 2018-13 on the Company’s consolidated financial statements.

XML

Summary of Significant Accounting Policies (Tables)

9 Months Ended

Sep. 30, 2018

Summary of Significant Accounting Policies [Abstract]

Schedule of disaggregation of revenue

	Three Months Ended September 30,				Nine Months Ended  September 30,
	2018		2017		2018		2017
	(Unaudited)		(Unaudited)		(Unaudited)		(Unaudited)
Revenues:
Consulting	$	802,114	$	1,173,023	$	2,471,223	$	3,672,036
Subscription		78,921,951		-		198,488,038		-
Marketing, promotional services, and films		1,615,177		-		3,991,575		-
Total revenues	$	81,339,242	$	1,173,023	$	204,950,836	$	3,672,036

XML

Acquisitions of MoviePass and Moviefone and the Formation of MoviePass Films (Tables)

9 Months Ended

Sep. 30, 2018

Moviefone [Member]

Business Acquisition [Line Items]

Schedule of fair values of assets acquired and liabilities assumed

Purchase consideration:	Moviefone
Cash	$	1,000,000
Common shares issued		7,599,459
Warrants for common shares issued		5,475,500
Fair value of consideration transferred	$	14,074,959
Trade names and trademarks	$	4,640,000
Technology		340,000
Customer relationships		560,000
Goodwill		8,534,959
Total purchase price allocation	$	14,074,959

MoviePass [Member]

Business Acquisition [Line Items]

Schedule of fair values of assets acquired and liabilities assumed

Purchase consideration:	MoviePass
Cash	$	32,671,792
Notes payable (includes Helios Convertible Note and Helios Note)		39,152,446
Fair value of consideration transferred	$	71,824,238
Recognized amounts of identifiable assets and liabilities acquired:
Cash acquired	$	1,106,171
Accounts receivable		9,669,390
Notes receivable		39,152,446
Investment option payment receivable		7,850,000
Prepaid expenses and other current assets		192,180
Property and equipment		39,320
Other assets		8,000
Identifiable intangible assets:
Tradenames and trademarks		19,550,000
Technology		3,800,000
Customer relationships		2,560,000
Liabilities assumed		(9,261,785	)
Deferred revenue		(38,718,397	)
Non-controlling interest		(43,260,264	)
Goodwill		79,137,177
Total purchase price allocation	$	71,824,238

XML

Net Loss Per Share Attributable to Common Stockholders (Tables)

9 Months Ended

Sep. 30, 2018

Net Loss Per Share Attributable to Common Stockholders [Abstract]

Schedule of diluted net loss per share attributable to common stockholder's

	September 30,		December 31,
	2018		2017
Warrants		67,468		38,526
Conversion features on convertible notes		-		5,482
Total potentially dilutive shares		67,468		44,008

XML

Prepaid Expenses and Other Current Assets (Tables)

9 Months Ended

Sep. 30, 2018

Prepaid Expenses and Other Current Assets [Abstract]

Schedule of prepaid expenses and other current assets

	September 30, 2018		December 31, 2017
Vendor deposits	$	2,293,641	$	147,533
Tax		105,503		108,433
Deposits		-		230,711
Insurance		167,016		86,181
Professional fees and services		61,359		33,333
Deferred stock compensation		250,333		2,885,278
Rent		-		52,650
Other		591,793		13,692
Total prepaid expenses and other current assets	$	3,469,645	$	3,557,811

XML

Intangible Assets, net and Goodwill (Tables)

9 Months Ended

Sep. 30, 2018

Intangible Assets, net and Goodwill [Abstract]

Schedule of intangibles assets

				September 30, 2018
	Estimate Useful Life (Years)	Gross Carrying Amount		Acquisitions		Accumulated Amortization			Impairments			Net Book Value
Customer relationships	7	$	2,560,000		560,000		(334,043	)		-			2,785,957
Technology	3		8,070,000		340,000		(3,773,338	)		(1,210	)		4,635,452
Tradenames and trademarks	10-20		19,873,224		4,640,000		(2,013,260	)		-			22,499,964
Patents	12		196,353		-		(20,327	)		-			176,026
		$	30,699,577		5,540,000		(6,140,968	)		(1,210	)		30,097,399

				December 31, 2017
	Estimate Useful Life (Years)	Gross  Carrying Amount		Acquisitions		Accumulated Amortization			Impairments			Net Book Value
Customer relationships	7	$	-	$	2,560,000	$	(20,645	)	$	-		$	2,539,355
Technology	3		4,270,000		3,800,000		(1,700,431	)		-			6,369,569
Tradenames and trademarks	10-20		1,977,000		19,550,000		(433,588	)		(1,653,776	)		19,439,636
Broker relationships	5		4,200		-		(962	)		(3,238	)		-
Patents	12		196,353		-		(8,131	)		-			188,222
		$	6,447,553	$	25,910,000	$	(2,163,757	)	$	(1,657,014	)	$	28,536,782

Schedule of estimated future annual amortization expense

September 30,
Remaining 2018	$	1,363,077
2019		5,246,717
2020		3,957,471
2021		2,678,569
2022		2,648,976
Thereafter		14,202,589
	$	30,097,399

Schedule of goodwill carrying value

Balance as of December 31, 2017	$	79,137,177
Acquisition of Moviefone		8,534,959
Impairment of a portion of MoviePass		(38,524,016	)
Balance as of September 30, 2018	$	49,148,120

XML

Accounts Payable and Accrued Expenses (Tables)

9 Months Ended

Sep. 30, 2018

Accounts Payable and Accrued Expenses [Abstract]

Schedule of accounts payable and accrued expenses

	September 30, 2018		December 31, 2017
Accounts payable	$	5,292,213	$	5,087,060
Accrued ticket expense		1,174,638		4,743,582
Accrued professional fees		1,763,670		597,187
Accrued credit card fees		-		782,670
Accrued payroll expense		4,111,418		312,149
Accrued other expense		3,755,564		852,840
Accrued interest		1,593,757		768,515
Total accounts payable and accrued expenses	$	17,691,260	$	13,144,003

XML

Senior Secured Convertible Notes and Warrants and Unit Offerings (Tables)

9 Months Ended

Sep. 30, 2018

Senior Secured Convertible Notes and Warrants and Unit Offerings [Abstract]

Schedule of MoviePass Films senior notes

	September 30, 2018		December 31, 2017
GFF79 loan from SSS Entertainment	$	150,000	$	-
A Vigilante loan from Film Science, LLC (See Note 16)		2,625,000		-
10 Minutes Gone loan from City National Bank		5,923,250		-
Balance at period end	$	8,698,250	$	-

Schedule of senior secured convertible notes

	September 30, 2018		December 31, 2017
August 2017 Notes	$	-	$	2,061,072
November 2017 Notes		-		1,550,555
Balance at period end	$	-	$	3,611,627

Schedule of carrying value of the senior secured convertible notes

	September 30, 2018		December 31, 2017
August 2017 Notes	$	-	$	4,505,440
November 2017 Notes		-		2,943,069
Unamortized discounts				(3,836,882	)
Balance at period end	$	-	$	3,611,627

Schedule of the Company's warrant activity

	Warrant Shares			Weighted Average Exercise Price		Weighted Average Remaining Contractual Life Years
Outstanding/exercisable – December 31, 2017		38,526		$	6.04		4.86
Granted		180,819			3.84		4.44
Exercised		(151,877	)		7.17		4.40
Forfeited/cancelled		-			-		-
Outstanding/exercisable – September 30, 2018		67,468			5.43		4.46

XML

Fair Value of Financial Assets and Liabilities Measured on a Recurring Basis (Tables)

9 Months Ended

Sep. 30, 2018

Fair Value of Financial Assets and Liabilities Measured on a Recurring Basis [Abstract]

Schedule of financial assets and liabilities measured at fair value on a recurring basis

	Amount at		Fair Value Measurement Using
	Fair Value		Level 1		Level 2		Level 3
September 30, 2018
Liabilities
Derivative liability – warrants	$	60,809	$	-	$	-	$	60,809
Total	$	60,809	$	-	$	-	$	60,809
December 31, 2017
Liabilities
Derivative liability – warrants	$	67,288,800	$	-	$	-	$	67,288,800
Derivative liability – conversion feature		4,834,462		-		-		4,834,462
Total	$	72,123,262	$	-	$	-	$	72,123,262

Summary of the changes in fair value

	Amount
Balance at December 31, 2017	$	72,123,262
Issuances to debt discount		105,223,694
Issuances to interest expense		40,734,226
Reclass from APIC to derivative - February offering		158,944,798
Reclass from APIC to derivative - April offering		33,997,600
Warrants issued in acquisition of Moviefone		5,475,500
Gain on exchange of warrants		(301,487	)
Settlement of warrant liability for March warrant exchange		(12,894,165	)
Settlement of warrant liability for June warrant exchange		(5,202,100	)
Gain on March exchange (cash paid)		(781,195	)
Conversion to paid-in capital		(134,365,641	)
Gain on extinguishment		(60,524,508	)
Change in FMV warrant		(194,058,069	)
Change in FMV derivative		(8,311,106	)
Balance at September 30, 2018	$	60,809

Schedule of fair value of the derivative conversion features and warrant liabilities

	September 30, 2018			December 31, 2017
	Amount			Amount
Dividend yield	0%	-	0%		0%
Expected volatility	165%	-	280%	45%	-	270%
Risk free interest rate	2.40%	-	2.93%	1.06%	-	2.20%
Contractual term (in years)	1.14	-	4.55%	0.19	-	5.00
Exercise price	$0.01	-	$1,812.50	$0.25 ($0.001 pre-split)	-	$3,577.50 ($14.310 pre-split)

XML

Stock Based Compensation (Tables)

9 Months Ended

Sep. 30, 2018

Stock Based Compensation [Abstract]

Schedule of stock based compensation activity

			Weighted Average
	Options for				Remaining		Aggregate
	Common Shares		Exercise Price		Contractual Term		Intrinsic Value
Outstanding as of December 31, 2017		28,396,428	$	0.14		9.13	$	8,313,684
Granted		39,809,175		0.43
Exercised		-
Forfeited, cancelled, expired		-
Outstanding as of September 30, 2018		68,205,603	$	0.31		8.93	$	6,760,947
Vested and exercisable at September 30, 2018		27,476,989	$	0.20		8.58	$	5,042,235

Schedule of weighted-average assumptions used to compute the fair value of options granted

	Nine months ended
	September 30, 2018
Risk-free interest rate		2.50	%
Expected life of options – years		5.79
Expected stock price volatility		37.20	%
Expected dividend yield		0.00	%

XML

Commitments and Contingencies (Tables)

9 Months Ended

Sep. 30, 2018

Commitments and Contingencies [Abstract]

Schedule of operating lease commitments

	Payments due by period
Less than 1 year	$	74,094
1 to 3 years		548,808
3 to 5 years		347,985
Thereafter		-
Total	$	970,887

XML

Segment Reporting (Tables)

9 Months Ended

Sep. 30, 2018

Segment Reporting [Abstract]

Schedule of segment reporting information

	For the Nine Months Ended September 30,
	2018			2017
Consulting
Revenue	$	2,471,223		$	3,672,036
Cost of revenue		2,023,707			2,969,357
Gross margin		447,516			702,679
Total operating expenses		19,908,946			6,280,032
Income/(loss) from operations		(19,461,430	)		(5,577,353	)
Total other income/(expense)		73,915,297			(44,914,576	)
Provision for income taxes		(8,826	)		39,110
Total net income/(loss)	$	54,445,041		$	(50,531,039	)
Technology
Revenue	$	-		$	-
Cost of revenue		-			-
Gross margin		-			-
Total operating expenses		2,871,608			4,601,330
Income/(loss) from operations		(2,871,608	)		(4,601,330	)
Total other income/(expense)		70			(47,220	)
Provision for income taxes		-			-
Total net income/(loss)	$	(2,871,538	)	$	(4,648,550	)
Subscription and Marketing, Promotional Services, and Films
Revenue		202,479,613			-
Cost of revenue		422,347,371			-
Gross margin		(219,867,758	)		-
Loss on goodwill		38,524,016
Total other operating expenses		40,060,927			-
Income/(loss) from operations		(298,452,701	)		-
Total other income/(expense)		-			-
Provision for income taxes		(38,127	)		-
Total net income/(loss)	$	(298,490,828	)	$	-

	As of September 30,			As of  December 31,
		2018			2017
Consulting
Cash and cash equivalents		$	3,674,904		$	569,886
Accounts receivable		$	290,561		$	332,753
Prepaid expenses and other current assets		$	638,522		$	3,382,127
Property and equipment		$	151,379		$	96,464
Intangible assets		$	805,482		$	-
Goodwill		$	-		$	-
Deposits and other assets		$	128,232		$	129,119
Accounts payable and accrued expenses		$	4,475,771		$	2,088,867
Liabilities to be settled in stock		$	5,669,263		$	20,875,045
Convertible notes payable		$	-		$	3,611,627
Warrant liability		$	60,809		$	67,288,800
Derivative liability		$	-		$	4,834,462
Technology
Cash and cash equivalents		$	160,124		$	21,933,765
Accounts receivable		$	-		$	-
Unbilled receivables		$	-		$	-
Prepaid expenses and other current assets		$	3,333		$	21,666
Property and equipment		$	81,613		$	95,301
Intangible assets		$	1,748,388		$	2,829,295
Goodwill		$	-		$	-
Deposits and other assets		$	10,052		$	10,052
Accounts payable and accrued expenses		$	164,447		$	607,622
Liabilities to be settled in stock		$	319,100		$	445,660
Convertible notes payable		$	-		$	-
Warrant liability		$	-		$	-
Derivative liability		$	-		$	-
Deferred revenue		$	-		$	-
Subscription and Marketing, Promotional Services, and Films
Cash and cash equivalents		$	1,015,944		$	2,445,742
Accounts receivable		$	30,432,024		$	27,137,466
Unbilled receivables		$	-		$	-
Prepaid expenses and other current assets		$	2,827,790		$	154,018
Property and equipment		$	146,674		$	42,270
Intangible assets		$	27,543,529		$	25,707,487
Goodwill		$	49,148,120		$	79,137,177
Deposits and other assets		$	496,888		$	8,000
Accounts payable and accrued expenses		$	13,051,042		$	10,447,514
Liabilities to be settled in stock		$	-		$	-
Note Payable		$	8,698,250
Convertible notes payable		$	-		$	-
Warrant liability		$	-		$	-
Derivative liability		$	-		$	-
Deferred revenue		$	27,035,060		$	54,425,630
Due to Related Parties		$	1,150,000		$	-
Investment in films		$	13,403,433		$	-

XML

Business and Basis of Presentation (Details)	1 Months Ended	9 Months Ended
	Jul. 24, 2018	Sep. 30, 2018	Jul. 16, 2018	May 23, 2018
Business and Basis of Presentation (Textual)
Reverse stock split, description	The Company effected a reverse stock-split of its issued and outstanding common stock at a ratio of one-for-250 ("Reverse Stock Split"). The Company filed a Certificate of Amendment to its Certificate of Incorporation with the Secretary of State of the State of Delaware effecting the Reverse Stock Split. The Reverse Stock Split did not affect the number of authorized shares of common stock, which, following the increase in authorized shares effected on July 23, 2018 discussed in Note 11, remains at 5,000,000,000 shares.	The Special Meeting of Stockholders scheduled to be held on November 14, 2018 to provide stockholders with an opportunity to vote on the proposed reverse stock split in a ratio of 1 share-for-2 shares up to a ratio of 1 share-for-500 shares has been cancelled. The Company was presenting the reverse stock split proposal in an effort to regain compliance with Rule 5550(a)(2). Since the Company will not be able to effect a reverse stock split ten business days prior to December 18, 2018, absent an extension by The Nasdaq Capital Market (of which there can be no assurance) the Company believes that our common stock will be subject to delisting from The Nasdaq Capital Market, which would adversely impact the liquidity and marketability of our common stock.
Description of consolidation of entities		The Company consolidates entities in which it owns more than 50% of the voting equity interests and controls operations.
MoviePass [Member]
Business and Basis of Presentation (Textual)
Ownership percentage				49.00%
Georgia Film Fund [Member]
Business and Basis of Presentation (Textual)
Ownership percentage			100.00%

XML

Summary of Significant Accounting Policies (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Revenues:
Consulting	$ 802,114	$ 1,173,023	$ 2,471,223	$ 3,672,036
Subscription	78,921,951		198,488,038
Marketing, promotional services, and films	1,615,177		3,991,575
Total revenues	$ 81,339,242	$ 1,173,023	$ 204,950,836	$ 3,672,036

XML

Summary of Significant Accounting Policies (Details Textual) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Summary of Significant Accounting Policies (Textual)
Impairment charge	$ 38,524,016		$ 38,524,016
Amortization expense	$ 1,363,638	$ 430,716	3,977,211	1,284,018
Total capitalized costs			17,212,981
Investment in films			(17,212,981)
Unamortized capitalized investment in film costs			13,403,433
Amortized costs			3,809,548
Impairments			1,178,125
Unamortized balance			2,376,451
Released film costs			$ 11,026,982
Maximum [Member]
Summary of Significant Accounting Policies (Textual)
Intangible assets useful lives range			12 years
Minimum [Member]
Summary of Significant Accounting Policies (Textual)
Intangible assets useful lives range			3 years

XML

Going Concern Analysis (Details) - USD ($)		1 Months Ended						3 Months Ended		9 Months Ended
	Feb. 13, 2018	Jun. 26, 2018	Apr. 30, 2018	Apr. 23, 2018	Apr. 18, 2018	Feb. 28, 2018	Jan. 31, 2018	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017	Jun. 21, 2018	Dec. 31, 2017	Feb. 08, 2017	Dec. 31, 2016
Going Concern Analysis (Textual)
Accumulated deficit								$ (377,266,866)		$ (377,266,866)			$ (189,495,185)
Cash								4,850,972	$ 1,663,879	4,850,972	$ 1,663,879		24,949,393		$ 2,747,240
Net cash used in operating activities										(321,093,755)	(7,644,296)
Working capital deficit								15,657,290		15,657,290			107,097,249
Warrant and derivative liabilities								60,809		$ 60,809			$ 72,123,262
Ownership interests, description							The Company filed a shelf registration statement on form S-3 that was declared effective by the SEC on February 9, 2018, which allows the Company to offer and sell up to $400,000,000 of its equity or equity-linked securities. Using the shelf registration statement, the Company completed an underwritten public offering of common stock and warrants for gross proceeds of $105,050,000 on February 13, 2018.
Description of convertible debt financing		The Company obtained preferred stock and convertible debt financing for up to $139,400,000 in gross proceeds, of which the Company had received $20,500,000 in gross proceeds as of September 30, 2018, which the Company used for general corporate purposes and transaction expenses.								The Company obtained convertible debt financing for up to $60,000,000 in gross proceeds on January 11, 2018, of which the Company had received $31,000,000 in gross proceeds as of September 30, 2018, which the Company used (i) to increase the Company's ownership interests or other rights and interests in MoviePass; (ii) to satisfy certain indebtedness; and (iii) for general corporate purposes and transaction expenses. The Company may also use the proceeds to make other acquisitions. Additionally, during the second and third quarter of 2018, the Company received $58,959,736 in gross proceeds related to the convertible debt financing obtained on November 7, 2017.
Total net proceeds from the public offering						$ 96,912,380
Loss from operations								(86,414,887)	$ (3,076,264)	$ (320,785,739)	$ (10,178,683)
Principal amount														$ 5,000,000
Offering sale of transaction, shares										627,933,083
Offering received net proceeds										$ 119,423,879
Share Price												$ 1.00
Reverse stock split ratio, description										The Special Meeting of Stockholders scheduled to be held on November 14, 2018 to provide stockholders with an opportunity to vote on the proposed reverse stock split in a ratio of 1 share-for-2 shares up to a ratio of 1 share-for-500 shares has been cancelled.
Public offering [Member]
Going Concern Analysis (Textual)
Total net proceeds from the public offering			$ 27,677,558
Underwritten public offering of common stock and warrants for gross proceeds	$ 105,050,000			$ 30,250,000
Canaccord Genuity LLC [Member]
Going Concern Analysis (Textual)
Common stock sale of offering price					$ 150,000,000
Convertible Debt [Member]
Going Concern Analysis (Textual)
Principal amount								49,388,861		$ 49,388,861
Senior Convertible Notes [Member] | November 7, 2017 [Member]
Going Concern Analysis (Textual)
Principal amount								0		0
Senior Convertible Notes [Member] | January 23, 2018 [Member]
Going Concern Analysis (Textual)
Principal amount								$ 0		$ 0

XML

Acquisitions of MoviePass and Moviefone and the Formation of MoviePass Films (Details)	Sep. 30, 2018 USD ($)
MoviePass [Member]
Purchase consideration:
Cash	$ 32,671,792
Notes payable (includes Helios Convertible Note and Helios Note)	39,152,446
Fair value of consideration transferred	71,824,238
Recognized amounts of identifiable assets and liabilities acquired:
Cash acquired	1,106,171
Accounts receivable	9,669,390
Notes receivable	39,152,446
Investment option payment receivable	7,850,000
Prepaid expenses and other current assets	192,180
Property and equipment	39,320
Other assets	8,000
Identifiable intangible assets:
Tradenames and trademarks	19,550,000
Technology	3,800,000
Customer relationships	2,560,000
Liabilities assumed	(9,261,785)
Deferred revenue	(38,718,397)
Non-controlling interest	(43,260,264)
Goodwill	79,137,177
Total purchase price allocation	71,824,238
Moviefone [Member]
Purchase consideration:
Cash	1,000,000
Common shares issued	7,599,459
Warrants for common shares issued	5,475,500
Fair value of consideration transferred	14,074,959
Identifiable intangible assets:
Tradenames and trademarks	4,640,000
Technology	340,000
Customer relationships	560,000
Goodwill	8,534,959
Total purchase price allocation	$ 14,074,959

XML

Acquisitions of MoviePass and Moviefone and the Formation of MoviePass Films (Details Textual) - USD ($)			1 Months Ended		2 Months Ended	6 Months Ended	9 Months Ended
	Mar. 08, 2018	Dec. 11, 2017	May 23, 2018	Apr. 04, 2018	Apr. 12, 2018	Sep. 30, 2018	Sep. 30, 2018	Mar. 31, 2018	Feb. 08, 2017
Acquisitions of MoviePass and Moviefone and the Formation of MoviePass Films (Textual)
Percentage of interest in joint venture			51.00%
Principal amount									$ 5,000,000
Contribution distribution agreements			The Company capitalized MoviePass Films with an initial capital contribution of $2,000,000 in cash and retained a 51% interest in MoviePass Films and capitalized MoviePass Films with an additional $4,200,000 as of September 30, 2018, for a total of $6,200,000 capitalized by the Company as of September 30, 2018.. EFO has assigned its rights in a film output agreement of EFO to MoviePass Films. MoviePass Films has begun operations, and the Company and EFO are finalizing the long form agreements that will further define the relative rights and duties of the Company and EFO with respect to MoviePass Films. In accordance with the LOI, as of September 30, 2018, the Company is committed to contribute 16,000 (4,000,000 pre-split) shares of common stock of the Company to EFO.
Maximum [Member]
Acquisitions of MoviePass and Moviefone and the Formation of MoviePass Films (Textual)
Estimated useful life (Years)							12 years
Percentage of purchased shares						100.00%	100.00%
Discount rates						22.10%	22.10%
Percentage of royalty rates						100.00%	100.00%
Minimum [Member]
Acquisitions of MoviePass and Moviefone and the Formation of MoviePass Films (Textual)
Estimated useful life (Years)							3 years
Percentage of purchased shares						0.00%	0.00%
Discount rates						9.00%	9.00%
Percentage of royalty rates						0.00%	0.00%
Tradenames and trademarks [Member]
Acquisitions of MoviePass and Moviefone and the Formation of MoviePass Films (Textual)
Estimated useful life (Years)		7 years					20 years
Percentage of purchased shares						10.00%	10.00%
Percentage of royalty rates						10.00%	10.00%
Customer relationships [Member]
Acquisitions of MoviePass and Moviefone and the Formation of MoviePass Films (Textual)
Estimated useful life (Years)		7 years					7 years
Technology [Member]
Acquisitions of MoviePass and Moviefone and the Formation of MoviePass Films (Textual)
Estimated useful life (Years)		3 years					3 years
MoviePass Transaction [Member]
Acquisitions of MoviePass and Moviefone and the Formation of MoviePass Films (Textual)
MoviePass acquisition, consideration, description		(1) a subordinated convertible promissory note in the principal amount of $12,000,000 (the "Helios Convertible Note"), which is convertible into shares of HMNY's common stock, as further described below; (2) a $5,000,000 promissory note issued to MoviePass (the "Helios Note"); (3) the exchange of a convertible promissory note issued by MoviePass to HMNY in an aggregate principal amount of $11,500,000 (plus accrued interest thereon); (4) $1,000,000 in cash to purchase outstanding convertible notes of MoviePass, which were converted into shares of MoviePass' common stock amounting to an additional 2% of the outstanding shares of MoviePass common stock; and (5) $20,000,000 in cash pursuant to the Investment Option Agreement, dated October 11, 2017, between the Company and MoviePass.
Principal amount		$ 1,000,000
Percentage of additional shares outstanding							62.41%
Controlling interest percentage		62.41%
Percentage of purchased shares	81.20%
Cash advances to MoviePass	$ 55,525,000
Percentage of common stock total outstanding shares	18.79%
Percentage of royalty rates	81.20%
Helios Convertible Note [Member]
Acquisitions of MoviePass and Moviefone and the Formation of MoviePass Films (Textual)
Additional payment amount value		$ 29,000,000
Unregistered common stock shares		16,000
Conversion Shares subject to forfeiture		2,667
Forfeiture provision value		$ 5,152,446
Royalty rate description		The significant assumptions used in certain valuations associated with the MoviePass Transaction include discount rates ranging from 10.0% to 51.0%. In determining the value of tradenames and trademarks the Company observed royalty rates ranging from 0.0% to 100.0%, and utilized a 1.0% rate for MoviePass's aggregated tradenames and trademarks. Additionally, the Company observed royalty rates related to MoviePass's technology assets acquired ranging from 0.0% to 50.0%, and used a 1.0% royalty rate in determining the fair value of the acquired technology.
Helios Convertible Note [Member] | Pre-split [Member]
Acquisitions of MoviePass and Moviefone and the Formation of MoviePass Films (Textual)
Unregistered common stock shares		4,000,000
Conversion Shares subject to forfeiture		666,667
MoviePass [Member]
Acquisitions of MoviePass and Moviefone and the Formation of MoviePass Films (Textual)
Percentage of purchased shares			49.00%		91.80%
Cash advances to MoviePass					$ 35,000,000	$ 187,285,000
Percentage of common stock total outstanding shares					10.60%
Pre-money valuation amount								$ 295,525,000
Percentage of royalty rates			49.00%		91.80%
Acquisition of Moviefone Brand [Member]
Acquisitions of MoviePass and Moviefone and the Formation of MoviePass Films (Textual)
Description of acquisition purchase price				(i) $1.0 million in cash, (ii) the issuance of 10,201 (2,550,154 pre-split) shares of common stock of the Company with a market value of $7.6 million as of the closing date, and (iii) the issuance of warrants to purchase 10,201 (2,550,154 pre-split) shares of common stock of the Company at an exercise price of $1,375 ($5.50 pre-split) per share. In addition, and pursuant to the Moviefone Purchase Agreement, the Company assumed certain specified liabilities incurred after the acquisition date and retained certain employees of Moviefone.
Letter of Intent [Member]
Acquisitions of MoviePass and Moviefone and the Formation of MoviePass Films (Textual)
Advances from affiliates			$ 2,000,000
Retained interest percentage			51.00%

XML

Net Loss Per Share Attributable to Common Stockholders (Details) - shares	9 Months Ended	12 Months Ended
	Sep. 30, 2018	Dec. 31, 2017
Net Income/(Loss) Per Share Attributable to Common Stockholders
Total potentially dilutive shares	67,468	44,008
Warrants [Member]
Net Income/(Loss) Per Share Attributable to Common Stockholders
Total potentially dilutive shares	67,468	38,526
Conversion features on convertible notes [Member]
Net Income/(Loss) Per Share Attributable to Common Stockholders
Total potentially dilutive shares		5,482

XML

Prepaid Expenses and Other Current Assets (Details) - USD ($)	Sep. 30, 2018	Dec. 31, 2017
Prepaid Expenses and Other Current Assets [Abstract]
Vendor deposits	$ 2,293,641	$ 147,533
Tax	105,503	108,433
Deposits		230,711
Insurance	167,016	86,181
Professional fees and services	61,359	33,333
Deferred stock compensation	250,333	2,885,278
Rent		52,650
Other	591,793	13,692
Total prepaid expenses and other current assets	$ 3,469,645	$ 3,557,811

XML

Intangible Assets, net and Goodwill (Details) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2018	Dec. 31, 2017
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 30,699,577	$ 6,447,553
Acquisitions	5,540,000	25,910,000
Accumulated Amortization	(6,140,968)	(2,163,757)
Impairments	(1,210)	(1,657,014)
Net Book Value	$ 30,097,399	$ 28,536,782
Minimum [Member]
Finite-Lived Intangible Assets [Line Items]
Estimate Useful Life (Years)	3 years
Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Estimate Useful Life (Years)	12 years
Customer relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Estimate Useful Life (Years)	7 years	7 years
Gross Carrying Amount	$ 2,560,000
Acquisitions	560,000	2,560,000
Accumulated Amortization	(334,043)	(20,645)
Impairments
Net Book Value	$ 2,785,957	$ 2,539,355
Technology [Member]
Finite-Lived Intangible Assets [Line Items]
Estimate Useful Life (Years)	3 years	3 years
Gross Carrying Amount	$ 8,070,000	$ 4,270,000
Acquisitions	340,000	3,800,000
Accumulated Amortization	(3,773,338)	(1,700,431)
Impairments	(1,210)
Net Book Value	4,635,452	$ 6,369,569
Tradenames and trademarks [Member]
Finite-Lived Intangible Assets [Line Items]
Estimate Useful Life (Years)		10 years
Gross Carrying Amount	19,873,224	$ 1,977,000
Acquisitions	4,640,000	19,550,000
Accumulated Amortization	(2,013,260)	(433,588)
Impairments		(1,653,776)
Net Book Value	$ 22,499,964	$ 19,439,636
Tradenames and trademarks [Member] | Minimum [Member]
Finite-Lived Intangible Assets [Line Items]
Estimate Useful Life (Years)	10 years
Tradenames and trademarks [Member] | Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Estimate Useful Life (Years)	20 years
Broker relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Estimate Useful Life (Years)		5 years
Gross Carrying Amount		$ 4,200
Acquisitions
Accumulated Amortization		(962)
Impairments		(3,238)
Net Book Value
Patents [Member]
Finite-Lived Intangible Assets [Line Items]
Estimate Useful Life (Years)	12 years	12 years
Gross Carrying Amount	$ 196,353	$ 196,353
Acquisitions
Accumulated Amortization	(20,327)	(8,131)
Impairments
Net Book Value	$ 176,026	$ 188,222

XML

Intangible Assets, net and Goodwill (Details 1)	Sep. 30, 2018 USD ($)
Intangible Assets, net and Goodwill [Abstract]
Remaining 2018	$ 1,363,077
2019	5,246,717
2020	3,957,471
2021	2,678,569
2022	2,648,976
Thereafter	14,202,589
Total	$ 30,097,399

XML

Intangible Assets, net and Goodwill (Details 2) - USD ($)	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Intangible Assets, net and Goodwill [Abstract]
Balance as of December 31, 2017	$ 79,137,177
Acquisition of Moviefone	8,534,959
Impairment of a portion of MoviePass	(38,524,016)
Balance as of June 30, 2018	$ 49,148,120

XML

Intangible Assets, net and Goodwill (Details Textual) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Intangible Assets, net and Goodwill (Textual)
Amortization expense	$ 1,363,638	$ 430,716	$ 3,977,211	$ 1,284,018
Goodwill and Intangible Asset Impairment	$ 38,524,016		$ 38,524,016
Revenue projections description			Revenue projections reflected declines in the current and next year, and revenues are expected to moderate to a terminal growth rate of 3%. The discount rate was 49.4% and the effective tax rate was 28%.

XML

Accounts Payable and Accrued Expenses (Details) - USD ($)	Sep. 30, 2018	Dec. 31, 2017
Accounts Payable and Accrued Expenses [Abstract]
Accounts payable	$ 5,292,213	$ 5,087,060
Accrued ticket expense	1,174,638	4,743,582
Accrued professional fees	1,763,670	597,187
Accrued credit card fees		782,670
Accrued payroll expense	4,111,418	312,149
Accrued other expense	3,755,564	852,840
Accrued interest	1,593,757	768,515
Total	$ 17,691,260	$ 13,144,003

XML

Senior Secured Convertible Notes and Warrants and Unit Offerings (Details) - USD ($)	Sep. 30, 2018	Dec. 31, 2017
Short-term Debt [Line Items]
Senior Notes	$ 8,698,250
Moviepass Films [Member] | GFF79 loan from SSS Entertainment [Member]
Short-term Debt [Line Items]
Senior Notes	150,000
Moviepass Films [Member] | A Vigilante loan from Film Science, LLC (See Note 16) [Member]
Short-term Debt [Line Items]
Senior Notes	2,625,000
Moviepass Films [Member] | 10 Minutes Gone loan from City National Bank [Member]
Short-term Debt [Line Items]
Senior Notes	$ 5,923,250

XML

Senior Secured Convertible Notes and Warrants and Unit Offerings (Details 1) - USD ($)	Sep. 30, 2018	Dec. 31, 2017
Short-term Debt [Line Items]
Senior secured convertible notes		$ 3,611,627
August 2017 Notes [Member]
Short-term Debt [Line Items]
Senior secured convertible notes		2,061,072
November 2017 Notes [Member]
Short-term Debt [Line Items]
Senior secured convertible notes		$ 1,550,555

XML

Senior Secured Convertible Notes and Warrants and Unit Offerings (Details 2) - USD ($)	Sep. 30, 2018	Dec. 31, 2017
Short-term Debt [Line Items]
Unamortized discounts		$ (3,836,882)
Carrying value of senior secured convertible notes		3,611,627
August 2017 Notes [Member]
Short-term Debt [Line Items]
Carrying value of senior secured convertible notes		4,505,440
November 2017 Notes [Member]
Short-term Debt [Line Items]
Carrying value of senior secured convertible notes		$ 2,943,069

XML

Senior Secured Convertible Notes and Warrants and Unit Offerings (Details 3) - Warrant Activity [Member]	9 Months Ended
	Sep. 30, 2018 USD ($) shares
Warrant Liability Activity
Outstanding/exercisable, Warrant Shares | shares	38,526
Granted, Warrant Shares | shares	180,819
Exercised, Warrant Shares | shares	(151,877)
Forfeited/cancelled, Warrant Shares | shares
Outstanding/exercisable, Warrant Shares | shares	67,468
Outstanding/exercisable, Weighted Average Exercise Price | $	$ 6.04
Granted, Weighted Average Exercise Price | $	3.84
Exercised, Weighted Average Exercise Price | $	7.17
Forfeited/cancelled, Weighted Average Exercise Price | $
Outstanding/exercisable, Weighted Average Exercise Price | $	$ 5.43
Outstanding/exercisable, Weighted Average Remaining Contractual Life Years	4 years 10 months 10 days
Granted, Weighted Average Remaining Contractual Life Years	4 years 5 months 9 days
Exercised, Weighted Average Remaining Contractual Life Years	4 years 4 months 24 days
Outstanding/exercisable, Weighted Average Remaining Contractual Life Years	4 years 5 months 16 days

XML

Senior Secured Convertible Notes and Warrants and Unit Offerings (Details Textual)										1 Months Ended												3 Months Ended			9 Months Ended		12 Months Ended
	Oct. 04, 2018 USD ($)	Sep. 10, 2018	Jul. 13, 2018 USD ($) $ / shares	Jun. 01, 2018	Apr. 03, 2018 USD ($)	Feb. 13, 2018 USD ($) $ / shares	Nov. 07, 2017 USD ($)	Oct. 23, 2017 USD ($) shares	Feb. 08, 2017 USD ($) ConvertibleNote	Jul. 31, 2018 USD ($)	Jul. 27, 2018 USD ($)	Jul. 24, 2018	Jun. 28, 2018 USD ($)	Jun. 26, 2018	Apr. 23, 2018	Mar. 31, 2018 USD ($) shares	Feb. 20, 2018 USD ($) shares	Jan. 23, 2018 USD ($)	Nov. 21, 2017 $ / shares shares	Aug. 27, 2017 USD ($)	Aug. 16, 2017 USD ($) ConvertibleNote $ / shares shares	Sep. 30, 2018 USD ($) $ / shares shares	Jun. 30, 2018 USD ($)	Sep. 30, 2017 USD ($)	Sep. 30, 2018 USD ($) $ / shares shares	Sep. 30, 2017 USD ($)	Dec. 31, 2017 USD ($) $ / shares shares	Jul. 23, 2018 $ / shares	Jul. 02, 2018 USD ($)	Apr. 04, 2018 $ / shares	Apr. 02, 2018 USD ($)	Jan. 26, 2018 USD ($)	Jan. 02, 2018 USD ($)
Senior Secured Convertible Notes and Warrants and Unit Offerings (Textual)
Principal amount									$ 5,000,000
Common stock at exercise prices | $ / shares																														$ 5.50
Interest expense																						$ 95,575,954		$ 11,563,078	$ 189,305,904	$ 16,856,284
Investor converted total																				$ 2,500,000
Reverse stock split, description												The Company effected a reverse stock-split of its issued and outstanding common stock at a ratio of one-for-250 ("Reverse Stock Split"). The Company filed a Certificate of Amendment to its Certificate of Incorporation with the Secretary of State of the State of Delaware effecting the Reverse Stock Split. The Reverse Stock Split did not affect the number of authorized shares of common stock, which, following the increase in authorized shares effected on July 23, 2018 discussed in Note 11, remains at 5,000,000,000 shares.													The Special Meeting of Stockholders scheduled to be held on November 14, 2018 to provide stockholders with an opportunity to vote on the proposed reverse stock split in a ratio of 1 share-for-2 shares up to a ratio of 1 share-for-500 shares has been cancelled. The Company was presenting the reverse stock split proposal in an effort to regain compliance with Rule 5550(a)(2). Since the Company will not be able to effect a reverse stock split ten business days prior to December 18, 2018, absent an extension by The Nasdaq Capital Market (of which there can be no assurance) the Company believes that our common stock will be subject to delisting from The Nasdaq Capital Market, which would adversely impact the liquidity and marketability of our common stock.
Gain on exchange of warrants																									$ 301,487
Unfunded portion investor note remaining																									$ 49,390,264
Converted pre split shares, description																						The Investor has converted a total of $40,756,847 in principal and $5,537,785 in interest into 728,934,054 (including 361,245 shares which were split affected (90,311,250 pre-split)) shares of the Company's common stock and for the nine months ended September 30, 2018, the Investor has converted a total of $64,959,736 in principal and $9,161,604 in interest into 729,185,600 (including 612,792 shares which were split affected (153,198,000 pre-split)) shares of the Company's common stock.
MoviePass Films entered into a note payable, description		Note payable for $7.2 million with annual interest equal to either a) 3.5% plus the prime rate plus 0.25% or b) the greater of (i) 3.5% and (ii) the LIBOR rate plus 2.75%. The note can be prepaid at anytime without penalty through the earlier of the abandonment of the production of the 10 Minutes Gone films or March 15, 2020.
Pre-split [Member]
Senior Secured Convertible Notes and Warrants and Unit Offerings (Textual)
New note shares of common stock | shares								552,782
Subsequent Events [Member]
Senior Secured Convertible Notes and Warrants and Unit Offerings (Textual)
Principal amount	$ 20,400,000
October exchange agreement, description	The Company entered into an Amendment and Exchange Agreement (the "October Exchange Agreement") with the holder of a June 2018 Convertible Note having an outstanding principal amount of $68,882,583 for the purpose of (i) netting the June 2018 Investor Note issued by such holder to the Company having an aggregate principal amount of $68,000,000 against such holder's June 2018 Convertible Note and (ii) following such netting transaction, exchanging the remaining outstanding amount payable under such holder's June 2018 Convertible Note for a new non-convertible Senior Note issued by the Company to such holder (the "New Non-Convertible Note") in an aggregate principal amount of $20,400,000, subject to reduction as provided in the New Non-Convertible Note. As a result, such holder's June 2018 Convertible Note and the corresponding June 2018 Investor Note issued by such holder were each cancelled and became null and void.
Placement Agent Notes and Warrants [Member]
Senior Secured Convertible Notes and Warrants and Unit Offerings (Textual)
Placement agent notes and warrants, description																									The June Placement Agent Warrants allow the purchase of up to 8% of the number of shares of the Company’s common stock determined by dividing the aggregate purchase price of the Preferred Stock purchased by the Conversion Price of the June 2018 Convertible Notes in effect as of the Subscription Date (as defined in the June Placement Agent Warrant) and eight percent (8%) of the number of shares of common stock into which any Unrestricted Principal of the June 2018 Convertible Notes purchased is initially convertible at the Conversion Price in effect as of the Subscription Date, at an exercise price equal to the Conversion Price of the June 2018 Convertible Notes in effect as of the Subscription Date, without regard to any adjustment of the Conversion Price resulting from the anti-dilution provision of the June 2018 Convertible Notes, other than proportionate adjustments to the Conversion Price resulting from stock splits or combinations or similar proportionately applied changes to the Company’s outstanding common stock. During the nine months ended September 30, 2018, the Company issued 3,200 (800,000 pre-split) warrants at an exercise prices of $250 ($1.00 pre-split) per share.
Warrant [Member]
Senior Secured Convertible Notes and Warrants and Unit Offerings (Textual)
Common stock nominal exercise price | $ / shares																						$ 0.001			$ 0.001
September Notes [Member] | Placement Agent Notes and Warrants [Member]
Senior Secured Convertible Notes and Warrants and Unit Offerings (Textual)
Interest expenses
Warrant term																									5 years
Description of convertible debt																									Through the first nine months of 2017, the Company received $5,000,000 of cash payments for the February 2017 Notes.
February 2017 Notes [Member]
Senior Secured Convertible Notes and Warrants and Unit Offerings (Textual)
Number of instruments issued | ConvertibleNote									2
Principal amount									$ 5,681,818
Interest percentage																											6.00%
Interest expenses																								42,750		173,963
Notes, maturity date									Oct. 08, 2017
Maturity date, description																									The maturity date of any New Note was 45 days following the issuance of the New Note, and the conversion price of the New Notes was $1,125 ($4.50 pre-split), or, at the election of the Investor, the Investor could convert at the Alternate Conversion Price. The Alternate Conversion Price was defined as either (A) the lower of (i) $1,125 ($4.50 pre-split) and (ii) the greater of (I) $1,000 ($4.00 pre-split) and (II) 85% of the quotient of (x) the sum of the volume weighted average price of the common stock for each of the 5 consecutive trading days ending on the trading day immediately preceding the delivery of the Conversion Notice, divided by (y) 5 or (B) that price which shall be the lowest of (i) $750 ($3.00 pre-split) and (ii) the greater of (I) the Floor Price then in effect and (II) 85% of the quotient of (x) the sum of the volume weighted average price of the Company's common stock for each of the 5 consecutive trading days ending and including the date of the alternate conversion, divided by (y) 5.
Common stock issued upon convertible notes | shares																											7,411
Floor price variances																									The Floor Price was defined as $750 ($3.00 pre-split) through October 4, 2017 and $125 ($0.50 pre-split) following October 4, 2017.
Principal amount									$ 681,818
Interest amount of common stock																											$ 49,000
February 2017 Notes [Member] | Pre-split [Member]
Senior Secured Convertible Notes and Warrants and Unit Offerings (Textual)
Common stock issued upon convertible notes | shares																											1,852,886
February 2017 Notes [Member] | Placement Agent Notes and Warrants [Member]
Senior Secured Convertible Notes and Warrants and Unit Offerings (Textual)
Interest percentage																						8.00%			8.00%
Warrants issued to purchase common stock | shares																						533			533
Warrants exercise price | $ / shares																									$ 250
Warrant term																									5 years
Warrants issued | shares																						751			751
February 2017 Notes [Member] | Placement Agent Notes and Warrants [Member] | Pre-split [Member]
Senior Secured Convertible Notes and Warrants and Unit Offerings (Textual)
Warrants issued to purchase common stock | shares																						133,334			133,334
Warrants exercise price | $ / shares																									$ 1.00
Warrants issued | shares																						187,711			187,711
August 2017 Notes [Member]
Senior Secured Convertible Notes and Warrants and Unit Offerings (Textual)
Number of instruments issued | ConvertibleNote																					3
Principal amount																					$ 10,300,000
Interest percentage																					6.00%
Notes, maturity date																					Apr. 16, 2018
Principal amount																					$ 8,800,000
Description of convertible debt																											Additional Series A Note and the Series B Note, were $1,000 ($4.00 pre-split) for the Initial Series A Note and the Additional Series A Note and $750 ($3.00 pre-split) for the Series B Note.
August 2017 Notes [Member] | Placement Agent Notes and Warrants [Member]
Senior Secured Convertible Notes and Warrants and Unit Offerings (Textual)
Consideration received in cash for convertible note																											$ 8,800,000
Principal amount																						$ 9,050,000			$ 9,050,000
Interest percentage																						8.00%			8.00%
Warrants issued to purchase common stock | shares																											704
Warrant term																									5 years
August 2017 Notes [Member] | Placement Agent Notes and Warrants [Member] | Pre-split [Member]
Senior Secured Convertible Notes and Warrants and Unit Offerings (Textual)
Warrants issued to purchase common stock | shares																											176,000
August 2017 Notes [Member] | Minimum [Member] | Placement Agent Notes and Warrants [Member]
Senior Secured Convertible Notes and Warrants and Unit Offerings (Textual)
Warrant exercisable pre-split value																											$ 750
August 2017 Notes [Member] | Minimum [Member] | Placement Agent Notes and Warrants [Member] | Pre-split [Member]
Senior Secured Convertible Notes and Warrants and Unit Offerings (Textual)
Common stock at exercise prices | $ / shares																											$ 3.00
August 2017 Notes [Member] | Maximum [Member] | Placement Agent Notes and Warrants [Member]
Senior Secured Convertible Notes and Warrants and Unit Offerings (Textual)
Warrant exercisable pre-split value																											$ 3,568
August 2017 Notes [Member] | Maximum [Member] | Placement Agent Notes and Warrants [Member] | Pre-split [Member]
Senior Secured Convertible Notes and Warrants and Unit Offerings (Textual)
Common stock at exercise prices | $ / shares																											$ 14.27
Investor Note [Member]
Senior Secured Convertible Notes and Warrants and Unit Offerings (Textual)
Principal amount																		$ 60,000,000														$ 2,894,062
Warrants issued to purchase common stock | shares																17,414
Cash payment																$ 779,219		25,000,000
Restricted principal outstanding amount																						$ 20,388,861			$ 20,388,861
Investor Note [Member] | Pre-split [Member]
Senior Secured Convertible Notes and Warrants and Unit Offerings (Textual)
Warrants issued to purchase common stock | shares																4,353,581
February 2017 Investor Note [Member]
Senior Secured Convertible Notes and Warrants and Unit Offerings (Textual)
Description of notes conversion agreement																									To effect an exchange (the "Share Exchange") of 3,365 (841,250 pre-split) shares of the Company's common stock (the "Exchange Shares") for one or more senior secured convertible promissory notes in the form of the February Additional Note (the "New Note"), with the right to substitute the alternate conversion price of the New Note with the alternate conversion price of the Company's Series B Senior Secured Convertible Note (the "Series B Note") that was issued on August 16, 2017. Any New Note issued would be in a principal amount equal to the product of the prepayment amount ($2,500,000) multiplied by a fraction, the numerator of which is the number of the aggregate shares being tendered to the Company in the Share Exchange and the denominator of which is 3,365 (841,250 pre-spilt).
Investor Warrant [Member]
Senior Secured Convertible Notes and Warrants and Unit Offerings (Textual)
Consideration received in cash for convertible note																					$ 220,000
Principal amount																								$ 697,000		$ 697,000
Warrants issued to purchase common stock | shares																			40		7,572						6,860
Interest expenses																									$ 12,878,864
Warrants value																											$ 977,142
Investor additional shares of common stock | shares																											1,303
Warrants exercise price | $ / shares																			$ 3,578		$ 812.50				$ 812.50
Warrant expiration date																			Nov. 21, 2022		Apr. 16, 2022
Warrant expiration term																					5 years
Convertible debt contract description																					The $220,000 secured promissory note payable by the Investor was issued in exchange for a $250,000 Senior Secured Convertible Note; therefore, a discount of $30,000 was recognized upon issuance and accreted into interest expense over the life of the note using the effective interest method. Upon issuance, the Investor Warrant, which was determined to be a liability, was recorded at fair value and accounted for as an original issuance discount to the August 2017 Notes.
Conversion price | $ / shares																						$ 750			750
Investor Warrant [Member] | Pre-split [Member]
Senior Secured Convertible Notes and Warrants and Unit Offerings (Textual)
Warrants issued to purchase common stock | shares																			10,000		1,892,972						1,715,006
Investor additional shares of common stock | shares																											325,714
Warrants exercise price | $ / shares																			$ 14.31		$ 3.25				3.25
Conversion price | $ / shares																						$ 3.00			$ 3.00
Investor Warrant [Member] | Minimum [Member]
Senior Secured Convertible Notes and Warrants and Unit Offerings (Textual)
Warrants issued to purchase common stock | shares																						7,572			7,572
Warrants exercise price | $ / shares																									$ 750
Investor Warrant [Member] | Minimum [Member] | Pre-split [Member]
Senior Secured Convertible Notes and Warrants and Unit Offerings (Textual)
Warrants issued to purchase common stock | shares																						1,892,972			1,892,972
Warrants exercise price | $ / shares																									$ 3.00
Investor Warrant [Member] | Maximum [Member]
Senior Secured Convertible Notes and Warrants and Unit Offerings (Textual)
Warrants issued to purchase common stock | shares																						8,203			8,203
Warrants exercise price | $ / shares																									$ 812.50
Investor Warrant [Member] | Maximum [Member] | Pre-split [Member]
Senior Secured Convertible Notes and Warrants and Unit Offerings (Textual)
Warrants issued to purchase common stock | shares																						2,050,720			2,050,720
Warrants exercise price | $ / shares																									$ 3.25
November 2017 Notes [Member]
Senior Secured Convertible Notes and Warrants and Unit Offerings (Textual)
Principal amount																						$ 0			$ 0
Cash prepayments																							$ 58,959,736		58,959,736
Interest expenses
Notes, maturity date							Nov. 07, 2019
Common stock issued upon convertible notes | shares																						411,448			251,546
Common stock at exercise prices | $ / shares																						$ 3,015			$ 3,015		$ 3,015
Description of convertible debt				The Company entered into an amendment to the securities purchase agreement between the Company and the institutional investors holding the November 2017 Notes to reduce the number of shares of common stock required to be reserved for issuance under the November 2017 Notes from 200% to 110% of the maximum number of shares of common stock issuable upon conversion of the November 2017 Notes until the earlier of the January 2018 Notes Stockholder Approval Date (as defined below) and August 1, 2018. After such date, the required reserve amount will be increased back to 200% . As more fully described in Note 19 Subsequent Events, the Securities Purchase Agreement between the Company and certain institutional investors pursuant to which the Company issued the November 2017 Notes was amended to reduce the number of shares of common stock of the Company required to be reserved for issuance under the November 2017 Notes to 100% of the maximum number of shares of common stock of the Company issuable upon conversion of the November 2017 Notes.			The November 2017 Notes consist of a Senior Secured Convertible Note in the amount of $5,000,000 (the "November Initial Note") and a Senior Secured Convertible Note in the amount of $95,000,000 (the "November Additional Note") in exchange for an upfront cash payment of $5,000,000 and a senior secured promissory note of $95,000,000 (the "November 2017 Investor Note"). As of December 31, 2017, purchasers of the November 2017 Notes prepaid $15,650,000 of the November 2017 Investor Note with the remaining principal being subject to master netting agreements between the Company and such holders.																		The Company received cash prepayments on the November 2017 Investor Notes of $58,959,736, of which $58,959,736 of principal and $8,252,583 of accrued interest, were converted into 612,792 (58,905,544 pre-split) shares of the Company's common stock during the nine months ended September 30, 2018. As of September 30, 2018, there was no outstanding unrestricted principal under the November 2017 Notes and $20,388,861 in restricted principal outstanding for which there was a corresponding amount due under corresponding November 2017 Investor Notes. For the three and nine months ended September 30, 2018, the Company recognized $261,657 and $5,994,771 of interest expense pertaining to the November 2017 Notes and had $261,657 of accrued interest as of September 30, 2018.
Convertible debt contract description							The November 2017 Investor Notes the Company owed to the Investors a 5.25% interest obligation which is due quarterly and calculated on a 360-day basis. For the funded portion of the November 2017 Notes the Company has a 10% interest obligation.
Outstanding balance																									$ 0
Net proceeds from the sale of units																									$ 5,000,000
Additional interest																													$ 714,977		$ 1,028,730		$ 646,263
Conversion price | $ / shares																						$ 0.02			$ 0.02
November 2017 Notes [Member] | Pre-split [Member]
Senior Secured Convertible Notes and Warrants and Unit Offerings (Textual)
Common stock issued upon convertible notes | shares																						61,717,150			62,886,625
Common stock at exercise prices | $ / shares																											$ 12.06
November 2017 Notes [Member] | Placement Agent Notes and Warrants [Member]
Senior Secured Convertible Notes and Warrants and Unit Offerings (Textual)
Consideration received in cash for convertible note
Principal amount																						$ 100,000,000			$ 100,000,000
Interest percentage																						8.00%			8.00%
Warrants issued to purchase common stock | shares
Cash payment																									$ 58,959,736
Common stock at exercise prices | $ / shares																						$ 3,015			$ 3,015
Warrant term																									5 years
Principal amount																									$ 0
Accrued amount																									$ 261,657
November 2017 Notes [Member] | Placement Agent Notes and Warrants [Member] | Pre-split [Member]
Senior Secured Convertible Notes and Warrants and Unit Offerings (Textual)
Common stock at exercise prices | $ / shares																						$ 12.06			$ 12.06
November 2017 Notes [Member] | Minimum [Member]
Senior Secured Convertible Notes and Warrants and Unit Offerings (Textual)
Accrued amount																									$ 0
November 2017 Notes [Member] | Maximum [Member]
Senior Secured Convertible Notes and Warrants and Unit Offerings (Textual)
Principal amount																						$ 58,959,736			58,959,736
Interest expense																						261,657			6,113,340
Accrued interest																						261,657			261,657
Accrued amount																						$ 8,252,583			$ 8,252,583
Exchange Note [Member]
Senior Secured Convertible Notes and Warrants and Unit Offerings (Textual)
New note shares of common stock | shares								3,789
Trading price								$ 19,950,000
Exchange Note [Member] | Pre-split [Member]
Senior Secured Convertible Notes and Warrants and Unit Offerings (Textual)
New note shares of common stock | shares								947,218
Series A-1 Note [Member]
Senior Secured Convertible Notes and Warrants and Unit Offerings (Textual)
Principal amount																		25,000,000
Notes, maturity date																									Jan. 23, 2020
Bear interest rate																						10.00%			10.00%
Series A-1 Note [Member] | Pre-split [Member]
Senior Secured Convertible Notes and Warrants and Unit Offerings (Textual)
Common stock at exercise prices | $ / shares						$ 6.50
Warrant exercisable pre-split value						$ 1,625
Series B-1 Note [Member]
Senior Secured Convertible Notes and Warrants and Unit Offerings (Textual)
Principal amount																		35,000,000
Series B-1 Note [Member] | Pre-split [Member]
Senior Secured Convertible Notes and Warrants and Unit Offerings (Textual)
Common stock at exercise prices | $ / shares						$ 5.50
Warrant exercisable pre-split value						$ 1,375
January 2018 Investor Note [Member]
Senior Secured Convertible Notes and Warrants and Unit Offerings (Textual)
Principal amount																		$ 35,000,000
January 2018 Notes [Member]
Senior Secured Convertible Notes and Warrants and Unit Offerings (Textual)
Cash payment																						$ 6,000,000
Interest expenses
Common stock issued upon convertible notes | shares
Common stock at exercise prices | $ / shares																						$ 2,860			$ 2,860
Principal amount																						$ 6,000,000
Interest expense																						372,167			$ 1,182,130
Accrued interest																						372,167			$ 372,167
Converted shares | shares																									2,860
Description of convertible debt				The Company and the buyer entered into an amendment to the January Securities Purchase Agreement and the January 2018 Notes to reduce the number of shares of common stock required to be reserved for issuance under the January 2018 Notes from 200% to 100% of the maximum number of shares of common stock issuable upon conversion of the January 2018 Notes until the earlier of (1) the date stockholders approve resolutions providing for the issuance of the January 2018 Notes and the shares of common stock issuable upon conversion of the January 2018 Notes (the "January 2018 Notes Stockholder Approval" and the date the Stockholder Approval is obtained, the "January 2018 Notes Stockholder Approval Date") and (2) August 1, 2018. After such date, the required reserve amount will be increased back to 200%. The amendment to the January Securities Purchase Agreement also extended the date by which the Company must hold the special meeting to obtain the January 2018 Notes Stockholder Approval from June 1, 2018 to August 1, 2018. As more fully described in Note 19 Subsequent events, the January Securities Purchase Agreement was amended to reduce the number of shares of common stock of the Company required to be reserved for issuance under the January 2018 Notes to 125% of the maximum number of shares of common stock of the Company issuable upon conversion of the January 2018 Notes.																					The Company received cash payments on the January 2018 Notes of $6,000,000, of which $6,000,000 of principal and $909,021 of accrued interest, were converted into 109,897,912 shares of the Company's common stock during the third quarter of 2018. Additionally, during the third quarter of 2018, the Company converted principal under the January 2018 Notes in the amount of $820,367, and interest of $128,068 into 1,896,872 shares of the Company's common stock. As of September 30, 2018, there was no outstanding unrestricted principal on the January Notes. For the three and nine months ended September 30, 2018, the Company recognized $372,167 and $1,182,130 of interest expense pertaining to the January 2018 Notes and had $372,167 of accrued interest as of September 30, 2018.
Additional interest amount					$ 468,180
Outstanding balance																									$ 0
Accrued amount																						$ 909,021
Capitalized balance																															$ 352,187
Conversion price | $ / shares																						$ 1.83			$ 1.83
Converted pre split shares, description																									Converted into 109,897,912 shares of the Company's common stock during the third quarter of 2018. Additionally, during the third quarter of 2018, the Company converted principal under the January 2018 Notes in the amount of $820,367, and interest of $128,068 into 1,896,872 shares of the Company's common stock.
January 2018 Notes [Member] | Pre-split [Member]
Senior Secured Convertible Notes and Warrants and Unit Offerings (Textual)
Common stock at exercise prices | $ / shares																						$ 11.44			$ 11.44
Warrants issued | shares																						216,786			216,786
January 2018 Notes [Member] | Placement Agent Notes and Warrants [Member]
Senior Secured Convertible Notes and Warrants and Unit Offerings (Textual)
Principal amount																						$ 0			$ 0
Interest percentage																						8.00%			8.00%
Cash payment																									$ 31,000,000
Warrant term																									5 years
Warrants issued | shares																						867			867
January 2018 Notes [Member] | Placement Agent Notes and Warrants [Member] | Pre-split [Member]
Senior Secured Convertible Notes and Warrants and Unit Offerings (Textual)
Common stock at exercise prices | $ / shares																						$ 11.44			$ 11.44
Warrant exercisable pre-split value																						$ 2,860			$ 2,860
Warrants issued | shares																						174,826			174,826
February 2018 Units Offering [Member]
Senior Secured Convertible Notes and Warrants and Unit Offerings (Textual)
Description of notes conversion agreement						The Company sold an aggregate of approximately $105 million worth of units (the "Units") of the Company's securities to Canaccord Genuity Inc., on behalf of itself and as representative of the underwriters (the "Underwriters"), pursuant to which the Company issued and sold to the Underwriters in a best-efforts underwritten public offering (the "Offering") at a purchase price of $5.192 per Unit with each Unit consisting of (A) 7,425,000 Series A-1 units (the "Series A-1 Units"), with each Series A-1 Unit consisting of (i) 0.004 (one pre-split) share of the Company's common stock, and (ii) 0.004 (one pre-split) Series A-1 warrant to purchase 0.004 (one pre-split) share of the Company's common stock (a "Series A-1 Warrant"); and (B) for those purchasers whose purchase of Series A-1 Units would result in the purchaser, together with its affiliates and certain related parties, beneficially owning more than 9.99% of the Company's outstanding common stock following the consummation of the Offering, 11,675,000 Series B-1 units (the "Series B-1 Units"), consisting of (i) 0.004 (one pre-split) pre-funded Series B-1 warrant to purchase 0.004 (one pre-split) share of common stock (a "Series B-1 Warrant"; and the Series B-1 Warrants, together with the Series A-1 Warrants, the "Warrants") and (ii) 0.004 (one pre-split) Series A-1 Warrant.																			In addition, the Series A-1 Warrants are subject to adjustment of the applicable exercise price then in effect, if, as of December 17, 2018 (the "Adjustment Date"), the quotient determined by dividing the (x) sum of the VWAP (as defined in the Series A-1 Warrant) of the common stock for each trading day during the 10 consecutive trading day period ending and including the trading day immediately preceding the Adjustment Date, divided by (y) 0.4 (10 pre-split) (all such determinations to be appropriately adjusted for any stock dividend, stock split, stock combination or other similar transaction during such period) (the "Adjustment Price"), is less than the applicable exercise price. If the Adjustment Price is less than the applicable exercise price as of the Adjustment Date, then the exercise price shall be automatically adjusted to be equal to the Adjustment Price.
Net proceeds from the sale of units																									$ 96,900,000
Underwriting discounts and commissions																									5,900,000
Offering expenses																									500,000
Financial advisory fee																									1,900,000
April 2018 Units Offering [Member]
Senior Secured Convertible Notes and Warrants and Unit Offerings (Textual)
Convertible debt contract description															The Company sold an aggregate of approximately $30 million worth of units (the "April 2018 Units") of the Company's securities to Canaccord Genuity Inc., on behalf of itself and as representative of the underwriters (the "April Offering Underwriters"), pursuant to which the Company issued and sold to the April Offering Underwriters in a best-efforts underwritten public offering (the "April 2018 Offering") at a purchase price of $2.59875 per April 2018 Unit with each April 2018 Unit consisting of (A) 10,500,000 Series A-2 units (the "Series A-2 Units"), with each Series A-2 Unit consisting of (i) 0.004 (one pre-split) share (an "April Share") of the Company's common stock, and (ii) 0.004 (one pre-split) Series A-2 warrant to purchase 0.004 (one pre-split) share of common stock (the "Series A-2 Warrants"); and (B) for those purchasers whose purchase of Series A-2 Units would result in the purchaser, together with its affiliates and certain related parties, beneficially owning more than 9.99% of the Company's outstanding common stock following the consummation of the April 2018 Offering, 500,000 Series B-2 units (the "Series B-2 Units", consisting of (i) 0.004 (one pre-split) pre-funded Series B-2 warrant to purchase 0.004 (one pre-split) share of common stock (the "Series B-2 Warrants", and together with the Series A-2 Warrants, the "April Warrants") and (ii) 0.004 (one pre-split) Series A-2 Warrant. The April Shares, Series A-2 Warrants and Series B-2 Warrants were immediately separable.
Additional interest amount																									600,000
Net proceeds from the sale of units																									27,700,000
Underwriting discounts and commissions																									1,700,000
Offering expenses																									$ 1,000,000
Series A-2 Warrants [Member]
Senior Secured Convertible Notes and Warrants and Unit Offerings (Textual)
Common stock at exercise prices | $ / shares																						$ 250			$ 250
Warrants issued | shares																						2,000			2,000
Series A-2 Warrants [Member] | Pre-split [Member]
Senior Secured Convertible Notes and Warrants and Unit Offerings (Textual)
Common stock at exercise prices | $ / shares																						$ 1.00			$ 1.00
Warrants issued | shares																						500,000			500,000
Series B-2 Warrants [Member]
Senior Secured Convertible Notes and Warrants and Unit Offerings (Textual)
Common stock at exercise prices | $ / shares																						$ 687.50			$ 687.50
Common stock nominal exercise price | $ / shares																						0.001			0.001
Series B-2 Warrants [Member] | Pre-split [Member]
Senior Secured Convertible Notes and Warrants and Unit Offerings (Textual)
Common stock at exercise prices | $ / shares																						$ 2.75			$ 2.75
June 2018 Convertible Notes and Series A Preferred Stock [Member]
Senior Secured Convertible Notes and Warrants and Unit Offerings (Textual)
Principal amount																						$ 0			$ 0
Interest percentage																						1.50%			1.50%
Interest expenses
Prepayments of the investor note																						24,600,000			$ 24,600,000
Description of notes conversion agreement														The Company issued and sold 20,500 shares of Series A Preferred Stock of the Company (the "Preferred Stock") and Series B-2 Senior Convertible Notes in the aggregate principal amount of $164,000,000 (which includes an approximate 15.0% original issue discount) (the "June 2018 Convertible Notes"), for total consideration consisting of an aggregate cash payment to the Company of $20,500,000 and secured promissory notes payable by the June Buyers to the Company (the "June 2018 Investor Notes") in the aggregate principal amount of $139,400,000. Unless earlier converted or redeemed, the June 2018 Convertible Notes would have matured on June 26, 2020. The maturity date of the June 2018 Investor Notes was June 26, 2060. Upon issuance, (i) $24,600,000 in principal amount of the June 2018 Convertible Notes consisted of "Unrestricted Principal", which is defined as that portion of the principal amount of June 2018 Convertible Note that may be converted at any time and is not subject to netting against any June 2018 Investor Notes, and (ii) the balance of the principal amount under the June 2018 Convertible Notes, equal to $139,400,000, consisted entirely of "Restricted Principal", which is defined as that portion of the principal amount of a June 2018 Convertible Note that equals the outstanding principal amount of a corresponding June 2018 Investor Note.											In the event of an event of default interest under the June 2018 Convertible Notes could be increased to 15% during the first 30 days following the occurrence and continuance of an event of default and to 18% thereafter (the "Default Rate").
Common stock at exercise prices | $ / shares																												$ 250
Principal amount																						0
Interest expense																						959,933			$ 965,233
Accrued interest																						$ 959,933			$ 959,933
Description of convertible debt																									On any unfunded principal balance of the June 2018 Investor Notes the Company owed to the June Buyers a 5.25% interest obligation which was due quarterly and calculated on a 360-day basis. For the funded portion of the June 2018 Notes the Company had a 10% interest obligation.
Accrued amount
Conversion price | $ / shares			$ 250																			$ 250			$ 250
Restricted principal outstanding amount																						$ 74,800,000			$ 74,800,000
June 2018 Convertible Notes and Series A Preferred Stock [Member] | Pre-split [Member]
Senior Secured Convertible Notes and Warrants and Unit Offerings (Textual)
Conversion price | $ / shares																						$ 1.00			$ 1.00			$ 1.00
July 13, 2018 Demand Note [Member]
Senior Secured Convertible Notes and Warrants and Unit Offerings (Textual)
Consideration received in cash for convertible note			$ 5,000,000
Principal amount			$ 6,806,850
Interest percentage			10.00%
Cash payment			$ 1,806,850
Outstanding balance										$ 6,800,000
Bear interest rate			15.00%
July 27, 2018 Demand Note [Member]
Senior Secured Convertible Notes and Warrants and Unit Offerings (Textual)
Consideration received in cash for convertible note											$ 5,000,000
Principal amount											$ 6,200,000
Interest percentage											15.00%
Convertible debt contract description											The holder could make a demand for full payment of the July 27 Demand Note from and after (x) with respect to up to $3,100,000 of the principal outstanding under the July 27 Demand Note (the "Initial Principal"), August 1, 2018 or (y) with respect to any other amounts then outstanding under the July 27 Demand Note, August 5, 2018. The Company was required to use all proceeds received by the Company on or after July 31, 2018 from sales of common stock under its ATM Offering against any Initial Principal until no Initial Principal remains outstanding, and thereafter, against any remaining amounts due under the July 27 Demand Note. The July 27 Demand Note's principal, together with accrued and unpaid late charges could be prepaid by the Company without penalty. With the agreement of the holder, principal and accrued and unpaid late charges on the July 27 Demand Note could be applied to all, or any part, of the purchase price of securities to be issued upon the consummation, after July 27, 2018, of an offering of securities by the Company to the holder. Any amount of principal or other amounts due which is not paid when due (a "Payment Default") would result in a late charge being incurred and payable by the Company to the holder in an amount equal to interest on such amount as the rate of 15% per year from the date such amount was due until the same was paid in full. If a Payment Default remained outstanding for a period of 48 hours, the holder could require the Company to redeem all or a portion of the July 27 Demand Note at a redemption price of 130%.
Outstanding balance																									$ 6,200,000
Original issue discount											$ 1,200,000
Notice of Potential Delisting from NASDAQ [Member]
Senior Secured Convertible Notes and Warrants and Unit Offerings (Textual)
Description of notes conversion agreement													The Company's common stock for the purpose of exchanging outstanding warrants to purchase an aggregate of 106,437 (26,609,269 pre-split) shares of common stock (the "June Exchange Warrants") for an aggregate of 90,472 (22,617,879 pre-split) shares of common stock (collectively, the "June Exchange Shares"), based on a ratio of 0.85 June Exchange Shares for each warrant share.
Gain on exchange of warrants													$ 301,500
MoviePass, Inc. [Member]
Senior Secured Convertible Notes and Warrants and Unit Offerings (Textual)
Common stock at exercise prices | $ / shares
Investor [Member]
Senior Secured Convertible Notes and Warrants and Unit Offerings (Textual)
Principal amount																						$ 40,756,847			$ 64,959,736
Interest amount of common stock																						$ 5,537,785			$ 9,161,604
Converted shares | shares																						728,934,054			729,185,600
Investor [Member] | Pre-split [Member]
Senior Secured Convertible Notes and Warrants and Unit Offerings (Textual)
Converted shares | shares																						23,303,205,463			23,362,110,963
Investor [Member] | August 2017 Notes [Member]
Senior Secured Convertible Notes and Warrants and Unit Offerings (Textual)
Principal amount																						$ 0			$ 0
Interest expenses																						$ 0			$ 37,126
Description of convertible debt																											The Investor had fully prepaid the August 2017 Investor Note and converted $5,794,560 in principal amount, plus accrued interest, of the August 2017 Notes into 5,931 (1,482,639 pre-split) shares of the Company's common stock. On any principal balance owed by the Company to the Investor, a 6% interest obligation is due quarterly and calculated on a 360-day basis.
New note shares of common stock | shares																	4,678
Outstanding balance																	$ 4,677,899
Accrued amount																	$ 37,126
Investor [Member] | August 2017 Notes [Member] | Pre-split [Member]
Senior Secured Convertible Notes and Warrants and Unit Offerings (Textual)
New note shares of common stock | shares																	1,169,475
Investor [Member] | November 2017 Notes [Member]
Senior Secured Convertible Notes and Warrants and Unit Offerings (Textual)
Principal amount							$ 100,000,000

XML

Common and Preferred Stock (Details) - $ / shares		1 Months Ended		9 Months Ended
	Feb. 05, 2018	Jul. 24, 2018	Jul. 23, 2018	Sep. 30, 2018	Dec. 31, 2017
Common and Preferred Stock (Textual)
Reverse stock split, description		The Company effected a reverse stock-split of its issued and outstanding common stock at a ratio of one-for-250 ("Reverse Stock Split"). The Company filed a Certificate of Amendment to its Certificate of Incorporation with the Secretary of State of the State of Delaware effecting the Reverse Stock Split. The Reverse Stock Split did not affect the number of authorized shares of common stock, which, following the increase in authorized shares effected on July 23, 2018 discussed in Note 11, remains at 5,000,000,000 shares.		The Special Meeting of Stockholders scheduled to be held on November 14, 2018 to provide stockholders with an opportunity to vote on the proposed reverse stock split in a ratio of 1 share-for-2 shares up to a ratio of 1 share-for-500 shares has been cancelled. The Company was presenting the reverse stock split proposal in an effort to regain compliance with Rule 5550(a)(2). Since the Company will not be able to effect a reverse stock split ten business days prior to December 18, 2018, absent an extension by The Nasdaq Capital Market (of which there can be no assurance) the Company believes that our common stock will be subject to delisting from The Nasdaq Capital Market, which would adversely impact the liquidity and marketability of our common stock.
Preferred stock, shares issued				20,500	0
Common stock voting rights				Each share of Preferred Stock is entitled to 3,205 votes per share on all matters on which holders of common stock are entitled to vote. However, the amount of votes with respect to the Preferred Stock held by any holder, when aggregated with any other voting securities of the Company held by such holder, cannot exceed 19.9% of the Company's outstanding voting power calculated as of June 21, 2018 (or such greater percentage allowed by Nasdaq without any stockholder approval requirements).
Redemption percentage				15.00%
Preferred stock, par value				$ 0.01	$ 0.01
Liquidation preference, description				Upon any liquidation, dissolution or winding up of the Company, the holders of the shares of Preferred Stock will be entitled to receive in cash out of the assets of the Company, before any amount is paid to the holders of any junior stock, including common stock of the Company, an amount per share of Preferred Stock equal to 100% of the stated value per share (which is equal to $1,000) plus $0.01.
Common Stock [Member]
Common and Preferred Stock (Textual)
Stockholders pre-split	<div>The Company’s stockholders approved an amendment to the Company’s Certificate of Incorporation to increase the number of authorized shares of common stock from 100,000,000 to 500,000,000 shares (the “Charter Amendment”).</div>		The Company's stockholders approved an amendment to the Company's Certificate of Incorporation to increase the number of authorized shares of common stock from 500,000,000 to 5,000,000,000 shares and to increase the total number of authorized shares of capital stock from 502,000,000 to 5,002,000,000 (the "Authorized Share Increase"), of which 2,000,000 shares with a par value of one cent ($0.01) per share shall be designated as "Preferred Stock" and 5,000,000,000 shares with a par value of one cent ($0.01) per share shall be designated as "Common Stock." Following the stockholder approval, a Certificate of Amendment to the Company's Certificate of Incorporation was filed with the Secretary of State of the State of Delaware on July 23, 2018, at which time the Authorized Share Increase became effective.
Board of Directors [Member]
Common and Preferred Stock (Textual)
Reverse stock split, description		The number of authorized shares of common stock, which (following the Authorized Share Increase) is 5,000,000,000 shares. A proportionate adjustment was made to (i) the per share exercise price and the number of shares issuable upon the exercise or conversion of the Company's outstanding equity awards, options and warrants to purchase shares of common stock and outstanding convertible notes and (ii) the number of shares reserved for issuance pursuant to the Company's 2014 Equity Incentive Plan. Fractional shares were not issued as a result of the Reverse Stock Split; instead, the Board of Directors, determined to effect an issuance of shares to holders that would otherwise be entitled to a fractional share such that any fractional shares were rounded up to the nearest whole number.

XML

Fair Value of Financial Assets and Liabilities Measured on a Recurring Basis (Details) - USD ($)	Sep. 30, 2018	Dec. 31, 2017
Liabilities
Derivative liability - warrants	$ 60,809	$ 67,288,800
Derivative liability - conversion feature		4,834,462
Total	60,809	72,123,262
Level 1 [Member]
Liabilities
Derivative liability - warrants	60,809
Derivative liability - conversion feature
Total	60,809
Level 2 [Member]
Liabilities
Derivative liability - warrants
Derivative liability - conversion feature
Total
Level 3 [Member]
Liabilities
Derivative liability - warrants	60,809	67,288,800
Derivative liability - conversion feature		4,834,462
Total	$ 60,809	$ 72,123,262

XML

Fair Value of Financial Assets and Liabilities Measured on a Recurring Basis (Details 1)	9 Months Ended
	Sep. 30, 2018 USD ($)
Fair Value of Financial Assets and Liabilities Measured on a Recurring Basis [Abstract]
Balance at December 31, 2017	$ 72,123,262
Issuances to debt discount	105,223,694
Issuances to interest expense	40,734,226
Reclass from APIC to derivative - February offering	158,944,798
Reclass from APIC to derivative - April offering	33,997,600
Warrants issued in acquisition of Moviefone	5,475,500
Gain on exchange of warrants	(301,487)
Settlement of warrant liability for March warrant exchange	(12,894,165)
Settlement of warrant liability for June warrant exchange	(5,202,100)
Gain on March exchange (cash paid)	(781,195)
Conversion to paid-in capital	(134,365,641)
Gain on extinguishment	(60,524,508)
Change in FMV warrant	(194,058,069)
Change in FMV derivative	(8,311,106)
Balance at September 30, 2018	$ 60,809

XML

Fair Value of Financial Assets and Liabilities Measured on a Recurring Basis (Details 2) - $ / shares	9 Months Ended	12 Months Ended
	Sep. 30, 2018	Dec. 31, 2017
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Dividend yield	0.00%	0.00%
Minimum [Member]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Expected volatility	165.00%	45.00%
Risk free interest rate	2.40%	1.06%
Contractual term (in years)	1 year 1 month 20 days	2 months 8 days
Exercise price	$ 0.25	$ 0.25
Exercise price pre split	$ 0.01	$ 0.001
Maximum [Member]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Expected volatility	280.00%	270.00%
Risk free interest rate	2.93%	2.20%
Contractual term (in years)	4 years 6 months 18 days	5 years
Exercise price	$ 3,015	$ 3,577.50
Exercise price pre split	$ 1,812.50	$ 14.310

XML

Stock Based Compensation (Details) - Stock option [Member]	9 Months Ended
	Sep. 30, 2018 USD ($) $ / shares shares
Option Indexed to Issuer's Equity [Line Items]
Outstanding, Options for Common Shares | shares	28,396,428
Granted, Options for Common Shares | shares	39,809,175
Exercised, Options for Common Shares | shares
Forfeited, cancelled, expired, Options for Common Shares | shares
Outstanding, Options for Common Shares | shares	68,205,603
Vested and exercisable, Options for Common Shares | shares	27,476,989
Outstanding, Weighted Average Exercise Price | $ / shares	$ 0.14
Granted, Weighted Average Exercise Price | $ / shares	0.43
Exercised, Weighted Average Exercise Price | $ / shares
Forfeited, cancelled, expired, Weighted Average Exercise Price | $ / shares
Outstanding, Weighted Average Exercise Price | $ / shares	0.31
Vested and exercisable, Weighted Average | $ / shares	$ 0.20
Outstanding, Remaining Contractual Term	9 years 1 month 16 days
Outstanding, Remaining Contractual Term	8 years 11 months 4 days
Vested and exercisable, Remaining Contractual Term	8 years 6 months 29 days
Outstanding, Aggregate Intrinsic Value | $	$ 8,313,684
Outstanding, Aggregate Intrinsic Value | $	6,760,947
Vested and exercisable, Aggregate Intrinsic Value | $	$ 5,042,235

XML

Stock Based Compensation (Details 1)	9 Months Ended
	Sep. 30, 2018
Stock Based Compensation [Abstract]
Risk-free interest rate	2.50%
Expected life of options - years	5 years 9 months 14 days
Expected stock price volatility	37.20%
Expected dividend yield	0.00%

XML

Stock Based Compensation (Details Textual) - USD ($)	3 Months Ended	9 Months Ended	12 Months Ended
	Sep. 30, 2018	Sep. 30, 2018	Dec. 31, 2017
Stock Based Compensation (Textual)
Selling, general and administrative expenses
Unamortized stock compensation expense
Weighted average grant date fair value per share of stock options granted		$ 0.16
Employee Stock Option [Member]
Stock Based Compensation (Textual)
Recognized expense	1,170,726	$ 4,257,970	$ 15,631,605
Unamortized stock compensation expense		250,333
Share based compensation expense	$ 232,188	$ 5,913,349
Granted shares		39,809,175
Exercise price		$ 0.43
Weighted average grant date fair value per share of stock options granted
MoviePass, Inc. [Member]
Stock Based Compensation (Textual)
Common stock for issuance grant	39,809,175	39,809,175
Exercise price		$ 0.43
Minimum [Member]
Stock Based Compensation (Textual)
Award date ranging from agreement		18 months
Maximum [Member]
Stock Based Compensation (Textual)
Award date ranging from agreement		24 months
Consultant [Member]
Stock Based Compensation (Textual)
Shares issued to plan
Equity incentive plan, description		The Company awarded 0 and 2,027 (506,750 pre-split) shares, respectively, to consultants who provided services to the Company.
Employees [Member] | Consultant [Member]
Stock Based Compensation (Textual)
Shares issued to plan
Equity incentive plan, description	The Company issued 0 and 4,809 (1,202,167 pre-split) shares of common stock to employees and consultants for services provided during 2017 during the three and nine months ended September 30, 2018, respectively.	The Company issued 0 and 6,809 (1,702,167 pre-split) shares of common stock to employees and consultants for services provided during 2017 during the three and nine months ended September 30, 2018, respectively
2014 Equity Incentive Plan [Member]
Stock Based Compensation (Textual)
Terminate date		Mar. 03, 2024
Equity incentive plan, description		The 2014 Plan as amended set aside and reserved 12,000 (3,000,000 pre-split) shares of the Company's common stock for grant and issuance in accordance with its terms and conditions. Persons eligible to receive awards from the 2014 Plan include employees (including officers and directors) of the Company and its affiliates, consultants who provide significant services to the Company or its affiliates, and directors who are not employees of the Company or its affiliates (the "Participants"). The 2014 Plan permits the Company to issue to Participants qualified and/or non-qualified options to purchase the Company's common stock, restricted common stock, performance units, and performance shares. The 2014 Plan will terminate on March 3, 2024. The Company's Board of Directors is responsible for administration of the 2014 Plan and has the sole discretion to determine which Participants will be granted awards and the terms and conditions of the awards granted. The 2014 Plan also provides for an annual automatic increase in the number of shares of common stock authorized for issuance thereunder by the lesser of (A) 12,000 (3,000,000 pre-split) shares of the Company's common stock or the equivalent of such number of shares after the administrator of the 2014 Plan, in its sole discretion, has interpreted the effect of any stock split, stock dividend, combination, recapitalization or similar transaction; (B) a number of shares of common stock equal to 5% of the Company's common stock outstanding on January 2nd of each year, and (C) an amount determined by the Company's Board of Directors. A total of 10,440 (2,610,000 pre-split) shares of common stock remained available for issuance as of September 30, 2018.
2011 Plan [Member] | MoviePass, Inc. [Member]
Stock Based Compensation (Textual)
Common stock for issuance grant	95,000,000	95,000,000
Stock options granted pursuant to the term, description		Stock options granted pursuant to the terms of the 2011 Plan generally cannot be granted with an exercise price of less than 100% of the fair market value on the date of grant. The term of the options granted under the 2011 Plan cannot be greater than 10 years. Options vest at varying rates generally over three to five years along with performance-based options.

XML

Concentration of Credit Risk (Details)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2018 Customer	Sep. 30, 2017 Customer	Sep. 30, 2018 Customer Vendor segments	Sep. 30, 2017 Customer	Dec. 31, 2017 Customer Vendor segments
Consulting revenues [Member]
Concentration of Credit Risk (Textual)
Number of customers	4	4	4	4
Concentration risk, percentage	85.00%	92.80%	92.30%	88.90%
Consulting accounts receivables [Member]
Concentration of Credit Risk (Textual)
Number of customers			7		4
Concentration risk, percentage			100.00%		62.60%
Consulting accounts payables [Member]
Concentration of Credit Risk (Textual)
Number of vendors | Vendor			5		3
Concentration risk, percentage			90.80%		82.70%
Technology accounts payables [Member]
Concentration of Credit Risk (Textual)
Number of vendors | Vendor			5		3
Concentration risk, percentage			90.80%		60.80%
Subscription accounts receivables [Member]
Concentration of Credit Risk (Textual)
Number of customers			4		2
Concentration risk, percentage			96.70%		100.00%
Subscription accounts payables [Member]
Concentration of Credit Risk (Textual)
Number of vendors | segments			6		1
Concentration risk, percentage			51.80%		41.00%

XML

Commitments and Contingencies (Details)	Sep. 30, 2018 USD ($)
Commitments and Contingencies [Abstract]
Less than 1 year	$ 74,094
1 to 3 years	548,808
3 to 5 years	347,985
Thereafter
Total	$ 970,887

XML

Commitments and Contingencies (Details Textual) - USD ($)	1 Months Ended	3 Months Ended		9 Months Ended
	Apr. 30, 2017	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Commitments and Contingencies (Textual)
Rent expense		$ 585,702	$ 81,051	$ 1,046,790	$ 215,068
Lease agreement, term	3 years
Monthly rent payments for the first 12 months	$ 5,026
Monthly rent payments for the next 12 months	5,177
Monthly rent payments for the last 12 months	$ 5,332
Lease expiration, date	Apr. 30, 2020

XML

Transactions with Related Parties (Details) - USD ($)		1 Months Ended		9 Months Ended
	Oct. 05, 2017	Aug. 28, 2018	May 22, 2018	Sep. 30, 2018	Sep. 25, 2018	Jul. 27, 2018
HMIT [Member]
Transactions with Related Parties (Textual)
Stockholders pre-split			In exchange for such Lockup Agreement the Company agreed to issue to HMIT 2,000 (500,000 pre-split) shares of HMNY stock. As of September 30, 2018, the shares issuable to HMIT had not yet been issued and accordingly, the Company accrued $225,000 with respect thereto, representing the value of the shares on May 22, 2018.
Moviepass Films [Member]
Transactions with Related Parties (Textual)
Payment of due to related parties					$ 100,000
Moviepass Films [Member] | Georgia Film Fund 56, LLC [Member]
Transactions with Related Parties (Textual)
Payments of related parties		$ 3,499,400
Payment of due to related parties		$ 2,625,000
Description of related parties		The terms of the related note payable provide for annual interest of 20% and the amounts are due in September 2020.
Moviepass Films [Member] | Georgia Film Fund 79, LLC [Member]
Transactions with Related Parties (Textual)
Description of related parties				George Furla and Randall Emmett, CO-CEO's of MoviePass Films, entered into equity finance agreements with Georgia Film Fund 79, LLC, a wholly owned subsidiary of MoviePass Films for the partial funding of the production of the film 10 Minutes Gone, in the amounts of $400,000 and $250,000, respectively. These amounts are included in due to related parties on the balance sheet at September 30, 2018.The principal amounts are repayable from the proceeds of the film plus interest at 20% per annum The maximum interest payable with respect to these equity finance agreements is subject to a two year cap.
Consulting Agreement [Member]
Transactions with Related Parties (Textual)
Servicing fees	$ 18,750
Mr. Gadiyaram [Member]
Transactions with Related Parties (Textual)
Servicing fees				$ 18,750
HMNY [Member] | Georgia Film Fund 50, LLC [Member]
Transactions with Related Parties (Textual)
Payments of related parties						$ 525,000
Payment of due to related parties						$ 400,000

XML

Provision for Income Taxes (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Provision for Income Taxes (Textual)
Tax provision	$ 10,283	$ (2,747)	$ 46,953	$ 39,110
US statutory tax rates			21.00%	35.00%

XML

Segment Reporting (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017	Dec. 31, 2017	Dec. 31, 2016
Segment Reporting Information [Line Items]
Revenue	$ 81,339,242	$ 1,173,023	$ 204,950,836	$ 3,672,036
Cost of revenue	109,635,383	946,308	424,371,078	2,969,357
Gross margin	(28,296,141)	226,715	(219,420,242)	702,679
Loss on goodwill	38,524,016		38,524,016
Total other operating expenses	58,118,746	3,302,979	101,365,497	10,881,362
Loss from operations	(86,414,887)	(3,076,264)	(320,785,739)	(10,178,683)
Total other income/(expense)	(50,770,628)	(40,386,701)	73,915,367	(44,961,796)
Provision for income taxes	10,283	(2,747)	46,953	39,110
Total net income/(loss)	(129,612,783)	(43,460,218)	(187,771,681)	(55,179,589)
Cash and cash equivalents	4,850,972	$ 1,663,879	4,850,972	1,663,879	$ 24,949,393	$ 2,747,240
Accounts receivable	30,722,585		30,722,585		27,470,219
Prepaid expenses and other current assets	3,469,645		3,469,645		3,557,811
Property and equipment	379,666		379,666		234,035
Intangible assets	30,097,399		30,097,399		28,536,782
Goodwill	49,148,120		49,148,120		79,137,177
Deposits and other assets	209,492		209,492		147,171
Accounts payable and accrued expenses	17,691,260		17,691,260		13,144,003
Liabilities to be settled in stock	5,988,363		5,988,363		21,320,705
Notes Payable, net of current portion	2,775,000		2,775,000
Derivative liability					4,834,462
Due to related parties	1,150,000		1,150,000
Investment in films	13,403,433		13,403,433
Consulting [Member]
Segment Reporting Information [Line Items]
Revenue			2,471,223	3,672,036
Cost of revenue			2,023,707	2,969,357
Gross margin			447,516	702,679
Total other operating expenses			19,908,946	6,280,032
Loss from operations			(19,461,430)	(5,577,353)
Total other income/(expense)			73,915,297	(44,914,576)
Provision for income taxes			(8,826)	39,110
Total net income/(loss)			54,445,041	(50,531,039)
Cash and cash equivalents	3,674,904		3,674,904		569,886
Accounts receivable	290,561		290,561		332,753
Prepaid expenses and other current assets	638,522		638,522		3,382,127
Property and equipment	151,379		151,379		96,464
Intangible assets	805,482		805,482
Goodwill
Deposits and other assets	128,232		128,232		129,119
Accounts payable and accrued expenses	4,475,771		4,475,771		2,088,867
Liabilities to be settled in stock	5,669,263		5,669,263		20,875,045
Convertible notes payable					3,611,627
Warrant liability	60,809		60,809		67,288,800
Derivative liability					4,834,462
Technology [Member]
Segment Reporting Information [Line Items]
Revenue
Cost of revenue
Gross margin
Total other operating expenses			2,871,608	4,601,330
Loss from operations			(2,871,608)	(4,601,330)
Total other income/(expense)			70	(47,220)
Provision for income taxes
Total net income/(loss)			(2,871,538)	(4,648,550)
Cash and cash equivalents	160,124		160,124		21,933,765
Accounts receivable
Unbilled receivables
Prepaid expenses and other current assets	3,333		3,333		21,666
Property and equipment	81,613		81,613		95,301
Intangible assets	1,748,388		1,748,388		2,829,295
Goodwill	8,534,958		8,534,958
Deposits and other assets	10,052		10,052		10,052
Accounts payable and accrued expenses	164,447		164,447		607,622
Liabilities to be settled in stock	319,100		319,100		445,660
Convertible notes payable
Warrant liability
Derivative liability
Deferred revenue
Subscription and Marketing, Promotional Services, and Films [Member]
Segment Reporting Information [Line Items]
Revenue			202,479,613
Cost of revenue			422,347,371
Gross margin			(219,867,758)
Loss on goodwill			38,524,016
Total other operating expenses			40,060,927
Loss from operations			(298,452,701)
Total other income/(expense)
Provision for income taxes			(38,127)
Total net income/(loss)			(298,490,828)
Cash and cash equivalents	1,015,944		1,015,944		2,445,742
Accounts receivable	30,432,024		30,432,024		27,137,466
Unbilled receivables
Prepaid expenses and other current assets	2,827,790		2,827,790		154,018
Property and equipment	146,674		146,674		42,270
Intangible assets	27,543,529		27,543,529		25,707,487
Goodwill	79,137,177		79,137,177		79,137,177
Deposits and other assets	496,888		496,888		8,000
Accounts payable and accrued expenses	13,051,042		13,051,042		10,447,514
Liabilities to be settled in stock
Notes Payable, net of current portion	8,698,250		8,698,250
Convertible notes payable
Warrant liability
Derivative liability
Deferred revenue	27,035,060		27,035,060		54,425,630
Due to related parties	1,150,000		1,150,000
Investment in films	$ 13,403,433		$ 13,403,433

XML

Segment Reporting (Details Textual)	9 Months Ended
	Sep. 30, 2018 segments
Segment Reporting (Textual)
Number of operating segments	3

XML

Subsequent Events (Details) - USD ($)			1 Months Ended				9 Months Ended
	Oct. 04, 2018	Nov. 06, 2017	Jul. 24, 2018	Jan. 31, 2018	Jan. 23, 2018	Aug. 27, 2017	Sep. 30, 2018
Subsequent Event Textual [Abstract]
Payments of company						$ 2,500,000
Ownership interests, description				The Company filed a shelf registration statement on form S-3 that was declared effective by the SEC on February 9, 2018, which allows the Company to offer and sell up to $400,000,000 of its equity or equity-linked securities. Using the shelf registration statement, the Company completed an underwritten public offering of common stock and warrants for gross proceeds of $105,050,000 on February 13, 2018.
Reverse stock split, description			The Company effected a reverse stock-split of its issued and outstanding common stock at a ratio of one-for-250 ("Reverse Stock Split"). The Company filed a Certificate of Amendment to its Certificate of Incorporation with the Secretary of State of the State of Delaware effecting the Reverse Stock Split. The Reverse Stock Split did not affect the number of authorized shares of common stock, which, following the increase in authorized shares effected on July 23, 2018 discussed in Note 11, remains at 5,000,000,000 shares.				The Special Meeting of Stockholders scheduled to be held on November 14, 2018 to provide stockholders with an opportunity to vote on the proposed reverse stock split in a ratio of 1 share-for-2 shares up to a ratio of 1 share-for-500 shares has been cancelled. The Company was presenting the reverse stock split proposal in an effort to regain compliance with Rule 5550(a)(2). Since the Company will not be able to effect a reverse stock split ten business days prior to December 18, 2018, absent an extension by The Nasdaq Capital Market (of which there can be no assurance) the Company believes that our common stock will be subject to delisting from The Nasdaq Capital Market, which would adversely impact the liquidity and marketability of our common stock.
Subsequent Events [Member]
Subsequent Event Textual [Abstract]
Principal amount	$ 20,400,000
Subsequent event, description	Under the October Exchange Agreement, at any time on or prior to the later of (i) the date that the New Non-Convertible Note no longer remains outstanding and (ii) the first anniversary of the date of the October Exchange Agreement, the Company and its subsidiaries may not effect any Subsequent Placement (as defined in the November Securities Purchase Agreement (as defined below)) unless the Company first offers to issue and sell to, or exchange with, the holder of the New Non-Convertible Note, at least 25% of the securities offered in the Subsequent Placement, subject to the terms and conditions of the October Exchange Agreement.
Amendment and exchange agreement, description	The Company entered into the October Exchange Agreement, with the holder of a June 2018 Convertible Note having an outstanding principal amount of approximately $68,750,000 for the purpose of (i) netting the June 2018 Investor Note issued by such holder to the Company having an aggregate principal amount of approximately $68,000,000 against such holder's June 2018 Convertible Note and (ii) following such netting transaction, exchanging the remaining outstanding amount payable under such holder's June 2018 Convertible Note for a new non-convertible Senior Note issued by the Company to such holder (the "New Non-Convertible Note") in an aggregate principal amount of $20,400,000, subject to reduction as provided in the New Non-Convertible Note. As a result such holder's June 2018 Convertible Note and the corresponding June 2018 Investor Note issued by such holder were each cancelled and became null and void.
November Buyer [Member]
Subsequent Event Textual [Abstract]
Description of november securities purchase agreement							Pursuant to the October Exchange Agreement, the Securities Purchase Agreement between the Company and certain institutional investors pursuant to which the Company issued the November 2017 Notes (the "November Securities Purchase Agreement") was amended to reduce the number of shares of common stock of the Company required to be reserved for issuance under the November 2017 Notes to 100% of the maximum number of shares of common stock of the Company issuable upon conversion of the November 2017 Notes.
Ownership interests, description							Pursuant to the October Exchange Agreement, the January Securities Purchase Agreement was amended to reduce the number of shares of common stock of the Company required to be reserved for issuance under the January 2018 Notes to 125% of the maximum number of shares of common stock of the Company issuable upon conversion of the January 2018 Notes.
New Non-Convertible Note [Member]
Subsequent Event Textual [Abstract]
Cash proceeds percentage		14.50%			14.50%
New Non-Convertible Note [Member] | Subsequent Events [Member]
Subsequent Event Textual [Abstract]
Interest percentage	3.00%
New non-convertible note, description	The Company has the right to redeem the New Non-Convertible Note at any time on or prior to the nine-month anniversary of the issuance of the New Non-Convertible Note for 50% of the principal being redeemed and 100% of the accrued and unpaid interest and late charges, if any. After the nine-month anniversary of the issuance of the New Non-Convertible Note, the Company has the right to redeem the New Non-Convertible Note at any time for 100% of the principal being redeemed and 100% of the accrued and unpaid interest and late charges, if any. If the Company does not redeem the New Non-Convertible Note within such nine-month period, the New Non-Convertible Note will amortize monthly in cash for, from June 28, 2019, four monthly payments of $850,000 per month (plus accrued and unpaid interest, including any capitalized interest) and, commencing on October 30, 2019, eight monthly payments of $2,125,000 (plus accrued and unpaid interest, including any capitalized interest). Upon an Event of Default, the Company must redeem the New Non-Convertible Note in cash at a price equal to, if the Event of Default occurs on or prior to the nine-month anniversary of the issuance of the New Non-Convertible Note, and there is neither a Primary Covenant Event of Default nor a Bankruptcy Default (each as defined in the New Non-Convertible Note), 50% of the principal being redeemed and 100% of the accrued and unpaid interest and late charges, if any, in each case, multiplied by a redemption premium. If the Event of Default occurs after the nine-month anniversary of the issuance of the New Non-Convertible Note, or there exists either a Primary Covenant Event of Default or a Bankruptcy Default, then the Company must redeem the New Non-Convertible Note in cash at a price equal to 100% of the principal being redeemed and 100% of the accrued and unpaid interest and late charges, if any, in each case, multiplied by a redemption premium.
Notes, maturity date	May 29, 2020